ANNUAL MEETING

ABSTRACTS

Seattle: April 2 –7
Virtual Experience: April 24–26
 What ’s
INSIDE
Introduction
This digital book lists 2022 Annual Meeting abstracts available in the following two
formats in Seattle:

Scientific Sessions: A group of abstracts covering a similar topic presented in

an oral format. Presentations are eight minutes in length with four minutes for
question and answer with the author.

Posters: A series of thematic abstract presentations in an electronic format.

There will also be more than 470 abstracts exclusively presented as posters during
the 2022 Annual Meeting Virtual Experience April 24-26. This digital book also lists
these abstracts.

To search a complete library of abstracts online, visit AAN.com/22Abstracts.

To register for the meeting or to learn about all of the science, education, and
networking opportunities at the 2022 Annual Meeting in Seattle or the distinct
virtual experience, visit AAN.com/AM.

Annual Meeting Abstracts

Seattle Scientific Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Sunday, April 3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Monday, April 4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Tuesday, April 5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Wednesday, April 6. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Thursday, April 7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Seattle Poster Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Saturday, April 2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
Sunday, April 3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
Monday, April 4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
Tuesday, April 5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
Wednesday, April 6. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
Thursday, April 7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
Virtual Experience Posters. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
 SCIENTIFIC SESSIONS
Date Goes Here
Scientific Sessions are a group of abstracts covering a similar topic presented in an oral format.
Presentations are 12 minutes in length with eight minutes for presentation and four minutes for questions
and answers with the author.
Sunday, April 3
1:00 p.m.–3:00 p.m. PT
S1 Sleep: Want To Hear The Latest? CME
2 S2
1:00 p.m.
2022 Sleep Science Award: This award recognizes distinguished
academic contributions by neurologists to the field of sleep medicine or the
contributions of non-neurologists to the interface area of sleep neurology.
Recipient: Louis J. Ptacek, MD, San Francisco, CA
1:24 p.m.
2022 Wayne A. Hening Sleep Medicine Investigator Award: This
award recognizes scientific contributions in sleep from promising young
investigators.
Recipient: John Kent Werner, Jr., MD, Bethesda, MD
1:36 p.m. S1.004
Longitudinal 123I-FP-CIT SPECT Imaging in Isolated REM Sleep Behavior
Disorder–Toji Miyagawa, Scott Przybelski, Daniela Maltais, Hoon-Ki Min, Lennon
Jordan, Timothy Lesnick, Michael H. Silber, Stuart McCarter, Erik Kent St. Louis,
Jonathan Graff-Radford, David T. Jones, Rodolfo Savica, David S. Knopman, Ronald
C. Petersen, Walter Kremers, Leah Kathleen Forsberg, Julie A. Fields, Tanis J.
Ferman, Hugo Botha, Vijay K. Ramanan, Laura Andelman Allen, Kejal Kantarci, Val
John Lowe, Bradley F. Boeve
1:48 p.m. S1.005
Acute blood biomarkers predict chronic insomnia trajectories following
traumatic brain injury: A TRACK-TBI study–Jackie Gottshall, Bryson Hewins,
Andrew Krystal, Jennifer Albrecht, Vincent F. Capaldi, Sonia Jain, Pratik Mukherjee,
Ashlee McKeon, Michael Timothy Smith, Joseph T. Giacino, Raquel Gardner,
Lindsay Nelson, Scott Graeme Williams, Jacob Collen, Shelly Sun, David Schnyer,
Amy Markowitz, Ramon R. Diaz-Arrastia, Geoffrey Manley, Emerson Wickwire,
John Kent Werner
2:00 p.m. S1.006
Poor sleep quality is associated with elevated exosomal inflammatory cytokines
in warfighters with chronic mild TBI–Jackie Gottshall, Phorum Sheth, Josephine
Pucci, Daniel Ian Brooks, Nora L. Watson, Ainslee Gabriel, Sara Mithani, Jacqueline
J. Leete, Chen Lai, Bao-Xi Qu, Christina Devoto, Jessica Gill, Kimbra L. Kenney, John
Kent Werner
2:12 p.m. S1.007
Impairment in Functioning and Quality of Life in Patients With Idiopathic
Hypersomnia: the Real World Idiopathic Hypersomnia Outcomes Study
(ARISE)–Logan D. Schneider, Joanne Stevens, Aatif M. Husain, Diane Ito, Wayne
Macfadden, Douglas S. Fuller, Phyllis C. Zee
2:24 p.m. S1.008
Cardiovascular Burden of Narcolepsy Disease (CV-BOND): a Real-World
Evidence Study–Rami Ben-Joseph, Ragy Saad, Jed Black, Elizabeth C. Dabrowski,
Benjamin Taylor, Sophia Gallucci, Virend Somers
2:36 p.m. S1.009
Safety and pharmacodynamics of a single infusion of TAK-925 in adults
with idiopathic hypersomnia–Emmanuel Mignot, Richard K. Bogan, Helene A.
Emsellem, Nancy R. Foldvary-Schaefer, Melissa Naylor, Rachel Neuwirth, Todd J.
Swick, Tina Olsson
2:48 p.m. S1.010
Good Night, Sleep Tight, Don’t Let the Sleep Disturbances Bite–Alexander
Poulakis, Michael Ibarra, Jennifer Lin, Sullafa Kadura
Information is accurate as of February 8, 2022, and is subject to change.
1:00 p.m.–3:00 p.m. PT
Behavioral Neurology CME
2
1:00 p.m.
2022 Norman Geschwind Prize in Behavioral Neurology: This prize is
awarded to an individual for outstanding research in the field of behavioral
neurology.
Recipient: Julio C. Rojas -Martinez, MD, PhD, San Francisco, CA
1:12 p.m. S2.002
Neuropsychological and neuropsychiatric traits among asymptomatic relatives
from C9orf72 repeat expansion kindreds–Marie Ryan, Emmet Costello, Mark
Heverin, Russell L. McLaughlin, Niall Pender, Orla Hardiman
1:24 p.m. S2.003
Economic Outcomes Associated with Behavioral Symptoms among
Commercially Insured Patients with Dementia in the US–Rezaul Khandker, Farid
Chekani, Kirti Mirchandani, Sreya Chakladar, Niranjan Kathe
1:36 p.m. S2.004
Tractography Examination of Dentato-rubro-thalamic Tract in Autopsy-
confirmed Variants of Progressive Supranuclear Palsy.–Rodolfo Gabriel Gatto,
Peter Martin, Farwa Ali, Heather Clark, Joseph Duffy, Rene Utianski, Hugo Botha,
Mary M. Machulda, J. Eric Ahlskog, Dennis W. Dickson, Keith A. Josephs, Jennifer
Louise Whitwell
1:48 p.m. S2.005
Patterns of CSF Biomarkers of Alzheimer’s Disease in Specialty Behavioral
Neurology Practices–Wentao Li, Ronald C. Petersen, Alicia Algeciras-Schimnich,
Joshua Bornhorst, Bradley F. Boeve, David T. Jones, Hugo Botha, Vijay K.
Ramanan, David S. Knopman, Rodolfo Savica, Keith A. Josephs, Christine Cliatt
Brown, Gregory S. Day, Neill R. Graff-Radford, Nilufer Taner, Bryan Keith Woodruff,
Richard J. Caselli, Jonathan Graff-Radford
2:00 p.m. S2.006
Brain Metabolic Changes in the Presymptomatic Stage of Frontotemporal
Dementia Associated with GRN Mutations–Dario Saracino, Leila Sellami, Hugo
Boniface, Maxime Locatelli, Melanie Pelegrini-Issac, Aurélie Funkiewiez, Marion
Houot, Daisy Rinaldi, Karim Dorgham, Florence Pasquier, Mathieu Chastan, Anne
Hitzel, Jeremie Pariente, Amandine Pallardy, Eric Guedj, Mira Didic, Aurelie Kas,
Marie-Odile Habert, Isabelle Le Ber
2:12 p.m. S2.007
Area Deprivation Index and Progression to Dementia–Maria Vassilaki, Jeremiah
Aakre, Anna Castillo, Alanna Chamberlain, Patrick Wilson, Walter Kremers,
Michelle M. Mielke, Yonas E. Geda, Mary M. Machulda, Rabe’ Alhurani, Jonathan
Graff-Radford, Prashanthi Vemuri, Val John Lowe, Clifford R. Jack, David S.
Knopman, Ronald C. Petersen
2:24 p.m. S2.008
Sex Differences in Cerebral Amyloid Angiopathy: The Role of Monocytes/
Macrophages–Carson Finger, Juneyoung Lee, Bharti Manwani
2:36 p.m. S2.009
PTSD, Depression, and Cognitive Performance in Military Service Members
With and Without History of mTBI–Carolyn Parsey, Hyun Jin Kang, Jason Barber,
Nancy Temkin, Christine MacDonald
2:48 p.m. S2.010
Towards Machine Learning-Based Cognitive Examination–Calvin William
Howard
AAN.com/AM 1
 SCIENTIFIC SESSIONS
Sunday, April 3
1:00 p.m.–3:00 p.m. PT
S3 Autoimmune Neurology 1: Mechanisms of CME
2 S4
Disease, Clinical Practice
1:00 p.m. S3.001
Coronavirus 2019: clinical and neuropathological aspects–David S. Younger
1:12 p.m. S3.002
Acute Neurological Inflammatory Diseases in Colombia: A Multi-center
Observational Study from Zika outbreak to SARS-CoV-2 pandemic–Susana
Carolina Dominguez Penuela, Martha Moyano, Jose Enrique Vargas Manotas,
Jorge Andres Jimenez-Arango, Guillermo Gonzalez-Manrique, Jairo Francisco
Lizarazo Nino, Jorge Angarita, Andres Felipe Zea-Vera, Reydmar Lopez, Daniela
Zuluaga Lotero, David Orlando Acero-Garces, Maria Alejandra Garcia-Dominguez,
Jose Miguel Enciso, Maria Fernanda Ramos Sanchez, Julie Benavides, Katherine
V Claros, Jaime Quintero, Jonathan Urrego, Christian Rojas, Juan Pablo Rojas,
Fernando Rosso, Gustavo Eduardo Ramos, Luis Carlos Quintero, Mario Llanos,
Angela Catalina Vallejo Cajigas, Viviana Martinez, Beatriz Parra, Lyda Osorio,
Carlos A. Pardo-Villamizar
1:24 p.m. S3.003
Reporting Rates of Encephalopathy Post-COVID-19 Vaccination: A Vaccine
Adverse Event Reporting System (VAERS)–Kazim Jaffry, Kranthi Kiran Mandava,
Mustafa Jaffry, Sanjana Rosario, Kamel Jedidi, Nizar Souayah
1:36 p.m. S3.004
Development of new or enlarging MRI lesions outside of attacks is rare in
myelin oligodendrocyte glycoprotein antibody-associated disease–Stephanie
Bridget Syc-Mazurek, Elia Sechi, John Chen, Padraig Morris, Karl Krecke, Steven
Anthony Messina, Jan-Mendelt Tillema, Alfonso Sebastian Lopez, Claudia F.
Lucchinetti, Nicholas L. Zalewski, Marina Buciuc, M. Tariq Bhatti, Sean J. Pittock,
Eoin P. Flanagan
1:48 p.m. S3.005
Acute Symptomatic Seizures Secondary to Myelin Oligodendrocyte
Glycoprotein Antibody-associated Disorder–Mayra Montalvo Perero, Jamal F.
Khattak, Vyanka Redenbaugh, Yong Guo, Cristina Valencia Sanchez, Jan-Mendelt
Tillema, Claudia F. Lucchinetti, John Chen, Andrew McKeon, Sean J. Pittock,
Jeffrey W. Britton, Eoin P. Flanagan, Divyanshu Dubey
2:00 p.m. S3.006
Surveying the Clinical and Radiographic Heterogeneity of Pediatric Anti-MOG-
Associated Disease–Jeffrey Russ, Elizabeth George, Alexandria Valdrighi, Camilla
Lindan, Heather Early, Mark Mamlouk, Emmanuelle Waubant, Carla Marina
Francisco, Yi Li
2:12 p.m. S3.007
Neuromyelitis Optica as an In-Vivo Model of Glymphatic System Alterations:
An MRI Study–Laura Cacciaguerra, Antonio Carotenuto, Elisabetta Pagani, Marta
Radaelli, Vittorio Martinelli, Massimo Filippi, Maria Assunta Rocca
2:24 p.m. S3.008
Evaluation of a Point-of-Care Diagnostic Test for Aquaporin-4 Seropositive
Neuromyelitis Optica Spectrum Disorder–Dylan R. Rice, Shuhei Nishiyama,
Santiago Pardo, Ana Maria Maria Cabal Herrera, Michael Levy, Farrah J. Mateen
2:36 p.m. S3.009
Matched or Unique Cerebrospinal Fluid Oligoclonal Bands: Clinical
Characteristics and Diagnostic Utility–Stefanie Jordan Rodenbeck, Justin
Abbatemarco, Jason Tsun-Yin Poon, Suzanne Liu, M. Mateo Paz Soldan, John E.
Greenlee, John W. Rose, Lisa Kay Peterson, Lisa Johnson, Stacey Clardy
2:48 p.m. S3.010
Potential Role of Variants of UNC13D in Pediatric Autoimmune CNS Disorders–
Saba Jafarpour, Nusrat Ahsan, Jonathan Santoro
2 2022 AAN Annual Meeting
1:00 p.m.–3:00 p.m. PT
Hot Topics in Headache Medicine CME
2
1:00 p.m. S4.001
Identifying Factors Pertaining to Migraine-Related Internalized Stigma from a
Novel Question Set: Results of the OVERCOME (US) study–Robert E. Shapiro,
Robert A. Nicholson, Anthony J Zagar, Yongin Kim, Michael L. Reed, Dawn C.
Buse, Eva Jolanda Muenzel, Sait Ashina, Eric M. Pearlman, Richard B. Lipton
1:12 p.m. S4.002
Impact of Monthly Headache Days on Migraine-Related Quality of Life: Results
From the CaMEO Study–Richard B. Lipton, Patricia Pozo-Rosich, Serena Orr,
Michael L. Reed, Kristina Fanning, Brett Dabruzzo, Dawn C. Buse
1:24 p.m. S4.003
Pre-pregnancy migraine and risk of adverse pregnancy outcomes–Alexandra
Purdue-Smithe, Jennifer J. Stuart, Leslie V. Farland, Jae Hee Kang, Rebecca C.
Burch, Janet Rich-Edwards, Kathryn Rexrode
1:36 p.m. S4.004
Characterizing Pre-headache (Prodrome) Features of Migraine Attacks: Results
From the CaMEO Study–Todd J. Schwedt, Stephanie J. Nahas, Kristina Fanning,
Janette Contreras-De Lama, Brittany L. Jordan, Michael L. Reed, Dawn C. Buse,
Richard B. Lipton
1:48 p.m. S4.005
Assessing Sleep Quality in Children with Migraines: Implementation of
Electronic Health Record Cue–Ezgi Saylam, Praveen Ramani, Brett James,
Matthew Robert Savage, Supriya Jambhekar, Aravindhan Veerapandiyan
2:00 p.m. S4.006
Investigating the Roles of the Enzymes MAGL and ABHD6 in Headache
Physiology via the KCl Model of Migraine–Aidan Levine, Erika Liktor-Busa, Seph
Palomino, Raveena Parmar, Tally Largent-Milnes
2:12 p.m. S4.007
An Altered Pontine-Hypothalamic Functional Interplay Could Predict Migraine
Disease Progression Over the Years–Roberta Messina, Paola Valsasina, Maria
Assunta Rocca, Massimo Filippi
2:24 p.m. S4.008
Headache as an Early Symptom and Post-Acute Sequela of COVID-19 in
Hospitalized COVID-19 Survivors–Teshamae Monteith, Alexandra Nicole
Cocores, Mejgan Mukhtarzada, Natalia Rincon, Yensea Mayra Costas
Encarnacion, Christina Kursewicz, Evie Sobczak, Emily Swafford, Daniel Samano,
Tatjana Rundek, Ayham Alkachroum
2:36 p.m. S4.009
Relative Frequency, Healthcare Resource Utilization, and Costs of Diagnosed
Drug-Induced Headache and Potential Acute Medication Overuse in Patients
With Migraine–Anand R. Shewale, Jennifer Brandenburg, Kate Burslem, Richard
B. Lipton, Jalpa Doshi
2:48 p.m. S4.010
Patient Experience of Telemedicine for Headache Care During the COVID-19
Pandemic: An American Migraine Foundation Survey Study–Chia-Chun Chiang,
Rashmi B. Halker Singh, Nim Lalvani, Kenneth Shubin Stein, Deborah Henscheid
Lorenz, Christine L. Lay, David W. Dodick, Lawrence C. Newman
 SCIENTIFIC SESSIONS
Sunday, April 3
3:30 p.m.–5:30 p.m. PT
S5 COVID and MS Basic Science
3:30 p.m.
2022 John Dystel Prize for Multiple Sclerosis Research: This
award recognizes outstanding contributions to research that have led to
breakthroughs in the understanding, prevention, treatment, or cure of MS.
Recipient: Xavier Montalban, MD, PhD, FAAN, Barcelona, Spain
3:54 p.m. S5.003
An Observational Study on the Humoral and Cellular Immune Response to
SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune
Neurological Disorders treated with Anti-CD20 Therapies–Tyler Lee Borko,
Sean Selva, Ryan Baxter, Berenice Cabrera-Martinez, Cody Rester, Stefan Sillau,
Daniel Pastula, Maite Sabalza, Iswariya Venkat, Jeffrey L. Bennett, Enrique Alvarez,
Robert H. Gross, Anna Shah, Ryan Kammeyer, Timothy L. Vollmer, Ross Kedl, John
Corboy, Elena Wen-Yuan Hsieh, Amanda Lee Piquet
4:06 p.m. S5.004
Bile Acids Metabolites as Predictors of long-term Multiple Sclerosis
Progression–Marianna Cortese, Kjetil Bjornevik, Clary B. Clish, Gilles Edan, Mark
S. Freedman, Hans-Peter Hartung, Xavier Montalban, Rupert Sandbrink, Ernst-
Wilhelm Radue, Frederik Barkhof, Eva-Maria Wicklein, Ludwig Kappos, Kassandra
L. Munger, Alberto Ascherio
4:18 p.m. S5.005
The Genetic Basis of Multiple Sclerosis Severity Suggests Central Nervous
System Involvement–Adil Harroud
4:30 p.m. S5.006
Adaptive B-cell and T-cell responses to SARS-CoV-2 vaccination in patients
with Multiple Sclerosis on disease modifying immunotherapy–Anna Tomczak,
Julia Sumera, Yamuna Joseph, Danwei Wu, Jamie C. McDonald, Neda
Sattarnezhad, Lucas Kipp, Christopher Lock, May Han, Jeffrey E. Dunn
4:42 p.m. S5.007
Immune responses to SARS-CoV-2 vaccination in multiple sclerosis: a
systematic review and meta-analysis–Grace Gombolay, Monideep Dutt, William
R. Tyor
4:54 p.m. S5.008
Impact of Multiple Sclerosis Disease-Modifying Therapies on Effectiveness
of SARS-Cov-2 Vaccines: A Longitudinal Total Population Study of National
Health Service (NHS) England–Afagh Garjani, Sameer Patel, Graham Law, Dhiren
Bharkhada, Waqar Rashid, Alasdair Coles, Nikolaos Evangelou
5:06 p.m. S5.009
WITHDRAWN
5:18 p.m. S5.010
Glymphatic Impairment in Multiple Sclerosis: A New Pathological Mechanism
Associated with Disease Burden–Antonio Carotenuto, Laura Cacciaguerra,
Elisabetta Pagani, Paolo Preziosa, Maria Assunta Rocca, Massimo Filippi
Information is accurate as of February 8, 2022, and is subject to change.
3:30 p.m.–5:30 p.m. PT
CME
2 S6 Cerebrovascular Disease: Diagnosis, Prediction CME
2
and Population Health
3:30 p.m.
2022 Alliance Award Founders: This award is designed to encourage
clinical and translational research in neuroscience by physicians in clinical
neurology training programs.
Recipient: Ronda Lun, MD, Ottawa, ON, Canada
3:42 p.m. S6.002
Temporal Trends & Outcomes Of Hospitalizations For Epilepsy With Aneurysmal
Subarachnoid hemorrhage–Parisha Bhatia, Varun Singh, Neena Viswanathan,
Tejinder Singh, Tanushri Bhushan
3:54 p.m. S6.003
Sex Differences in the Delivery of Stroke Care via Telemedicine in a Large
National Telestroke Practice–Johanna L. Morton, Kristina L. Boyd, Eric Anderson,
Robert Jason Hallock
4:06 p.m. S6.004
Risk of Seizures after Posterior Reversible Encephalopathy Syndrome–Sarah
Christine Parauda, Cenai Zhang, Setareh Salehi Omran, Andrew D. Schweitzer,
Santosh Bhaskar Murthy, Alexander Merkler, Babak Navi, Hooman Kamel, Neal
S. Parikh
4:18 p.m. S6.005
Adherence to Blood Pressure Guidelines Predicts Hospital Readmission After
Acute Stroke: The Florida Stroke Registry–Oriana Tascione, Hannah Gardener,
Carolina Gutierrez, David Z. Rose, Tatjana Rundek, Angus Jameson, Jose Gabriel
Romano, Ralph L. Sacco, Sebastian Koch, Negar Asdaghi, Gillian L. Gordon-Perue
4:30 p.m. S6.006
Access to Mechanical Thrombectomy for Large Vessel Occlusion Stroke: An
MT2020+ Report on Global Disparities–Kaiz Shabbar Asif, Nabeel Herial, Fadar
Oliver Otite, Shashvat Desai, Santiago Ortega Gutierrez, Adam A. Dmytriw, Fawaz
Al-Mufti, Priyank Khandelwal, Violiza A. Inoa, Siddharth Galav, Viktor Szeder,
Tanzila Kulman, Gabor Toth, Alicia Clara Castonguay, Jennifer Potter-Vig, Victor C.
Urrutia, Kaustubh S. Limaye, Hesham Masoud, Syed F. Zaidi, Dileep R. Yavagal
4:42 p.m. S6.007
Identification of early ischemia on non-contrast CT head using artificial
intelligence–James Michael Hillis, Bernardo Canedo Bizzo, Romane Gauriau,
Christopher Philip Bridge, John Kent Chin, Stuart Robert Pomerantz, Keith Dreyer,
Katherine Patricia Andriole, Michael H. Lev, Ramon Gilberto Gonzalez
4:54 p.m. S6.008
Determinants and Outcomes of Cerebrovascular Disease in Patients with
COVID-19 in the Philippines: An Analysis of 10881 Cases–Mario Bugay Prado,
Roland Dominic Jamora, Marie Charmaine Cootauco Sy, Michelle Anlacan, Adrian
Isidoro Espiritu
5:06 p.m. S6.009
The SPA prediction score for presence of intracranial aneurysms during
follow-up screening in persons with a positive family history of subarachnoid
hemorrhage–Charlotte Zuurbier, Romain Bourcier, Pacome Constant Dit Beaufils,
Richard Redon, Hubert Desal, Stijntje Bor, Antti Lindgren, Gabriel Rinkel, Jacoba P.
Greving, Ynte Ruigrok
5:18 p.m. S6.010
Novel Ischemic Stroke Treatment Protocol for Salvageable Penumbra in Acute
Small Vessel Disease–Farah Yolanda Fourcand, Hemal Patel, Sean W. Scarpiello,
Muhammad Nagy, Siddhart Kumar Mehta, Haralabos Zacharatos, Jawad F.
Kirmani
AAN.com/AM 3
 SCIENTIFIC SESSIONS
Sunday, April 3
3:30 p.m.–5:30 p.m. PT
S7 Epilepsy and Clinical Neurophysiology (EEG) 1 CME
2 S8
3:30 p.m.
2022 Dreifuss-Penry Epilepsy Award: This award recognizes physicians
in the early stages of their careers who have made an independent
contribution to epilepsy research.
Recipient: Piero Perucca, MD, Heidelberg, Australia
3:42 p.m. S7.002
Combining Machine-detected EEG Epileptiform Abnormalities and Quantitative
EEG Spectral Features Predicts Post Traumatic Epilepsy–Yilun Chen, Songlu Li,
Hsin Yi Chen, Daniel Doherty, Alison Herman, Safa Kaleem, Kan Ding, Gamaleldin
M. Osman, Christa Brittany Swisher, Christine Smith, Carolina B. Maciel, Ayham
M. Alkhachroum, Jong Woo Lee, Monica B. Dhakar, Emily Jean Gilmore, Sacit
Bulent Omay, Brian Edlow, M. Brandon Westover, Jennifer A. Kim
3:54 p.m. S7.003
Use of an Electronic Medical Record Alarm to Prevent Iatrogenic Interventions
in Patients with Psychogenic Non-Epileptic Seizures–Serena Yin, Lydia
Wolkiewicz, Bichum Ouyang, Elana Wagner, Sarah Abdel-Hadi, Adriana C. Bermeo
Ovalle
4:06 p.m. S7.004
Real-Time & Passive Localization of the Epileptic Network based on Single-
Pulse Electrical Stimulation: Correlation with the standard of care and surgical
outcomes UPMC HBM Lab–Tritan Joseph Plute, Rafeed Alkawadri
4:18 p.m. S7.005
Neurology resident epileptiform discharge identification training– a randomized
controlled educational trial.–Fabio Augusto Nascimento E Silva, Jin Jing,
Christopher Bentley Traner, Erik P. Duhaime, Jeremy Moeller, Michael Brandon
Westover
4:30 p.m. S7.006
A Machine Learning Approach for Identifying Factors that Contribute to Seizure
Freedom Following Temporal Lobectomy for Mesial Temporal Lobe Epilepsy–
Sara Elizabeth Ratican, Seo Ho Song, George Zanazzi, Jennifer Hong
4:42 p.m. S7.007
Validation of a semi-automated method for tracking quality metrics in
benzodiazepine-resistant status epilepticus–Benjamin Siegel, Mohammed
Shahnawaz, Kathryn Coreil Elkins, Ammar Kheder, Evan Orenstein
4:54 p.m. S7.008
Seizure Detection Enabled by Information Theory on Human Intracortical
Electroencephalography–Lisa Yamada, Tomiko Oskotsky, Paul Nuyujukian
5:06 p.m. S7.009
Network Analysis of Focal Seizure Dynamics Suggests a Possible Mechanism
of Seizure Termination–Stefan Louis Sumsky, L John Greenfield
5:18 p.m. S7.010
Bilateral temporal lobe epilepsy: How many seizures are required in chronic
ambulatory electrocorticography to estimate the laterality ratio?–Sharon
Chiang, Joline M. Fan, Vikram Rao
4 2022 AAN Annual Meeting
3:30 p.m.–5:30 p.m. PT
General Neurology: Clinical Treatment and CME
2
Practice
3:30 p.m. S8.001
Clinical Diversity of Patients with Neuronal Intranuclear Inclusion Disease–
Tomoko Okamoto, Tasuku Ishihara, Masayuki Miyazaki, Ken Saida, Yuji Saitoh,
Toshiyuki Yamamoto, Tadashi Tsukamoto, Yuko Saito, Noriko Sato, Naomichi
Matsumoto, Yuji Takahashi
3:42 p.m. S8.002
Cipaglucosidase alfa/miglustat Versus alglucosidase alfa/placebo in Late-onset
Pompe Disease (LOPD): PROPEL Study Subgroup Analyses–Tahseen Mozaffar,
Drago Bratkovic, Barry Byrne, Jordi Diaz Manera, Pascal Lafort, Ans Van Der Ploeg,
Mark Roberts, Benedikt Schoser, Antonio Toscano, Hai Jiang, Sheela Sitaraman,
Mitchell Goldman, Jeff Castelli, Priya Kishnani
3:54 p.m. S8.003
HELIOS-A: Results from the Phase 3 Study of Vutrisiran in Patients with
Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy–David D.
Adams, Ivajlo Tournev, Mark Taylor, Teresa Coelho, Violaine Plante-Bordeneuve,
John L. Berk, Maria Alejandra Gonzalez Duarte, Julian D. Gillmore, Soon-Chai Low,
Yoshiki Sekijima, Laura Piera Obici, Chongshu Chen, Prajakta Badri, Seth Arum,
John Vest, Michael J. Polydefkis
4:06 p.m. S8.004
Virtual vs In-person Neurological Exam Study (VINES) in Response to the
COVID-19 Crisis and Beyond–Lauren Hophing, Tiffany Tse, Nicole Julia Naimer,
Houman Khosravani, Charles Kassardjian, Sara Mitchell
4:18 p.m. S8.005
VA National TeleNeurology Program: Patient Characteristics and Access to
Care–Steven S. Schreiber, Aditi Narechania, Heidi Watson, Brandon Edwards,
Holly Martin, Linda S. Williams, Jayne R. Wilkinson
4:30 p.m. S8.006
Differential Associations of Kidney Function with Cerebral Gray and White
Matter Tissue Health in Middle-Aged and Older Adults–Mei-jun Shu, Ding-Ding
Zhang, Fei Han, Li-Xin Zhou, Jun Ni, Ming Yao, Shu-Yang Zhang, Li-Ying Cui, Zheng-
Yu Jin, Yi-Cheng Zhu
4:42 p.m. S8.007
Longitudinal Evaluation of Neuro-PASC Symptoms–Jacqueline Shanley, Andrew
Valenciano, Garrett Malloy Timmons, Visesha Kakarla, Annalise E. Miner, Torge
Rempe, Jennifer Graves
4:54 p.m. S8.008
High Patient Satisfaction and Acceptability of Tele-Neurology Consultations at
a Regional Tertiary Referral Hospital in Kenya During the COVID-19 Pandemic–
Fazal Yakub, Jasmit Shah, Dilraj Singh Sokhi
5:06 p.m. S8.009
A Placebo-Controlled Phase I Study of NVG-291 in Healthy Subjects, Targeting
CNS Receptor Protein Tyrosine Phosphatase Sigma (PTPs)–Daniel D. Mikol,
Betty Lawrence, Nana Collett, Judy Toews, Matvey Lukashev, Marc DePaul
5:18 p.m. S8.010
Neutralizing Antibody Conversion With Onabotulinumtoxina From Global
Studies Across Multiple Indications In Nearly 30,000 Patient Records: A Meta-
Analysis–Joseph Jankovic, Jean Carruthers, Markus Naumann, Terry Boodhoo,
Swati Gupta, Mayssa Attar, Rita Singh, Irina Yushmanova, John Soliman, Mitchell
F. Brin, Jie Shen
 SCIENTIFIC SESSIONS
Monday, April 4

1:00 p.m.–1:50 p.m. PT 1:00 p.m.–1:50 p.m. PT

S9 Neuromodulation and Alternatives to Reduce CME

0.75
Opioid Use in Pain Management
1:00 p.m.
2022 Mitchell B. Max Award for Neuropathic Pain: This award
recognizes an individual for outstanding work in the field of neuropathic
pain for either a single contribution or for lifetime achievement.
Recipient: John Markman, MD, FAAN, Rochester, NY
1:12 p.m. S9.002
Pramipexole Improves the Analgesic Properties of Low-dose Morphine in the
Treatment of Acute Pain–Ryan Patton, Allison Mainhart, Stefan Clemens, Kori
Brewer
1:24 p.m. S9.003
Repetitive Transcranial Magnetic Stimulation for the Treatment of Fibromyalgia:
An open label clinical trial–Nilson Nogueira Mendes Neto, Poty Jales, Jessika
Thais da Silva Maia
1:36 p.m. S9.004
Non-Invasive Brain Stimulation For Diabetic Neuropathic Pain–Persen
Sukpornchairak, Krishnakant Shah Aka Khandelwal, Salim Hayek, Christopher
Connor, Paola Gonzalez Mego, Gautham Chitturu, Ryan Tatton, Anisha Yarlagadda,
Felipe Fregni, Uri Eden, Tim Wagner, Laura Dipietro, Ciro Ramos Estebanez
S10 Neuro-rehabilitation: Neuromodulation CME
0.75
1:00 p.m. S10.001
At-Home Transcranial Direct Current Stimulation (tDCS) for Teleinterventions:
Safety and Tolerability with Remote Supervision–Giuseppina Pilloni, Pamela
Best, Allan George, Matthew Lustberg, Ibraheem Mirza, Lana Zhovtis Ryerson,
Lauren B. Krupp, Leigh Elkins Charvet
1:12 p.m. S10.002
Evaluation of repetitive Transcranial Magnetic Stimulation as an adjunct to
modified Constraint Induced Movement Therapy in improving Upper Limb
Function in Children with Unilateral Cerebral Palsy aged 5 – 18 years - A
Randomized Controlled Trial–Juhi Gupta, Sheffali Gulati, Upinderpal Singh,
Atin Kumar, Prashant Jauhari, Biswaroop Chakrabarty, R M Pandey, Renu Bhatia,
Suman Jain, Achal K. Srivastava
1:24 p.m. S10.003
Baseline presentation and goal setting for patients undergoing treatment
for lower limb spasticity with abobotulinumtoxinA in routine practice. Data
from the AboLiSh study–Alberto Esquenazi, Richard Zorowitz, Stephen Ashford,
Francoise Calvi-Gries, Pascal Maisonobe, Simon Page, Jorge Jacinto
1:36 p.m. S10.004
Transcranial Direct Current Stimulation (tDCS) Enhanced Stroke Recovery
and Cortical Reorganization–Timea M. Hodics, Alexander W. Dromerick, John
Pezzullo, Karen Kowalske, Leonardo G. Cohen

Information is accurate as of February 8, 2022, and is subject to change. AAN.com/AM 5

 SCIENTIFIC SESSIONS
Monday, April 4
1:00 p.m.–3:00 p.m. PT
S11 ALS and Motor Neuron Disorders CME
2 S12 Neuroepidemiology
1:00 p.m.
2022 Sheila Essey Award: An Award for ALS Research: This award
recognizes an individual who has made significant research contributions
in the search for the cause, prevention of, and cure for amyotrophic lateral
sclerosis (ALS).
Recipient: Matthew Colm Kiernan, PhD, FRACP, MBBS, Sydney, Australia
1:24 p.m. S11.003
Deciphering the Phenotype of ALS Patients with Intermediate ATXN2 PolyQ
Expansion–Adriano Chio, Cristina Moglia, Antonio Canosa, Umberto Manera,
Maura Brunetti, Salvatore Gallone, Ruth Chia, Jinhui Ding, J. Raphael Gibbs,
Clifton Dalgard, Sandra D’Alfonso, Lucia Corrado, Fabiola De Marchi, Letizia
Mazzini, Bryan Traynor, Andrea Calvo
1:36 p.m. S11.004
GBA Variants Influence Cognitive Status of ALS Patients–Adriano Chio,
Maurizio Grassano, Cristina Moglia, Barbara Iazzolino, Laura Peotta, Salvatore
Gallone, Maura Brunetti, Francesca Palumbo, Sara Cabras, Umberto Manera,
Rosario Vasta, Bryan Traynor, Lucia Corrado, Sandra D’Alfonso, Letizia Mazzini,
Andrea Calvo, Antonio Canosa
1:48 p.m. S11.005
Safety of a Fixed-Dose Coformulation of Sodium Phenylbutyrate and
Taurursodiol in Amyotrophic Lateral Sclerosis and Alzheimer’s Disease:
Integrated Clinical Trials Experience–Steven E. Arnold, Sabrina Paganoni,
Suzanne Hendrix, Jessie Johnson, Samuel Dickson, Newman Knowlton, Jay W.
Mason, Jamie Timmons, Machelle Manuel, Shide Badri, Patrick Yeramian, Merit
E. Cudkowicz
2:00 p.m. S11.006
Unraveling the clinical and genetic spectrum of FUS-ALS–Maurizio Grassano,
Andrea Calvo, Cristina Moglia, Antonio Canosa, Umberto Manera, Alessandro
Bombaci, Giorgia Brodini, Giovanni De Marco, Bryan Traynor, Adriano Chio
2:12 p.m. S11.007
A Clinical Bulbar Assessment Scale for ALS/MND: Preliminary Validation–Gary
L. Pattee, Jenenne Geske, Elizabeth Burton, Laura Ball
2:24 p.m. S11.008
Using mfn2 Knockout Zebrafish as a Novel Model of ALS–Kristi Russell, Jon
Downie, Summer Gibson, Karla Patricia Figueroa, Mark B. Bromberg, Joshua
Bonkowsky, Lynn Jorde, Stefan M. Pulst
2:36 p.m. S11.009
Clinical Outcomes in Primary Lateral Sclerosis: A Prospective Natural History
Study–Eoin Finegan, Rangariroyashe Chipika, Stacey Li Hi Shing, Orla Hardiman,
Peter Bede
2:48 p.m. S11.010
Accurate Test of Limb Isometric Strength (ATLIS) as an Outcome Measure in
ALS and as a Marker of Upper Motor Neuron Involvement in Primary Lateral
Sclerosis–Samuel Frank, Peggy Allred, Youstina Haidy Makary, Sophia Katherine
Mostowy, Richard A. Lewis, Robert H. Baloh, Matthew Burford, Frank Diaz
6 2022 AAN Annual Meeting
1:00 p.m.–3:00 p.m. PT
CME
2
1:00 p.m.
2022 Bruce S. Schoenberg International Award in
Neuroepidemiology: This award salutes a promising young investigator
from a developing country or Eastern Europe.
Recipient: Adrian Isidoro Espiritu, MD, Manila, Philippines
1:24 p.m. S12.003
Incidence Trends of Early-Onset Parkinson’s Disease in Olmsted County, MN:
1976-2013.–Emanuele Camerucci, Aidan Mullan, Pierpaolo Turcano, Cole Daniel
Stang, Delana Weis, Bradley F. Boeve, James H. Bower, J. Ahlskog, Rodolfo Savica
1:36 p.m. S12.004
Functional Status at 30 and 90 Days After Mild Ischemic Stroke–Hannah
Gardener, Leo Armando Romano, Eric E. Smith, Iszet Campo-Bustillo, Yosef Khan,
Sofie Tai, Ralph L. Sacco, Pooja Khatri, Heather Alger, Brian Mac Grory, Deepak
Gulati, Navdeep Sangha, Karin E. Olds, Curtis G. Benesch, Adam Kelly, Scott
Brehaut, Amit Kansara, Lee H. Schwamm, Jose Gabriel Romano
1:48 p.m. S12.005
Cost utility analysis of dabigatran and warfarin for stroke prevention among
patients with Non-Valvular Atrial Fibrillation in India–Rajeswari Aghoram,
Mathan Kumar S, Rajasulochana Subramania Raju, Sitanshu Sekhar Kar, Rakesh
Aggarwal
2:00 p.m. S12.006
Characterization and Analysis of Neurologic Adverse Events Associated with
COVID-19 Vaccination–Abhilasha Pankaj Boruah, Erica Westenberg, Abdul Hanif
Khan Yusof Khan, Fan Kee Hoo, Alla Borisovna Guekht, Marianna Spatola, Ismael
Calandri, Sunderraj Netravathi, Tissa Wijeratne, Elyce Warburton, Mohamed
Fahmy Doheim, Carolin Pulickal, Jakin David Chen, Kiran Thakur, Nicholas Ravindra
Mulchan, Vivian Ssonko, Lindsay Tetreault, James J. Sejvar, Simon Faissner,
Jeyanthan Charles James, Jessica Hunter, David García-Azorín, Arina Tamborska,
Maja Bresjanac, Guillermo Ruben Delgado-Garcia, Nina Singh, Betul Baykan,
Hasim Gezegen, Nana Yaa Kyei-Frimpong, Andrea Winkler, Jennifer A. Frontera
2:12 p.m. S12.007
Comorbidity Phenotype Trajectories in Veterans Before and After Emergence of
Epilepsy–Mary Jo Pugh, W. Curt LaFrance, Sidney Hinds, Alan R. Towne, Anne C.
Van Cott, Christine B. Baca, Hamada Hamid Altalib, Chen-Pin Wang
2:24 p.m. S12.008
Incidence and Clinical Characteristics of Parkinson’s Disease Psychosis
in a Population-based Incidence Cohort in Olmsted County, MN
(2006-2015).–Emanuele Camerucci, Aidan Mullan, Gretchen Ahrens, Pierpaolo
Turcano, Cole Daniel Stang, James H. Bower, Bradley F. Boeve, Rodolfo Savica
2:36 p.m. S12.009
Incidence of Creutzfeldt-Jakob Disease in the United States 1993-2014–Alison
Seitz, Cenai Zhang, Alexander Merkler
2:48 p.m. S12.010
Selective ß2-Adrenoreceptor Agonists and Long-Term Parkinson’s Disease
Risk–Julia Axiina Tuominen, Kjetil Bjornevik, Julia Romanowska, Magne Solheim,
Trond Riise, Jannicke Igland
 SCIENTIFIC SESSIONS
Monday, April 4
1:00 p.m.–3:00 p.m. PT
S13 Epilepsy/Clinical Neurophysiology (EEG): CME
2 S14 MS Therapeutics
Antiseizure Medications
1:00 p.m. S13.001
Real-world Study of Brivaracetam in the United States–Hina N. Dave,
Jacqueline French, Hamada Hamid Altalib, Heidi L. Henninger, Roger J. Porter,
Michael Gelfand, Melinda S. Martin, Prashant Dongre, Sami Elmoufti, Anne-Liv
Schulz, Michael R. Sperling
1:12 p.m. S13.002
Pronounced Antiepileptic Activity of Darigabat, a Subtype-Selective GABAA
Receptor Positive Allosteric Modulator, in the Mesial Temporal Lobe Model of
Drug-Resistant Focal Epilepsy–Rachel Gurrell, Philip A. Iredale, Alexis Evrard,
Venceslas Duveau, Celine Ruggiero, Corinne Roucard
1:24 p.m. S13.003
Effect of Steroids on cortical excitability in children with Encephalopathy with
Status Epilepticus in Sleep (ESES): A TMS based longitudinal study–Gautam
Kamila, Prashant Jauhari, Sheffali Gulati, Biswaroop Chakrabarty, Atin Kumar,
Shobha Sharma, Suman Jain, Jeeva Sankar, R M Pandey
1:36 p.m. S13.004
Cenobamate Plasma Concentrations in Patients Reaching =50% or 100%
Responder Rates for =12 Months: A Post-hoc Analysis–Stephen Greene, William
E. Rosenfeld, Louis Ferrari
1:48 p.m. S13.005
Extended Duration Safety and Efficacy of Adjunctive Ganaxolone Treatment
in Patients with CDKL5 Deficiency Disorder: 8-Month Minimum Open-Label
Extension Follow-up–Heather E. Olson, Ahsan Moosa Naduvil Valappil, Eva
Rybak, Alex Aimetti, Joseph Hulihan, Elia Margarita Pestana Knight
2:00 p.m. S13.006
Efficacy of Cenobamate by Focal Seizure Subtypes: Post-hoc Analysis of a
Phase 3, Multicenter, Open-Label Study–William E. Rosenfeld, Louis Ferrari,
Marc Kamin
2:12 p.m. S13.007
Preclinical Development of NRTX-1001, an Inhibitory Interneuron Cellular
Therapeutic for the Treatment of Chronic Focal Epilepsy–Mansi Parekh, Philip
Hampel, Marina Radoul, Eric Steven Sevilla, David Traver, Hannah Kim, Nathalie
Picard, Andrew Adler, Luis Fuentealba, Jiayin Li, Adrian Bates, Daniel Cherkowsky,
Marina Bershteyn, Yves Maury, Myriam M. Chaumeil, Catherine Priest, Cory
Nicholas
2:24 p.m. S13.008
Maternal Symptomatic Toxicity and Oxcarbazepine Free Fraction during
Pregnancy in Women with Epilepsy–Page B. Pennell, Angela K. Birnbaum, Charul
Avachat, Sean Hwang, Laura A. Kalayjian, Elizabeth Gerard, Abigail G. Matthews,
Carrie Brown, Kimford J. Meador
2:36 p.m. S13.009
Ganaxolone Significantly Reduces Major Motor Seizures Associated with
CDKL5 Deficiency Disorder: A Randomized, Double-blind, Placebo-Controlled
Phase 3 Study–Elia Pestana-Knight, Sam Amin, Timothy A. Benke, J. Helen Cross,
Heather E. Olson, Tom Fleming, Scott Thomas Demarest, Nicola Specchio
2:48 p.m. S13.010
Interim Analysis of Long-Term Safety and Efficacy of FINTEPLA (fenfluramine)
in Patients with Lennox-Gastaut Syndrome–Kelly G. Knupp, Ingrid E. Scheffer,
Berten Ceulemans, Joseph Sullivan, Katherine C. Nickels, Lieven G. Lagae, Renzo
Guerrini, Sameer M Zuberi, Rima Nabbout, Catherine Riney, Svetlana Shore,
Anupam Agarwal, Michael Lock, Gail M Farfel, Bradley Galer, Arnold Gammaitoni,
Ronald G. Davis, Antonio Gil-Nagel
Information is accurate as of February 8, 2022, and is subject to change.
3:30 p.m.–5:30 p.m. PT
CME
2
3:30 p.m.
2022 Alliance Award S. Weir Mitchell: This award is designed to
encourage basic research in neuroscience by physicians in clinical neurology
training programs.
Recipient: Jean-Pierre René Falet, MD, CM, Montreal, QC, Canada
3:42 p.m. S14.002
Mediterranean Diet Score is Associated with Disability and Brain Atrophy in
Multiple Sclerosis–Ilana B. Katz Sand, Kathryn Fitzgerald, Tali R. Sorets, Sarah
Ann Levy, James F. Sumowski
3:54 p.m. S14.003
Safety and Clinical Efficacy Outcomes From the Long-term Extension Study of
Tolebrutinib in Patients With Relapsing Multiple Sclerosis: 18-Month Results–
Jiwon Oh, Sana Syed, Atuyota Larry Orogun, Deborah Dukovic, Robert J. Fox
4:06 p.m. S14.004
Long-term Safety of Ofatumumab in Patients With Relapsing Multiple
Sclerosis–Stephen L. Hauser, Anne H. Cross, Kevin Winthrop, Heinz Wiendl,
Jacqueline Ann Nicholas, Sven G. Meuth, Paul Giacomini, Francesco Sacca,
Ronald Zielman, Ayan Das Gupta, Jing Xi, Ratnakar Pingili, Roseanne Sullivan,
Virginia De Las Heras Revilla, Wendy Su, Ludwig Kappos
4:18 p.m. S14.005
Primary Results of NOVA: a Randomized Controlled Study of the Efficacy
of 6-Week Dosing of Natalizumab Versus Continued 4-Week Treatment for
Multiple Sclerosis–John F. Foley, Gilles Defer, Lana Zhovtis Ryerson, Jeffrey
Alan Cohen, Douglas L. Arnold, Helmut Butzkueven, Gary Raymond Cutter, Gavin
Giovannoni, Joep Killestein, Heinz Wiendl, Karen Smirnakis, Shan Xiao, George
Kong, Robert Kuhelj, Nolan Campbell
4:30 p.m. S14.006
The Role of Cerebellar Damage in Explaining Disability and Cognition in
Multiple Sclerosis Phenotypes: A Multiparametric MRI Study–Raffaello
Bonacchi, Alessandro Meani, Elisabetta Pagani, Olga Marchesi, Massimo Filippi,
Maria Assunta Rocca
4:42 p.m. S14.007
Safety Profile Characterization of Evobrutinib in Over 1000 Patients from Phase
II Clinical Trials in Multiple Sclerosis, Rheumatoid Arthritis and Systemic Lupus
Erythematosus–Hans Guehring, Daniel Wallace, Mark C. Genovese, Davorka
Tomic, Dana Parsons-Rich, Claire Le Bolay, Amy H. Kao, Xavier Montalban
4:54 p.m. S14.008
Efficacy of Ofatumumab on Microglial Activity in Patients with Relapsing forms
of Multiple Sclerosis: Interim Analysis–Tarun Singhal, Kelsey Carter, John Ficke,
Preksha Kukreja, Eero Rissanen, Gauruv Bose, Bonnie Glanz, Jonathan D. Zurawski,
Steven Cicero, Maria K. Houtchens, Christopher Severson, Shipra Dubey, Bo
Yeun, Brandon Brown, Rohit Bakshi, Harald Kropshofer, Tanuja Chitnis, Howard L.
Weiner, Marina Ollervides Ziehn
5:06 p.m. S14.009
Effects of Evobrutinib, a Bruton’s Tyrosine Kinase Inhibitor, on Slowly Expanding
Lesions: An Emerging Imaging Marker of Chronic Tissue Loss in Multiple
Sclerosis–Douglas L. Arnold, Colm Elliott, Xavier Montalban, Emily C. Martin, Yann
Hyvert, Davorka Tomic
5:18 p.m. S14.010
MRI Activity versus Relapses as Markers of Disease Activity in SPMS: Data
from Adelphi Real-World MS Disease Specific Programme and The Phase 3
EXPAND Study–Gavin Giovannoni, Emma Houchen, Lukas Sobisek, Himanshu
Karu, Suzannah Ryan, Eddie Jones, Patricia Dominguez Castro, Vladimir Bezlyak,
Daniela Piani Meier, Virginia De Las Heras Revilla, Carol Lines
AAN.com/AM 7
 SCIENTIFIC SESSIONS
Monday, April 4
3:30 p.m.–5:30 p.m. PT
S15 Aging and Dementia 1 CME
2 S16 Movement Disorders: PD Biomarkers and Clinical
3:30 p.m. S15.001
Psychosis in Neurodegenerative Disease–Andrew Breithaupt, Georges Naasan,
Suzie Shdo, Estrella Morenas Rodriguez, Lucia Lopez, Anna Karydas, Salvatore
Spina, Lea Grinberg, William Seeley, Bruce L. Miller, Katherine P. Rankin
3:42 p.m. S15.002
Slow motor neurons resist pathological TDP-43 and mediate motor recovery in
the rNLS8 model of Amyotrophic Lateral Sclerosis.–Myrna Dominique, Krista
Spiller
3:54 p.m. S15.003
African Locus Reduces the Effect of ApoE e4 Allele in Alzheimer’s Disease–
Farid Rajabli, Gary W. Beecham, Hugh Hendrie, Olusegun Baiyewu, Adesola
Ogunniyi, Sujuan Gao, Nicholas Kushch, Marina Lipkin Vasquez, Kara Hamilton-
Nelson, Juan Young, Derek Dykxhoorn, Karen Nuytemans, Brian Kunkle, Liyong
Wang, Fulai Jin, Xiaoxiao Liu, Briseida E. Feliciano Astacio, Alzheimer’s Disease
Genetic Consortium, Clifton Dalgard, Anthony J. Griswold, Goldie S. Byrd,
Christiane Reitz, Jonathan Haines, Margaret A. Pericak-Vance, Jeffery M. Vance
4:06 p.m. S15.004
Belgian Carriers of Rare ABCA7 Mutations Present with Pronounced Cerebral
Amyloid Angiopathy and Alzheimer’s Disease–Elisabeth Hendrickx Van de
Craen, Liene Bossaerts, Anne Sieben, Sebastiaan Engelborghs, Caroline Maria
Jozef Loos, Laetitia Yperzeele, Peter P. De Deyn, Patrick Cras, Christine Van
Broeckhoven
4:18 p.m. S15.005
Prevalence and Location of White Matter Hyperintensities in Traumatic Brain
Injury and Relationship to Outcome–Abbie Chan, Emily Ai, James J. Gugger,
Alexa Walter, Emily Xu, Andrew Kim, Ramon R. Diaz-Arrastia
4:30 p.m. S15.006
Association of the Mediterranean Diet and Cognition Function among
Hispanics/Latinos–Gabriela Trifan, Bayan Moustafa, Carmen Isasi, Richard B.
Lipton, Daniela Sotres-Alvarez, Jianwen Cai, Wassim Tarraf, Hector M. Gonzalez,
Ariana Stickel, Josiemer Mattei, Gregory Anthony Talavera, Martha Daviglus,
Fernando Testai
4:42 p.m. S15.007
Evaluation of Intensive Versus Standard Blood Pressure Reduction and
Association with Cognitive Decline and Dementia: A Systematic Review and
Meta-Analysis–Caroline Dallaire-Théroux, Marie-Hélène Quesnel-Olivo, Karine
Brochu, Frederic Bergeron, Sarah O’Connor, Alexis Turgeon, Robert Laforce, Steve
Verreault, Marie-Christine Camden, Simon Duchesne
4:54 p.m. S15.008
Cardiorespiratory Fitness Is Protective Against Alzheimer’s and Related
Disorders–Edward Y. Zamrini, Yan Cheng, Peter Kokkinos, Charles Faselis, Helen
M. Sheriff, Yijun Shao, Ali Ahmed, Qing Zeng-Treitler
5:06 p.m. S15.009
A Retrospective Study of Androgen Targeting Therapies and Incidence of
Neurodegenerative Outcomes in Male Prostate Cancer Patients: Implications
for Clinic to Bench Translation–Greg Lawrence Branigan, Georgina Torrandell
Haro, Kathleen Rodgers, Roberta Diaz Brinton
5:18 p.m. S15.010
Statin Responder Analysis for Precision Prevention of Neurological Diseases–
Georgina Torrandell Haro, Greg Lawrence Branigan, Kathleen Rodgers, Roberta
Diaz Brinton
8 2022 AAN Annual Meeting
3:30 p.m.–5:30 p.m. PT
CME
2
Trials
3:30 p.m.
2022 Jon Stolk Award in Movement Disorders for Young
Investigators: This award recognizes young investigators who have made
significant contributions to movement disorders research.
Recipient: Bhooma Rajagopalan Aravamuthan, MD, PhD, St. Louis, MO
3:42 p.m. S16.002
Biomarkers for Parkinson’s Disease with Reflex Tears Stratified by Disease
Duration–Mark F. Lew, Srikanth Janga, Yaping Ju, Danielle Feigenbaum, Amir
Besharat, Dan Freire, Daniel Gerke, Maria Edman, Wendy Mack, Curtis Okamoto,
Sarah Hamm-Alvarez
3:54 p.m. S16.003
Serial olfactory testing for the diagnosis of prodromal Parkinson disease in the
Parkinson Associated Risk Syndrome (PARS) study–Pavan Vaswani, James F.
Morley, Danna L. Jennings, Andrew D. Siderowf, Kenneth L. Marek
4:06 p.m. S16.004
Artificial intelligence identifies spectral biomarkers for use in adaptive deep
brain stimulation in Parkinson’s disease–Lauren Hammer, Carina Renate Oehrn,
Clay Smyth, Stephanie Cernera, Roee Gilron, Simon Little, Philip Starr
4:18 p.m. S16.005
Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction
in Parkinson’s Disease–Katerina Markopoulou, Kevin Novak, Bruce A. Chase,
Jaishree T. Narayanan, Premananda Indic
4:30 p.m. S16.006
Long-Term Evaluation of Deep Brain Stimulation for Treatment of Parkinson’s
Disease Using a Multiple-Source, Constant-Current System: 5-year Follow-Up
of a Prospective, Double-Blind RCT–Jerrold L. Vitek, INTREPID Study Group, Lilly
Chen, Roshini Jain, Philip Starr
4:42 p.m. S16.007
Evaluating Outcomes in Parkinson’s Disease Patients Following COVID-19
Interventions–Ari Vandersluis, Shnehal Patel, John Elliott
4:54 p.m. S16.008
A 104-week delayed-start analysis of PASADENA (Phase II study evaluating
the safety and efficacy of prasinezumab in early Parkinson’s disease)–Gennaro
Pagano, Stefano Zanigni, Annabelle Monnet, Kirsten I. Taylor, Andrea Hahn,
Kenneth L. Marek, Ronald Postuma, Nicola Pavese, Fabrizio Stocchi, Tanya Simuni,
Giulia D’Urso, Nathalie Pross, Michael Lindemann, Hanno Svoboda, Paulo Pacheco
Fontoura, Rachelle Doody, Geoffrey A. Kerchner, Azad Bonni, Tania Nikolcheva
5:06 p.m. S16.009
Safety and Efficacy of 24-Hour/Day Subcutaneous Infusion of Foslevodopa/
Foscarbidopa in Advanced Parkinson’s Disease During a Phase 3 Study:
6-Month Interim Results–Jason Lamar Aldred, Bruno Bergmans, Camille Carroll,
Eric Freire Alvarez, Jia Jia, Hideki Mochizuki, Weining Robieson, Amy Spiegel,
David G. Standaert, Maurizio F. Facheris, Victor Fung
5:18 p.m. S16.010
A Phase 3 Trial of IPX203 vs CD-LD IR in Parkinson’s Disease Patients with
Motor Fluctuations (RISE-PD)–Robert A. Hauser, Alberto J. Espay, Peter A.
LeWitt, Aaron Ellenbogen, Stuart H. Isaacson, Rajesh Pahwa, Fabrizio Stocchi,
Hester Visser, Richard DSouza
 SCIENTIFIC SESSIONS
Monday, April 4

3:30 p.m.–5:30 p.m. PT

S17 Cerebrovascular Disease: Clinical Trials and
Outcomes Studies
3:30 p.m.
2022 Michael S. Pessin Stroke Leadership Prize: This award
recognizes emerging neurologists who have a strong interest in and have
demonstrated a passion for learning and expanding the field of stroke
research.
Recipient: Amy Y. X. Yu, MD, Toronto, ON, Canada
3:42 p.m. S17.002
Home blood pressure telemonitoring-enhanced versus usual post-acute
stroke care in an underserved setting: the Telehealth After Stroke Care pilot
randomized clinical trial–Imama Ali Naqvi, Ken Cheung, Kevin Strobino, Kevin
Schmitt, Hanlin Li, Yuliya Baratt, Kyra Lizardo, Marie Carmel Garcon, Carmen
Elisabeth Castillo, Sarah Tom, Adriana Arcia, Olajide Abiodun Williams, Ian
Kronish, Mitchell S. V. Elkind
3:54 p.m. S17.003
AHORA: An easy to use Spanish version of the BEFAST stroke scale–Trilok
Stead, Anjali Banerjee, Latha Ganti, Maricela Gonzalez Wilson, Paul Banerjee
4:06 p.m. S17.004
The Effects of Hyperglycemia in Diabetic and Non-Diabetic Patients on
Collateral Circulation with Large Vessel Occlusions Undergoing Mechanical
Thrombectomy: A Single Center Experience–Omar Saeed, Brittany Marie
Kasturiarachi, Leila Gachechiladze, Diana Leigh Alsbrook, Savdeep Singh, Ghaida
Khalaf Zaid, Prasanna Venkatesan Eswaradass, Cheran Elangovan, Marc Malkoff,
Adam Arthur, Balaji Krishnaiah, Andrei V. Alexandrov
CME 4:18 p.m. S17.005
2 Early withdrawal of life-sustaining treatments after out-of-hospital cardiac
arrest: a sub-analysis of a randomized trial of prehospital hypothermia–Sarah
Wahlster, Kyle Danielson, Lindy Craft, Nassim Matin, James A. Town, Vasisht
Srinivasan, David Carlbom, Francis Kim, Nicholas J. Johnson, David L. Tirschwell
4:30 p.m. S17.006
Variable Picture Naming Activation Patterns in Post-stroke Aphasia: A
Functional Near-infrared Spectroscopy (fNIRS) Case Series Investigation.–Lisa
Bunker, Hana Kim, Erin Meier, Argye E. Hillis
4:42 p.m. S17.007
Tenecteplase is Safe and Efficacious in Telestroke Patients with Confirmed
Large Vessel Occlusions–Chris Hackett, Konark Malhotra, Russell Mitesh Cerejo,
Christy A. Shurina, Kayla Marie Powell, Melanie Henderson, June Butterfield,
Christine New, Patty Noah, Sandeep S. Rana, Robert Fishman, David G. Wright,
Richard Williamson, Ashis H. Tayal
4:54 p.m. S17.008
Efficacy and Safety of Mechanical Thrombectomy in Elderly Patients–Aisha
Maqsood Ali, Gabriela Trifan, Fernando Testai
5:06 p.m. S17.009
Cerebrovascular Injury During Left Ventricular Assist Device Support and
Neurologic Outcomes After Cardiac Transplant–Aaron Shoskes, Catherine
Hassett, Merry Huang, Randall Starling, Sung-Min Cho, Ken Uchino
5:18 p.m. S17.010
Non-invasive vagus nerve stimulation for the acute treatment of stroke–Ethem
Murat Arsava, Mehmet Topcuoglu, Ilknur Ay, Eric J. Liebler, Hakan Ay

Industry Therapeutic Update From

Sarepta Therapeutics: Exploring New
Horizons in the Diagnosis and Care of
Individuals With Duchenne
Clinical Update on an Investigational
rAAVrh74-based Gene Transfer Therapy

Tuesday, April 5, 2022 Hear expert insights into key

7:00 pm PDT considerations along the gene
Grand Hyatt Seattle transfer therapy journey for
Princessa Ballroom neurologists and caregivers of
721 Pine Street, Seattle, WA individuals with Duchenne.

This is not a CME program nor will CME credits be given for attendance. This program is not
part of the AAN Annual Meeting Education or Scientific programs and/or endorsed by the AAN.
©2022 SAREPTA THERAPEUTICS. Copying of this material by any means
without Sarepta’s prior written consent is prohibited. C-NP-US-1355 02/22
Information is accurate as of February 8, 2022, and is subject to change. AAN.com/AM 9
 SCIENTIFIC SESSIONS
Tuesday, April 5

1:00 p.m.–3:00 p.m. PT 1:00 p.m.–3:00 p.m. PT

S18 COVID-19: From Bedside and Beyond CME

2 S19 MS Biomarkers and Symptom Management CME
2

1:00 p.m. S18.001 1:00 p.m. S19.001

Neurologic Manifestations of Patients Hospitalized with COVID-19 in the SCCM
VIRUS Registry–Anna Marisa Cervantes-Arslanian, Chakradhar V K Venkata, Pria
Anand, Joseph D. Burns, Charlene Jennifer Ong, Allison LeMahieu, Phillip Schulte,
Tarun Deep Singh, Alejandro A. Rabinstein, Vishakha Kumar, Allan Walkey, Rahul
Kashyap
1:12 p.m. S18.002
Association Between COVID-19 Vaccination and Cerebrovascular Accidents
in Adults: A Vaccine Adverse Event Reporting System (VAERS) Study–Jeffrey
M. Kornitzer, Kranthi Kiran Mandava, Mustafa Jaffry, Tarek Elshourbagy, Nizar
Souayah
1:24 p.m. S18.003
Features of hospitalized pediatric patients with seizures and respiratory
viruses: a comparison of SARS-CoV2, other coronaviruses, and influenza–
Monique Rochlle Anderson, Yijin Xiang, Shasha Bai, Christina Rostad, Grace
Gombolay
1:36 p.m. S18.004
Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid
in the CSF of COVID-19 hospitalized patients–Erica Normandin, Kathryn Holroyd,
Sarah I. Collens, Bennett McClain Shaw, Katherine Joyce Siddle, Gordon Adams,
Melissa Ann Rudy, Isaac H Solomon, Melis Anahtar, Jacob Lemieux, Bianca A.
Trombetta, Pia Kivisakk Webb, Steven E. Arnold, Otto Rapalino, Anne Piantadosi,
Pritha Sen, Eric S. Rosenberg, John A. Branda, Pardis Christine Sabeti, Shibani
Sharon Mukerji
1:48 p.m. S18.005
The post-acute sequelae of COVID-19 (PASC) experience in an outpatient
neurology setting–Sujata P. Thawani, Peyton Meyer, Lisena Hasanaj, Jennifer A.
Frontera, Azizi Seixas, Steven Galetta, Laura J. Balcer
2:00 p.m. S18.006
Association Between COVID-19 Vaccination and Rhabdomyolysis in Adults:
A Vaccine Adverse Event Reporting System (VAERS) Study–Kranthi Kiran
Mandava, Mustafa Jaffry, Sanjana Rosario, Kamel Jedidi, Nizar Souayah
2:12 p.m. S18.007
Neuroradiological profile of Rhinoorbitocerebral mucormycosis in COVID-19
pandemic.–P.Haritha Kumari, Lakshmi N. Ranganathan, Thamilpavai Natarajan,
Shrivarthan R
2:24 p.m. S18.008
Neurological impact of COVID-19: Sub-acute brain microstructural alterations in
self-isolated individuals–Nick Teller, Jordan Chad, Eugenie Roudaia, Ali Hashemi,
Haddas Grosbein, Asaf Gilboa, Maged Goubran, Ivy Cheng, Sandra E. Black, Rob
Fowler, Chinthaka Heyn, Fuqiang Gao, Mario Masellis, Jennifer Rabin, Xiang Ji,
Aravinthan Jegatheesan, Benjamin Lam, Allison Sekuler, Bradley MacIntosh,
Simon James Graham, Jean Chen
2:36 p.m. S18.009
Phenotyping the Chronic Neurological Sequelae of Acute SARS-CoV-2
Infections–Matthew K. Schindler, Dennis L. Kolson, Danielle Sandsmark, Sara
Manning
2:48 p.m. S18.010
Do Neurological Manifestations Following SARS-CoV-2 Infection Beget A
Poor Prognosis?–Steve N. Gad, Kranthi Kiran Mandava, Mustafa Jaffry, Mohsen
Ahmed, Kazim Jaffry, Nizar Souayah
Applicability of sNFL in Multiple Sclerosis as Additional Measure to Monitor
Treatments in Clinical Practice and Implications in NEDA-3 Evaluation–Simona
Malucchi, Paola Valentino, Fabiana Marnetto, Cecelia Irene Bava, Serena Martire,
Antonio Bertolotto, Marco Alfonso Narduc Capobianco
1:12 p.m. S19.002
Early Levels of Neurofilament Light Chain and Glial Fibrillary Acidic Protein Improve
Prediction of MS Outcomes–Gauruv Bose, Brian Curran Healy, Shrishti Saxena,
Fermisk Saleh, Anu Paul, Marinos G. Sotiropoulos, Hrishikesh A. Lokhande, Mariann
Polgar-Turcsanyi, Bonnie Glanz, Charles R.G. Guttmann, Rohit Bakshi, Howard L.
Weiner, Tanuja Chitnis
1:24 p.m. S19.003
Kappa Free Light Chains Intrathecal Synthesis Biomarkers are Efficient Tools for
the Diagnosis of Multiple Sclerosis: a Large Multicenter Cohort Study–Michael
Levraut, Xavier Ayrignac, Kevin Bigaut, Sabine Chabalier, Manon Rival, Hanane
Agherbi, Sanae Squalli, Helene Zephir, Tifanie Alberto, Jean David Pekar, Jonathan
Ciron, Noellie Freitas, Damien Biotti, Jean-Phillippe Camdessanche, Yannick Tholance,
Vincent Visneux, Olivier Casez, Audrey Le Gouellec, Jeanne Marion, Audrey Le
Gouellec, Thibault Moreau, Daniela Lakomy, Thomasset Audrey, Elisabeth Maillart,
Delphine Sterlin, Aude Maurousset, Auriane Rocher, Mikael Cohen, Adrien Delourme,
Saskia Bresch, David Laplaud, Edith Bigot-Corbel, Jean Pelletier, José Boucraut, Pierre
Labauge, Sophie Huby, Thierry Vincent, Jerome De Seze, Isabelle Jahn, Barbara Seitz-
Polski, Eric Thouvenot, Beverly Aagard-Kienitz
1:36 p.m. S19.004
Utilizing P100 Wave Latency to Enhance The Accuracy of Diagnosing Multiple
Sclerosis and Neuromyelitis Optica Spectrum Disorder–Mays Amir Garah, Lama
Rayyis, Gulzar Karim, Manal A. Badawi, Ahmed Basndowah, Areej Bushnag, Edward J.
Cupler, Ahmad Hassan, Fawzi Babtain
1:48 p.m. S19.005
Increased Serum Neurofilament Light and Thin Ganglion Cell–Inner Plexiform Layer
Are Additive Risk Factors for Disease Activity in Early Multiple Sclerosis–Ting-Yi
Lin, Viktoriya Vitkova, Susanna Asseyer, Ivette Martorell Serra, Seyedamirhosein
Motamedi, Claudia Chien, Marc Ditzhaus, Athina Papadopoulou, Pascal Benkert, Jens
Kuhle, Judith Bellmann-Strobl, Klemens Ruprecht, Friedemann Paul, Alexander U.
Brandt, Hanna Zimmermann
2:00 p.m. S19.006
Lower Cerebral Arterial Blood Flow is Associated with Greater Serum
Neurofilament Light Chain Levels in Multiple Sclerosis Patients–Dejan Jakimovski,
Niels Bergsland, Michael G. Dwyer, Kunsang Choedun, Karen L. Marr, Bianca
Weinstock-Guttman, Robert Zivadinov
2:12 p.m. S19.007
Monoaminergic Networks Abnormalities Associated with Fatigue and Depression
in Multiple Sclerosis–Maria Assunta Rocca, Antonio Carotenuto, Paola Valsasina,
Paolo Preziosa, Laura Cacciaguerra, Raffaello Bonacchi, Massimo Filippi
2:24 p.m. S19.008
Repetitive transcranial magnetic stimulation with the H-coil combined with
intensive rehabilitation to improve gait in people with Multiple Sclerosis: a
randomized controlled trial–Letizia Leocani, Simone Guerrieri, Marco Pisa, Gloria Dalla
Costa, Marco Rovaris, Giancarlo Comi
2:36 p.m. S19.009
Long-term efficacy of cognitive-behavioral approaches (CBT) in the management of
fatigue in patients with relapsing remitting multiple sclerosis (RRMS): a randomized,
parallel-group, multicenter, open-label, controlled trial versus standard care– Olivier
Heinzlef, Fanny Hamelin, Frederic Barbot, Isabelle Vaugier, Marie Blanchere, Eric
Manchon, Djamel Bensmail, Marie Claire Gay
2:48 p.m. S19.010
Assessing cognitive impairment in Multiple Sclerosis using Smartphone-Based
training Games: Results of a feasibility study–Silvan Pless, Tim Woelfle, Yvonne
Naegelin, Johannes Lorscheider, Andrea Wiencierz, Óscar Gabriel Reyes Pupo, Jose
Maria Santos, Pasquale Calabrese, Ludwig Kappos

10 2022 AAN Annual Meeting

 SCIENTIFIC SESSIONS
Tuesday, April 5
1:00 p.m.–3:00 p.m. PT
S20 Aging and Dementia 2 CME
2 S21 Neurocritical Care
1:00 p.m.
2022 Potamkin Prize for Research in Pick’s, Alzheimer’s, and
Related Diseases: This award recognizes major contributions to the
understanding of the causes, prevention, treatment, and cure for Pick’s,
Alzheimer’s, and related diseases.
Recipient: Vladimir Hachinski, MD, DSc, FAAN, London, ON, Canada
1:24 p.m. S20.003
Head-to-head comparison of tau and amyloid PET visual reads for differential
diagnosis: An international, multi-center study–David Nima Soleimani-
Meigooni, Ruben Smith, Karine Provost, Orit Lesman-Segev, Hanna Cho, Lauren
Edwards, Leonardo Iaccarino, Renaud La Joie, Rik Ossenkoppele, Olof Strandberg,
Amelia Strom, Chul Hyoung Lyoo, Oskar Hansson, Gil Dan Rabinovici
1:36 p.m. S20.004
Plasma Neurofilament Trajectories are Markers of Disease Progression and
Severity in Genetic Frontotemporal Dementia–Dario Saracino, Karim Dorgham,
Agnes Camuzat, Daisy Rinaldi, Armelle Rametti Lacroux, Marion Houot, Florence
Pasquier, Philippe Couratier, Claire Boutoleau-Bretonniere, Jeremie Pariente, Mira
Didic, Olivier Colliot, Richard Levy, Isabelle Le Ber
1:48 p.m. S20.005
Speech and Language Correlates of Decreased and Increased Functional
Connectivity in Semantic Variant Primary Progressive Aphasia–Maxime
Montembeault, Zachary Miller, Amandine Geraudie, Peter Pressman, Antoine
Slegers, Maria Luisa Mandelli, Nina Dronkers, Bruce L. Miller, Simona M.
Brambati, Maria Gorno Tempini, Giovanni Battistella
2:00 p.m. S20.006
Frequent MAPT p.R406W Carriers with a Nonconforming FTD Phenotype in
the Belgian Population–Helena Gossye, Sara Van Mossevelde, Julie Van Der Zee,
Anne Sieben, Maria Bjerke, Sebastiaan Engelborghs, Peter P. De Deyn, Jan L. De
Bleecker, Jan Versijpt, Jenneke Van Den Ende, Olivier Deryck, Paul M. Bourgeois,
Jean-Christophe Bier, Maarten Goethals, Christine Van Broeckhoven
2:12 p.m. S20.007
Differences in rate and trajectory of TDP-43-associated neurodegeneration in
brains with and without frontotemporal lobar degeneration–Marina Buciuc,
Peter Martin, Nirubol Tosakulwong, Melissa Murray, Leonard Petrucelli, Matthew
Senjem, Anthony Spychalla, David S. Knopman, Bradley F. Boeve, Ronald C.
Petersen, Joseph E. Parisi, Ross Reichard, Dennis W. Dickson, Clifford R. Jack,
Jennifer Louise Whitwell, Keith A. Josephs
2:24 p.m. S20.008
Education, Early Life Socioeconomic Status, and Later Life Alzheimer’s Disease-
Related Neuropathological Lesions–Amol Mehul Mehta, Sarah Tom, Paul Crane,
David A. Bennett, Stephanie Izard, Philip De Jager, Julie A. Schneider
2:36 p.m. S20.009
Dissecting the Neurodegenerative Causes of Rapidly Progressive Dementia: An
Autopsy Study–Evelyn Lazar, Nikhil Bharat Ghayal, Shanu Roemer, Neill R. Graff-
Radford, Dennis W. Dickson, Gregory S. Day
2:48 p.m. S20.010
Safety, Target Engagement and Effects of Bosutinib in Dementia with Lewy
Bodies–Fernando L. Pagan, Yasar Alejandro Torres-Yaghi, Michaeline Hebron,
Barbara Wilmarth, Dalila Ferrante, Sara Matar, Raymond Turner, Jaeil Ahn,
Charbel E H Moussa
Information is accurate as of February 8, 2022, and is subject to change.
1:00 p.m.–3:00 p.m. PT
CME
2
1:00 p.m. S21.001
Cerebral Autoregulatory Function Before, During, and After Therapeutic
Interventions Following Severe Traumatic Brain Injury: A Secondary Analysis
of the BOOST-II Study–Ayush Prasad, Jessica Kobsa, Alexandria Soto, David
Bartolome, Yelyzaveta Begunova, Jennifer A. Kim, Emily Jean Gilmore, Kevin N.
Sheth, Charles Matouk, Adam De Havenon, Ramon R. Diaz-Arrastia, Nils Petersen
1:12 p.m. S21.002
Poor Collaterals and Rapid Early Infarct Progression Are Associated With
Increased Vulnerability to Blood Pressure Reductions–Yelyzaveta Begunova,
David Bartolome, Jessica Kobsa, Alexandria Soto, Ayush Prasad, Milagros
Galecio-Castillo, Juan A. Vivanco-Suarez, Darko Ernesto Quispe Orozco, Mudassir
Farooqui, Lauren Hachmann Sansing, Joseph Schindler, Adam De Havenon,
Charles Matouk, Kevin N. Sheth, Santiago Ortega Gutierrez, Nils Petersen
1:24 p.m. S21.003
Radiographic predictors of ventriculoperitoneal shunt requirement in
aneurysmal subarachnoid hemorrhage–Aiden Meyer, Elyse Forman, Scott
Moody, Christoph Stretz, Nicholas S. Potter, Linda C. Wendell, Bradford B.
Thompson, Jesse Menville, Karen L. Furie, Ali Mahta
1:36 p.m. S21.004
Association Of Hemoglobin Over The First Week With Clinical Outcomes And
Neuroimaging Characteristics In Patients With Spontaneous Intracerebral
Hemorrhage–Camilo Diaz-Cruz, Kori Anahi Porosnicu Rodriguez, John Richard
Gatti, David Zhao, Radhika Avadhani, Issam Awad, Daniel F. Hanley, Wendy C. Ziai
1:48 p.m. S21.005
Guillain-Barre Syndrome after HPV Vaccination: A Report from the Vaccine
Adverse Event Reporting System (VAERS) (2006-2021)–Tarek Elshourbagy,
Kranthi Kiran Mandava, Mustafa Jaffry, Nizar Souayah
2:00 p.m. S21.006
The Experiences And Needs Of Families Of Comatose Patients After Cardiac
Arrest And Severe Neurotrauma: The Perspectives Of A National Key
Stakeholders During An NIH-Funded Workshop–Susanne Muehlschlegel, Sarah
Perman, Jonathan Elmer, Adrianne Haggins, Natalie Dyane Teixeira, Jennifer
Huang, Liz Jansky, Jessica Kirchner, Renee Kasperek-Wynn, Paula Darby Lipman,
Michael Fetters, Neal W. Dickert, Robert Silbergleit
2:12 p.m. S21.007
Survey of Practices and Physician Attitudes on Post-Cardiac Arrest Care–
Melody Eckert, Nilan Bhakta, Fernanda Jacinto Pereira Teixeira, Carolina B.
Maciel, Torben K. Becker, Casey Carr
2:24 p.m. S21.008
Quantitative Pupil Characteristics Following Analgo-Sedative Administration in
Critically Ill Patients with Neurologic Emergencies–Wang Pong Chan, Brenton
Prescott, Megan Barra, David Young Chung, Hanife Saglam, Emelia Benjamin,
Stelios M. Smirnakis, Josee Dupuis, David M. Greer, Charlene Jennifer Ong
2:36 p.m. S21.009
Implementation of systematic safety checklists in a Neurointensive Care Unit:
A quality and improvement study.–Gabriel Torrealba Acosta, Cesar Eduardo
Escamilla-Ocanas, Pitchaiah Mandava, Eric Bershad, Mohammad I. Hirzallah,
Chethan K. Venkatasubba Rao, Barbara Lorena Gutierrez-Flores, Rahul Damani
2:48 p.m. S21.010
Between Scylla and Charybdis: Risks of Early Therapeutic Anticoagulation for
Venous Thromboembolism After Acute Intracranial Hemorrhage–Thuhien
Nguyen, Monisha Sharma, Charles Patrick Crooks, Pratik Vishnu Patel, Robert
Bonow, Claire Creutzfeldt, Sarah Wahlster
AAN.com/AM 11
 SCIENTIFIC SESSIONS
Tuesday, April 5

3:30 p.m.–4:10 p.m. PT 3:30 p.m.–5:30 p.m. PT

S22 History of Neurology CME

0.5 S23 Therapeutics for Muscle Diseases CME
2

3:30 p.m. 3:30 p.m. S23.001

2022 Lawrence C. McHenry: An Award for the History of Neurology:
This award recognizes excellence in research in the history of neurology.
Recipient: David B. Burkholder, MD, Rochester, MN
3:54 p.m. S22.003
André Strohl: Why Was his Name Omitted from Guillain-Barré Syndrome’s
Eponym?–Ahmed Abbas, Faisal Abdelaziz Ibrahim
WITHDRAWN
3:42 p.m. S23.002
A Phase 2 Clinical Trial Evaluating the Safety and Efficacy of SRP-9001 for
Treating Patients with Duchenne Muscular Dystrophy–Jerry R. Mendell, Perry
Shieh, Zarife Sahenk, Kelly Lehman, Linda Pax Lowes, Natalie F. Reash, Megan
Iammarino, Lindsay N. Alfano, Brenna Powers, Jeremy Woods, Christy Skura,
Howard Mao, Loretta Staudt, Rachael Potter, Danielle A. Griffin, Sarah Lewis,
Tianle Hu, Sameer Upadhyay, Tejdip Singh, Louise R. Rodino-Klapac
3:54 p.m. S23.003
Antibody-Oligonucleotide Conjugates (AOCs) Demonstrate Potent and Durable
Exon Skipping and Dystrophin Restoration in a Mouse Model of Duchenne
Muscular Dystrophy–Usue Etxaniz, Matthew Diaz, Raghav Bhardwaj, Olecya
Tyaglo, Kellie Lemoine, Maria Azzurra Missinato, Aaron George Anderson, Philip
Kovach, Isaac Marks, Tyler Albin, Michael Cochran, Hae Won Kwon, Verna Zhao,
Husam Younis, William M. Flanagan, Arthur A. Levin
4:06 p.m. S23.004
Phase 1/2a Trial of SRP-9001 in Patients with Duchenne Muscular Dystrophy:
3-Year Safety and Functional Outcomes–Jerry R. Mendell, Zarife Sahenk, Kelly
Lehman, Carrie Nease, Linda Pax Lowes, Natalie F. Reash, Megan Iammarino,
Lindsay N. Alfano, Jordan Vaiea, Sarah E. Lewis, Kathleen Church, Richard Shell,
Rachael Potter, Danielle A. Griffin, Eric Pozsgai, Mark Hogan, Tianle Hu, Kathryn
Anne Giblin, Louise R. Rodino-Klapac
4:18 p.m. S23.005
Safety, ß-Sarcoglycan Expression, and Functional Outcomes From Systemic
Gene Transfer of rAAVrh74.MHCK7.hSGCB in LGMD2E/R4–Louise R. Rodino-
Klapac, Eric Pozsgai, Sarah Lewis, Danielle A. Griffin, Aaron Meadows, Kelly
Lehman, Kathleen Church, Natalie F. Reash, Megan Iammarino, Brenna Powers,
Lindsay N. Alfano, Linda Pax Lowes, Erica Koenig, Sarah Berten Neuhaus, Xiaoxi Li,
Jerry R. Mendell
4:30 p.m. S23.006
Study Design of AOC 1001-CS1, a Phase 1/2 Clinical Trial Evaluating the
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AOC 1001
Administered Intravenously to Adult Patients with Myotonic Dystrophy Type 1
(DM1) (MARINA)–Nicholas Elwood Johnson, John W. Day, Johanna Hamel, Katy
Eichinger, S H. Subramony, William D. Arnold, Charles A. Thornton, Matthew P.
Wicklund, Payam Soltanzadeh, Ben Knisely, Varun Goel, Kelly Ditrapani, Chao-Yin
Chen, Kristi R. R, Alissa N. Peters, Carrie Heusner, Husam Younis, Mohita Kumar,
Li-Jung Tai, Elizabeth Jane Ackermann
4:42 p.m. S23.007
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 48-Week Study of
the Efficacy and Safety of Losmapimod in Subjects with FSHD: ReDUX4–Alrabi
Tawil, Katy Eichinger, Leo Hong-Li Wang, Angela L. Genge, Sabrina Sacconi,
Hanns Lochmuller, David Reyes Leiva, Jordi Diaz Manera, Jorge Alonso-Perez,
Nuria Muelas, Juan Jesus Vilchez Padilla, Alan Pestronk, Summer Gibson,
Namita Goyal, Johanna Hamel, Lawrence J. Hayward, Nicholas Elwood Johnson,
Samantha Jo LoRusso, Miriam L. Freimer, Perry Shieh, S H. Subramony, Doris
G. Leung, Baziel G M van Engelen, Joost Kools, Olof Dahlqvist Leinhard, Per
Wildholm, John Jiang, Adefowope Odueyungbo, William Tracewell, Alejandro
Rojas, Anthony Accorsi, Lucienne Ronco, Diego Cadavid, Christopher Moxham,
Christopher Morabito, Robert Gould, Michelle L. Mellion

12 2022 AAN Annual Meeting

 SCIENTIFIC SESSIONS
Tuesday, April 5
S23 Therapeutics for Muscle Diseases CME
2 S24 Epilepsy/Clinical Neurophysiology (EEG): Clinical
4:54 p.m. S23.008
An Open-Label Study of Losmapimod to Evaluate the Safety, Tolerability,
and Biomarker and Clinical Outcome Assessment Changes in Subjects with
FSHD1–Joost Kools, Nicol Voermans, Karlien Mul, Lucienne Ronco, John Jiang,
Jennifer Shoskes, Kelly Marshall, Diego Cadavid, Michelle L. Mellion, Baziel G M
van Engelen
5:06 p.m. S23.009
Whole Body MRI Quantitative muscle analysis to evaluate Efficacy of
Losmapimod in a Phase 2 Placebo-Controlled Study in Subjects with FSHD
(ReDUX4)–Michelle L. Mellion, Alrabi Tawil, Katy Eichinger, Leo Hong-Li Wang,
Angela L. Genge, Sabrina Sacconi, Hanns Lochmuller, David Reyes Leiva, Jordi
Diaz Manera, Jorge Alonso-Perez, Nuria Muelas, Juan Jesus Vilchez Padilla, Alan
Pestronk, Summer Gibson, Namita Goyal, Johanna Hamel, Lawrence J. Hayward,
Nicholas Elwood Johnson, Samantha Jo LoRusso, Miriam L. Freimer, Perry Shieh,
S H. Subramony, Doris G. Leung, Baziel G M van Engelen, Joost Kools, Olof
Dahlqvist Leinhard, Per Wildholm, John Jiang, Adefowope Odueyungbo, William
Tracewell, Alejandro Rojas, Anthony Accorsi, Lucienne Ronco, Diego Cadavid,
Christopher Moxham, Christopher Morabito, Robert Gould
5:18 p.m. S23.010
A Randomized, Double-Blind, Placebo-Controlled Study of Arimoclomol in
Patients with Inclusion Body Myositis–Pedro Machado, Richard J. Barohn,
Michael McDermott, Thomas Blaettler, Thomas E. Lloyd, Aziz I. Shaibani, Miriam L.
Freimer, Anthony A. Amato, Emma Ciafaloni, Sarah M. Jones, Tahseen Mozaffar,
Summer Gibson, Matthew P. Wicklund, Todd D. Levine, Claus Sundgreen, Thomas
Carstensen, Karen Bonefeld, Anders Noerkaer Joergensen, Karina Phonekeo,
Andrew Heim, Laura Herbelin, Michael George Hanna, Mazen M. Dimachkie
Information is accurate as of February 8, 2022, and is subject to change.
3:30 p.m.–5:30 p.m. PT
CME
2
Epilepsy
3:30 p.m. S24.001
The New-Onset Refractory Status Epilepticus (NORSE/FIRES) Family Registry–
Karnig Kazazian, Nicolas Gaspard, Lawrence J. Hirsch, Marissa Kellogg, Sara E.
Hocker, Nora Wong, Raquel Farias-Moeller, Krista L. Eschbach, Teneille Gofton
3:42 p.m. S24.002
Limited resection preserved verbal memory outcome in drug-resistant
dominant temporal lobe epilepsy due to temporal encephaloceles–Kelsey Marie
Smith, Eva Alden, Kiran M. Kanth, Karl Krecke, Robert Witte, Jamie J. Van Gompel,
Elson L. So, Jeffrey W. Britton, Gregory D. Cascino, Lily Wong-Kisiel
3:54 p.m. S24.003
Brain Temperature Elevations Parallel Unrestricted Water Movement And
Increased Myelination In Temporal Lobe Epilepsy–Jerzy P. Szaflarski, Ayushe
Alicia Sharma, Adam M. Goodman, Rodolphe Nenert
4:06 p.m. S24.004
Comparison of nationwide trends in 30-day readmission rates after laser
interstitial thermal therapy (LITT) and open surgical procedures for refractory
epilepsy (Nationwide Readmission database 2012-2018)–Varun Kumar, Mark
Warman, Parisha Bhatia, Chirag Narshibhai Savani, Tejinder Singh
4:18 p.m. S24.005
Long-Term Cardiovascular Safety of Fenfluramine for Lennox-Gastaut
Syndrome: Interim Analysis of Open-Label Safety Study–Anupam Agarwal, Gail
M Farfel, Arnold Gammaitoni, Pierre Wong, Fausto J. Pinto, Bradley Galer
4:30 p.m. S24.006
Generic substitution of antiseizure medications: Is it time for narrow
therapeutic index classification?–Sarah Elmer, Samba Reddy
4:42 p.m. S24.007
Use of Ceribell Rapid-Response EEG in 100 consecutive cases correlated with a
reduction in anti-seizure medication usage–Deepika Kurup, Zach Davey, Phuong
Thi Hoang, Katherine Michelle Clifford, Katherine Werbaneth, Varun Bipinchandra
Shah, Prasanthi Govindarajan, Kimford J. Meador
4:54 p.m. S24.008
Clinical and EEG factors associated with antiseizure medication resistance in
idiopathic generalized epilepsy–Brad Kenichi Kamitaki, Haiqun Lin, Gary Heiman,
Hyunmi Choi
5:06 p.m. S24.009
Outcomes and Resource Utilization Associated with Readmissions after laser
interstitial thermal therapy for refractory epilepsy: A Nationwide Readmission
database study (2010-2018)–Varun Kumar, Mark Warman, Parisha Bhatia, Chirag
Narshibhai Savani, Tejinder Singh
5:18 p.m. S24.010
Frequency of New Onset Seizures Amongst Adult Hospitalized Patients with
COVID-19; A Systematic Review and Meta-Analysis–Daniah Shamim, Fatima
Ashraf Ashraf, Gary S. Gronseth
AAN.com/AM 13
 SCIENTIFIC SESSIONS
Tuesday, April 5

3:30 p.m.–5:30 p.m. PT

S25 Autoimmune Neurology 2: Clinical Trials and CME

2
Treatment
3:30 p.m. S25.001
Anti-C1q Therapy ANX005 Inhibits CSF Antibody-Driven Complement
Activity Elevated in Early Stage Guillain-Barré Syndrome– Poojan Suri, Sethu
Sankaranarayanan, Ellen Cahir McFarland, Henk-Andre Kroon, Zhahirul Islam, Ted
Yednock
3:42 p.m. S25.002
Effect of Combined Intravenous Immunoglobulin and Classical Complement Inhibitor
ANX005 in Guillain-Barré Syndrome–Thomas Harbo, Zhahirul Islam, Nowshin Papri,
Shoma Hayat, Ananna Rahman, Israt Jahan, Gurudas Mondal, Sadekur Rahman
Sarkar, Eric Humphriss, Ping Lin, Sanjay C. Keswani, Dean Richard Artis, Anita Grover,
Henk-Andre Kroon, Quazi Deen Mohammad
3:54 p.m. S25.003
WITHDRAWN
4:06 p.m. S25.004
Long-term Safety, Tolerability, and Efficacy of Efgartigimod in Patients With
Generalized Myasthenia Gravis: Interim Results of the ADAPT+ Study–James F.
Howard, Vera Bril, Tuan Hoang Vu, Chafic Y. Karam, Stojan Peric, Jan L. De Bleecker,
Hiroyuki Murai, Andreas Meisel, Said R. Beydoun, Mamatha Pasnoor, Antonio
Guglietta, Peter Ulrichts, Caroline T’ joen, Kimiaki Utsugisawa, Jan Verschuuren,
Renato Mantegazza
4:18 p.m. S25.005
Long-term Efficacy and Safety of Ravulizumab, a Long-acting Terminal Complement
Inhibitor, in Adults with Anti-Acetylcholine Receptor Antibody-Positive Generalized
Myasthenia Gravis: Results from the Phase 3 CHAMPION MG Open-label
Extension–James F. Howard, Tuan Hoang Vu, Renato Mantegazza, Djillali Annane,
Masahisa Katsuno, Rasha Aguzzi, Nishi Rampal, Andreas Meisel
4:30 p.m. S25.006
Real-world experience of eculizumab treatment for generalized myasthenia gravis:
initial data from a registry of patients with generalized myasthenia gravis in the
USA–Pushpa Narayanaswami, Gary Raymond Cutter, Richard J. Nowak, Ericka P.
Greene, Srikanth Muppidi, Tahseen Mozaffar, Ema Rodrigues, Houari Korideck, James
F. Howard
4:42 p.m. S25.007
Serum IgG and Autoantibody Lowering by the Anti-FcRn Monoclonal Antibody,
Nipocalimab, Correlates with Improvement in MG-ADL in Generalized Myasthenia
Patients–Jeff Guptill, Carlo Antozzi, Vera Bril, Josep Gamez, Sven G. Meuth, Richard
J. Nowak, Dianna Quan, Teresa Sevilla, Leona Ling, Yaowei Zhu, Keith Karcher, Sindhu
Ramchandren, Hong Sun
4:54 p.m. S25.008
Therapeutic Plasma Exchange in the Management of Stiff Person Syndrome
Spectrum Disorders: A Case Series and Review of the Literature–Shuvro Roy,
Nicolas Mercure-Corriveau, Yujie Wang, Danielle Obando, Xianming Zhu, Laetitia
Daou, Aaron Tobian, Evan M. Bloch, Scott Douglas Newsome
5:06 p.m. S25.009
Long-term Efficacy of Satralizumab in Aquaporin-4-IgG-seropositive Neuromyelitis
Optica Spectrum Disorder (NMOSD): Results from the Open-label Extension Periods
of SAkuraSky and SAkuraStar–Ingo Kleiter, Anthony Traboulsee, Jacqueline Palace,
Takashi Yamamura, Kazuo Fujihara, Albert Saiz, H. Christian Von Buedingen, Daniela
Stokmaier, Gaelle Klingelschmitt, Jeffrey L. Bennett
5:18 p.m. S25.010
Long-term Safety of Satralizumab in Neuromyelitis Optica Spectrum Disorder
(NMOSD): Results from the Phase 3 SAkuraSky and SAkuraStar Studies–Benjamin
M. Greenberg, Jerome De Seze, Albert Saiz, Takashi Yamamura, Michael R.
Yeaman, Carole Marcillat, Xiujing Kou, Kristina Weber, Kathleen Blondeau, Brian G.
Weinshenker, Francesco Patti

14 2022 AAN Annual Meeting

 ADVERTISEMENT

HELP YOUR ADULT PATIENTS

WITH TARDIVE DYSKINESIA (TD)

Take. Control.
INGREZZA is the simple, once-daily
choice to reduce TD severity1
Not actual size Actor portrayal

THE SIMPLE CHOICE SYMPTOM REDUCTION SAVINGS & SUPPORT

Once-daily INGREZZA INGREZZA 80 mg reduced uncontrolled $10 or less out-of-pocket
is the simple choice to support movements in 7 of 10 patients at 6 weeks is what most patients
patient adherence1,2,* (post hoc analysis)1,3,† pay for INGREZZA4
*Compared to once-daily regimens, timing adherence is 27% lower for twice-daily regimens, according to a meta-analysis of 51 studies in patients with chronic conditions.
†
Post hoc analysis included patients who had a baseline and a Week 6 AIMS total score. Reduction in uncontrolled movements as assessed by ≥1-point decrease in AIMS total score.

MOST PRESCRIBED TREATMENT

FOR TARDIVE DYSKINESIA5

Click to View the Complete INGREZZA Story Visit Booth 300

Important Information
INDICATION & USAGE
INGREZZA® (valbenazine) capsules is indicated for the treatment of adults with tardive dyskinesia.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS WARNINGS & PRECAUTIONS (continued)
INGREZZA is contraindicated in patients with a history of Parkinsonism
hypersensitivity to valbenazine or any components of INGREZZA. INGREZZA may cause parkinsonism in patients with tardive dyskinesia.
Rash, urticaria, and reactions consistent with angioedema Parkinsonism has also been observed with other VMAT2 inhibitors.
(e.g., swelling of the face, lips, and mouth) have been reported. Reduce the dose or discontinue INGREZZA treatment in patients who
WARNINGS & PRECAUTIONS develop clinically significant parkinson-like signs or symptoms.
Somnolence ADVERSE REACTIONS
INGREZZA can cause somnolence. Patients should not perform The most common adverse reaction (≥5% and twice the rate
activities requiring mental alertness such as operating a motor of placebo) is somnolence. Other adverse reactions (≥2% and
vehicle or operating hazardous machinery until they know how >Placebo) include: anticholinergic effects, balance disorders/falls,
they will be affected by INGREZZA. headache, akathisia, vomiting, nausea, and arthralgia.
QT Prolongation You are encouraged to report negative side effects of prescription
INGREZZA may prolong the QT interval, although the degree of QT drugs to the FDA. Visit MedWatch at www.fda.gov/medwatch or
prolongation is not clinically significant at concentrations expected call 1-800-FDA-1088.
with recommended dosing. INGREZZA should be avoided in patients with Please see INGREZZA full Prescribing Information.
congenital long QT syndrome or with arrhythmias associated with a
prolonged QT interval. For patients at increased risk of a prolonged QT
interval, assess the QT interval before increasing the dosage.
REFERENCES: 1. INGREZZA [package insert]. San Diego, CA: Neurocrine Biosciences, Inc. 2. Coleman CI, Limone B, Sobieraj DM, et al.
Dosing frequency and medication adherence in chronic disease. J Manag Care Pharm. 2012;18(7):527-539. 3. Data on file. Neurocrine
Biosciences, Inc. 4. Data on file as of Q1 2021. Neurocrine Biosciences, Inc. 5. Data on file as of Q3 2021. Neurocrine Biosciences, Inc.

©2022 Neurocrine Biosciences, Inc. All Rights Reserved. CP-VBZ-US-1889 03/2022

 SCIENTIFIC SESSIONS
Wednesday, April 6

1:00 p.m.–3:00 p.m. PT 1:00 p.m.–3:00 p.m. PT

S26 MS Imaging CME

2 S27 Innovations in Neuro-oncology CME
2

1:00 p.m. S26.001 1:00 p.m.

Magnetic resonance imaging criteria at onset to differentiate pediatric multiple 2022 Neuro-oncology Scientific Award: This award recognizes an
sclerosis from acute disseminated encephalomyelitis: A nationwide cohort individual from any discipline and of any academic rank for a singular
study–Magnus Spangsberg Boesen, Morten Bjorn Blinkenberg, Lau Thygesen, scientific achievement that has advanced the field of neuro-oncology.
Jurgita Ilginiene, Annika Langkilde Recipient: Elizabeth R. Gerstner, MD, Boston, MA
1:12 p.m. S26.002
1:12 p.m. S27.002
Differences in age-related retinal and cortical atrophy rates in multiple
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome:
sclerosis–Christian Cordano, Bardia Nourbakhsh, Hao H. Yiu, Nico Papinutto,
an international consensus recommendation–Scott R. Plotkin, Ludwine
Eduardo Caverzasi, Ahmed Mohamed Taha Abdelhak, Frederike Cosima Oertel,
Messiaen, Pierre Wolkenstein, Patrice Susan Pancza, Susan Huson, Gareth Evans,
Alexandra Beaudry-richard, Adam Santaniello, Simone Sacco, Daniel Bennett,
Eric Legius
Apraham Gomez, Christina Sigurdson, Stephen L. Hauser, Bruce A. C. Cree,
Roberta Magliozzi, Roland G. Henry, Ari Green 1:24 p.m. S27.003
Revised diagnostic criteria and nomenclature for neurofibromatosis 2 and
1:24 p.m. S26.003
schwannomatosis: an international consensus recommendation–Scott R.
Phenotyping Of Multiple Sclerosis Lesions According To Innate Immune
Plotkin, Ludwine Messiaen, Eric Legius, Patrice Susan Pancza, Susan Huson, Pierre
Cell Activation Using TSPO-PET–Marjo Nylund, Marcus Sucksdorff, Markus
Wolkenstein, Gareth Evans
Matilainen, Eero Polvinen, Jouni Tuisku, Laura Airas
1:36 p.m. S27.004
1:36 p.m. S26.004
Detection of Neoplasms by Metagenomic Next-Generation Sequencing of
Machine Learning-Based Detection of Slowly Expanding Lesions using
Cerebrospinal Fluid–Wei Gu, Andreas Rauschecker, Elaine Hsu, Kelsey Zorn,
Radiomic Features from Cross-sectional Brain MRI–Bastien Caba, Arie Gafson,
Yasemin Sucu, Scot Federman, Shaun Arevalo, Hannah Sample, Eric Nguyen, Eric
Aurélien Lombard, Dawei Liu, Alexandre Cafaro, Enzo Battistella, Rodrigo Perea,
Talevich, Bardia Nourbakhsh, Carl Aaron Gold, Bruce A. C. Cree, Vanja C. Douglas,
Elizabeth Fisher, Nathalie Franchimont, Douglas L. Arnold, Colm Elliott, Nikos
Megan Richie, Maulik Shah, S. Andrew Josephson, Jeffrey Marc Gelfand, Steve
Paragios, Shibeshih Belachew
Miller, Linlin Wang, Tarik Tihan, Michael R. Wilson
1:48 p.m. S26.005
1:48 p.m. S27.005
A Combined Lesion Distribution Parameter Predicts Disease Progression in
Leptomeningeal Disease in Patients with Histone-Mutant Gliomas–Maria Diaz
Multiple Sclerosis–Eero Polvinen, Markus Matilainen, Marjo Nylund, Marcus
Ordonez, Carlos Correia, Andrew L. Lin, Alexandra M. Miller, Elena Pentsova
Sucksdorff, Laura Airas
2:00 p.m. S27.006
2:00 p.m. S26.006
Caregiver Distress and Burden Over Time in Newly Diagnosed Gliomas–Lauryn
Defining the spinal cord reserve concept in multiple sclerosis - measurement
Hemminger, Chinazom Uchenna Ibegbu, Jennifer N. Serventi, Joy Ellen Burke,
and association with disability of the spinal cord canal area–Jaume Sastre-
Jessica Faith Occhiogrosso, Benzi Kluger, Nimish A. Mohile
Garriga, Alex Rovira, Aran Garcia-Vidal, Pere Carbonell, Manel Alberich, Cristina
Auger, Mar Tinore, Xavier Montalban, Debora Pareto 2:12 p.m. S27.007
2:12 p.m. S26.007 Clinical and Molecular Determinants of Survival Outcomes in Glioblastoma
Patients Treated with Immune Checkpoint Inhibitors–Pushan Richard Dasgupta,
Slowly-Expanding Lesions Predict 9-Year Multiple Sclerosis Disease
Heather Lin, Zaid Arif Soomro, Charles Bornstein, Kristin Alfaro-Munoz, Ying Yuan,
Progression–Paolo Preziosa, Elisabetta Pagani, Alessandro Meani, Lucia Moiola,
John F. De Groot, Nazanin Koohbanani Majd
Mariaemma Rodegher, Massimo Filippi, Maria Assunta Rocca
2:24 p.m. S27.008
2:24 p.m. S26.008
Long-term survival and cognitive function follow up of primary CNS lymphoma
Paramagnetic Rims in Treatment Naïve Persons Around the Time of Multiple
treated with R-MVP followed by high dose chemotherapy with autologous
Sclerosis Diagnosis–Margareta A. Clarke, Rachael Elaine Cheek, Reece Clarke,
stem cell transplant consolidation–Kate Elizabeth Therkelsen, Christian Grommes
Colin McKnight, Joy Derwenskus, James Everett Eaton, Run Fan, Fei Ye, Kristin
O’Grady, Baxter Rogers, Seth A. Smith, Francesca Bagnato 2:36 p.m. S27.009
2:36 p.m. S26.009 CAR-T Cell Therapy in Recurrent Primary CNS Lymphoma (PCNSL): A Phase 2
Clinical Trial–Jorg Dietrich, Yi-Bin Chen, Kathleen Mary Ellen Gallagher, Justin
Machine Learning-Based Prediction of New Multiple Sclerosis Lesion
T. Jordan, Deborah A. Forst, Scott R. Plotkin, Kevin Arthur Lindell, Daniella Cook,
Formation Using Radiomic Features from Pre-Lesion Normal Appearing White
Gabriel DePinho, Michael Andrew Trailor, Tracy T. Batchelor, Marcela Maus,
Matter–Bastien Caba, Arie Gafson, Aurélien Lombard, Dawei Liu, Alexandre
Matthew Frigault
Cafaro, Enzo Battistella, Rodrigo Perea, Elizabeth Fisher, Nathalie Franchimont,
Douglas L. Arnold, Colm Elliott, Nikos Paragios, Shibeshih Belachew 2:48 p.m. S27.010
2:48 p.m. S26.010 Clinical and Pathologic Determinants of Outcome for Non-Optic Pathway
Gliomas in Adults with Neurofibromatosis Type 1–Anna Piotrowski, Jian
Serum Neurofilament Light Associates with Microglial Activation in the
Campion, Rebecca M. Brown, Jose Diarte, Fausto Rodriguez, Tejus Bale, Sonika
Multiple Sclerosis Brain–Maija Saraste, Markus Matilainen, Marcus Sucksdorff,
Dahiya, Laura Prichett, Ingo K. Mellinghoff, Jaishri Blakeley, Carlos Ramos
David Leppert, Jens Kuhle, Laura Airas

16 2022 AAN Annual Meeting

 SCIENTIFIC SESSIONS
Wednesday, April 6

1:00 p.m.–3:00 p.m. PT 1:00 p.m.–3:00 p.m. PT

S28 Health Care Disparities CME

2 S29 Preclinical and Observational Studies of CME
2
Neuromuscular Diseases
1:00 p.m. S28.001 1:00 p.m. S29.001
Gender Authorship in Accepted AAN Abstracts During the COVID-19 PROMISE-MG: A Multicenter Prospective Observational Comparative Effectiveness
Pandemic–Minseon Kim, Reniba Babu, Anjail Sharrief, Kristin Angelica Brown, Study of Myasthenia Gravis Treatments–Pushpa Narayanaswami, Donald B.
Suur Biliciler, Thy Nguyen Sanders, Jeff Guptill, Fan Li, Rishi Desai, Bo Liu, Jurgen Venitz, Andrew C. Krueger,
Kathie Marie Bibeau, PROMISE-MG Study Group
1:12 p.m. S28.002
Racial Disparities in Long-Term Functional Outcome After Traumatic Brain 1:12 p.m. S29.002
Injury: An update–Alex Y. Chen, Leticia Simo, Shalini Tummala, Rachel Mahas, Preclinical Pharmacology and Toxicology of intrathecally infused AAV9-hABCD1, a
Sonia Veronica Eden gene therapy candidate for AMN, in Non-Human Primates–Vidyullatha Vasireddy,
Sean W. Clark, Mark Emory Cartwright, Karen Kozarsky, David William Anderson
1:24 p.m. S28.003
1:24 p.m. S29.003
Strong Heart Study: Cultural Factors and Risk of Cardiovascular Disease INSPIRE-IBM: An NIH-funded, two-year, multicenter, observational study in
and Stroke in American Indians/Alaskan Natives–Tyria Heath, Ka-Ho Wong, inclusion body myositis (IBM)–Marie Wencel, Namita Goyal, Tahseen Mozaffar, The
Cameron Arkin, Adam De Havenon INSPIRE-IBM Study Group
1:36 p.m. S28.004 1:36 p.m. S29.004
Racial Disparities in Dementia and Parkinson’s Disease Incidence, Healthcare Cell Culture Based Platform for High Throughput Screening of Biomolecules
Utilization, and Outcomes among Medicare Beneficiaries–Jay B. Lusk, Catherine with Neuroprotective Effect Against Bortezomib-Induced Peripheral Neuropathy
Barasch Ford, Amy Clark, Melissa Greiner, Kim Graham Johnson, Margarethe (BIPN) –Irina Utkina-Susunova, Hai Li, Charles Karan, Serge Przedborski
Goetz, Brystana Kaufman, Sneha Mantri, Ying Xian, Richard J. O’Brien, Emily 1:48 p.m. S29.005
O’Brien Repeat expansion size predicts age of onset in RFC1 CANVAS and disease
1:48 p.m. S28.005 spectrum–Andrea Cortese, Riccardo Curro, Natalia Dominik, Marios Hadjivassiliou,
Predictors of ED Presentation Times in Stroke Code Patients–Razaz Mageid, Annette Hartmann, Nazli Basak, Elisa Vegezzi, Marina Kennerson, Richard Roxburgh,
Nigel G. Laing, Davide Pareyson, Franco Taroni, Fiore Manganelli, Paola Mandich,
Richa Sharma, Dalton Neu, Rita Okumu, Ranisha Parker, Adam S. Jasne, Rachel Gian Maria Fabrizi, Chiara Briani, Sinead Murphy, Manu Jokela, Jon Infante Ceberio,
Forman Filippo Santorelli, Alfredo Brusco, Gabriella Silvestri, Stephan Zuchner, Tanya Stojkovic,
2:00 p.m. S28.006 Charlotte J. Sumner, Matthis Synofzik, Mary Reilly, Henry Houlden, on Behalf of the
Cerebral small vessel disease and depressive symptoms in adults living in RFC1 Study Group
precarious housing or homelessness: A network approach–Andrea Amy Jones, 2:00 p.m. S29.006
Melissa Woodward, Lianne Cho, Lily Zhou, Jacob Stubbs, Alasdair Barr, Allen Inflammasome inhibitors for the treatment of muscular dystrophies–Nicolas
Thornton, Alexander Rauscher, Donna Lang, William Panenka, William Honer, Dubuisson, Michel Abou Samra, Romain Versèle, Maria America Davis-López de
Thalia S. Field Carrizosa, Camille Selvais, Laurence Noel, Peter Y.K. Van den Bergh, Sonia Brichard
2:12 p.m. S28.007 2:12 p.m. S29.007
Neighborhood income inequality associated with functional independence Motor Outcomes to Validate Evaluations in Facioscapulohumeral muscular
after ischemic stroke: a cohort study–Kathryn Cote, Megan Elizabeth Pudlo, dystrophy (MOVE FSHD): Protocol for an observational study.–Michaela Walker,
Russell Butterfield, John W. Day, Katy Eichinger, Bakri Elsheikh, Anna Faino, Seth
Emma Jost-Price, Lester Y. Leung Friedman, Kiley Higgs, Nicholas Elwood Johnson, Peter Lawrence Jones, Doris G.
2:24 p.m. S28.008 Leung, Leann Lewis, William Martens, Dennis W. Shaw, Perry Shieh, S H. Subramony,
Geographic Distribution of Neurologists in Rural Areas–Micaela Rose Owens, Jaya Raghav Trivedi, Leo Hong-Li Wang, Matthew P. Wicklund, Alrabi Tawil, Jeffrey
Jasmine Owens, Christopher J. Whiting Statland
2:36 p.m. S28.009 2:24 p.m. S29.008
Increasing Mortality from Ischemic Stroke in the US, Racial and Etiological Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve):
Baseline characteristics–Jeffrey Statland, Katy Eichinger, Michael McDermott, Kiley
Analysis–Ali Abbas Fadhil, Sarah Delozier, Sophia Sundararajan
Higgs, Michaela Walker, Doris G. Leung, Sabrina Sacconi, Karlien Mul, Valeria A.
2:48 p.m. S28.010 Sansone, Elena Carraro, Leo Hong-Li Wang, Perry Shieh, Bakri Elsheikh, Samantha Jo
Embedding general neurology and tertiary care headache services in LoRusso, Russell Butterfield, Nicholas Elwood Johnson, Alrabi Tawil, Jeffrey Statland
community health centers (CHCs) in Boston, MA: establishment and early 2:36 p.m. S29.009
experiences–Angeliki Vgontzas, Cynthia So-Armah, Nadia Raymond, Pivel Bioassay-confirmed Pathogenic De Novo ATP1A1 Variants Cause a Complex
Morton, Juan Jaime de Zengotita Neurodevelopmental Syndrome–Maike Dohrn, Adriana Rebelo, Siddharth Srivastava,
Gerarda Cappuccio, Robert Smigiel, Alka Malhotra, Donald Basel, Ingrid M.B. Van de
Laar, Rinze F Neuteboom, Nicola Brunetti Pierri, Stephan Zuchner
2:48 p.m. S29.010
Ataxia And Cough Are Indicative For Biallelic RFC1 Repeat Expansions In Hereditary
Sensory And Autonomic Neuropathy–Danique Beijer, Maike Dohrn, Jonathan De
Winter, Sarah Fazal, Andrea Cortese, Tanya Stojkovic, Gorka Fernandez-Eulate, Mattia
Gentile, Gauthier Remiche, Matthis Synofzik, Peter De Jonghe, Stephan Zuchner,
Jonathan Baets

Information is accurate as of February 8, 2022, and is subject to change. AAN.com/AM 17

 SCIENTIFIC SESSIONS
Wednesday, April 6

3:30 p.m.–4:00 p.m. PT 3:30 p.m.–5:30 p.m. PT

S30 Autonomic Disorders CME

0.5 S31 Advances in Migraine Therapeutics CME
2

3:30 p.m. 3:30 p.m.

2022 Irwin Schatz Award for Autonomic Disorders: This award
recognizes young investigators who have advanced the field of autonomic
disorders, or senior investigators who have made major contributions to the
field.
Recipient: Eduardo E. Benarroch, MD, FAAN, Rochester, MN
3:42 p.m. S30.002
Alpha-Synuclein Oligomers and Neurofilament Light Chain Predict
Phenoconversion of Pure Autonomic Failure–Wolfgang Singer, Ann M.
Schmeichel, Mohammad Shahnawaz, James Schmelzer, David Michael Sletten,
Tonette Gehrking, Jade Gehrking, Mariana Suarez, Pinaki Pramathadhip Misra,
Claudio Soto, Phillip A. Low
2022 Harold Wolff-John Graham Award: An Award for Headache/
Facial Pain Research: This award recognizes early investigators who have
submitted research results in the field of headache and facial pain.
Recipient: Caroline Ran, PhD, Stockholm, Sweden
3:42 p.m. S31.002
Patients With Chronic Migraine Improving to ≤4 Monthly Headache Days is an
Effective Treatment Goal for CM–Robert G. Kaniecki, Deborah I. Friedman, Joe
Hirman, Roger Cady
3:54 p.m. S31.003
Atogepant – an orally-administered CGRP antagonist – attenuates activation
of meningeal nociceptors by Cortical Spreading Depression (CSD)–Andrew
Strassman, Agustin Melo Carrillo, Timothy Houle, Aubrey Manack Adams, Mitchell
F. Brin, Rami Burstein
4:06 p.m. S31.004
Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending
Doses of Intranasal Zavegepant in Healthy Adults–Richard Bertz, Mary Kathleen
Donohue, Jennifer Madonia, Rajinder K. Bhardwaj, Joseph Stringfellow, Matt
Anderson, David Stock, Beth Morris, Vladimir Coric, Robert Croop
4:18 p.m. S31.005
Efficacy and Safety of Erenumab 70 mg in Adult Patients with Chronic Migraine:
Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled
DRAGON Study–Shuu-Jiun Wang, Byung-kun Kim, Hebo Wang, Jiying Zhou, Qi
Wan, Tingmin Yu, Yajun Lian, Michal Arkuszewski, Laurent Ecochard, Shihua Wen,
Fangfang Yin, Zheng Li, Wendy Su, Shengyuan Yu
4:30 p.m. S31.006
Within-Person Analysis of Ubrogepant Treatment of Mild Versus Moderate-
Severe Headache Pain during a Phase 3 Long-Term Safety Extension
Trial–Richard B. Lipton, David W. Dodick, Peter Goadsby, Sung Yun Yu, Brittany L.
Jordan, Julia Ma, Janette Contreras-De Lama, Rami Burstein
4:42 p.m. S31.007
Six-month Safety and Efficacy of Fremanezumab in Migraine: Pooled Analysis
from the Phase 3 FOCUS and HALO Studies–Larry Charleston, Verena Ramirez
Campos, Xiaoping Ning, Lynda Krasenbaum, Lindsay Janka, Yoel Kessler,
Stephanie J. Nahas
4:54 p.m. S31.008
Monthly Migraine Days, Acute Medication Use Days, and Migraine-Specific
Quality of Life in Responders to Atogepant: A Post Hoc Analysis–David W.
Dodick, Richard B. Lipton, Stephanie J. Nahas, Patricia Pozo-Rosich, Peter J.
McAllister, Laszlo Mechtler, Julia Ma, Brett Dabruzzo, Matthew Beau Dufek,
Lawrence Severt, Michelle Finnegan, Joel M. Trugman
5:06 p.m. S31.009
Utility of a Novel, Combined Biofeedback-Virtual Reality Tool as Add-on
Treatment for Chronic Migraine–Ami Zarrillo Cuneo, Robin Yang, Ke Wang,
Haoran Zhou, Sarah Goh, Yuntao Wang, John Raiti, Daniel Krashin, Natalia
Murinova
5:18 p.m. S31.010
Reduction in Opioid Prescription Fills and Morphine Milligram Equivalent
Dispensed Following Initiation of Nurtec ODT Treatment – A Real World
Administrative Claims Study–Ali Mohajer, Jared Scripture, Gilbert J. L’Italien,
Linda Harris, Vladimir Coric, Noah Rosen

18 2022 AAN Annual Meeting

 SCIENTIFIC SESSIONS
Wednesday, April 6
3:30 p.m.–5:30 p.m. PT
S32 Movement Disorders: Dystonia and Tremor CME
2 S33 Cerebrovascular Disease: Basic Sciences and
Disorders
3:30 p.m.
2022 Movement Disorders Research Award: This award recognizes
an individual for outstanding work in the field of Parkinson’s disease or
other movement disorders for either a single outstanding contribution or for
lifetime achievement.
Recipient: Charles H. Adler, MD, PhD, FAAN, Scottsdale, AZ
3:54 p.m. S32.003
A Virtual Reality Platform to Facilitate Training on Treatment of Lower Limb
Spasticity With OnabotulinumtoxinA–Erin McGonigle, Sherrya A. Downie,
Alberto Esquenazi, Gerard E. Francisco, Monica Verduzco-Gutierrez, Kimberly
Ifantides, Amin Boroujerdi, Adam Buser, Gaurang Patel, Nicholas Ketchum
4:06 p.m. S32.004
Effect of Unilateral & Bilateral Ventral Intermediate Nucleus Deep Brain
Stimulation on Vocal Tremor and Voice in Patients with Essential Tremor and
Vocal Tremor. A Case Series.–Caroline Wilson, Kathryn Ruckart, Mary Moya-
Mendez, Lyndsay L. Madden, Carolyn Ann Nguyen, Jessica Tate, Mustafa S.
Siddiqui
4:18 p.m. S32.005
Repetitive Transcranial Magnetic Stimulation to the Inferior Parietal Lobule in
Task-Specific Focal Hand Dystonia: A Randomized, Sham control, Double Blind,
Crossover Study–Seethalekshmi Bhadran, Roopa Rajan
4:30 p.m. S32.006
Role of supplementary motor area in cervical dystonia and sensory tricks–Hyun
Joo Cho, Rebecca Waugh, Pattamon Panyakaew, Karin Mente, Demelio Alejandro
Urbano, Mark Hallett, Silvina Horovitz
4:42 p.m. S32.007
Histopathology of the Cerebellar Cortex in Essential Tremor and Other
Neurodegenerative Motor Disorders: Comparative Analysis of 311 Brains–Elan
D. Louis, Regina Martuscello, Morgan C. McCreary, Sheng-Han Kuo, Jean Paul
Vonsattel, Phyllis Faust
4:54 p.m. S32.008
Quantitative motion analysis and clinical characteristics of Holmes tremor
as compared to other tremor types–Sally Rebecca Williams, Johnathan Lucas
McKay, Douglas Bernhard, Mark Saad, Anh-Thu Ngo Vu, Richa Tripathi, Stewart A.
Factor, Christine Doss Esper
5:06 p.m. S32.009
Translational Pharmacology of PRAX-944, a Novel T-type Calcium Channel
Blocker for the Treatment of Essential Tremor–Corey Puryear, Liam Scott, Gabriel
M. Belfort, Shane Raines, Zoe Hughes, Bernard M. Ravina, Marion Wittmann
5:18 p.m. S32.010
Prevalence of Dystonia-Parkinsonism Gene Variants in Individuals with
Parkinsonism and Normal Dopamine Transporter Imaging–Yajing Yan Yan Xiong,
Kelly Nudelman, Lola Shukla, Jeanine Schulze, Marco Antonio Abreu, Tatiana
Foroud, Lana Chahine
Information is accurate as of February 8, 2022, and is subject to change.
3:30 p.m.–5:30 p.m. PT
CME
2
Cohort Studies
3:30 p.m. S33.001
Histone Deacetylase 3 Inhibition Decreases Cerebral Edema and Protects
the Blood-Brain Barrier after Stroke–Hui Lu, Chin Lin, Victoria Clendaniel, Rudy
Matheson, Marc Fisher, Eng Lo, Magdy H. Selim, Amjad Shehadah
3:42 p.m. S33.002
Role of ACE Polymorphism in Acute Ischemic Stroke–Alvee Saluja, Ankit Goyal,
Kallur Nava Saraswathy, Priya Bansal, Kallur Saraswathy
3:54 p.m. S33.003
Skin Capillary Amylin Deposition Resembles Brain Amylin Vasculopathy–Saurav
Das, Nirmal Verma, Gregory A. Jicha, Donna M. Wilcock, Larry B. Goldstein, Florin
Despa
4:06 p.m. S33.004
Correlation between Optical Coherence Tomography Angiography ( OCT- A)
changes at 3 to 6 weeks and functional outcome ( modified Rankin Scale –
mRS) at 3 months of onset of acute ischemic stroke due to Extracranial Internal
Carotid Artery Atherosclerotic Disease (ECAD)–Biswamohan Mishra, Awadh K.
Pandit, Rohan Chawla, Swati Phuljhele, Padma Vasantha Hadakasira, Ajay Garg,
Achal K. Srivastava, Venugopalan Y Vishnu, Rohit Bhatia, Shubham Misra
4:18 p.m. S33.005
Association of Plasma NfL Levels with Risk of Cardiovascular Disease in the
Framingham Heart Study–Hugo Javier Aparicio, Jayandra J. Himali, Dibya
Himali, Jose Rafael Romero, Vasileios-Arsenios Lioutas, Matthew Pase, Claudia L.
Satizabal, Alexa Beiser, Ramachandran Vasan, Sudha Seshadri
4:30 p.m. S33.006
Sirtuin 1 Mediated Modulation of Inflammasome Signaling Confers
Neuroprotection in Rodent Model of Ischemic Stroke Following Endovascular
Mesenchymal Stem Cell Therapy–Deepaneeta Sarmah, Aishika Datta, Antra
Chaudhary, Kiran Kalia, Anne-Marie Rodriguez, Dileep R. Yavagal, Pallab
Bhattacharya
4:42 p.m. S33.007
Correlation Between Serum Low Density Lipoprotein (ldl) Levels And
Hemorrhagic Stroke Severity: A Retrospective Review From Siren (preliminary
findings)–Oladotun Victor Olalusi, Rufus O. Akinyemi, Mayowa Owolabi,
Akintomiwa Makanjuola
4:54 p.m. S33.008
Vascular Territories In Spinal Cord Strokes: Topographic Analysis In 61
Cases–David Orlando Acero-Garces, Paula Barreras, Susana Carolina Dominguez
Penuela, Carlos A. Pardo-Villamizar
5:06 p.m. S33.009
Temporal Evaluation of MicroRNA Expression profile in Acute Anterior
Circulation Large Vessel Occlusion Stroke–Shraddha Mainali, Amy Hite, Paolo
Fadda, Naduparambil K. Jacob, Elliott Crouser, Daniel Woo
5:18 p.m. S33.010
Genetic Analyses Support a Causal Role of Lung Cancer in Ischemic Stroke–
Kevin Nhat Vanent, Julian Acosta, Cameron Both, Audrey Leasure, Victor Manuel
Torres-Lopez, Natalia Szejko, Cyprien Rivier, Adam De Havenon, Richa Sharma,
Michael Levitt, Kevin N. Sheth, Guido Jose Falcone
AAN.com/AM 19
 SCIENTIFIC SESSIONS
Thursday, April 7

1:00 p.m.–3:00 p.m. PT 1:00 p.m.–3:00 p.m. PT

S34 Research Methodology and Education CME

2 S35 Cerebrovascular Disease: Meta-analyses and CME
2
Outcomes Research
1:00 p.m. S34.001 1:00 p.m. S35.001
A Formal Mentored Peer Review Program Quantitatively Improves the Quality Mortality and One-Year Readmission Rates Following Hospital Discharge in a
of Peer Review–Whitley Warfield Aamodt, Ariel Maia Lyons-Warren, Kathleen M. Large Canadian Cerebral Venous Thrombosis Cohort–Lily Zhou, Long Ngo, Thalia
Pieper, Roy E. Strowd S. Field
1:12 p.m. S34.002 1:12 p.m. S35.002
Gender Disparities in Neurology Research–Deborah Hall, Carolyn Cahill, Ana- Sickle Cell Disease and Stroke: Data from the Florida Stroke Registry–Nastajjia
Claire L. Meyer, Amanda C. Peltier, Marisela E. Dy-Hollins, Myla D. Goldman Krementz, Kefeng Wang, Carolina Gutierrez, Negar Asdaghi, Ralph L. Sacco, Jose
1:24 p.m. S34.003 Gabriel Romano, Tatjana Rundek, Iszet Campo-Bustillo
The Neurology® Resident & Fellow Section (RFS): Performance, 1:24 p.m. S35.003
Internationalization, and Recent Challenges–Guillermo Ruben Delgado-Garcia, Age-Related Macular Degeneration is Associated with Cerebral Amyloid
Whitley Warfield Aamodt, Jose G. Merino, Roy E. Strowd Angiopathy–Bhrugun Anisetti, Hossam Youssef, Ahamed Mamoun Elkhair,
1:36 p.m. S34.004 Michelle P. Lin
Enhancing Quality Improvement Education in a Neurology Residency Program– 1:36 p.m. S35.004
Sushma Kola, Monica Ann Krause, Rafid Mustafa, Andrea N. Leep Hunderfund, One-Year Survival and Related Prognostic Factors of Stroke Patients: The
Lyell K. Jones PROVE-Stroke Study–Mahshid Givi, Negin Badihian, Mazieh Taheri, Roya Rezvani
1:48 p.m. S34.005 Habibabadi, Mohammad Saadatnia, Nizal Sarrafzadegan
The American Academy of Neurology Residents as Educators Workgroup 1:48 p.m. S35.005
Initiative: Nurturing future neurology educators–Miguel Chuquilin Arista, Joseph Neurogenic Cardiac Outcome in Patients with Acute Ischemic Stroke: The
E. Safdieh, Marie C. Eugene, Dara V. Albert, Erica A. Schuyler, Igor Rybinnik, Doris Brain-Heart Connection–Jiangyong Min, Grant James Young, Abdullah Umar,
Kung, Taylor Bartlett Harrison, Suur Biliciler, Adam Quick, Erin Furr-Stimming Andrew Kampfschulte, Nabil Wees, Nadeem I. Khan, Malgorzata Miller, Muhib
2:00 p.m. S34.006 Khan
Enhancing medical student interest in careers in the clinical neurosciences 2:00 p.m. S35.006
through a hands-on procedure workshop–Collin James Sanderson, Khadijah The Efficacy of PFO Closure in Addition to Medical Management in Reducing
Mazhar, Hina N. Dave the Recurrence of Cryptogenic Stroke - an Umbrella Meta-Analysis–Chetna
2:12 p.m. S34.007 Dengri, David Pielykh, Greshaben Patel, Muhammad Imtiaz Tar, Aakash Baskar,
A Longitudinal, Integrated Teleneurology Trainee Curriculum–Steve Choongheon Yogesh Kothari, Satish Tadepalli, Appala Suman Peela, Syed Nazeer Mahmood,
Han, Rebecca Stainman, Neil A. Busis, Scott Grossman, Sujata P. Thawani, Arielle Amit Munshi Sharma, Urvish K Patel, Shamik Shah
Marisa Kurzweil 2:12 p.m. S35.007
2:24 p.m. S34.008 Mobile Stroke Units in Acute Ischemic Stroke: A Network Meta-analysis–
Scoping Review: Innovations in Clinical Neurology Education–William Denney Abdulrahman Ibrahim Hagrass, Mohammed Al-kafarna, Aya Mamdouh Fayoud,
Zimmerman, Melissa Betts Pergakis, Emily Gorman, Nicholas Allen Morris Aboalmagd Hamdallah, Bashar Khaled Almaghary, Mohammed Tarek Elgammal,
2:36 p.m. S34.009 Sarah Makram Makram, Khaled Mohamed Ragab, Mohamed Abdelhady
Adjusting to a new normal: A single center survey of neurology applicants Abdelsadik Mostafa, Mohamed Fahmy Doheim
participating in virtual interviews–Syed Daniyal Asad, Pireh Ansari, Erica A. 2:24 p.m. S35.008
Schuyler An Association of Antiplatelet Use and Outcomes In Aneurysmal Subarachnoid
2:48 p.m. S34.010 Hemorrhage–Bianca Haley Persaud, Kareem Joudi, Christoph Stretz, Nicholas
Experiential learning of communication and professionalism for neurology S. Potter, Shawna M. Cutting, Linda C. Wendell, Bradford B. Thompson, Karen L.
faculty through virtual objective structured clinical examinations (OSCEs): Furie, Jesse Menville, Ali Mahta
Methodology and preliminary survey results–Cen Zhang, Ariane Lewis, Perrin A. 2:36 p.m. S35.009
Pleninger, Aaron Lane Nelson, Lindsey Gurin, Sondra Zabar, Steven Galetta, Laura Cholesterol-Lowering Medication Use Prior to Ischemic Strokes Secondary
J. Balcer, Arielle Marisa Kurzweil to Large Artery Atherosclerosis or Small Vessel Disease: A Single Center
Study–Anisha Garg, Anna Baker, Kamil Faridi, Adam De Havenon, Kevin N. Sheth,
Rachel Forman, Richa Sharma
2:48 p.m. S35.010
Contrast-Enhanced Transcranial Doppler Ultrasonography Versus
Transesophageal Echocardiography as Screening Tool in Embolic Stroke–Farah
Yolanda Fourcand, Nancy Gadallah, Arifa Ghori, Danisette Torres, Spozhmy
Panezai, Laura Suhan, Siddhart Kumar Mehta, Jawad F. Kirmani

20 2022 AAN Annual Meeting

 SCIENTIFIC SESSIONS
Thursday, April 7

1:00 p.m.–3:00 p.m. PT 3:30 p.m.–4:00 p.m. PT

S36 Movement Disorders: Clinical and Pathologic CME

2 S37 Global Neurology CME
0.5
Characterization of Neurodegenerative Movement
Disorders 3:30 p.m. S37.001
1:00 p.m. S36.001 Age-, sex-, and risk-specific burden of neurological diseases in the Middle East
Clinical spectrum of corticobasal degeneration: review of 238 autopsy- and North Africa from 1990 to 2019: A systematic analysis of data from the
confirmed patients–Shunsuke Koga, Aya Murakami, Ece Bayram, Naomi Kouri, Global Burden of Disease Study 2019–Abolfazl Avan, Derrick Bennett, Vladimir
Irene Litvan, Dennis W. Dickson Hachinski, Saverio Stranges, Mayowa Owolabi, Valery L. Feigin
1:12 p.m. S36.002 3:42 p.m. S37.002
Later Onset Multiple System Atrophy: Poor Prognosis and Diagnostic Characteristics of Adults With First-Ever and Recurrent Strokes in Zambia–
Challenge–Hiroaki Sekiya, Shunsuke Koga, Yoshihisa Ohtsuka, Norio Chihara, Aparna Nutakki, Lorraine Chishimba, Mashina Chomba, Stanley Zimba, Deanna
Takehiro Ueda, Kenji Sekiguchi, Yukihiro Yoneda, Yasufumi Kageyama, Riki Saylor
Matsumoto, Dennis W. Dickson
1:24 p.m. S36.003
Tau histopathological lesion type correlates of structural magnetic resonance
imaging (MRI) and diffusion tensor imaging (DTI) biomarkers in 4-repeat
tauopathies.–Arenn Faye Carlos, Nirubol Tosakulwong, Stephen Weigand, Marina
Buciuc, Farwa Ali, Heather Clark, Hugo Botha, Joseph Duffy, Rene Utianski, Mary
M. Machulda, Christopher Schwarz, Robert I. Reid, Matthew Senjem, Clifford
R. Jack, J. Eric Ahlskog, Dennis W. Dickson, Keith A. Josephs, Jennifer Louise
Whitwell
1:36 p.m. S36.004
Inhibition of C1q Reduces Nerve Damage as Measured by Neurofilament Light
Chain in the HD R6/2 Mouse Model–Alessia Tassoni, Vidhu Mathur, Joseph
Vereen, Ellen Cahir McFarland, Sethu Sankaranarayanan, Ted Yednock, Yaisa
Andrews-zwilling
1:48 p.m. S36.005
Cutaneous Alpha-Synuclein Detection in Patients with Suspected
Synucleinopathies–Christopher H. Gibbons, Bailey Bellaire, Roy L. Freeman, Todd
D. Levine
2:00 p.m. S36.006
Glucocerebrosidase Deficiency Mediates Propagation of Protein Aggregation
in Neurodegeneration via Modification of Extracellular Vesicles–Arnav Khera,
Bernice Lin, Kathryn Jewett, Ruth Thomas, Chi Q. Phan, Selina Yu, Raja Elizabeth
Estes, Leo Pallanck, Jessica Young, Marie Ynez Davis
2:12 p.m. S36.007
Preclinical In Vivo Characterization of UCB0599, an Orally Available, Small
Molecule Inhibitor of a-Synuclein Misfolding in Development for Parkinson’s
Disease–Diana Luz Price, Asma Khan, Rachel Angers, Alvaro Jesus Cardenas,
Maria Key Prato, Martin Citron, Doug Bonhaus, Anja-Leona Biere
2:24 p.m. S36.008
Patterns of TDP-43 Deposition in Brains with LRRK2 G2019S Mutations–Julian
Paul Agin-Liebes, Richard Hickman, Jean Paul Vonsattel, Xena Flowers, Richard P.
Mayeux, Matthew Surface, Karen S. Marder, Roy Alcalay
2:36 p.m. S36.009
Longitudinal Treatment Patterns for Chorea in Patients with Huntington
Disease: Data from Enroll-HD–Erin Furr-Stimming, Daniel O. Claassen, Ginny Sen,
Mallory Farrar, Ericha Franey, Chuck Yonan, Dietrich Haubenberger
2:48 p.m. S36.010
Mitochondrial Antigen Presentation In Correlation To Parkinson’s Disease-like
Symptoms.–Moustafa Nouh Badr, Annie Laplante, Diana Matheoud

Information is accurate as of February 8, 2022, and is subject to change. AAN.com/AM 21

 SCIENTIFIC SESSIONS
Thursday, April 7
3:30 p.m.–5:30 p.m. PT
S38 All Things HIV and ID CME
2 S39 Child Neurology and Developmental Neurology
3:30 p.m.
2022 AAN Neuro-infectious Disease Award: This award recognizes
individuals who have made a contribution to neuro-infectious disease
research.
Recipient: Payal B. Patel, MD, Bellevue, WA
3:42 p.m. S38.002
Evolving Clinical and Epidemiological Patterns of CNS Infections in People with
HIV Over 25 Years–Miranda Wan, Michael John Gill, Kevin Fonseca, Christopher
Power, Raynell Lang
3:54 p.m. S38.003
Decreased Myelin Content and Associated Cognitive Performance in Adults
Living with Perinatally-Acquired HIV–Payal B. Patel, Alyssa Vecchio, Peter Yi
Ch’en, Jennifer Chiarella, Shannon Kolind, Michael N. Hoff, Serena Spudich,
Christina Marra, Robert H. Paul, Swati Rane Levendovszky
4:06 p.m. S38.004
Unique Brain-Specific Antibody Signatures in Chronic HIV Infection–Marianna
Spatola, Shibani Sharon Mukerji, Dana H. Gabuzda, Galit Alter
4:18 p.m. S38.005
Circadian trends in CSF Amyloid beta-42 levels in HIV–Visesha Kakarla, Ahmed
Chenna, Christos John Petropoulos, Yolanda Lie, Dusica Curanovic, Melanie
Crescini, John Winslow, Erin Sundermann, Scott L. Letendre, Ronald J. Ellis
4:30 p.m. S38.006
Time to Confirmed Neuro-infection Diagnoses: Characterization of Current
Trends and Implications for Diagnostic Testing Approaches–Rachelle Dugue,
Eileen Harrigan, Carla Kim, Abhilasha Pankaj Boruah, Kiran Thakur
4:42 p.m. S38.007
Infectious Causes of Chronic Meningitis in Neurosurgical Patients–Tyler
Crissinger, Joseph Seemiller, John Herbst, J. David Avila, Kelly Baldwin
4:54 p.m. S38.008
Acute seizure risk in encephalitis; analysis and modelling of 436 patients from
two independent multi-centre cohorts–Greta Wood, Mark Alexander Ellul, Rhys
Huw Thomas, Ava Maria Easton, Girvan Burnside, Cordelia Dunai, Ali Alam, Sarah
Aimee Boardman, Ceryce Collie, Hannah Castell, Bethany Facer, Sylviane Defres,
Julia Granerod Whitehouse, David William Brown, Angela Vincent, Tom Solomon,
Benedict Daniel Michael
5:06 p.m. S38.009
Utility and Feasibility of Portable Ultra-Low Field MRI in Patients with
Progressive Multifocal Leukoencephalopathy–Karan Divyam Kawatra, Serhat
Vahip Okar, Samantha By, Yair Mina, Anita M. Fletcher, Shila Azodi, Daniel Reich,
Govind Nair, Irene CM Cortese
5:18 p.m. S38.010
Diagnostic Value of Clinical Phenotype and Clinical Tests in Early Creutzfeldt-
Jakob Disease–Dror Shir, Evelyn Lazar, Jonathan Graff-Radford, Allen J. Aksamit,
Jeremy K. Cutsforth-Gregory, David T. Jones, Hugo Botha, Vijay K. Ramanan,
Christian Cameron Prusinski, Amanda Lynn Porter, Gregory S. Day
22 2022 AAN Annual Meeting
3:30 p.m.–5:30 p.m. PT
CME
2
3:30 p.m. S39.001
Development of Therapy for Canavan Disease Using Human Induced Pluripotent
Stem Cells–Neal Prakash, Lizhao Feng, Jianfei Chao, Yanhong Shi
3:42 p.m. S39.002
Effectiveness and Safety of Onasemnogene Abeparvovec in Older Patients
with Spinal Muscular Atrophy (SMA): Real-World Outcomes from the RESTORE
Registry–Laurent Servais, Darryl C. De Vivo, Janbernd Kirschner, Eugenio Mercuri,
Francesco Muntoni, Eduardo Tizzano, Susana Quijano-Roy, Kyoko Saito, Melissa
Menier, Nicole LaMarca, Fred Anderson, Omar Dabbous, Richard S. Finkel
3:54 p.m. S39.003
SUNFISH: 3-year Efficacy and Safety of Risdiplam in Types 2 and 3 SMA–John W.
Day, Nicholas Deconinck, Janbernd Kirschner, Elena Mazzone, Andrés Nascimento,
Maryam Oskoui, Kyoko Saito, Carole Vuillerot, Giovanni Baranello, Odile Boespflug-
Tanguy, Nathalie M. Goemans, Anna Kostera-Pruszczyk, Laurent Servais, Jessica
Braid, Marianne Gerber, Ksenija Gorni, Carmen Martin, Renata Scalco, Wai Yin Yeung,
Eugenio Mercuri
4:06 p.m. S39.004
Onasemnogene Abeparvovec for Presymptomatic Infants with Spinal Muscular
Atrophy and Two Copies of SMN2–Kevin Strauss, Francesco Muntoni, Michelle A.
Farrar, Kyoko Saito, Jerry R. Mendell, Laurent Servais, Hugh John McMillan, Richard
S. Finkel, Kathryn J. Swoboda, Jennifer M. Kwon, Craig M. Zaidman, Claudia A.
Chiriboga, Susan T. Iannaccone, Jena M. Krueger, Julie Anne Parsons, Perry Shieh,
Sarah Kavanagh, Deepa Chand, Sitra Tauscher-Wisniewski, Bryan McGill, Thomas
Macek
4:18 p.m. S39.005
FIREFISH Parts 1 and 2: 24-month Safety and Efficacy of Risdiplam in Type 1
SMA–Basil T. Darras, Odile Boespflug-Tanguy, John W. Day, Nicholas Deconinck,
Andrea Klein, Ricardo Masson, Maria Mazurkiewicz Beldzin, Eugenio Mercuri, Kristy
Rose, Laurent Servais, Dmitry Vlodavets, Hui Xiong, Edmar Zanoteli, Angela Dodman,
Muna El-Khairi, Eleni Gaki, Marianne Gerber, Ksenija Gorni, Heidemarie Kletzl, Giovanni
Baranello
4:30 p.m. S39.006
Eladocagene Exuparvovec Gene Therapy Improves Motor Development in
Patients With Aromatic L-Amino Acid Decarboxylase Deficiency–Paul Wuh-
Liang Hwu, Yin-Hsiu Chien, Ni-Chung Lee, Sheng-Hong Tseng, Antonia Wang, Traci B.
Schilling, Chun-Hwei Tai
4:42 p.m. S39.007
Phase 2/3 Clinical Trial Results: Safety & Efficacy Results of RT001, a site-specific
(C11) di-deutero synthetic homologue of linoleic acid, in Infantile Neuroaxonal
Dystrophy–Alexander James Fay, Darius Adams, Paldeep Atwal, Frederic Heerinckx,
Mark Midei, Peter Milner
4:54 p.m. S39.008
Updated results of Transpher A, a multicenter, single-dose, Phase 1/2 clinical
trial of ABO-102 investigational gene therapy for Sanfilippo syndrome type A
(mucopolysaccharidosis IIIA)–Kevin M. Flanigan, Nicholas JC Smith, ML Couce, Maria
Escolar, KV Truxal, KL McBride, MJ de Castro, M Fuller, Astrid Pañeda, J Ruiz, Ana Del
Campo, Igor Grachev
5:06 p.m. S39.009
Contributions of Purine Synthesis and Recycling During Brain Development:
Relevance to Lesch Nyhan Disease–Fatemeh Seifar, Diane J. Sutcliffe, Piyush Joshi,
H. A. Jinnah
5:18 p.m. S39.010
Systematic Analysis of Brain MRI Findings in Adaptor Protein Complex 4 –
associated Hereditary Spastic Paraplegia Reveals Patterns for Diagnosis and
Disease Progression–Darius Ebrahimi-Fakhari, Julian Alecu, Marvin Ziegler, Afshin
Saffari, Sanjay Prabhu, Mustafa Sahin, Edward Yang
 SCIENTIFIC SESSIONS
Thursday, April 7

3:30 p.m.–5:30 p.m. PT 3:30 p.m.–5:30 p.m. PT

S40 MS Diversity and Epidemiology CME

2 S41 Autoimmune Neurology 3: Autoimmune
3:30 p.m. S40.001
Treatment Patterns Among Newly Diagnosed Patients With Multiple Sclerosis
by Race and Ethnicity–Caroline K. Geiger, Daniel Sheinson, Tu My To, David E.
Jones, Nicole Bonine
3:42 p.m. S40.002
Association of Socioeconomic Disadvantage and Neighborhood Disparities
with Clinical Outcomes in Progressive Multiple Sclerosis–Justin Abbatemarco,
Alise Carlson, Daniel Ontaneda, Marisa P. McGinley, Robert A. Bermel, Scott
Husak, David Bruckman, Jesse Schold, Deborah M. Miller
3:54 p.m. S40.003
Racial Disparities in Hypertension Management Among Multiple Sclerosis
Patients–Devon Conway, Farren Briggs, Ellen M. Mowry, Kathryn Fitzgerald, Carrie
Michelle Hersh
4:06 p.m. S40.004
The impact of socioeconomic status on subsequent neurological outcomes
in multiple sclerosis–Devi Sai Sri Kavya Boorgu, Shruthi Venkatesh, Chirag M.
Lakhani, Ines Aguerre, Claire Riley, Chirag Patel, Philip De Jager, Zongqi Xia
4:18 p.m. S40.005
Significant gender differences in clinical disease activity and severity of
multiple sclerosis: a Danish nationwide cohort study–Melinda Magyari, Nils
Koch-Henriksen
4:30 p.m. S40.006
A Prospective Study of Serum Levels of Polyunsaturated Fatty Acids and
Effects on Multiple Sclerosis Disease Activity and Progression–Kassandra
L. Munger, Kjetil Bjornevik, Marianna Cortese, Gilles Edan, Mark S. Freedman,
Hans-Peter Hartung, Xavier Montalban, Rupert Sandbrink, Ernst-Wilhelm Radue,
Frederik Barkhof, Eva-Maria Wicklein, Ludwig Kappos, Alberto Ascherio
4:42 p.m. S40.007
Ketogenic Diet as a Strategy for Improved Wellness and Reduced Disability in
Relapsing Multiple Sclerosis–James Nick Brenton, Diana Lehner-Gulotta, Emma
Woolbright, Rachael Coleman, Mark Conaway, Brenda Banwell, A. G. Christina
Bergqvist, Myla D. Goldman
4:54 p.m. S40.008
The Burden of Opportunistic Infections in Hospitalized Multiple Sclerosis
Patients: a United States population-based study of 25.8 million patients–
Lindsay Petrenchik, Farren Briggs
5:06 p.m. S40.009
B cell subset dynamic during pregnancy and early post-partum in women with
MS–Doriana Landi, Martina Severa, Alfonso Grimaldi, Gaia Cola, Giovanni Di
Mauro, Giorgia Mataluni, Carolina Gabri Nicoletti, Fabiana Rizzo, Daniela Ricci,
Eliana Marina Coccia, Gerolama Marfia
5:18 p.m. S40.010
Factors associated with Influenza vaccination rates among people with
Multiple Sclerosis–Gaviria Mariana, Carolina Ferreira, Saul Reyes, Aristides
Duque, Gavin Giovannoni
CME
2
Encephalitis, Paraneoplastic Neurologic
Disorders, Antibody-Mediated Diseases,
Immunology
3:30 p.m. S41.001
Applicability of Autoimmune Encephalitis Criteria in Clinical Practice–Emma
Jilliana Orozco, Cristina Valencia Sanchez, Divyanshu Dubey, Eoin P. Flanagan,
Nicholas L. Zalewski, Anastasia Zekeridou, Sean J. Pittock, Andrew McKeon
3:42 p.m. S41.002
Encephalitis with Autoantibodies against the Glutamate Kainate Receptor
(GluK2)–Mar Guasp, Jon Landa, Federico Javier Miguez Cabello, Joana Almeida,
Takayasu Mishima, Fumiko Oda, Frauke Zipp, Vladimir Krajinovic, Peter Fuhr,
Jerome Honnorat, Maarten Jan Titulaer, Mateus Mistieri Simabukuro, Jesùs
Planagumà, Eugenia Martinez-Hernandez, Thais Armangue, Albert Saiz, Xavier
Gasull, David Soto Del Cerro, Francesc R. Graus, Lidia Sabater, Josep O. Dalmau
3:54 p.m. S41.003
Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD within a
Real-world Large Institution Cohort–Giovanna Manzano, Rebecca Salky, Farrah
J. Mateen, Eric Klawiter, Tanuja Chitnis, Michael Levy, Marcelo Matiello
4:06 p.m. S41.004
Interaction of Anti-Yo and anti-Hu Antibodies with Neurons in Living Mice
Following Intracranial Injection or Infusion: Demonstration of Neuronal
Antibody Uptake and Early Detection of Neuronal Death–Tammy L. Smith,
Daniel R. Scoles, Noel Carlson, Stacey Clardy, John E. Greenlee
4:18 p.m. S41.005
Neurofilament light chain levels in anti-NMDAR encephalitis and primary
psychiatric psychosis–Mar Guasp, Lorena Martín-Aguilar, Lidia Sabater, Miquel
Bioque, Thais Armangue, Eugenia Martinez-Hernandez, Jon Landa, Estibaliz
Maudes, Roger Borras, Amaia Muñoz-Lopetegi, Albert Saiz, Josefina Castro-
Fornieles, Eduard Parellada, Francesc R. Graus, Luis Querol, Josep O. Dalmau
4:30 p.m. S41.006
Ovarian resection in anti-NMDAr encephalitis: A comparison of aggressive and
conservative approaches–Yajur Iyengar, Julien Hebert, Seth Andrew Climans,
Alexandra Muccilli, Gregory S. Day, Richard Wennberg, David F. Tang-Wai
4:42 p.m. S41.007
Paraneoplastic Cochleovestibulopathy: Clinical Presentations, Oncological and
Serological Associations–M Bakri Hammami, Scott D. Eggers, Ajay Madhavan,
Mayra Montalvo Perero, Sean J. Pittock, Divyanshu Dubey
4:54 p.m. S41.008
Pathogenic Th17 Cells in Autoimmune Myasthenia Gravis Exhibit a Pro-
inflammatory Transcriptomic Signature that Promotes Disease Pathogenesis–
Yingkai Li, John Yi, Changxin Wan, Zhicheng Ji, Tabitha Karatz, James F. Howard,
Janice M. Massey, Vern C. Juel, Lisa Hobson-Webb, Karissa Gable, Manisha
Chopra, Shruti M. Raja, Jeff Guptill
5:06 p.m. S41.009
Real-world effectiveness of eculizumab in generalized myasthenia gravis in
Japan: 1-year post-marketing surveillance data–Hiroyuki Murai, Shigeaki Suzuki,
Yuji Fukamizu, Takehiko Osawa, Hidekazu Kikui, Kimiaki Utsugisawa
5:18 p.m. S41.010
Real-World Eculizumab Effectiveness on US Patient Outcomes in Myasthenia
Gravis (ELEVATE): a Retrospective Chart Review–Ali A. Habib, Andrew Klink,
Srikanth Muppidi, Anju Parthan, Chloe Sader, Alexandrina Balanean, AJeet Gajra,
Richard J. Nowak, James F. Howard

Information is accurate as of February 8, 2022, and is subject to change. AAN.com/AM 23

Your Partner
in Neurology
In labs, clinics and hospitals around the world, we’re pursuing
breakthroughs that will change neurology. For everyone struggling
with Alzheimer’s, MS or any other disorder, we are leading the way for
the future of neurology. Trust our comprehensive neurology portfolio
to help you do more for your patients.

Visit us at Booth 440

To learn more, scan QR code or visit

©2022 Laboratory Corporation of America® Holdings All rights reserved. 40650-0222 labcorp.com/neurology
 SEATTLE
Poster # Date POSTERS
Goes Here Time

The Poster Hall is going high tech with all digital displays. Visit the Poster Hall multiple times per day
to catch all the latest abstract presentations with an interactive, touchscreen experience. Appropriate
cleaning protocols will occur between each use.

Posters on related topics are grouped together in “neighborhoods” for easy navigation. Standby times
when authors will be available to present their research and answer questions will occur daily from 8:00
a.m.–9:00 a.m., 11:45 a.m.–12:45 p.m., and 5:30 p.m.–6:30 p.m.

Poster Session 1 Saturday, April 2 8:00 a.m.–9:00 a.m.

1 Autoimmune Neurology
Autoimmune Neurology: Autoimmune
Encephalitis 1
P1.1-001
Anti-GABAA receptor encephalitis in patients
with multiple myeloma after autologous stem
cell transplant: A report of 3 cases – Yoji
Hoshina, Jonathan Ross Galli, Ka-Ho Wong, Tibor
Kovacsovics, Mary Steinbach, Eric Lancaster, M.
Mateo Paz Soldan, Stacey Clardy
P1.1-002
A Case of FIRES/NORSE Associated with a
Pathogenic Heterozygous Variant in TNFRSF13B
Implicated in Common Variable Immunodeficiency
– Jennifer H. Yang, Jamie LaBuzetta, Cynthia
Gonzalez, Daniel R. Cleary, Nicholas Scanlon,
Anastasie M. Dunn-Pirio
P1.1-003
Cyclophosphamide in Autoimmune GFAP
Astrocytopathy – Mohona Reza, Bridget A. Bagert
P1.1-004
Paraneoplastic Cerebellar Degeneration
– Uncommon Presentations, Unclassified
Autoantibodies – Susmit Tripathi, Harini Sarva,
Rachna Malani
P1.1-005
Seizure Control and Cognitive Outcomes in
Patients with Encephalitis - A Retrospective
Review – Omer Waqar Naveed, Rizamarie
Empeno, John Furey, Edward J. Gettings,
Mercedes P. Jacobson
P1.1-006
Neuroimaging Findings In Case Series Of 8
Patients With Autoimmune Encephalitis In A
Single Academic Center – Hongxuyang Yu,
Hongyan Wu, Joe Joseph, Shitiz K. Sriwastava
P1.1-007
A Pathway for Evaluation and Management
of Anti-NMDA Receptor Encephalitis During
Pregnancy – Diana Ontiveros, James Pham Ho,
Dena Little
2 Headache
Headache: Advances in CGRP Inhibition
for Precision Medicine 1
P1.2-001
Atogepant 60 mg Once-Daily Shows Efficacy for
the Preventive Treatment of Migraine: Results
From a 52-Week Open-Label Extension Trial –
Messoud Ashina, Stewart J. Tepper, Uwe Reuter,
Andrew M. Blumenfeld, Susan Hutchinson, Jing
Xia, Rosa Miceli, Lawrence Severt, Michelle
Finnegan, Joel M. Trugman
P1.2-002
Decrease in Body Weight With Once-Daily
Atogepant for the Preventive Treatment of
Migraine: A Post Hoc Analysis – David W.
Dodick, Debbie L. Hay, Christopher Stuart Walker,
Peter Goadsby, Jessica Ailani, Lawrence Severt,
Michelle Finnegan, Julia Ma, Hua Guo, Joel M.
Trugman
P1.2-003
Evaluation of Headache Profiles in Pediatric
Patients Pre and Post Participation in Anti-
Calcitonin Gene-Related Peptide Monoclonal
Antibody (Anti-CGRP mAb) Studies – Megan
Rooney, Jennifer McVige, Patrick Eugeni
P1.2-004
Safety and Efficacy of Fremanezumab in Different
Racial and Ethnic Subgroups of Patients With
Migraine: A Pooled Analysis of Phase 3 Studies –
Larry Charleston, Joshua M. Cohen, Xiaoping Ning,
Verena Ramirez Campos, Steve Barash, Tamar
Lengil, Byung-kun Kim
P1.2-005
A Case Report of 58-year-old Man with
CADASIL Leading to Acute Ischemic Stroke and
Intracerebral Hemorrhage Consecutively. – Dong
Jin Shin, Tae Young Kim
3 Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Risk Factors and
Basic Science 1
P1.3-001
Association of Diastolic Dysfunction and
Cognitive Impairment in the Framingham Heart
Study – Alicia S. Parker, Jayandra J. Himali, Mini
Jacob, Mitzi Gonzales, Alexa Beiser, Vinutha
Ganapathy, Leila Saadatpour, Jonathan Donnelly,
Ramachandran Vasan, Sudha Seshadri
P1.3-002
Air Pollution and Dementia: A Systematic Review
and Meta-Analysis – Elissa Wilker, Marwa
Osman, Marc Weisskopf
P1.3-003
Two novel brain iron networks explain aging-
related variation in deep gray matter – Jack
Reeves, Niels Bergsland, Dejan Jakimovski,
Fahad Salman, Juliane Damm, Nicklas Alexander
Meineke, Michael G. Dwyer, Robert Zivadinov,
Ferdinand Schweser
P1.3-004
Offspring Sex and Parental Cognition in Mid-life
and Older Adulthood – Katrin Wolfova, Di Wu,
Jordan Weiss, Pavla Cermakova, Hans-Peter
Kohler, Vegard Skirbekk, Yaakov Stern, Alison
Gemmill, Sarah Tom

Publication Code Key

26 2022 AAN Annual Meeting Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
 Poster Session 1
Poster
#Saturday, AprilHere Time
4
Pain and Palliative Care
Addressing Unmet Needs in Pain and
Palliative Care
P1.4-001
NYX-2925, a novel N-methyl-D-aspartate
Receptor Positive Allosteric-Modulator,
showed antinociceptive Activity in functional
Neuroimaging evaluations correlated with
improved Patient reported Pain and Fibromyalgia
Symptoms – Harald Murck, Steven Harte, Tony
E. Larkin, Andrew D. Schrepf, Chelsea Kaplan,
Richard Harris
P1.4-002
Clinical Milestones in PSP and MSA as Triggers
for Palliative Care Intervention – Robin Bessemer,
Alla Iansavitchene, Mary E. Jenkins, Elizabeth
Finger, Teneille Gofton
P1.4-003
Out of Sight and Out of Mind: The Nocebo Effect;
An Unmet Educational Need in Academic Medical
Centers – Derek J. Notch, Daniel Krashin, Natalia
Murinova
P1.4-004
Racial Differences In Palliative Care Utilization
And Impact On Inpatient Mortality Length Stay
And Costs Among Patients With Intracerebral
Hemorrhage – Kahtan Fadah, Mohammad Rauf
A. Chaudhry, Baljinder Singh, Danish Kherani,
Mohammad Ghatali, Saqib A. Chaudhry, Anantha
Ramana Vellipuram, Paisith Piriyawat, Alberto
Maud, Gustavo J. Rodriguez, Isabel Victoria
Narvaez- Correa
P1.4-005
Implementing a Neuropalliative Care Curriculum
for Neurology Residents – Sonya Taryn Gleicher,
Caroline Hurd, Patricia Anne Weisner, Ali Marisa
Mendelson, Claire Creutzfeldt, Breana Lynese
Taylor
P1.4-006
Implementing Team-Based Outpatient Palliative
Care in Parkinson’s Foundation Centers of
Excellence (COE): Study Design – Megan Dini,
Sandhya Seshadri, Sally Norton, Jodi Summers
Holtrop, Peggy Auinger, Nicole Lessard Yarab,
Benzi Kluger
P1.4-007
Fluoroscopy Guided Block in Nervus Intermedius
Neuralgia – MerryJean Losso, Tigran Kesayan
P1.4-008
Timing and Utilization of Inpatient Palliative Care
Consultation in People with High-Grade Glioma
– Rita Caroline Crooms, Nathalie Jette, Rachelle
Hornick, Parul Agarwal, Nathan Goldstein, Barbara
G. Vickrey
Information is accurate as of February 8, 2022, and is subject to change.
Date Goes
2 8:00 a.m.–9:00 a.m.
P1.4-009
Stressors Experienced by Primary Caregivers of
Severe Acute Brain Injury Patients Recovering
from Coma in Neurointensive Care Units:
Preliminary Findings from a Multicenter
Qualitative Study – Katherine Meurer, Rina
Kubota, Nithyashri Baskaran, Qiang Zhang,
Sarah M Bannon, Nathan Stone Fishbein, Mira
Reichman, Paula Popok, Ethan Lester, Melissa
Motta, Susanne Muehlschlegel, Jesse Menville,
Matthew N. Jaffa, Claire Creutzfeldt, Corey
R. Fehnel, Craig A. Williamson, Ana-Maria
Vranceanu, David Y. Hwang, COMA-F Investigators
P1.4-010
Ongoing Trial of Transcranial Magnetic Stimulation
(TMS) for Chronic OroFacial Pain (COFP) – Mallory
Blackwood, Mark Witcher
P1.4-011
Continuous subcutaneous apomorphine infusion
for the management of Parkinson’s disease at the
end-of-life: two preliminary case reports – Manon
Auffret, Matthieu Béreau, Laurent Tatu, Marc Verin
5 Child Neurology and
Developmental Neurology
Child Neurology: Demyelinating/
Leukodystrophy/Neuroimmunology 1
P1.5-001
Virtual Reality Testing to Assess Cerebral Visual
Impairment in X-linked Adrenoleukodystrophy
– Melissa Bambery, Camille Sierra Corre, Daniel
Conor Kelly, Amanda Marie Nagy, Catherine
Becker, Claire Manley, Christopher Richard
Bennett, Lotfi Merabet, Florian Eichler
P1.5-002
Refractory Acute Disseminated
Encephalomyelitis-like Illness Found to be CNS-
isolated Hemophagocytic Lymphohistiocytosis
due to a Novel PRF1 Mutation – Natalia Gonzalez
Caldito, Cynthia X. Wang
P1.5-003
Functional MRI Correlates of Intelligence Quotient
and Visual-Motor Coordination in Pediatric
Multiple Sclerosis – Laura Cacciaguerra, Chiara
Curatoli, Carmen Vizzino, Paola Valsasina, Maria
Assunta Rocca, Massimo Filippi
P1.5-004
Cerebral Visual Impairment in Cerebral
Adrenoleukodystrophy: Prevalence, Presentation,
and Neuroimaging Correlates – Camille Sierra
Corre, Melissa Bambery, Christopher Richard
Bennett, Haley Andonian, Daniel Conor Kelly, Lotfi
Merabet, Florian Eichler
P1.5-005
Comparing the natural history of pediatric multiple
sclerosis with onset before or after pubertal
age – Ermelinda De Meo, Massimo Filippi, Maria
Trojano, Giancarlo Comi, Francesco Patti, Vincenzo
Brescia Morra, Giuseppe Salemi, Marco Onofrj,
Giacomo Lus, Eleonora Cocco, Mattia Fonderico,
Valentina Torri Clerici, Giorgia Teresa Maniscalco,
Paola Valentino, Antonio Bertolotto, Alessandra
Lugaresi, Roberto Bergamaschi, Marco Rovaris,
Patrizia Sola, Gioacchino Tedeschi, Ilaria Pesci,
Umberto Aguglia, Paola Cavalla, Davide Maimone,
Franco Granella, Marika Vianello, Marta Simone,
Emilio Portaccio, Maria Pia Amato
6
Aging, Dementia, Cognitive, and
Behavioral Neurology
Cognitive Aging, Dementia, and Memory 1
P1.6-001
The interplay between age at menopause,
insomnia, and cognitive health: a population-
based study – Monica Shieu, Tiffany Braley,
Afsara Zaheed, Julie Stein Perry, Jill B. Becker,
Galit Levi Dunietz
P1.6-002
Improving Early Recognition of Mimics of
Creutzfeldt-Jakob Disease in Clinical Practice
– Evelyn Lazar, Amanda Lynn Porter, Christian
Cameron Prusinski, Steven Richard Dunham,
Alfonso Sebastian Lopez, M Bakri Hammami,
Divyanshu Dubey, Gregory S. Day
P1.6-003
Transient global amnesia recurrence: prevalence
and risk factor meta-analysis – Micaela
Hernandez, Julieta E. Arena, Lucas Alessandro,
Ricardo F. Allegri, Ismael Calandri
P1.6-004
Companion Animals and Cognitive Health; A
Population-Based Study – Monica Shieu, Jennifer
W. Applebaum, Galit Levi Dunietz, Tiffany Braley
P1.6-005
Open-ended, value-based decision making
requires semantic memory: a computational,
imaging, and clinical study – Andrew Kayser,
Zhihao Zhang, Samira Maboudian, Ashley Jeanne
Jackson, Sang Ngo, Winston Chiong, Ming Hsu
P1.6-006
Clinical Profile of Frontotemporal Dementia: Case
Series from a Neurological Care Center in Peru –
Sheila Castro Suarez, Erik Alberto Guevara-Silva,
Mario R. Cornejo Olivas
AAN.com/AM 27
 Poster Session 1
7 10
Sleep
Sleep: Focus on Hypersomnia and RBD 1
P1.7-001
Psychometric Evaluation of the Idiopathic
Hypersomnia Severity Scale – Benjamin
Banderas, Susan Morris, Luke Hickey, Caitlyn
Lowe, Ethan Arenson, Junji Lin, Patricia Chandler,
Yves Dauvilliers
P1.7-002
Hybrid Interviews to Confirm the Content Validity
of the Quantitatively Valid Idiopathic Hypersomnia
Severity Scale – Bhavini Srivastava, Susan Morris,
Benjamin Banderas, Caitlyn Lowe, Yves Dauvilliers
P1.7-003
Long-Term Effects of Lower-Sodium Oxybate on
Functioning and Work Productivity in Participants
With Idiopathic Hypersomnia – Richard K. Bogan,
Isabelle Arnulf, Michael J. Thorpy, Nancy R.
Foldvary-Schaefer, Patricia Chandler, Luke Hickey,
Jed Black, Yves Dauvilliers
P1.7-004
Long-Term Efficacy and Safety of Lower-Sodium
Oxybate in a Placebo-Controlled, Double-Blind,
Randomized Withdrawal Study in Adults With
Idiopathic Hypersomnia – Nancy R. Foldvary-
Schaefer, Richard K. Bogan, Isabelle Arnulf,
Michael J. Thorpy, Patricia Chandler, Luke Hickey,
Jed Black, Yves Dauvilliers
P1.7-005
Timing and Duration of Adverse Events in
a Clinical Trial of Lower-Sodium Oxybate in
Participants With Narcolepsy With Cataplexy –
Richard K. Bogan, Nancy R. Foldvary-Schaefer,
Roman Skowronski, Abby Chen, Michael J. Thorpy
8 Epilepsy/Clinical Neurophysiology
(EEG)
Epilepsy/Clinical Neurophysiology (EEG):
ASMs General 1
P1.8-001
Cardiac Effects of Lamotrigine in a Veteran
Population – Alexis Biehl, Maralena Taube, Barry
E. Gidal, Robert Joseph Kotloski
P1.8-002
Aggregated Safety and Tolerability Experience
from the Ganaxolone Development Program –
Maciej Gasior, Joseph Hulihan, Ian Miller
P1.8-003
Non-Seizure Related Outcomes With Real-World
Use of Cannabidiol (CBD) in Lennox-Gastaut
Syndrome and Dravet Syndrome: BECOME, A
Caregiver Survey – Anne T. Berg, M. Scott Perry,
Tracy Dixon-Salazar, Mary Anne Meskis, Ngoc
Minh Dang Le, Sherry Danese
28 2022 AAN Annual Meeting
Saturday, April 2 8:00 a.m.–9:00 a.m.
P1.8-004
Cannabidiol decreases seizure severity and brain
temperature in treatment-resistant epilepsy. –
Ayushe Alicia Sharma, Jerzy P. Szaflarski
P1.8-005
The Effects of Pregnancy on Levetiracetam Levels
and Seizure Frequency – Kruthika Shanmugam,
Chloe Electra Hill, Temenuzhka G. Mihaylova
P1.8-006
Cenobamate for Uncontrolled Focal Seizures
in Patients Living in a Group Home or With a
Developmental Disability – Gregory S. Connor
9 Infectious Disease
Infectious Disease: Acute and Subacute
Responses to COVID-19 1
P1.9-001
Are Elevated Interleukin-6 Serum Levels
Associated with Increased Encephalopathy and
In-hospital Mortality rates in SARS-CoV2 Patients
– Pratibha Surathi, Sviatoslav Redko, Toluwalase
Oluwakemi Tofade, Evan Huff, Mustafa Jaffry,
Kranthi Kiran Mandava, Jeffrey M. Kornitzer, Nizar
Souayah
P1.9-002
Refractory Rhombencephalitis Secondary to
SARS-CoV-2 Infection: A Case Report – Alexandra
Mae Wood, Sam Hooshmand, Ahmed Z. Obeidat
P1.9-003
A rare case of an acute ascending longitudinally
extensive necrotizing transverse myelitis in a
young woman: a severe post-COVID-19 infection
neurological complication – Franklyn Rocha
Cabrero, Nicole Baldwin, Luis Guada-Delgado,
Ashok Verma
P1.9-004
Diagnostic Characteristics and Outcomes of
Chronic Meningitis – Joseph Seemiller, Tyler
Crissinger, Jose Eduardo Eduardo Sarti, John
Herbst, Eunice H. Bae, J. David Avila, Kelly Baldwin
P1.9-005
Creutzfeldt-Jacob Disease: The Long and Short of
It – Katherine Alexandra Stiles, Saima Chaudhry
P1.9-006
A Case of Creutzfeldt-Jakob Disease Suspected
to be Acquired from Gelatin Capsules – Gaurav
Kathuria, Shimron Brown, Sean T. Kenniff
P1.9-007
Infectious Causes of Chronic Meningitis – Tyler
Crissinger, Joseph Seemiller, John Herbst, J. David
Avila, Kelly Baldwin
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
Cerebrovascular Disease and
Interventional Neurology
Cerebrovascular Disease: Interesting
Cases 1
P1.10-001
Cryoglobulinemic Vasculitis as a Cause of
Recurrent Small Vessel Strokes – Aaron Shoskes,
Ghulam Abbas Kharal
P1.10-002
A Challenging Case of Cerebral Amyloid
Angiopathy-related Inflammation (CAAri):
Implications for Secondary Stroke Prevention and
Immunomodulation Therapies – Grant William
Zeigler, Kerstin Bettermann, Cunfeng Pu
P1.10-003
Tremor Associated with a Frontal and Parietal
Cortical Infarct – Sayyeda Zahra, Cleo Zarina Alejo
Reyes, Erafat Rehim, Tsneem Mbydeen, Hussam
A. Yacoub
P1.10-004
Carotis Stenosis Presenting as Hemichorea –
Parisa Heidari, Daniela Zambrano
P1.10-005
Cortical Hemiballismus Associated With An
Isolated Insular And Temporal Infarct: A Case
Report – Jaemyoung Sung, Cleo Zarina Alejo
Reyes, Erafat Rehim, Ye Su, Atef Kokash, Yevgeniy
Isayev
P1.10-006
An unusual relapse of Amyloid-Beta related
Angiitis – Lamya Ibrahim, Grant Meeks, Ashley
Streseman, Muhammad Bilal Tariq, Meenakshi
Bidwai Bhattacharjee, Sean I. Savitz
P1.10-007
Cavernous Malformations: A Mini-Case-Series
on Diagnosis and Management – Khadija Awais,
Chetan Saini, Balaji Krishnaiah, Nitin Goyal
P1.10-008
Ischemic Stroke as a Rare Manifestation
from Graft Versus Host Renal Failure and
Immunosuppressive Therapy – Mahrin Rahman,
Ann Nguyen Ly, Lama M. Al-Khoury, Christian
Adolfo Sam, Mark Girgis, Rony Dekermenjian
P1.10-009
An Unusual Cause of Septic Emboli – Mariel
Davila Martinez
P1.10-010
Severe Allergic Reaction with Cerebral Edema
Post Flow-Diverter Device Placement for Cerebral
Aneurysm – Avi Landman, Jorge Luis Morales,
Ankur Garg, Muhammad-Atif Zubairi
 Poster Session 1 Saturday, April 2 8:00 a.m.–9:00 a.m.

11
Movement Disorders
Movement Disorders: COVID,
Telemedicine, and Community 1
P1.11-001
Telemedicine utilization and patient satisfaction
in an ambulatory movement disorders clinic during
COVID-19 – Shubhendu Mishra, Nikhil Dhuna,
Nicola Lancki, Chen Yeh, Danielle Larson
P1.11-002
TeleSCOPE: A Real-World Study of Telehealth
for the Detection and Treatment of Drug-Induced
Movement Disorders – Rimal Bera, Ericha Franey,
Kendra Martello, Morgan Bron, Chuck Yonan
P1.11-003
The Impact of Telemedicine on Serious Mental
Illness and Movement Disorders: A Literature
Review and Gap Analysis – Morgan Boname, Eric
Jen, Kendra Martello
P1.11-004
Impact of COVID-19 on Movement Disorders
Patients in the Outpatient Setting – Shaila
Ghanekar, Fnu Madhuri, Alina Shub, Luis Alejandro
Lozano, Yangxin Huang, Yarema B Bezchlibnyk,
Donald A. Smith, Robert A. Hauser, Arielle
Mitchell, Theresa A. Zesiewicz
P1.11-005
THRIVE-PD: Transforming Health and Resilience
through Interdisciplinary Virtual Engagement in
12
General Neurology
General Neurology: Cerebrovascular 1
P1.12-001
Factors associated with Idiopathic Intracranial
Hypertension (IIH) in a population-based cohort. –
Parashar Koirala, Sean Gratton
P1.12-002
Posterior Reversible Encephalopathy Syndrome
(PRES) from Immune Check Point Inhibitors (ICIs)
– Sumayya Naz, Jonathan Doan, Prajwal Hegde,
Sidra Saleem, Mehmood Rashid, Imran I. Ali
P1.12-003
Posterior Reversible Encephalopathy Syndrome
(PRES) in a Patient with Isolated Bilateral
Hippocampal Atrophy: A Case Report – Dushawn
Harley, Adena Shahinian, Tapasya Dharmesh
Surti, John Ko, Christopher Do, Chee Lim, Mark
Mckenzie, Paul H. Janda
P1.12-004
Case Report and Novel Theory for Transient Global
Amnesia – William J. Kingston, Anne M. Moss
P1.12-005
A case of pembrolizumab related PRES – Shreeja
Kadakia, Catherine Rachel Craven, Seung Yun Kim,
Brian James Hanrahan
P1.13-004
Inhibiting C1q Improves Compound Muscle Action
Potential and Reduces Neuronal Damage in the
SOD1G93A Mouse Model – Yaisa Andrews-
zwilling, Vidhu Mathur, Logan Kuhn, Sethu
Sankaranarayanan, Ellen Cahir McFarland, Ted
Yednock
P1.13-005
Suppression of MicroRNA-9-5p Mitigates TDP-43
Neurotoxicity in ALS – Liang Lu, Yan Zhang, Han-
Cheon Kim
P1.13-006
Chlorovirus Exposure in ALS Patients Identified
through Serum Antibodies also Accelerates Motor
Deterioration in SOD1G93A Transgenic Mice –
Gary L. Pattee, Tom Petro, Irina Agarkova, David
Dunigan, James Van Etten
P1.13-007
Filtration attenuates sporadic ALS CSF-induced
motor neuron death in vitro – Ivy Gao, Rose
Putnam Griffin, Nadia Merve Celestin, Jamie
Wong, Saud A. Sadiq
P1.13-008
Using In Vitro Experiments to Determine MFN2’s
Function in ALS – Kristi Russell, Jon Downie,
Summer Gibson, Karla Patricia Figueroa, Mark B.
Bromberg, Charles Murtaugh, Lynn Jorde, Stefan
M. Pulst

Parkinson Disease – Roshini Srinivasan, Sneha
Mantri, Kyle T. Mitchell
P1.11-006
The Impact of COVID-19 on People with
Parkinson’s: Insights from Wearable Sensors –
Meghan Elizabeth Pawlik, Stella Jensen-Roberts,
Emma Waddell, Taylor Myers, Julia Marie Soto,
Emily Hartman, Ekene Nnadika, Phillip T. Yang,
Renee Wilson, Karlo J. Lizarraga, Christopher
Tarolli, Ruth Schneider, E. Ray Dorsey, Jamie Lynn
Adams
P1.11-007
A novel tele-rehabilitation program aimed at
reducing fall risk in Parkinson’s Disease patients –
Noel Cabanas, Mitra Afshari, Andrea Hernandez,
Glenn Thurston Stebbins, Christopher Goetz
P1.11-008
Clinical Characteristics of COVID-19 in Patients
with Parkinson’s Disease – Carlos Ivan Salazar
Deras, Brad Tyson, Pinky Agarwal
13
Neuromuscular and Clinical
Neurophysiology (EMG)
Neuromuscular Disease: Amyotrophic
Lateral Sclerosis 1
P1.13-001
24-Week Results From Phase 3 Study MT-
1186-A01 an Open-Label, Multicenter Safety
Study of Oral Edaravone in Subjects With
Amyotrophic Lateral Sclerosis – Angela L. Genge,
Gary L. Pattee, Gen Sobue, Philippe Couratier,
Daniel Selness, Manabu Hirai, Takeshi Sakata,
Alejandro Salah, Stephen Apple
P1.13-002
Lessons Learned From A Large-Scale Audio-Visual
Remote Data Collection For Amyotrophic Lateral
Sclerosis Research – Vikram Ramanarayananan,
Michael Neumann, Aria Anvar, David
Suendermann-Oeft, Oliver Roesler, Jackson
Liscombe, Hardik Kothare, James D. Berry, Ernest
Fraenkel, Raquel Norel, Alexander Sherman,
Jochen Kumm, Indu Navar
P1.13-003
Machine Learning Enables Smaller ALS Clinical
Trials – Daniele Bertolini, Katelyn Arnemann,
Diana Hall, Jonathan Walsh

Information is accurate as of February 8, 2022, and is subject to change. AAN.com/AM 29

 Poster Session 2
1
Autoimmune Neurology
Autoimmune Neurology: Autoimmune
Encephalitis 2
P2.1-001
Approach to patients with autoimmune
encephalitis with no identifiable antibodies –
Carolina Gil Tommee, Praveen Ramani, Erika
Santos Horta, Sisira Yadala
P2.1-002
Co-Occurrence of Sj/ITPR1 and NMDA Antibodies:
A Case Report – William Daniel Chapman, Allison
Macke, Joseph P. Broderick, Simona Ferioli
P2.1-003
Isolated headache as the sole manifestation of
autoimmune GFAP astrocytopathy – Eslam Hamdy
Shosha, Colleen M. Connolly, Adrian Budhram
P2.1-004
A Curious Case of LGI1 Autoimmune Encephalitis
Presenting as Chronic Hyponatremia and
Subacute Dementia Without Faciobrachial
Dystonic Seizures – Joshua Luster, Ashley Barasa,
William Hoffman
P2.1-005
New Onset Seizures and Rapidly Progressive
Cognitive Impairment in a Patient With Prion
Negative 14-3-3 Tauopathy and GABA- B Receptor
Antibody Encephalitis: Case Report and Literature
Review – Schweta Parag Rane, Xiang Fang
P2.1-006
Autoimmune Glial Fibrillary Acidic Protein
Astrocytopathy Presenting as Dementia with
Lewy Bodies – Caroline Olvera, Thomas Jack
Shoemaker, Jori Fleisher
P2.1-007
A Case of Opsoclonus-Myoclonus Ataxia with
Neuronal Intermediate Filament IgG Detected in
CSF – Melody Merati, Janet C. Rucker, Sean J.
Pittock, Andrew McKeon, Laura J. Balcer, Steven
Galetta
2
Headache
Headache: Advances in CGRP Inhibition
for Precision Medicine 2
P2.2-001
Effect of Strong P-gp and BCRP Inhibition, Using
Cyclosporine and Quinidine as Probes, on the
Pharmacokinetics of Oral Rimegepant 75 mg in
Healthy Subjects – Richard Bertz, Matt Anderson,
Julie Collins, Joseph Stringfellow, Jennifer
Madonia, Rajinder K. Bhardwaj, Jeri-anne Finley,
David W. Dodick, Vladimir Coric, Robert Croop
30 2022 AAN Annual Meeting
Saturday, April 2 11:45 a.m.–12:45 p.m.
P2.2-002
Acute Treatment with Oral Rimegepant 75 mg
Reduces Migraine-Related Disability in Adults
With and Without a History of Triptan Treatment
Failure: Results from a One-Year, Open-Label
Safety Study – Christopher Jensen, Alexandra
Thiry, Edward Kim, Meghan Lovegren, Robert
Croop, Vladimir Coric, Gilbert J. L’Italien, Richard
B. Lipton
P2.2-003
Within-Person Consistency of Acute Treatment
Success With Ubrogepant: Results From a Long-
term Safety Study – Charles Iaconangelo, Daniel
Serrano, Ella Engstrom, Janette Contreras-De
Lama, Joel M. Trugman, Aubrey Manack Adams,
Richard B. Lipton
P2.2-004
Evaluation of the Pharmacokinetic Interaction
and Safety of Coadministered Atogepant
and Topiramate – Ramesh Boinpally, Danielle
McGeeney, Lisa Borbridge, Matthew Butler,
Lawrence Severt
P2.2-005
Post-hoc Analysis of Safety in Phase 3 Atogepant
ADVANCE Trial Participants with or without
Cardiovascular Disease Risk Factors – Andrew
M. Blumenfeld, Susan Hutchinson, Jelena M.
Pavlovic, Patricia Jeanne Markovi Best, Teshamae
Monteith, Julia Ma, Jonathan H. Smith, Lawrence
Severt, Brett Dabruzzo, Stephanie J. Nahas
P2.2-006
An Open-label, Intermediate-sized, Expanded
Access Protocol of Rimegepant in the Acute
Treatment of Migraine – Robert Croop, Thomas
Shiovitz, Arif Khan, Tamara Noonan, Stephen
Kaplita, Mitch Mitchell Seymour, Christopher
Jensen, Vladimir Coric
3 Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Risk Factors and
Basic Science 2
P2.3-001
Proteostasis Network Changes in Dermal
Fibroblasts in Aging and Neurodegeneration –
Ashlyn Johnson, James Webster, Eric Dammer,
Duc Duong, Chad Hales
P2.3-002
Chromatin accessibility differences between
African and European Alzheimer Disease brains.
– Katrina Celis, Anthony J. Griswold, Farid Rajabli,
Kara Hamilton-Nelson, Sandra Weintraub, Marla
Gearing, Changiz Geula, John Q. Trojanowski,
Clifton Dalgard, David A. Bennett, Margaret A.
Pericak-Vance, Juan Young, Jeffery M. Vance
P2.3-003
Improving Precision For Early Detection of Stroke
Risk: Biological Aging Physiology and DNA
methylation Cross-Talk – Reem Waziry, Amelia
Katharine Boehme, Daniel W. Belsky, Yian Gu
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P2.3-004
AMPKa2 and Neuronal Structure: Implications for
Metformin – Jonas Kruse, Kiran Chaudhari, Linshu
Wang, Ali Winters, Ran Liu, Shaohua Yang
P2.3-005
The Effects of Prolonged Water-Only Fasting on
Senescence Associated Secretory Phenotype –
Eugene L. Scharf, Marina Buciuc, Evelyn Zeiler,
Breno Diniz, Toshia Myers
4
MS and CNS Inflammatory
Disease
MS Biomarkers
P2.4-001
Elevated Serum Glial Fibrillary Acidic Protein is a
Biomarker of Disease Progression in Progressive
Multiple Sclerosis Patients – Christian Barro, Brian
Curran Healy, Yanqing Liu, Shrishti Saxena, Anu
Paul, Mariann Polgar-Turcsanyi, Harald Kropshofer,
Howard L. Weiner, Tanuja Chitnis
P2.4-002
Association Between Serum Glial Fibrillary Acidic
Protein and Retinal Structural Changes in Patients
with AQP4-antibody Positive Neuromyelitis
Optica Spectrum Disorder – Ting-Yi Lin, Patrick
Schindler, Frederike Cosima Oertel, Angelo Lu,
Seyedamirhosein Motamedi, Ankelien Duchow,
Jens Kuhle, Pascal Benkert, Alexander U. Brandt,
Friedemann Paul, Klemens Ruprecht, Hanna
Zimmermann
P2.4-003
Superiority of Serum NFL in Predicting Multiple
Sclerosis STo develop and validate mathematical
adjustment of serum neurofilament light chain
(sNFL) for relevant confounders to strengthen
its clinical utility everity – Peter Kosa, Ruturaj
Masvekar, Mika Komori, Jonathan Phillips,
Vighnesh Ramesh, Mihael Vito Varosanec, Mary
Sandford, Bibiana Bielekova
P2.4-004
miRNA as biomarkers of NEDA-3 in multiple
sclerosis patients treated with fingolimod,
glatiramer acetate and dimethyl-fumarate:
Preliminary results – Alicia Gonzalez-Martinez,
Brian Curran Healy, Hrishikesh A. Lokhande, Anu
Paul, Shrishti Saxena, Mariann Polgar-Turcsanyi,
Howard L. Weiner, Tanuja Chitnis
P2.4-005
Functional analysis of validated miRNAs
associated with MS disability – Alicia Gonzalez-
Martinez, Hrishikesh A. Lokhande, Tanuja Chitnis
P2.4-006
The role of serum neurofilament light chain
in an adult cohort of patients with acquired
demyelinating syndromes of the central
nervous system – Luca Bollo, Pietro Iaffaldano,
Maddalena Ruggieri, Claudia Palazzo, Mariangela
Mastrapasqua, Francesca Caputo, Tommaso
Guerra, Alessia Manni, Damiano Paolicelli, Marta
Simone, Antonio Frigeri, Maria Trojano
 Poster Session 2
P2.4-007
Exploratory Analysis of Serum GDF-15 Levels in
Patients Receiving Subcutaneous Interferon ß-1a
in the REFLEX Trial – Mali Cristina Coray, Andrea
Seitzinger, Sanjeev Roy, Mark S. Freedman,
Frederik Barkhof, Giancarlo Comi, Nicola De
Stefano, Ludwig Kappos, Jens Kuhle, Matthias
Mehling
P2.4-008
Cortical remyelination failure predicts cortical
atrophy and clinical progression in early
multiple sclerosis – Andrea Lazzarotto, Mariem
Hamzaoui, Matteo Tonietto, Vito Antonio Gerardo
Ricigliano, Giacomo Boffa, Michael Khalil, Lukas
Pirpamer, Stefan Ropele, Christian Enzinger,
Marco Battaglini, Maria Laura Stromillo, Nicola
De Stefano, Maria Assunta Rocca, Paolo Gallo,
Claudio Gasperini, Bruno Stankoff, Benedetta
Bodini
P2.4-009
Association of Neuroaxonal and Glial Biomarkers
with Clinical Phenotype in Underrepresented
Minority Multiple Sclerosis Populations – Neda
Sattarnezhad, Daniel B. Hier, Jason P. Mendoza,
Linda A. Piccinini, Michael D. Carrithers
MS COVID 1
P2.4-010
COVID19 infections in patients with Multiple
Sclerosis (MS) on Various treatments at Kaiser
Permanent Mid-Atlantic States (KPMAS) – Ejaz
Shamim, Kyle Tse, Crystal Xue, Daniel Tadeo,
Edward Jiwon Yoon, Andrew J. Dutka, Melvin
W. Kong, Ella Akkerman, Venkatesh Pusarla,
Christopher Gordon-Cuno, Stephen Winn
P2.4-011
The impact of COVID-19 on the disease activity of
multiple sclerosis: A Retrospective cohort study
– Abdulaziz Bajafar, Fawzi Babtain, Ohood Nazmi,
Manal A. Badawi, Ahmed Basndowah, Areej
Bushnag, Edward J. Cupler, Ahmad Hassan
5 Child Neurology and
Developmental Neurology
Child Neurology: Demyelinating/
Leukodystrophy/Neuroimmunology 2
P2.5-001
NMDAR-Ab Encephalitis Presenting as a Rett
Syndrome Mimic in a 2 year old – Young-Min Kim,
Taryn Liu, Montserrat Montesinos, Sunitha Lena
Nune, Gregory S. Aaen
P2.5-002
Neurodegenerative Encephalomyelopathy
Associated with ACOX-1 Gain-of-Function
Mutation Partially Responsive to Immunotherapy
– Saba Jafarpour, Mellad Khoshnood, Jonathan
Santoro
Information is accurate as of February 8, 2022, and is subject to change.
Saturday, April 2 11:45 a.m.–12:45 p.m.
Child Neurology: Neurodevelopmental
Disorders/CP/ASD 1
P2.5-003
Expanding the Phenotypic Spectrum of ECEL1-
Associated Distal Arthrogryposis – Akshata
Huddar, Kiran Polavarapu, Preethish Kumar
Veeramani, Mainak Bardhan, Gopikrishnan
Unnikrishnan, Saraswati Nashi, Seena Vengalil,
Karthik Kulanthaivelu, Gauthaman Arunachal,
Atchayaram Nalini
P2.5-004
The Mitochondrial Neurodegenerative Diseases
MELAS and LHON-Plus: How Translational
Research Converts Challenges into Therapeutic
Opportunities and Clinical Trial Design – Andrea
L. Gropman, Martine Uittenbogaard, Anne
Chiaramello
P2.5-005
FARSA Mutations Causing Cerebral Microcysts,
Cystic Interstitial Lung Disease, Growth
Restriction, and Developmental Delay – Charles J.
Kidd, Cole Phillips Denkensohn
6 Aging, Dementia, Cognitive, and
Behavioral Neurology
Cognitive Aging, Dementia, and Memory 2
P2.6-001
The relation between thyroid dysregulation and
impaired cognition/behaviour: An integrative
review – Manizhe Eslami-Amirabadi, S. Ahmad
Sajjadi
P2.6-002
Factors Influencing Compliance in Independent
In-Home Exercise Trial for Older Adults – Margaret
Kelly Specht, Katherine Elaine Snyder, Justin
Barber, Barbara J. Martin, Shani H. Bardach,
Gregory A. Jicha
P2.6-003
Delayed Leukoencephalopathy after an Opioid-
related Acute Amnestic Syndrome – Brady T.
Mannett, Luis Guillermo Manrique, Elias Samaha
P2.6-004
Keep it in Sight: A Case of the Heidenhain Variant
in Creutzfeldt-Jakob Disease – Claudia Vallin,
Maria Gabriela Martucci, Damon Salzman
P2.6-005
A case of apperceptive visual agnosia mistaken
for Broca aphasia – Manizhe Eslami-Amirabadi,
Oleg Yerokhin Yerstein
7
Sleep
Sleep: Focus on Hypersomnia and RBD 2
P2.7-001
Validation of a Clinical Scale for Defining RBD
Severity in Participants of the North American
Prodromal Synucleinopathy (NAPS) Consortium
– Andrea Oana Busicescu, Parichita Choudhury,
Joyce K. Lee-Iannotti, Pooja Rangan, David
Shprecher, Maria Livia Fantini, Miranda M. Lim,
John Elliott, Alon Y. Avidan, Daniel Huddleston,
Donald Biwise, Michael J. Howell, Carlos H.
Schenck, Susan Criswell, Emmanuel H. During,
Emmanuel Mignot, Jennifer Svoboda McLeland,
Amelie Pelletier, Jean-Francois Gagnon, Leah
Kathleen Forsberg, Julie A. Fields, Erik Kent St.
Louis, Aleksandar Videnovic, Yo-El Ju, Bradley F.
Boeve, Ronald Postuma
P2.7-002
Symptom Severity and Treatment Satisfaction in
Patients With Idiopathic Hypersomnia: the Real
World Idiopathic Hypersomnia Outcomes Study
(ARISE) – Logan D. Schneider, Joanne Stevens,
Aatif M. Husain, Diane Ito, Wayne Macfadden,
Douglas S. Fuller, Phyllis C. Zee
P2.7-003
Where do patients get diagnosed with idiopathic
Rapid Eye Movement Behavior Disorder? –
Isabelle Havis, Vikas Kotagal
P2.7-004
Development and Description of the International
RBD Study Group RBD Symptom Severity Scale –
Ronald Postuma, Maria Livia Fantini, Bruno Pereira,
Parichita Choudhury, Joyce K. Lee-Iannotti
P2.7-005
Factors Associated with Sleep Disturbance after
Hemorrhagic Stroke – Sarah Ecker, Aaron S. Lord,
Lindsey Gurin, Koto Ishida, Kara R. Melmed, Jose
L. Torres, Barry M. Czeisler, Cen Zhang, Jennifer A.
Frontera, Ariane Lewis
AAN.com/AM 31
 Poster Session 2
8 Epilepsy/Clinical Neurophysiology
(EEG)
Epilepsy/Clinical Neurophysiology (EEG):
COVID 19 and Others 1
P2.8-001
Position and Patient Safety Measures in the
Epilepsy Monitoring Unit – Pamela O’Dea, Jeffrey
Karduck, Juliana Leonardo, Andrew C. Schomer,
Mark S. Quigg
P2.8-002
NeuroMeasures™: Implementation of a Web-
Based Real-Time Quality Metric Tool to Improve
Provider Practices in an Epilepsy Clinic – Maryam
Jamil Syed, Rohit Ajay Marawar, Maysaa Merhi
Basha, Deepti Zutshi
P2.8-003
WITHDRAWN
P2.8-004
Assessment of Adherence to Telehealth Versus In-
person Epilepsy Clinic Visits in the Pre- and During
COVID-19 Era – Saniya Pervin, Ruta Nandan
Yardi, Meriem K. Bensalem Owen, Sally Valentina
Mathias
P2.8-005
Seizure Control During COVID-19: A Study Using
the Responsive Neurostimulation System (RNS)
– Ryan Ward, Cemal Karakas, Henry Skrehot,
Alexandra Vallera, Stephen Cleboski, Zulfi Haneef
P2.8-006
COVID-19 Patient’s Background Frequency on
EEG Predictive of Hospital Discharge Disposition
– Wonhee Lee, Kaitlin Seibert, Amy Espinal,
Alexandra Eid, Sumayyah Abumurad, Sara A.
Klein, Shasha Wu, Sandra Rose, James X. Tao,
Naoum P. Issa
P2.8-007
Ensuring the Continuity of Data Collection in a
Focal Epilepsy Clinical Trial During the COVID-19
Pandemic – Lilly Frohlich, Laura Whitmore,
Stephanie Pfister, Rachel Gurrell, Ann Marie
Dandurand, Pamela Perry, Matthew Leoni
32 2022 AAN Annual Meeting
Saturday, April 2 11:45 a.m.–12:45 p.m.
9 Infectious Disease
Infectious Disease: Acute and Subacute
Responses to COVID-19 2
P2.9-001
A Novel Case of Longitudinally Extensive
Transverse Myelitis following COVID-19
Vaccination in a Pediatric Patient – Amna Imran,
Susana Soto, Rupin Singh, Migvis Monduy
P2.9-002
Acute Transverse Myelitis: an upcoming
complication of COVID-19 infection –
Harshadayani Jagadish Kumar, Siddharth
Bhattacharjee, Yash Bhattarai
P2.9-003
Transverse Myelitis associated with COVID-19
in adults – Allyson Heng, Nidhi Shankar Kikkeri,
Vanessa Sui, William R. Meador, Shruti Prabodh
Agnihotri
Diagnostics and Other Considerations for
Neuroinfectious Diseases 2
P2.9-004
Application of Metagenomic Next-Generation
Sequencing in the Diagnosis of Neuroinfectious
Diseases – Abhilasha Pankaj Boruah, Adam
Kroopnick, Carla Kim, Riddhi Thakkar, Rachelle
Dugue, Eileen Harrigan, Walter Ian Lipkin, Nischay
Mishra, Kiran Thakur
P2.9-005
Inclusion Criteria for Sending Cerebrospinal
Fluid pathogen Metagenomic Next-Generation
Sequencing – Lei Liu, Jingxiao Zhang
P2.9-006
Atypical Presentation of Neurosarcoidosis: A
Case Report – Cleo Zarina Alejo Reyes, Negar
Moheb, Ramiro Gabriel Castro Apolo, Christopher
Melinosky
P2.9-007
Delayed Toxic Encephalopathy Masquerading as
Creutzfeldt-Jakob disease – Cory P. Hackmyer,
Jenifer Nicole Moceri, Nora Ko, Brian James
Hanrahan
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
10 Cerebrovascular Disease and
Interventional Neurology
Cerebrovascular Disease: Interesting
Cases 2
P2.10-001
Acute Embolic Stroke Presenting With Complete
Hearing Loss – Ventaka Bendi, Connor Eggleston,
Ram Mohan R. Sankaraneni
P2.10-002
Reversible rapidly progressive dementia due to
a high-grade, dural arteriovenous fistula: a case
report – Juan José Mendez Gallardo, Mallyolo
Eliezer Pelayo Salazar, Ivan Camilo Baracaldo,
Santiago Ortega Gutierrez, Antonio Arauz, Alfredo
Montenegro
P2.10-003
Cerebral Venous Thrombosis: A Possible
Complication of Clomiphene Therapy for in vitro
Fertilization – Moises-Zacariah Garcia, Emily Liu,
Arthur Andrada, Jebun Nahar
P2.10-004
Iron Deficiency Anemia with Reactive
Thrombocytosis Associated with Internal Carotid
Artery Thrombus and Ischemic Infarction – Ashley
Nelson, Cassie Lee Nankee, Chirantan Banerjee
P2.10-005
Can she ever fly again? A curious case of a PICA
infarct in a healthy woman at high altitude and a
review of known cerebrovascular changes at high
elevations – William Hoffman
P2.10-006
Case Report of Takayasu Arteritis Presenting
as Stroke – Sean W. Scarpiello, Hemal Patel,
Hamidreza Abbasi, Nancy Gadallah, Jawad F.
Kirmani
P2.10-007
Isolated Abducens Nerve Palsy as a Presentation
of Extracranial Internal Carotid Artery Dissection:
A Case Report – Keyvan Heshmati, Jorge Luis
Rodriguez Lee, Nora Montealegre, Volodymyr
Vulkanov
P2.10-008
Massive Cerebral Air Embolism in a Patient with
Pulmonary Aspergillosis – Hyun-Wook Nah
P2.10-009
Horizontal Gaze Palsy in Two Patients with
Subcortical Stroke. Case Report – Leigham
Breckenridge, Vaibhav Goswami
P2.10-010
Retinal Claudication: A Rare Case of Light-Induced
Amaurosis Fugax Secondary to Occlusive Carotid
Artery Disease. – Ahmer Asif, Oleksandra Los,
Juliane Chainakul, Ahmad Al-Awwad
 Poster Session 2
11
Movement Disorders
Movement Disorders: Outcomes in DBS
and PD 1
P2.11-001
Real-World Outcomes Using a Novel Directional
DBS System for Parkinson’s disease – Guenther
Deuschl, Roshini Jain, Heleen Scholtes, Alex
Wang, Michael Barbe, Steffen Paschen, Chong S.
Lee, Andrea Kuehn, Jan Vesper
P2.11-002
Social Support and Clinical Outcomes in Patients
with Parkinson Disease After Deep Brain
Stimulation – Sydney Morgan Spagna, Asra
Askari, Parag Patil, Kelvin L. Chou
P2.11-003
Real-World Deep Brain Stimulation Outcomes
Using DBS Systems with Directionality and
Multiple Independent Current Control – Theresa
A. Zesiewicz, Michael Barbe, Steffen Paschen,
Corneliu C. Luca, Cong Zhi Zhao, Francisco Ponce,
Jennifer Lyn Durphy, Jill L. Ostrem, Nestor Tomycz,
Tino Prell, Mustafa S. Siddiqui, Lilly Chen, Roshini
Jain
P2.11-004
Outcomes After IPG Replacement Surgery Near
End of Life in Parkinson’s Disease – Charlotte
Wahle, Jacob Esper Yomtoob, Phillip Cem Cezayirli,
Emad Eskandar, Todd Herrington
P2.11-005
Effectiveness of Clinical Decision Support for the
California Parkinson’s Disease Registry – Emily
Laltoo, Lawrence Dardick, Keith Garb, Lauren Claire
Byrne, April Michelle Taylor, Laxmi Kumar, Andrew
M. Wilson, Allan Ding Wu
P2.11-006
Impact of caregiver characteristics on patient
outcomes in Parkinson’s disease – Rudmila
Rashid, Nabila Dahodwala
P2.11-007
Tandem gait step-width declines more rapidly in a
stage-dependent manner with Parkinson’s disease
progression – Jennie Burns, Lakshmi Pillai, Aliyah
Jasmine Glover, Tuhin Virmani
Information is accurate as of February 8, 2022, and is subject to change.
Saturday, April 2 11:45 a.m.–12:45 p.m.
12
General Neurology
General Neurology: Cerebrovascular 2
P2.12-001
Assessment of Olfactory Function in Classical
(Infratentorial) Superficial Siderosis – Natallia
Kharytaniuk, Menelaos Pavlou, David Werring,
Doris-Eva Bamiou
P2.12-002
Delayed Post-hypoxic Leukoencephalopathy
Presenting as Acute Psychosis without Focal
Neurologic Deficits – Jeff Wang Jin, Samantha
Hentosh, James Walker Wiggins, Vivek Nishad
Mehta, Jordan Shull, Jay-Jiguang Zhu, Meenakshi
Bidwai Bhattacharjee
P2.12-003
Diffusion restriction in the splenium of the corpus
callosum: Clinical presentation, neuro-imaging
findings, and hospitalization outcomes – Brian
Stamm, Christina Lineback, Mengxuan Tang, Dan
Tong Jia, Farzaneh Aghdassi Sorond, Behnam
Sabayan
P2.12-004
Hypoxic-ischemic Injury as a Rare Complication
of Sudden Severe Anemia – Alexandre Mason
Sharma, Nikhil B. Bhana, James E. Siegler
P2.12-005
Ascorbic Acid Deficiency As Culprit Of Cortical
Spontaneous Subarachnoid Hemorrhage. Case
Report And Literature Review. – Maria Shoaib,
Ramsha Ali Bhutta, Nidhiben A. Anadani, Ahmad
Al-Awwad
13 Neuromuscular and Clinical
Neurophysiology (EMG)
Neuromuscular Disease: Amyotrophic
Lateral Sclerosis 2
P2.13-001
Retrospective Review of Outcomes After
Intervention for Enteral Nutrition in ALS Patients
Enrolled in Midwest Multi-disciplinary ALS
Clinics – Timothy R. Fullam, Suzanne Hunt, Swathy
Chandrashekhar, Omar Jawdat, Brian Ghafari-
Naraghi, Ezequiel A. Piccione, J. Americo M.
Fernandes, Richard J. Barohn, Katy Eichinger
P2.13-002
Is There Any Association Between the Prevalence
of ALS and Exposure to Hazardous Wastes? A
Statewide Planning and Research Cooperative
System (SPARCS) Study (2002-2014) – Yueqing
Zhang, Sanjila Islam, Kranthi Kiran Mandava,
Mustafa Jaffry, Nizar Souayah
P2.13-003
Use of Electrical Impedance Tomography to
Assess Pulmonary Function in ALS Patients
– Courtney E. McIlduff, Allaire Doussan, Irene
Yator, Sarah Verga, Soleil Samaan, Hilda Victoria
Gutierrez, Ethan K Murphy, Elijah Stommel, Sean
Levy, Ryan J Halter, Seward B. Rutkove
P2.13-004
Continued Intravenous Edaravone Treatment in
Patients with Amyotrophic Lateral Sclerosis (ALS)
Increases Overall Survival Compared With No
Intravenous Edaravone Treatment: Results from a
US Administrative Claims Database – Benjamin R.
Brooks, James D. Berry, Malgorzata Ciepielewska,
Jeffrey Zhang, Ying Liu, Gustavo A. Suarez-
Zambrano, Melissa Hagan
P2.13-005
Treatment Outcomes Among Amyotrophic
Lateral Sclerosis Patients Receiving Intravenous
Edaravone (IV): 44 Months of Follow-up From
US Specialty Infusion Centers – Melissa Hagan,
Malgorzata Ciepielewska, Polina Da Silva, Ying Liu,
Jeffrey Zhang, Barbara Prosser, Daniel Rosenberg,
Anusha Patni, Marlena Anderson, Kayla Ortlip,
Karen Martin, Stephen Apple
P2.13-006
Clinical and Electrophysiological Findings in
C9orf72 ALS – Sri Raghav Seshu Sista, Shahar
Shelly, Carolina Parra-Cantu, Jennifer Marie
Martinez-Thompson, Nathan P. Staff, Ruple S.
Laughlin
P2.13-007
Prognosis of Pathologically Confirmed Japanese
Amyotrophic Lateral Sclerosis with Tracheostomy
Invasive Ventilation, a Retrospective Institute-
based Study – Kiyonobu Komai, Chiho Ishida,
Kazuya Takahashi, Yuko Motozaki, Atsuro Tagami
P2.13-008
Study Design for a Phase 3, Multicenter, Open-
Label, Safety Extension Study of Oral Edaravone
Administered Over 96 Weeks in Patients with ALS
(MT-1186-A03) – Daniel Selness, Manabu Hirai,
Takeshi Sakata, Alejandro Salah, Stephen Apple
AAN.com/AM 33
 Poster Session 3
1 Autoimmune Neurology
Autoimmune Neurology: Peripheral
Nervous System and Muscle 1
P3.1-001
Baseline Characteristics and Demographics of
Patients Enrolled in an Expanded Access Program
for Efgartigimod in Adult Patients with Generalized
Myasthenia Gravis – Deborah Gelinas, Omar
Rahman, Erin Powers Lambert, Benjamin Van
Hoorick
P3.1-002
Pharmacokinetics and Pharmacodynamics
of Ravulizumab in Adults with Generalized
Myasthenia Gravis: Results from the Phase 3
CHAMPION MG Study – Tuan Hoang Vu, Stephan
Ortiz, Masahisa Katsuno, Djilalli Annane, Renato
Mantegazza, Kathleen Beasley, James F. Howard
P3.1-003
Safety of different IVIG doses for treatment of
CIDP. The ProCID study – Elisabeth Clodi, David R.
Cornblath, Pieter Van Doorn, Hans-Peter Hartung,
Ingemar S.J. Merkies, Hans D. Katzberg, Doris
Hinterberger, and the ProCID Investigators
P3.1-004
The ProDERM study: Safety and Tolerability Results
from randomized, double-blind, placebo-controlled
Phase-III-Trial in Patients with Dermatomyositis.
– Rohit Aggarwal, Christina Charles-Schoeman,
Joachim Schessl, Zsuzsanna Bata-Csorgo, Mazen
M. Dimachkie, Zoltan Griger, Sergey Moiseev,
Chet Oddis, Elena Schiopu, Jiri Vencovsky, Irene
Beckmann, Elisabeth Clodi, Todd D. Levine, and the
ProDERM Investigators
P3.1-005
Missed Opportunities to Prevent N-methyl-D-
aspartate Receptor (NMDAR) Encephalitis in a
DREAMer – Paul Daniel Crane, Matthew Jensen,
Suzanne Liu, Justin Abbatemarco, Jana Wold, Holly
Leydard, Umang Swami, Michelle Miranda, Stacey
Clardy
P3.1-006
A case of a 4-year-old female with Leucine Rich
Glioma Inactivated protein (LGI1) encephalitis
associated with a cystic nephroma, responsive to
intravenous immunoglobulin (IVIG), corticosteroids,
and rituximab – Brandon Chase Neeley, Alfred
Balasa, Elizabeth McQuade, Sara A. McGuire
34 2022 AAN Annual Meeting
Saturday, April 2 5:30 p.m.–6:30 p.m.
2 Headache
Headache: Advances in CGRP Inhibition
for Precision Medicine 3
P3.2-001
Evaluation of the Long-Term Safety and Tolerability
of Oral Atogepant 60 Mg Once Daily for Preventive
Treatment of Migraine: A Phase 3, 40-Week,
Multicenter Extension to the Advance Trial – Brad
C. Klein, Rosa Miceli, Lawrence Severt, Peter J.
McAllister, Laszlo Mechtler, Jennifer McVige, Merle
Diamond, Michael J. Marmura, Hua Guo, Michelle
Finnegan, Joel M. Trugman
P3.2-002
ALLEVIATE, a Clinical Trial-in-Progress of
Eptinezumab in Patients With Episodic Cluster
Headache – Stewart J. Tepper, Neli Boneva, Mette
Josiassen, Elin Lof, Rigmor Jensen
P3.2-003
Changes in Heart Rate and Blood Pressure in
Participants Treated With Fremanezumab for
Migraine: A Pooled Analysis of Phase 3 Studies
– Steffen Naegel, Joshua M. Cohen, Yoel Kessler,
Verena Ramirez Campos, Steve Barash, Xiaoping
Ning, Stephanie J. Nahas
P3.2-004
Efficacy and Disability Outcomes of Fremanezumab
in Patients With Prior OnabotulinumtoxinA
Treatment Failure: Pooled Results of 3 Randomized,
Double-blind, Placebo-controlled Phase 3 Studies
– Juliana VanderPluym, Xiaoping Ning, Verena
Ramirez Campos, Steve Barash, Lynda Krasenbaum,
Peter J. McAllister
P3.2-005
Long-term Safety and Tolerability of Erenumab
In Episodic Migraine: A Pooled Analysis From
Two Clinical Trials and Their Extension Phases –
Messoud Ashina, Uwe Reuter, David W. Dodick,
Feng Zhang, Shannon Ritter, Tracy E. Stites, Gabriel
Paiva da Silva Lima, Michal Arkuszewski, Peter
Goadsby
P3.2-006
Optimization of Acute Treatment and Headache-
Related Impact Following Eptinezumab Initiated
During a Migraine Attack: Post Hoc Analysis of the
RELIEF Study – Dawn C. Buse, Richard B. Lipton,
Anders Ettrup, Mette Josiassen, Annika Lindsten,
Roger Cady
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
3 Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Biomarkers and
COVID-19 Impact 1
P3.3-001
Inflammatory biomarkers and cerebral small vessel
disease: a community-based cohort study – Ding-
Ding Zhang, Yuan Cao, Jing-Yu Mu, Yi-Ming Liu,
Feng Gao, Fei Han, Fei-Fei Zhai, Li-Xin Zhou, Jun Ni,
Ming Yao, Mingli Li, Zheng-Yu Jin, Shu-Yang Zhang,
Li-Ying Cui, Yong Shen, Yi-Cheng Zhu
P3.3-002
COVID-19 case fatality and Alzheimer’s disease –
Qiang Johnson Zhang, Jordan L. Schultz, Georgina
M. Aldridge, Jacob E. Simmering, YoungCho Kim,
Amy Ogilvie, Nandakumar Narayanan
P3.3-003
Simple risk scores for the prediction of brain
ß-amyloid and tau status in older adults with mild
cognitive impairment – Ali Ezzati, Richard B. Lipton,
Kellen Petersen
P3.3-004
High Sensitivity Simoa Immunoassays to Evaluate
Levels of Postsynaptic density protein 95 and
Neuronal Pentraxin II as Predictors of Cognitive
Function Loss in Alzheimer’s Diseases – Hana Na,
Valerie Brachet
P3.3-005
An Ultrasensitive Immunoassay for the Detection
of p-tau231 in Plasma, Serum & CSF – Yao Chen,
Valerie Brachet
4 MS and CNS Inflammatory
Disease
MS Clinical Practice & Decision Making 1
P3.4-001
Sick leave and occupational burnout among nurse
practitioners caring for patients with multiple
sclerosis – Gustavo Saposnik, Guillermo Bueno,
Beatriz del Río Muñoz, Alejandro Lendínez-Mesa,
Cristina Azanza, Noelia Becerril Rios, Haydee
Goicochea Briceño, Rosalia Horno Ocaña, Cesar
Manuel Sanchez Franco, Nicolas Medrano, Jorge
Maurino
P3.4-002
Small Fiber Neuropathy in Multiple Sclerosis: A
Case Series – Natalie Karina Erlich-Malona, Syed
Rizvi, Todd Nguyen, Saima Chaudhry, Kara Stavros,
Jonathan Cahill
P3.4-003
Retrospective Evaluation of De-Escalation from
Anti-CD20 Therapies to Fumarates as a Treatment
Approach – Brandi L. Vollmer, Evan Riddle, Jason P.
Mendoza, Enrique Alvarez
 Poster Session 3
P3.4-004
Risk Perception in Multiple Sclerosis: Reasons for
Switching Treatment Between High Efficacy and
Non-high Efficacy Disease-modifying Therapies –
Gustavo Seifer, Patricia Dominguez Castro, James
Pike, Eddie Jones, Rainel Sanchez-De La Rosa
P3.4-005
Dimethyl Fumarate Demonstrates Treatment
Effectiveness in Patients One Year After Switching
From Teriflunomide – Kathryn Giles, Richard A
L Macdonell, Filipe Branco, Phoebe Jiang, Seth
Nathatn Levin, Sai Shankar, Thomas Alois Berger
MS Immunology and Basic Science 1
P3.4-006
The Role of Human and Mouse BTK in Myeloid
Cells – Claudia Bassani, Marta Molinari, Vittorio
Martinelli, Roland Grenningloh, Ursula Boschert
Shafaatian, Giancarlo Comi, Gianvito Martino, Luca
Muzio, Cinthia Farina
P3.4-007
Autoantibodies to an RNA binding
protein exacerbate clinical disability and
neurodegeneration in an in vivo model of multiple
sclerosis – Cole Libner, Hannah Salapa, Michael C.
Levin
P3.4-008
Disruption of Stem Cell Proliferation and
Differentiation Capacity in a Cerebral Organoid
Model of Multiple Sclerosis – Mia DiCostanzo, Tara
Edwards, Nicolas Daviaud
P3.4-009
Long-term effects of oligodendrocyte-specific
FGFR1 deletion on the signaling cascade and myelin
protein expression in the CNS of adult C57BL/6J
mice – Vinothkumar Rajendran, Ranjithkumar
Rajendran, Franziska Kissel, Christine Stadelmann-
Nessler, Srikanth Karnati, Martin Berghoff
P3.4-010
Quantitative Analysis of Wild Type (WT) and
Shiverer (SHR) Mouse Spinal Cords using
Ultrahigh-b DWI (UHb-DWI) – Kyle E. Jeong, Sophie
Lee, Sukkeu Yeom, Noel Carlson, Lubdha Shah,
John W. Rose, Eun-Kee Jeong
P3.4-011
Thyromimetics improve disease endpoints and
modulate potential target engagement biomarkers
in rodent models of ALD and MS – Michaelanne
Woerner, Jeffrey Vivian, Aryan Alavi, Amy Klova,
Marc Hellerstein, Rohan Gandhi, Chan Beals, Brian
Stearns, Deidre MacKenna
Information is accurate as of February 8, 2022, and is subject to change.
Saturday, April 2 5:30 p.m.–6:30 p.m.
5
Child Neurology and
Developmental Neurology
Child Neurology: Demyelinating/
Leukodystrophy/Neuroimmunology 3
P3.5-001
Effects of sulfatide accumulation on peripheral
nerves in metachromatic leukodystrophy – Christian
Krarup, Christine I. Dali, Samuel Groeschel, Mihai
Moldovan, David Whiteman, Ingeborg Krageloh-
Mann, Jing Li, Norman W. Barton, Mohamed Farah
P3.5-002
Increased Anxiety, Depression and Suicidal Ideation
in Children with Neuromyelitis Optica – Margaret
Codispoti, Alfred Balasa, Nikita Shukla, Timothy E.
Lotze
Child Neurology: Neurodevelopmental
Disorders/CP/ASD 2
P3.5-003
Tic Severity and Family Function in Children with
Tourette Syndrome and Coprophenomena –
Samantha Paige Myers, Jonathan W. Mink, Jennifer
Anne Vermilion
P3.5-004
Pediatric Functional Neurological Disorder:
Investigating Demographic & Clinical Factors and
Impacts on Management – Ria Pal, Emira Romero,
Zihuai He, Terrell Stevenson, Cynthia Campen
P3.5-005
Non Decussating Retinal-fugal Fiber Achiasmatic
Syndrome, Expanding The Clinical and Radiological
Features of an Exceedingly Rare Cause of
Congenital Nystagmus, a Report of Additional
Three Patients and a Review – Abdulhafeez Khair,
Rahul Nikam, Stephen Falchek
6 Aging, Dementia, Cognitive, and
Behavioral Neurology
Cognitive and Behavioral Neuroimaging
Topics 1
P3.6-001
Network Localization of Visual Anosognosia from
28 Cases of Anton Syndrome – Kyla Ann Gaudet,
Michael D. Fox, Isaiah Kletenik
P3.6-002
Discourse Comprehension in Healthy Adults and
Individuals with Acute Aphasia: an fNIRS Study –
Hana Kim, Lisa Bunker, Erin Meier, Argye E. Hillis
P3.6-003
Volumetric Brain MRI Quantification in Early
Versus Late Onset Alzheimer’s Disease – Somayeh
Meysami, Cyrus A. Raji, David Merrill, Verna R.
Porter, Youssef I. Khattab
P3.6-004
In Response to Social Acceptance, Nucleus
Accumbens Mu Opioid Receptor Activation is
Associated with Increased Self-Esteem and
Positive Mood – Kathryn Hill, Stephan Taylor, Todd
Ogden, Ramin Parsey, Christine DeLorenzo
P3.6-005
Clinical Features and Neuroimaging of Anomic
Progressive Aphasia – Christine Cliatt Brown,
Jonathan Graff-Radford, Joseph Duffy, Rene
Utianski, Heather Clark, Mary M. Machulda,
Wentao Li, Jennifer Louise Whitwell, Keith A.
Josephs, Hugo Botha
7
Practice, Policy, and Ethics
Practice, Pitfalls, and Innovation 1
P3.7-001
Real-World Resource Utilization and Productivity
Loss among Patients with Myasthenia Gravis in
Sweden: A Nationwide Population-based Study –
Qiaoyi Zhang, Qian Cai, Nurgul Batyrbekova, Lilla Di
Scala, Shane Kavanagh
P3.7-002
Brain Dead or Alive: Pitfalls in Neurological
Prognostication – Danielle Bazer, Matthew Orwitz,
Nicholas Koroneos, Ryan Christopher Corn, Philip
Yeung, Elizbieta Wirkowski
P3.7-003
Defining and Understanding Barriers to Medication
Reconciliation in the Outpatient Neurology Clinic –
Alex Joseph Luke, Debolina Kanjilal, Binod Wagle
P3.7-004
Seizure Alert: An Interdisciplinary Protocol for
Timely Anti-Seizure Medication Administration
in the Setting of Status Epilepticus – Kelly Lauren
Block, Lauren Skalomenos, Joanna Jinghan Wu,
Shaun O. Smart
7 Sleep
Sleep: Focus on Hypersomnia and RBD 3
P3.7-005
The Effect of Sleep Disordered Breathing on
Cognitive Function in Patients with Normal
Pressure Hydrocephalus – Raman Bhambra, Aruna
S. Rao
AAN.com/AM 35
 Poster Session 3
8 9
Epilepsy/Clinical Neurophysiology
(EEG)
Epilepsy/Clinical Neurophysiology (EEG):
ASMs General 2
P3.8-001
Safety Profiles of Second-Generation Antiseizure
Medications: A Pharmacovigilance Study –
Mokshal Porwal, Dhruvkumar Patel, Mit Patel,
Hannah Carlson, Kushal Porwal
P3.8-002
Everolimus for Treatment of Refractory Seizures
in Tuberous Sclerosis – Nayana Prabhu, Hira Zafar,
Praveen Ramani, Salman Zahoor, Sisira Yadala,
Erika Santos Horta
P3.8-003
Antiseizure drugs adherence in elderly patients
with epilepsy – Carla Portinari, Tomas Ibañez,
Adriana Sotelo, Gonzalo Lage, Federicoí Fabio
Ramos, Marcos Sorbara, Gisela Zanga, Romina
Diaz, Maria Martha Esnaola Y Rojas
P3.8-004
Atypical Presentation of Lance Adams Syndrome in
the setting of Clonazepam overdose and SARS-
CoV-2 pneumonia – Kaleb Logan Culpepper, Lauren
A. Terpak, Luis Alberto Cruz-Saavedra, Suparna R.
Krishnaiengar
P3.8-005
WITHDRAWN
P3.8-006
New-Onset Refractory Status Epilepticus After
Pfizer-BioNTech COVID-19 Vaccination – Kristie
Bauman, Jonathan Rosenthal, Jessica Lin
9 P3.10-003
Infectious Disease
Infectious Disease: Long COVID and
Vaccines 1
P3.9-001
Epochs Of Sternutation Induced By Coronavirus 19
– Sunjeet Brar, Alan R. Hirsch
P3.9-002
Covid-19 Associated Extreme Fatigue Effects on
Activities of Daily Living in Mild and Long-Haul
Infections: Patient Perspectives from a Remote
Patient Monitoring Program – Nicki Mohammadi,
Emma Reford, Natalia Romano Spica, Jenna
Tosto, Laura Rosenbaum Tabacof, David Putrino,
Christopher Kellner
P3.9-003
New Neurological Syndromes with COVID-19
Infection: Is Immune System Hyperactivity to
Blame? – Mahjabin Islam, Maaz Nayyer, Daniel
Madarshahian, Thomas M Jenkins
36 2022 AAN Annual Meeting
Saturday, April 2 5:30 p.m.–6:30 p.m.
Neuro-oncology
Neuro-oncology: Neuroimaging and
Informatics 1
P3.9-004
Machine learning approaches for automated
segmentation of gliomas – Avery Lum, Waverly
Rose Brim, Harry Subramanian, Sam Payabvash,
Ichiro Ikuta, MingDe Lin, Khaled Bousabarah,
Michele Hackley Johnson, Ajay Malhotra, Mariam
Aboian
P3.9-005
Quality Improvement Project: Number of
Neurofibromatosis Type I Patients with Unidentified
Bright Objects (UBOs) on MRI that Developed
Subsequent Gliomas – Mekka Rae Garcia, Monica
Eunseo Kim, Nora Jandhyala, Devorah Segal, Kaleb
H. Yohay
10 Cerebrovascular Disease and
Interventional Neurology
Cerebrovascular Disease: Interesting
Cases 3
P3.10-001
Loeffler’s endocarditis: A rare cause of stroke
resulting in person in the barrel syndrome – Maya
Gabel, Faddi Ghassan M. Saleh Velez, Victor J. Del
Brutto, Sebastian Koch
P3.10-002
Recurrent Ischemic Strokes in Biliary tract
malignancy: Role of Direct-Acting Oral
Anticoagulants and Early Screening – Case Series
– Noor Mahmoud, Sara Habib, Ahmad Al-Awwad
A Case of Hemichorea-Hemiballism Following a
Cortical Stroke from Occlusion of an Anomalous
Accessory Middle Cerebral Artery – Priyanka
Moondra, Vishal Gupta, Ritesh Ramdhani, Jeffrey
M. Katz, Rohan Arora, Richard Libman
P3.10-004
Knot so Straight Forward: A Rare Case of Mixed
Pial-Dural Arteriovenous Malformation combined
with an Arteriovenous Fistula of the Posterior
Circulation – Maria Gabriela Martucci, Claudia
Vallin, Michal Obrzut
P3.10-005
Cervico-Thoracic Spinal Dural Arteriovenous Fistula
in a Patient with Lower Extremity Weakness
Exacerbated by Steroids and Lumbar Puncture –
Sukhraj Gill, Sandeep Gill, Matthew Hart, Mitchell
Onken
P3.10-006
Ocular lateral deviation as a clinical sign of medial
PICA infarct – Nicole Platti, Rami Fakih, Joan Maley,
Kaancan Deniz, Busranur Agac, Deema A. Fattal
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P3.10-007
A Rare Case of Adult Onset Mitochondrial
Encephalomyopathy, Lactic Acidosis and Stroke-like
Episodes at Age 60 – Adriana Carola Mendez,
Sruthi Devarinti, Azima Shaji
P3.10-008
Subarachnoid Hemorrhage Secondary to
An Exceedingly Rare Case of STELARA®
(Ustekinumab) Induced Reversible Cerebral
Vasoconstrictive Syndrome – Michael Hadler,
Victoria Michelle Rice, Erika Webster, Tamra Ishan
Jayendra Ranasinghe
P3.10-009
Pulmonary Arteriovenous Malformation (PAVM):
An Uncommon Cause of Cryptogenic and Embolic
Stroke of Undetermined Source (ESUS). – Teye
Aniefiok Umanah, Farah Yolanda Fourcand, Siddhart
Kumar Mehta, Gautam Karteek Visveswaran, Jawad
F. Kirmani, Sara Strauss
P3.10-010
Short Term Acute Ischemic Stroke after Initiation
of Gender-Affirming Hormone Therapy: A Case
Report – Ricardo Murguia Fuentes, Abdullahi Musa
Adamu, Prabandh Reddy Buchhanolla, Muhammed
Ikbal Arvas
11
Movement Disorders
Movement Disorders: Huntington’s
Disease
P3.11-001
Young-Onset Huntington’s Disease: Defining
an Emerging Clinical Cohort – Miguel Alonso
Ruvalcaba, Christopher Jay Campos, Alexandra
O’Neill Duffy
P3.11-002
Differences in visual-cognitive performance
between asymptomatic and symptomatic carriers
of Huntington’s disease – Miriam Turuelo, Marian
Acera, Maria Diez-Cirarda, Tamara Fernandez,
Beatriz Tijero, Mar Carmona, Marta Ruiz Lopez,
Johanne Hatteland Somme, Javier Ruiz-Martínez,
Andrea Gabilondo, Ioana Croitoru, Lara Pardina
Vilella, Naia Ayo, Ane Murueta-Goyena, Inigo
Gabilondo Cuellar, Juan Carlos Gomez Esteban,
Rocio Del Pino
P3.11-003
Patient Experiences in early Huntington’s Disease
- Qualitative Research to Inform Development
of a Patient-Reported Instrument of Everyday
Functioning – Jennifer Billet, Adele Levine, Jason K.
Johannesen, Teya Lovell, Alissa Rams, Emily Gusse,
Stefan Cano, Aaron Koenig
 Poster Session 3
P3.11-004
The Association Between Lifestyle Factors and
Huntington´s Disease Mortality – Esther Cubo
Delgado, Laura Aguado García, Gonzalo Gamez
Leyva Hernandez, Sara Calvo, Asuncion Martinez-
Descalls, Natividad Mariscal-Pérez, Maria Dolores
Diaz Pineiro, Ignacio Muñoz-Siscart, Carla Collazo,
Alvaro Garcia Bustillo, Lucía Simón Vicente, Irene
Miguel, Carlos Fernandez Ramajo
P3.11-005
Psychometric Validation of Huntington’s Disease
Everyday Functioning (Hi-DEF) Scale –Study Design
and Sample Characteristics – Jennifer Billet, Adele
Levine, Jason K. Johannesen, Ruta Sawant, Teya
Lovell, Alissa Rams, Emma Elliott, Aviva Gillman,
Jee Bang, Danny Bega, Jennifer Klapper, Rajeev
Kumar, Henry Paul Moore, Susan L. Perlman, Luis
Alberto Sierra, Stefan Cano, Aaron Koenig
P3.11-006
A Sentiment Analysis of Unstructured Electronic
Medical Record Data of Patients Treated With
Vesicular Monoamine Transporter 2 Inhibitors
in Huntington’s Disease and Tardive Dyskinesia
– Victor W. Sung, Christopher W. Yee, Rajeev
Ayyagari, Jessica K. Alexander, Pooja Gandhi, Sam
Leo
P3.11-007
Clinical evidence that treatment with pepinemab,
a novel regulator of neuroinflammation, provides
cognitive benefit to patients with Huntington’s and
potentially other neurodegenerative diseases –
Elizabeth E. Evans, Terrence Fisher, Vikas Mishra,
Megan Boise, Amber Lynn Foster, Ernest Smith,
John Leonard, Andrew S. Feigin, Eric R. Siemers,
Maurice Zauderer
12 General Neurology
General Neurology: Cerebrovascular 3
P3.12-001
Pontine Cavernous Hemangioma As a Possible
Cause of New Onset Seizures and Millard-Gubler
Syndrome in a Middle aged Female – Dylan
Weaver, Schweta Parag Rane, Xiang Fang
P3.12-002
No More Tissue: Elimination of Sneezing Due To
Cerebellar Hemorrhage – Ashmeet Singh Sahni,
Alan R. Hirsch
P3.12-003
Transient Opening of the Blood-Brain Barrier by
Vasoactive Peptides to Increase CNS Drug Delivery:
Reality versus Wishful Thinking? – Matthew Smith-
Cohn, Nicholas Bond Burley, Stuart A. Grossman
Information is accurate as of February 8, 2022, and is subject to change.
Saturday, April 2 5:30 p.m.–6:30 p.m.
13
Neuromuscular and Clinical
Neurophysiology (EMG)
Neuromuscular Disease: Amyotrophic
Lateral Sclerosis 3
P3.13-001
Clinical utility and feasibility of an ALS specific
advance care directive: A retrospective chart
review – Tyra Swanson, Kendall Nichols, Samuel
J. Maiser
P3.13-002
ALS and cerebellum: Study of Eyeblink conditioning
in Subjects with ALS – Aiga Rakhesh, Amanda
Haskell, Labeeby Servatius, Rick Servatius
P3.13-003
Edaravone in The Disease Course of ALS Effect.
Retrospective Trial – Federico Guido Man, Sara
Palacios, Cecilia Quarracino Benchetrit, Mariana
Bendersky, Natalia Bohorquez Morera, Raul Rey,
Gabriel Rodriguez
P3.13-004
Evaluation of Gastrointestinal Symptoms in an ALS
Cohort – Rizamarie Empeno, Omer Waqar Naveed,
John Furey, Terry D. Heiman-Patterson
P3.13-005
An Open Label Study of Poly-MVA to Treat Fatigue
in ALS – Amer Avdagic, Tejas R. Mehta, Krista
Schoff, Raghav Govindarajan
P3.13-006
Degeneration of upper and lower motor neurons
in a novel CSF-mediated animal model of sporadic
ALS – Rose Putnam Griffin, Ivy Gao, Nadia Merve
Celestin, Jamie Wong, Saud Sadiq
P3.13-007
COVID-19 Amyotrophic Lateral Sclerosis (ALS)
Registry NCT04559009 – Urvi G. Desai, Benjamin
R. Brooks
P3.13-008
Adipose Tissue Distribution as a Predictor of Rate
of Progression in Patients with Amyotrophic Lateral
Sclerosis – Gracia Luoma-Overstreet, Rebecca
Rhodes, Kelly G. Gwathmey
P3.13-009
Barriers and facilitators to continuing non-invasive
ventilation use in individuals with amyotrophic
lateral sclerosis – Jennifer L. Marsella, Cynthia
Gibson, Emma Ciafaloni
P3.13-010
RACK1 Knockdown Alleviates TDP-43-Associated
Global Translational Suppression in vitro, and
Neurodegeneration in vivo – Beibei Zhao, Catherine
M. Cowan, Ananya Saraph, Darren David Christy,
Juliane Ashleigh Coutts, Johanne M. Kaplan, Neil
R. Cashman
AAN.com/AM 37
 Poster Session 4
1 2
Autoimmune Neurology
Autoimmune Neurology: Peripheral
Nervous System and Muscle 2
P4.1-001
Changes in Guillain-Barre Syndrome –Associated
Ganglioside Antibody Test Results at a National
Clinical Laboratory During the COVID-19 Pandemic
– Michael K. Racke, Raymond Lorenz, Justin K.
Niles, Harvey W. Kaufman
P4.1-002
COVID-19 Cytokine Storm in Myasthenia Gravis
Treated with Mesenchymal Stem Cells: A Case
Report – Aldanica Olano, Mark Anthony Jalbuena
Sta. Maria, Genica Lynne Maylem, Marc Joseph
Oliver Buensalido, Karl Evans Rivera Henson, Alma
Reyes Calavera
P4.1-003
Autoimmune Acute Myelitis with Guillain-Barré
Syndrome and Cerebellar Ataxia after COVID-19
Infection: a Case Report – Masashi Watanabe,
Yukitoshi Takahashi, Keiko Tanaka, Ayumi Uchibori,
Atsuro Chiba, Hitoshi Kubo, Itaru Kyoraku, Kensho
Okamoto
P4.1-004
New Diagnosis of Myasthenia Gravis in the
Setting of COVID-19 Infection – Serena Wong,
Osher Rechester, Anila Thomas
P4.1-005
Myasthenia Gravis Syndrome Following COVID-19
Vaccination and Subsequent Tolerance of Booster
Vaccine: A Case Report – Dana Most, Michelle
Tiem, Dominic A. Ferrey, Anastasie M. Dunn-Pirio
Autoimmune Neurology: Autoimmune
Encephalitis and Antibody Associated
Neurologic Disorders 3
P4.1-006
A case of Refractory Status Epilepticus in
Autoimmune Encephalitis with autoantibodies
against GABA-B receptors, and robust response to
combination therapy. – Binod Wagle, Robert Evan
Ungerer
P4.1-007
Overlapping Autoimmune Neurologic Syndrome,
A case report of triple-positive antibody – Kyle
Edward Bonner, Hassan Osama Mostafa Aboul
Nour, Anza Memon
38 2022 AAN Annual Meeting
Sunday, April 3 8:00 a.m.–9:00 a.m.
Headache
Headache: Clinically Oriented Headache
Studies 1
P4.2-001
Nummular Headache in Children: A Case Series
and Systematic Literature Review – Daniel Lax,
Marielle Kabbouche, Joanne Kacperski, Andrew
D. Hershey
P4.2-002
A Rare Case of Chronic Refractory Short lasting
Unilateral Neuralgiform Headache Attacks with
Cranial Autonomic Symptoms [SUNA] responding
well to Erenumab – Raja Hassan Imtiaz, Rosamma
Joseph
P4.2-003
Prevalence of Cognitive Dysfunction in Episodic
and Chronic Migraine in an Academic Headache
Clinic – Zachary Robateau, Daniel Krashin, Ami
Zarrillo Cuneo, Sau Mui Chan-Goh, Marcel Budica,
Natalia Murinova
P4.2-004
Oculomotor, vestibular, reaction time, and
cognitive assessment in vestibular migraine –
Claire Ceriani, Alexandr Braverman, Alex Kiderman
3
Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Biomarkers and
COVID-19 Impact 2
P4.3-001
Association of plasma GFAP with neuroimaging
measures of amyloid, tau, neurodegeneration
and vascular pathology – Dror Shir, Jonathan
Graff-Radford, Ekaterina Hofrenning, Timothy
Lesnick, Scott Przybelski, Val John Lowe, David
S. Knopman, Ronald C. Petersen, Clifford R. Jack,
Prashanthi Vemuri, Michelle M. Mielke
P4.3-002
Retinal Amyloid Count And Venular Tortuosity
Correlate With Neurocognitive Status – Tania
Torbati, Julia Sheyn, Dale Sherman, Mazyiar
Khansari, Keith Black, Patrick D. Lyden, Yosef
Koronyo, Maya Koronyo-Hamaoui, Oana Maria
Dumitrascu
P4.3-003
Association of Multiple Inflammatory Biomarkers
with Cerebral Arterial Atherosclerosis and
Dolichoectasia – Yuan Cao, Ding-Ding Zhang, Jing-
Yu Mu, Yi-Ming Liu, Feng Gao, Fei Han, Fei-Fei
Zhai, Li-Xin Zhou, Jun Ni, Ming Yao, Mingli Li,
Zheng-Yu Jin, Shu-Yang Zhang, Li-Ying Cui, Yong
Shen, Yi-Cheng Zhu
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P4.3-004
Clinical Prospective Research during COVID-19:
Strategies to Mitigate the Impact of the Pandemic
– Ryu Platinum Dorn, Erica S. Westphal, Maxwell
Daniel Yargeau, Mandy Spaltman, Sarah Harlock,
Bela Ajtai, Nandor K. Pinter
P4.3-005
Plasma neurofilament light chain as a promising
biomarker in preclinical and prodromal stages
of Alzheimer’s Disease – Giulia Giacomucci,
Valentina Bessi, Silvia Bagnoli, Deborah Leccese,
Salvatore Mazzeo, Assunta Ingannato, Sonia
Padiglioni, Sandro Sorbi, Benedetta Nacmias
4 MS and CNS Inflammatory
Disease
MS Immunology and Basic Science 2
P4.4-001
NLPR3 Inflammasome Activation within
Demyelinating Lesions in Cerebral
Adrenoleukodystrophy – Isha Srivastava,
Alejandro Aguirre, Romain Cayrol, Hannes Vogel,
Troy Lund, Keith Van Haren
P4.4-002
Neuroprotective effect of AZ257, a novel urea-
based dopamine transporter inhibitor, in the
experimental autoimmune encephalitis (EAE)
mouse model – Mirla L. Avila, Jie Pan, Smathorn
Thakolwiboon, Volker Neugebauer, Guangchen Ji,
Nadezhda German
P4.4-003
Function of miRNA profiled in Teriflunomide
treated multiple sclerosis (MS) patients – Fermisk
Saleh, Anu Paul, Tanuja Chitnis, Howard L. Weiner
P4.4-004
Interleukin-6 as a Potential Prognostic Biomarker
in Relapsing MOG Antibody Disease – Jamie C.
McDonald, Neda Sattarnezhad, Anna Tomczak,
Julia Sumera, Christopher Lock, May Han
MS Special Populations 1
P4.4-005
Demographics and Baseline Disease
Characteristics of Black and Hispanic Patients
With Multiple Sclerosis in the CHIMES Trial
– Lilyana M. Amezcua, Annette Okai, Anne H.
Cross, Nancy Monson, Ben W. Thrower, Anthony
Reder, Jeffrey B. English, Gregory F. Wu, Evanthia
Bernitsas, Shereen Yap, Jugena Ndrio, Jinglan Pei,
Ellen M. Mowry, Fabio Magrini, Mitzi Joi Williams
P4.4-006
Academic Underachievement is Common in
Pediatric-Onset Multiple Sclerosis – Wendy Sulina
Vargas, Michael Glendinning, Hannah Zoe Street,
Nicole A Ampatey, Gabriella Tosto, Robert Fee,
Brenda Banwell, Philip De Jager
 Poster Session 4
P4.4-007
Pregnancy Outcomes in Patients with Multiple
Sclerosis Following Exposure to Ofatumumab –
Kerstin Hellwig, Bassem I. Yamout, Riley Bove,
Pranava Reddy Katkuri, Ulf Schulze Topphoff, Dee
Stoneman, Ronald Zielman, Ratnakar Pingili, Maria
K. Houtchens
P4.4-008
Cladribine and Pregnancy in Women with Multiple
Sclerosis – a Case Series from Germany – Karen
Dost-Kovalsky, Sandra Thiel, Andrea Ines Ciplea,
Ralf Gold, Kerstin Hellwig
P4.4-009
Comparison of Pharmacokinetic Profiles and
Safety Outcomes with Peginterferon Beta-1a
Administration in Black/African American and
White Participants – Yuan Zhao, Jonathan Smith,
Nancy Ramia, Maria Naylor, Cherie Butts
P4.4-010
Safety and Effectiveness of Peginterferon Beta-1a
in a Subgroup of African American Patients:
Plegridy Observational Program (POP) Interim
Analysis – Sibyl E. Wray, Marco Salvetti, Gereon
Nelles, Arman Altincatal, Nydije Grimes, Achint
Kumar, Maria Naylor
P4.4-011
Enrollment of Non-White Participants and
Reporting of Race and Ethnicity in Phase III Trials
of MS DMTs: A Systematic Review – Helen
Onuorah, Odelin Charron, Ethan Isaac Meltzer,
Amanda Montague, Alexis Crispino, Avery Largent,
Ashlea Lucas, Leorah Aude Emmanuelle Freeman
5
General Neurology
Neuroepidemiology 1
P4.5-001
Public-Private Collaboration in ALS Research by
GUID Utilization Paves the Road to Patient-Centric
Precision Research in Neurological Diseases –
Alex Berger, Ervin Sinani, Igor Katsovskiy, Jaime
Raymond, Derek D’Agostino, Natalia Tarasenko,
Paul Mehta, Alexander Sherman
P4.5-002
Spatial Clustering of Amyotrophic Lateral
Sclerosis in Virginia – David Wheeler, Ryan Louis
Naum, Paula Burke Brockenbrough, Michelle
Gebhardt, LaVon Smith, Tremetris Harrell, Danielle
Stewart, Kelly G. Gwathmey
P4.5-003
Examination of Participant Demographics and ALS
Symptom Characteristics from Pooled Resource
Open-Access ALS Clinical Trials and National ALS
Registry – Moon Han, Jaime Raymond, Theodore
Larson, Paul Mehta, D Kevin Horton
Information is accurate as of February 8, 2022, and is subject to change.
Sunday, April 3 8:00 a.m.–9:00 a.m.
P4.5-004
Impact of Melatonin on Survival in ALS – Isaac
Whitworth, Ervin Sinani, Derek D’Agostino,
Kenneth Faulconer, Igor Katsovskiy, Natalia
Tarasenko, Isaac Whitworth, Alexander Sherman
P4.5-005
Chronic Inflammatory Demyelinating
Polyneuropathy (CIDP) and Hazardous Waste
Sites? A Statewide Planning and Research
Cooperative System (SPARCS) Study 1998-
2014 – Yueqing Zhang, Sanjila Islam, Mustafa
Jaffry, Kranthi Kiran Mandava, Kazim Jaffry, Nizar
Souayah
6 Aging, Dementia, Cognitive, and
Behavioral Neurology
Cognitive and Behavioral Neuroimaging
Topics 2
P4.6-001
Exercise Changes White Matter and Neurite
Morphology in Patients with Idiopathic
Generalized Epilepsy – Malik Bolaji, Adam M.
Goodman, Rodolphe Nenert, Jerzy P. Szaflarski,
Jane B. Allendorfer
P4.6-002
Thermodynamic Indices of Brain Activity to
Identify People with Good Cognitive Capacity –
Shivabalan K R, Anjali Byale, Karthik Ajith, Devvrat
Yadav, Rahul Mishra, Misha Gautam
P4.6-003
Machine learning methods to predict amyloid
positivity using domain scores from cognitive
tests – Guogen Shan, Jiong Shi, Charles Bernick
P4.6-004
Coherent Activity in EEG Response to Gamma
Sensory Stimulation Predicts Positive Outcome
in Cognitive and Functional Abilities, and Brain
Atrophy in Subjects with Alzheimer’s Disease
– Aylin Cimenser, Holly Mrozak, Xiao Da, Taylor
Travers, Evan R. Hempel, Chandran Seshagiri,
Alyssa Boasso, Brent Vaughan, Jonathan Thomas
Megerian, Zach Malchano, Mihaly Hajos
Genetics and Other Cognitive Topics 1
P4.6-005
Sharpening the Razor: Online Core Curriculum and
Mastery (OCCAM) of Behavioral Neurology and
Neuropsychiatry Program Strengths and Areas of
Improvement – Lealani Mae Acosta, Maya Neeley,
Charlene Dewey
P4.6-006
Vitamin D is Associated with Visual Memory in
Northern Adolescents – Katherine Rachel Fehr
Bailey, Jacqueline Pettersen
7
Sleep
Sleep: Focus on Insomnia and TBI 1
P4.7-001
Assessment of the Effect of Lemborexant Versus
Placebo and Zolpidem on the Duration of REM
Sleep by Quarter-of-the-Night Intervals in Older
Adults with Insomnia Disorder – Gary Zammit,
Thomas Roth, Dinesh Kumar, Carlos Perdomo,
Margaret Moline
P4.7-002
An Assessment of Wake Bouts in Adults with
Insomnia Treated With Lemborexant or Zolpidem
– Thomas Roth, Gary Zammit, Dinesh Kumar,
Margaret Moline
P4.7-003
Patient-reported Experiences Associated with
Falling Asleep/Sleep Onset in an Open-label Study
of Lemborexant and Zolpidem – Charles Brendan
Montano, Manoj Malhotra, Dinesh Kumar, Carlos
Perdomo, Margaret Moline
P4.7-004
Self-reported Perceptions of Medication
Effectiveness in Subjects Receiving Lemborexant
for up to 12 Months – Christopher Lawrence
Drake, Jane Yardley, Kate Pinner, Carlos Perdomo,
Margaret Moline
8
Epilepsy/Clinical Neurophysiology
(EEG)
Epilepsy/Clinical Neurophysiology (EEG):
Epilepsy Imaging 1
P4.8-001
The Utility of 18-FDG PET Neuroimaging in the
Preoperative Workup for Epilepsy Surgery; Real
World Experiences from an Irish Tertiary Referral
Centre – Sarah Wrigley, Daniel Costello
P4.8-002
Comparing CECT with NCCT in drug-responsive
focal epilepsy- A prospective observational
study – Jasmine Parihar, Mamta Bhushan Singh,
Ajay Garg, Leve Joseph Devarajan Devarajan,
Anuj Prabhakar, Maroof A. Khan, Padma Vasantha
Hadakasira, Vinay Goyal Goyal, Vishnu VY,
Shailesh Gaikwad, Garima Shukla
P4.8-003
Handedness and Language Dominance as
Revealed by Magnetoencephalography – Emma
Balaan, Ajay Niranjan, Anto Bagic, Niravkumar
Barot
P4.8-004
Resting-State Voxel-Based Pathophysiologic
Changes in Medial Temporal Lobe Epilepsy –
Jonathan Michael Towne, Vahid Eslami, Jose E.
Cavazos, Peter T. Fox
AAN.com/AM 39
 Poster Session 4
P4.8-005
Functional Parcellation of the Cingulate Gyrus in
Epilepsy Surgical Planning: Electrical stimulation,
Electrocorticography, and fMRI study – Tritan
Joseph Plute, Rafeed Alkawadri
P4.8-006
Functional Parcellation of the Cingulate Gyrus in
Epilepsy Surgical Planning: Electrical Stimulation,
Electrocorticography, and fMRI. – Rawan
Mahgoub, Ayse Bayram, Rafeed Alkawadri
9 Thrombolysis Outcomes in Telestroke Patients
Infectious Disease
Infectious Disease: Long COVID and
Vaccines 2
P4.9-001
Investigating the relationship of Miller Fisher
Syndrome and COVID-19 Vaccination: A Vaccine
Adverse Event Reporting (VAERS) Study – Jorge
Luis Rodriguez Lee, Mustafa Jaffry, Kranthi Kiran
Mandava, Sanjana Rosario, Tarek Elshourbagy,
Kazim Jaffry, Kamel Jedidi, Nizar Souayah
P4.9-002
Post Covid-19 Neurological Impairment Effects
on Activities of Daily Living: Patient Perspectives
from a Remote Patient Monitoring Program –
Emma Reford, Nicki Mohammadi, Natalia Romano
Spica, Jenna Tosto, Laura Rosenbaum Tabacof,
David Putrino, Christopher Kellner
P4.9-003
Post-acute sequelae of SARS-CoV-2 infection
(PASC): peripheral, autonomic, and central
nervous system features in a child – David S.
Younger
9 L. Torres, Kara R. Melmed, Aaron S. Lord, Koto
Neuro-oncology
Advancing Care in Neuro-oncology 1
P4.9-004
Comparing Methods Used to Identify People
with Rare Tumor Predisposition Syndrome in
the Electronic Health Record – Macy Early, John
Richard Gatti, Bronwyn Slobogean, Bonnie J.
Woods, Robert Bruce Ackerman, Anil Mathur,
Joshua Roberts, Jaishri Blakeley
P4.9-005
Breakthrough Seizures after COVID-19 Vaccines
in Patients with Glioma – Trusha Shah, Karl Cristie
Fines Figuracion, Bianca Schteiden, Jerome J.
Graber
P4.9-006
Functional Neurological Disorders in Primary Brain
Tumor Patients – Katherine B. Peters, Margaret O.
Johnson
40 2022 AAN Annual Meeting
Sunday, April 3 8:00 a.m.–9:00 a.m.
10
Cerebrovascular Disease and
Interventional Neurology
Interventional Neurology and
Thrombolytic Therapy 1
P4.10-001
Differences in Peripheral Leukocyte Subtypes
Between Slow and Fast Progressors of Anterior
Circulation Large Vessel Occlusion Stroke – Ji
Yeon Son, Marcelo Rocha
P4.10-002
Early Infarct Growth Rate is Correlated with IV
– Chris Hackett, Maulik Kantawala, Konark
Malhotra, Sandeep S. Rana, David G. Wright,
Richard Williamson, Timothy Quezada, Ashis H.
Tayal, Russell Mitesh Cerejo
P4.10-003
Emergent Intracranial Rescue Stenting for
Acute Ischemic Stroke patients undergoing
Thrombectomy with Incomplete Recanalization –
Maria A. Parekh, Juan Carlos Martinez-Gutierrez,
Juan Carlos Rodriguez, Sergio Salazar Marioni,
Rania Abdelkhaleq, Arash Niktabe, Youngran Kim,
Peng R. Chen, Spiros Blackburn, Gary Richard
Spiegel, Sunil Sheth
P4.10-004
Associations of Admission and Follow-up
Neutrophil-lymphocyte Ratios with Clinical
Outcomes in Patients with Ischemic Stroke
Undergoing Endovascular Therapy – Russell E.
Bartt, Erica Sercy, Yasaman Pirahanchi, Donald
Frei, David Bar-Or
P4.10-005
In-Hospital Glucose Measurements are
Associated with Mortality after Thrombectomy
for Acute Ischemic Stroke – Penina Krieger,
Amanda Jin Zhao, Leah Croll, Hannah Irvine, Jose
Ishida, Jennifer A. Frontera, Ariane Lewis
P4.10-006
A Comparison Of Primary Angioplasty versus
Angioplasty with Stent Placement for Treatment
of Internal Carotid Artery Occlusion in Acute
Ischemic Stroke Settings – Sachin M. Bhagavan,
Nitish Kumar, Attiya Jaura, Muhammad Fawad
Ishfaq, Brandi R. French, Camilo Ramiro Gomez,
Farhan Siddiq, Adnan I. Qureshi
P4.10-007
Failure of Tenecteplase in Maintaining Collateral
Circulation in Large Vessel Occlusion Strokes –
Farah Yolanda Fourcand, Nancy Gadallah, Arifa
Ghori, Danisette Torres, Abdallah Omar Amireh,
Haralabos Zacharatos, Siddhart Kumar Mehta,
Jawad F. Kirmani
P4.10-008
Predicting Risk of Malignant Stroke Post
Thrombectomy in Anterior Circulation Stroke using
ASPECT-PASS Score (A-P Score), a Retrospective
Cohort Study – Avirag Goswami, Juan Solano,
Jonathan Dissin, Aparna M. Prabhu
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P4.10-009
Real-World Bridging with Intra-arterial therapy
is safe after Tenectplase in patients with Acute
Ischemic Stroke – Sindhu Sahito, Hemal Patel,
Nasar Ali, Teye Aniefiok Umanah, Siddhart Kumar
Mehta, Haralabos Zacharatos, Spozhmy Panezai,
Farah Yolanda Fourcand, Jawad F. Kirmani, Yenna
Le
P4.10-010
Initial Experience with Tenecteplase as the
Intravenous Thrombolytic of Choice Before
Mechanical Thrombectomy for Large Vessel
Occlusion Acute Ischemic Stroke – Steven
Frederick Platko, Fatima Zahra Bensabeur, Umran
Ugur, Ronald Markert, David Mark Peters, John
Brooks Terry, Esteban Cheng-Ching
11 Movement Disorders
Movement Disorders: PD Non-Motor
Symptoms or Parkinsonism and NMS 1
P4.11-001
Predictive value of UPSIT subsets in prodromal
Parkinson disease – Pavan Vaswani, James F.
Morley, Danna L. Jennings, Andrew D. Siderowf,
Kenneth L. Marek
P4.11-002
Dysautonomia as a Prognostic Marker for
Phenoconversion and Functional Dependence in
Prodromal Parkinson’s Disease – Cameron Miller-
Patterson, Jesse Yenchih Hsu, Lana Chahine,
James F. Morley, Allison Wright Willis
P4.11-003
Influence of Co-Morbid PTSD in Parkinson’s
Disease on Motor and Non-Motor Symptoms –
Gulrana Syed, Eric Cheung, Yaseen Saleh, Dilip
Pandey, Brandon Barton
P4.11-004
Prevalence, Consequences and Correlates of
Aggression Towards Caregivers in Parkinson’s
Disease and Related Disorders: A Mixed Methods
Approach – Zachary Macchi, Roman Ayele,
Meredith Bock, Janis Miyasaki, Steven Z. Pantilat,
Elizabeth Santos, Hillary Lum, Stefan Sillau, Benzi
Kluger
P4.11-005
Olfactory dysfunction in incidental Lewy body
disease and Parkinson’s disease: An update –
Shemonti Hasan, Charles H. Adler, Cynthia M.
Stonnington, Geidy Serrano, Lucia Sue, Holly A.
Shill, Shyamal Mehta, Thomas Beach, Erika Driver-
Dunckley
P4.11-006
Clinical characteristics to predict the onset of
visual hallucinations in Parkinson’s disease –
Sayaka Akazawa, Hiroaki Sekiya, Yoshihisa Otsuka,
Yukihiro Yoneda, Yasufumi Kageyama
 Poster Session 4 Sunday, April 3 8:00 a.m.–9:00 a.m.

P4.11-007
Survival Differences Among Patients with
Parkinson’s Disease and Parkinson’s Disease
Psychosis: a Population-based Study (2006-2015).
– Cole Daniel Stang, Emanuele Camerucci, Aidan
Mullan, Gretchen Ahrens, Pierpaolo Turcano,
James H. Bower, Bradley F. Boeve, Rodolfo Savica
P4.11-008
Apathetic Parkinson’s Disease Patients Have
Slower Gait Initiation Following a Verbal Cue –
Ségolène De Waele, Emke Maréchal, Patrick Cras,
Ann Hallemans, David Crosiers
13
Neuromuscular and Clinical
Neurophysiology (EMG)
Diagnostic Techniques, Biomarkers and
Therapies in Neuromuscular Disease 1
P4.13-001
Benefit of nerve ultrasound in patients with
combined central and peripheral demyelination
(CCPD) – Amandine Kassab
P4.13-002
Ultrasound-enhanced Electrical Impedance
Tomography as a New Tool to Assess Primary
Muscle Disease – Irene Yator, Ethan K Murphy,
Hilda Victoria Gutierrez, Soleil Samaan, Sarah
Neuromuscular Disease: Spinal Muscular
Atrophy and Other Motor Neuron
Disorders 1
P4.13-009
Novel Use of Nusinersen in a Premature Neonate
as a Therapeutic Bridge to Onasemnogene
Abeparvovec-xioi – Wilfreda Johnice Lindsey,
Leah Ferrante, Alexandria Melendez-Zaidi, Timothy
E. Lotze
P4.13-010
Single Center Experience of Nusinersen Treatment
in Spinal Muscular Atrophy Type 2 And Type 3 in
Turkey – Arman Cakar, Sezan Mergen Kilic, Hacer
Durmus, Fatma Yesim Parman

12 General Neurology Verga, Courtney E. McIlduff, Seward B. Rutkove,

General Neurology: Clinical Practice and
Telemedicine 1
P4.12-001
Teleneurology Outpatient Consultations: Patient
and Referring Provider Perceptions – Linda S.
Williams, Holly Martin, Ziyi Yang, Joanne Daggy,
Steven S. Schreiber, Aditi Narechania, Jayne R.
Wilkinson
P4.12-002
The National TeleNeurology Program (NTNP):
Targeting rural Veterans to provide equitable
access to specialty care – Aditi Narechania,
Steven S. Schreiber, Heidi Watson, Linda S.
Williams, Holly Martin, Jayne R. Wilkinson
P4.12-003
A Longitudinal Comparison of Ambulatory
Neurology Patient Experiences with Telehealth
during the COVID-19 Pandemic: How have
telehealth interest and satisfaction changed
over time? – Kevin Alexander Soltany, Carly Jo
Olszewski, Sharon Thomson, Kelly Ann Pring,
Rebecca Siobhan-Ivy Cox, Rebecca Merrill, Emily
Fishman, Alexander Paul Ambrosini, Gabriella
Marie Bognet, Lauren Doyle Strauss, Rachel
Graham, Amy K. Guzik, Roy E. Strowd
P4.12-004
Differences in Ambulatory Neurology Patient
Experiences According to Distance Traveled:
How do telephone and video visits compare to
in-person? – Alexander Paul Ambrosini, Carly
Jo Olszewski, Sharon Thomson, Kelly Ann Pring,
Rebecca Siobhan-Ivy Cox, Rebecca Merrill, Emily
Fishman, Kevin Alexander Soltany, Gabriella Marie
Bognet, Lauren Doyle Strauss, Rachel Graham,
Amy K. Guzik, Roy E. Strowd
P4.12-005
Telehealth in Outpatient Neurology: Physician
and Patient Perspectives – Shreya Shah, Babar
Khokhar, Jeremy Moeller
Ryan J Halter
P4.13-011
Change in Body Mass Index is a Significant
P4.13-003 Predictor of Change in Patient-reported Function
Predictive Value of Single Fiber Electromyography in Adults with Spinal Muscular Atrophy Monitored
in a Low Prevalence Cohort – Yorjannys Gomez, Over a 10-year Period – Kristina Marie Kelly,
Araya Puwanant, James B. Caress Wendy Marie King, Matt Linsenmayer, Jerold E.
P4.13-004 Reynolds, Amy M. Bartlett, Marco Tellez, John T.
Kissel, Stephen J. Kolb, William D. Arnold, Bakri
Clinical, Electrodiagnostic, and Radiographic
Elsheikh
Features of Patients with Brachial Plexopathy
following Axillary Artery Cannulation – Andres De
Leon Benedetti, Rocio Carolina Garcia Santibanez,
Adam Singer, Philip Wong, Nicholas Boulis, Vita
Kesner
P4.13-005
Comparing Acute Skeletal Muscle Repair in Aged
and Young Mice – Katerine Alvarez
P4.13-006
Caregiver burden and soluble urokinase-type
plasminogen activator receptor (SuPAR) levels in
healthy volunteers – Jessica Joyce, Noel Cabanas,
Rohan Pisharody, Roshni A. Patel, Bichum Ouyang,
Jochen Reiser, Deborah Hall, Natalie P. Witek
P4.13-007
Intravenous Immune Globulins vs Plasma
Exchange Usage in Patients with Neuromuscular
and Neuro-immunological Conditions – Melissa
Jeannie Rethana, Adeel Zubair, Anthony K. Ma,
Lindsay Sarah McAlpine, Ahmad Abulaban,
Richard J. Nowak, Bhaskar Roy
P4.13-008
Reachable Workspace to Evaluate Efficacy of
Losmapimod in Subjects with FSHD in Two
Phase 2 Studies – Michelle L. Mellion, Jay Han,
Jennifer Shoskes, Alrabi Tawil, Katy Eichinger,
Leo Hong-Li Wang, Angela L. Genge, Sabrina
Sacconi, Hanns Lochmuller, David Reyes Leiva,
Jordi Diaz Manera, Jorge Alonso-Perez, Nuria
Muelas, Juan Jesus Vilchez Padilla, Alan Pestronk,
Summer Gibson, Namita Goyal, Johanna Hamel,
Lawrence J. Hayward, Nicholas Elwood Johnson,
Samantha Jo LoRusso, Miriam L. Freimer, Perry
Shieh, S H. Subramony, Doris G. Leung, Baziel G M
van Engelen, Joost Kools, Christopher Morabito,
John Jiang, William Tracewell, Alejandro Rojas,
Anthony Accorsi

Information is accurate as of February 8, 2022, and is subject to change. AAN.com/AM 41

 Poster Session 5
1 2
Autoimmune Neurology
Autoimmune Neurology: Autoimmune
Encephalitis 3
P5.1-001
Serial Longitudinal EEG as a Biomarker in
Autoimmune Encephalitis: A Retrospective Cohort
Analysis – Cameron Mohammadi, Tian Wang,
Amy Li Safadi, Robert K. Shin, Tricia Y. Ting
P5.1-002
Residual Symptoms and Long-term Outcomes
after All-Cause Autoimmune Encephalitis –
Hesham Ahmed Abboud, Farren Briggs, Robin A.
Buerki, Mohamed Elkasaby, Guadalupe Fernandez-
Baca Vaca, Neel Fotedar, Christopher D. Geiger,
Cynthia Griggins, Catherine Lee, Alexander
Lewis, Alessandro Serra, Rajeet Shrestha, Jill
Winegardner, Aasef Shaikh
P5.1-003
Validation of Clinical, Radiographic, and
Laboratory Screening Criteria for Autoimmune
Encephalitis – Daniela Raffaela Galluzzo, Sidra
Zaheer, Kristina Maselli, Sydney Moseley, Yarden
Bornovski, Jin Li
P5.1-004
The ExTINGUISH Trial: A Phase-2B Randomized
Placebo-Controlled Trial of Inebilizumab in
Anti-NMDA Receptor Encephalitis – Gregory
S. Day, Maarten Jan Titulaer, Ka-Ho Wong,
James C. Torner, Merit E. Cudkowicz, Christopher
Coffey, Codrin I. Lungu, Eric Klawiter, J. Robinson
Singleton, Dana Katherine Mitchell, Janel Fedler,
Dixie Jean Ecklund, David Klements, Michele
Costigan, Stacey Clardy
P5.1-005
Brazilian autoimmune encephalitis network
(BrAIN): results from a nationwide multicentric
study – Fabio Fieni Toso, Bruna Dias, Maria
Eduarda Slhessarenko, Rene De Araújo Gleizer,
Alessandra Dellavance, Luiz Eduardo Andrade,
Romana Hoeftberger, Livia Almeida Dutra Antonio
P5.1-006
Autoimmune encephalitis in a tertiary hospital in
the Philippines – Nikolai Gil Diwa Reyes, Adrian
Isidoro Espiritu, Jerson Flores Agabao, Joshual
Emmanuel Abejero, Rhea Angela M. Salonga,
Leonor Cabral-Lim, Roland Dominic Jamora, Jose
Leonard R Pascual, Marc Laurence Fernandez,
Katerina Tanya Perez Gosiengfiao
P5.1-007
Balint Syndrome as an Atypical Presentation of
Paraneoplastic Anti-NMDA Receptor Encephalitis:
A Case Report and Review of the Literature –
Neda Sattarnezhad, Jamie C. McDonald, Evan
Madill, May Han
42 2022 AAN Annual Meeting
Sunday, April 3 11:45 a.m.–12:45 p.m.
Headache
Headache: Clinically Oriented Headache
Studies 2
P5.2-001
Arachnoiditis After Epidural Blood Patch to Treat
Low Pressure Headache : A Case Study – Shawna
Huckell, Shawna Huckell, Andrew R. Sas
P5.2-002
Migraine-Associated Gene Expression in Vascular
Cell Types – Luke Skyler Vest, Mengyi Xu, Angeliki
Vgontzas, William R. Renthal
P5.2-003
Perfusion Imaging in Acute Hemiplegic Migraine –
Kyle R. Marden, James E. Siegler
Headache and Population Health 1
P5.2-004
Patient Satisfaction Is Associated With Positive
Communications With Health Care Professionals:
Interim Results From a Survey of an Online
Migraine Community – Heather Lapidus Glassner,
Jaclyn Klepper, Jessica Cirillo, Edward Kim,
Richard B. Lipton
P5.2-005
Alcohol as a risk factor for migraine attacks.
Results from a large prospective cohort study in
English-speaking countries. – Marina Vives-
Mestres, Xavier Puig, Josep Ginebra, Amparo
Casanova, Noah Rosen
P5.2-006
Migraine and Adverse Pregnancy Outcomes: the
nuMoM2b Study – Gular Mammadli, Eliza Miller,
Sarah Vollbracht, Whitney Booker, Leslie Moroz,
Cynthia Gyamfi-Bannerman, Marianna Yugrakh,
David Haas, Mary D’Alton, Ronald Wapner, Natalie
Bello, Kristi Chau, William Grobman, Lisa Levine
3
Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Clinical Trials 1
P5.3-001
Cerezen (Renew™ NCP-5) for the Treatment of
Mild Cognitive Impairment due to Alzheimer’s
Disease or Mild Dementia of the Alzheimer’s Type
in Subjects With Type 2 Diabetes – Patrick M.
Moriarty, Lauryn K. Gorby, David H. Salat, Jeffrey
M. Burns, Thomas Moreno, Jonathan Helfgott
P5.3-002
A Phase 1 Study of AL003 in Healthy Volunteers
and Participants with Alzheimer’s disease –
Daniel Maslyar, Robert Paul, Hua Long, Herve
Rhinn, Ilaria Tassi, Glenn Morrison, Felix Leejia
Yeh, Tina Schwabe, Michael Ward
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P5.3-003
A First-in-Human Study of the Anti-Sortilin
Antibody AL101 – Michael Ward, Robert Paul,
Felix Leejia Yeh, Hua Long, Michael Kurnellas,
Amber Silva, Emmanuel Ang, Jane Green, Daniel
Maslyar
P5.3-004
A Phase 1 Study of AL002 in Healthy Volunteers
– Michael Ward, Robert Paul, Hua Long, Herve
Rhinn, Anna Rychkova, Guang Tu, Cheryl Barner,
Santiago Viveros Salazar, Felix Leejia Yeh, Tina
Schwabe, Sam Jackson
P5.3-005
A Phase 2 Study of AL001 in Frontotemporal
Dementia Patients Carrying a Granulin Mutation –
Julie Huang, Robert Paul, Felix Leejia Yeh, Michael
Ward, Herve Rhinn, Jenna Pappalardo, Yijie Liao,
Hua Long, Sam Jackson
4 MS and CNS Inflammatory
Disease
MS Clinical Trials and Therapeutics 1
P5.4-001
Safety and Efficacy of Evobrutinib, a Bruton’s
Tyrosine Kinase Inhibitor in Relapsing Multiple
Sclerosis Over 2.5 Years of The Open-Label
Extension to a Phase II Trial – Xavier Montalban,
Jerry S. Wolinsky, Douglas L. Arnold, Martin
Weber, Ivan Staikov, Karolina Piasecka-
Stryczynska, Davorka Tomic, Emily C. Martin,
Kristina Holmberg, Hans Guehring
P5.4-002
Analyses of the Effect of Baseline Age on the
Efficacy and Safety of Siponimod in Patients with
Active Secondary Progressive Multiple Sclerosis
from the Phase 3 EXPAND Study – Le Hua, Amit
Bar-Or, Fred D. Lublin, Xiangyi Meng, Gina Cox,
Bruce A. C. Cree, Robert J. Fox
P5.4-003
Efficacy and Safety of Ocrelizumab in Patients
With RRMS With Suboptimal Response to Prior
Disease-Modifying Therapies: 3-Year Data From
CASTING and LIBERTO (LIBERTO 1-Year Interim
Results) – Patrick Vermersch, Celia Oreja Guevara,
Bart Van Wijmeersch, Heinz Wiendl, Jens Wuerfel,
Regine Buffels, Petra Dirks, Thomas Kuenzel, Karen
Kadner, Giancarlo Comi
P5.4-004
Long-term Efficacy of Ofatumumab in Patients
With Relapsing Multiple Sclerosis – Stephen L.
Hauser, Edward J. Fox, Angela Aungst, Wendy
Su, Ronald Zielman, Ayan Das Gupta, Xixi Hu, Dee
Stoneman, Derrick Robertson, Jeffrey Alan Cohen,
Ludwig Kappos
 Poster Session 5
P5.4-005
Impact of ozanimod treatment on cortical grey
matter volume: up to 5 years’ experience in phase
3 and extension trials – Chahin Pachai, James
K. Sheffield, Xavier Montalban, Bruce A. C. Cree,
Ludwig Kappos, Giancarlo Comi, Hans-Peter
Hartung, Chun-Yen Cheng, Diego Silva, Jeffrey
Alan Cohen, Douglas L. Arnold
P5.4-006
Cognitive Processing Speed Predicts Disease
Progression in Secondary Progressive Multiple
Sclerosis: Post Hoc Analysis from the EXPAND
Study – Iris Katharina Penner, Gavin Giovannoni,
Tanuja Chitnis, Patrick Vermersch, Sophie Arnould,
Jeff Maca, Virginia De Las Heras Revilla, Goeril
Karlsson, Daniela Piani Meier, Ludwig Kappos,
Ralph H. B. Benedict
P5.4-007
Vaginal Estriol as a potential adjunctive therapy
for MS remyelination – Mirla L. Avila, Jie Pan,
Roberto Hernandez Quintana, Dargelis Chi,
Smathorn Thakolwiboon, Alan Peiris, Kenn Alan
Freedman, Charles D. Thompson, John Matthew
Garza
P5.4-008
Effect of Ponesimod Compared With Teriflunomide
on Treatment With Concomitant Corticosteroids
for Relapse in Patients with Relapsing Forms
of Multiple Sclerosis – Camilo Obando, Ibrahim
Turkoz, James Simples, Monica Doring, Maria Ait
Tihyaty
P5.4-009
Disability Improvements With Ublituximab in
Relapsing Multiple Sclerosis (RMS): Expanded
Disability Status Scale (EDSS), 9-Hole Peg Test
(9-HPT), and Timed 25-Foot Walk (T25FW)
Evaluations From the Phase 3 ULTIMATE I and
II Studies – Bruce A. C. Cree, Edward J. Fox,
Hans-Peter Hartung, Enrique Alvarez, Peiqing Qian,
Sibyl E. Wray, Derrick Robertson, Deren Huang,
Krzysztof W. Selmaj, Daniel R. Wynn, Michael S.
Weiss, Jenna Bosco, Sean Power, Koby Mok, Lily
Lee, Lawrence Steinman
P5.4-010
Five Years Analysis of anti-Glatiramer Acetate
(GA) Antibodies in Patients with Relapsing
Remitting Multiple Sclerosis Treated with GA
Depot – Shlomo Flechter, Ariel L. Miller, Laura
Popper, Nadav Bleich Kimelman, Shai Rubnov, Uri
Danon, Ehud Marom, Ron E. Milo, Joab Chapman,
Alla Shifrin, Ronit Gilad, Chen Hoffmann, Tamir
Ben Hur, Dimitrios Karussis, Arnon Karni
Information is accurate as of February 8, 2022, and is subject to change.
Sunday, April 3 11:45 a.m.–12:45 p.m.
P5.4-011
Multi-center, Randomized, Double-blinded
Assessment of TERIFLUNOMIDE (Aubagio®)
in Extending the Time to the First Attack in
Radiologically Isolated Syndrome: Baseline
Characteristics of the TERIS Study. – Christine
Lebrun Frenay, Cassandre Landes-Chateau, Aksel
Siva, Maria Pia Sormani, Lydiane Mondot, Patrick
Vermersch, Anne Caroline Papeix, Eric Thouvenot,
Pierre Labauge, Francoise Durand Dubief, Husnu
Efendi, Emmanuelle Le Page, Murat Terzi, Nathalie
Derache, Bertrand Bourre, Robert Hoepner, Rana
Karabudak, Jerome De Seze, Jonathan Ciron,
Pierre Clavelou, Sandrine Wiertlewski, Omer
Faruk Turan, Nur Yuceyar, Mikael Cohen, Orhun H.
Kantarci, Daniel Pelletier, Darin T. Okuda
5
General Neurology
Neuroepidemiology 2
P5.5-001
Physical Activity Moderates the Association
Between White Matter Hyperintensity Burden
and Cognitive Change – Suhang Song, Yunglin
Gazes, Seonjoo Lee, Christian Habeck, Yaakov
Stern, Yian Gu
P5.5-002
Survival analysis of patients with adult-onset
leukoencephalopathy with axonal spheroids and
pigmented glia (ALSP): data from a systematic
literature review of published case studies
– Spyridon Papapetropoulos, Angela Pontius,
Matthew Brennan, Ryan O’Mara
P5.5-003
COVID-19 Outcomes of 10,881 patients:
Retrospective study Of Neurological symptoms
and Associated manifestations (Philippine
CORONA Study) – Adrian Isidoro Espiritu, Marie
Charmaine Cootauco Sy, Michelle Anlacan, Roland
Dominic Jamora
P5-5.004
WITHDRAWN
P5.5-005
Head Injury and All-Cause Mortality in
Community-Dwelling Adults – Holly Elser, Rebecca
F. Gottesman, Alexa Walter, Josef Coresh, Ramon
R. Diaz-Arrastia, Tom Mosley, Andrea Lauren
Christman Schneider
6
Aging, Dementia, Cognitive, and
Behavioral Neurology
Genetics and Other Cognitive Topics 2
P5.6-001
Efficacy of Everolimus for Tuberous Sclerosis
Complex: A Systematic Review and Meta-
analysis. – Fatma Mohamed Sayed, Mohamed
Sayed Zaazouee, Elfatih A. Hasabo, Sara
Mohamed Hasan, Anas Zakarya Nourelden, Alaa
Ahmed Elshinbary, Manar Mohammed Hosny,
Amal Abdelfattah Mahmoud, Amira Benmelouka,
Mariam Abdelwhaab Asela, Ghada Said Hammad,
Mostafa Mahmoud Meshref, Sherouk Shawkat
Moham Elkady, Khaled Mohamed Ragab,
Mohamed Fahmy Doheim
P5.6-002
A Rare MED13 Variant as the Potential Cause
of Early Onset Cognitive Decline and Brain Iron
Accumulation: A Case Report – Kaancan Deniz,
Tiffany K. Grider, Chad Eric Grueter, Joel C.
Geerling
P5.6-003
Multifaceted presentation of a rare mitochondrial
syndrome- HAREL-YOON SYNDROME - Story of 3
siblings – Muralikrishna Konda
P5.6-004
C9Orf72 Repeat Expansion and Myoclonus-
Epilepsy: a case report and literature review
– Nivedita Jha, Subin Mathew, Christopher M.
McGraw
P5.6-005
Gene Expression Analysis of CCL2, MOBP
and OPALIN in Major Depressive Disorder and
Suicidality – Rui Tang, Javier Vargas Medrano,
Enrique Ivan Ramos, Peter Thompson, Bharathi
Gadad
P5.6-006
A New Adult Neurodevelopmental Disabilities
Clinic: Description of Population and Yield of
Genetic Testing in the First Year – Moriah Mabry,
Sharon Scarbro, Jessica Sanders
7
Medical Student Essay Awards
P5.7-001
A Comparison of Telehealth and In-Person Visits in
Ambulatory Neurology: What are the factors that
patients consider when selecting future visit type?
– Carly Jo Olszewski, Sharon Thomson, Kelly Ann
Pring, Rebecca Siobhan-Ivy Cox, Rebecca Merrill,
Emily Fishman, Alexander Paul Ambrosini, Kevin
Alexander Soltany, Gabriella Marie Bognet, Lauren
Doyle Strauss, Rachel Graham, Amy K. Guzik, Roy
E. Strowd
AAN.com/AM 43
 Poster Session 5
8 Epilepsy/Clinical Neurophysiology
(EEG)
Epilepsy and Clinical Neurophysiology
(EEG): Epilepsy Imaging 2
P5.8-001
Hyperintense acute reperfusion marker (HARM)
due to status epilepticus- A potential imaging
pitfall’ – Mustafa Al-Chalabi, Sidra Saleem, Ajaz
Sheikh
P5.8-002
Focal Seizures with Ictal Bradycardia from Right
Insular Lesion in Tuberous Sclerosis: A Rare Case
– Alok Dabi, Kamakshi A. Patel, Vijaya Lakshmi
Valaparla, Brian Walter
P5.8-003
A novel customized representation of source
space in epilepsy pre-surgical evaluation – Darion
Toutant, Graham Alexander McLeod, Parandoush
Abbasian, Amirhossein Ghassemi, Maziar Fazel
Darbandi, Marcus Ng
Epilepsy/Clinical Neurophysiology (EEG):
Epilepsy Genetics and Surgery 1
P5.8-004
Long-term seizure and functional outcome
following occipital or ”occipital-plus” resection
for refractory epilepsy in children – Elham
Abushanab, Ahsan Moosa Naduvil Valappil,
William Bingaman, Deepak K. Lachhwani, Elia
Margarita Pestana Knight
P5.8-005
Infantile Spasms in Cardiofaciocutaneous
Syndrome: Associations with Genotype,
Phenotype and Treatment Response – Dante
James Rogers, Samuel Kroening, Ashley
Whitmarsh, Abigail Zatkalik, Martin Zenker, Amy
Roberts, Rene Pierpont, Daniel L. Kenney-Jung
P5.8-006
Genetic Testing Informs Epilepsy Treatment
Management: Results from An International
Study of Clinical Practice and Patient Outcomes
– Dianalee McKnight, Ana Morales, Kathryn
Hatchell, Sara Bristow, Edward D. Esplin, Chad
Moretz, Felippe Borlot, Kaitlin Angione, M. Scott
Perry, Joshua Bonkowsky, Loreto Rios-Pohl, Anne
T. Berg, Swaroop Aradhya
P5.8-007
Cognitive Outcomes Following Pediatric Epilepsy
Surgery – Navkiranjot Kaur, Amy Nowacki,
Jennifer Haut, Patricia Klaas, Lisa Ferguson,
Deepak K. Lachhwani, William Bingaman, Tara T.
Lineweaver, Robyn Busch
44 2022 AAN Annual Meeting
Sunday, April 3 11:45 a.m.–12:45 p.m.
9 Infectious Disease
Infectious Disease: Tricky Viruses 1
P5.9-001
Varicella Zoster Meningitis Presenting as
Unilateral Vocal Cord Paralysis – Omar Muhsin
Ali Al-Janabi, Supreeth Gowda Narayana Gowda,
Padmaja Sudhakar
P5.9-002
West Nile Myelitis Disguised as Severe
Compressive Myelopathy – Elizabeth Anderson,
Tejas Ranade, Connor David Welsh, Huiam
Mubarak
P5.9-003
Clinical Characteristics of 11 Cases with Visual
Impairment After Herpes Virus Infection –
Jingxiao Zhang, Lei Liu
P5.9-004
Perpetuating PML- Alcohol Induced Lymphopenia
causing JC virus Reactivation – Mikul Minesh
Bhikha, Chandra Sekhar Mannyam, Camille
Barbour
9
Neuro-oncology
Neuro-oncology: Therapies and Toxicities
1 Validating Existing Stroke Scales for Acute
P5.9-005
Concurrent Olaparib and Temozolomide for
Recurrent Glioma – Marina Kushnirsky, Andrew
L. Lin, Alexandra M. Miller, Igor T. Gavrilovic,
Craig Nolan, Elena Pentsova, Ingo K. Mellinghoff,
Thomas J. Kaley, Lauren Rhea Schaff
P5.9-006
A multicenter observational study of Cs-131 seeds
embedded in a collagen carrier tile in intracranial
brain neoplasms – trial in progress – Erin M.
Dunbar, David Jason McCracken, Adam Wayne
Nowlan, Clark Chen, Kathryn Dusenbery, Rupesh
Kotecha, Michael William McDermott, John
Wanebo, Kenneth Stuart Lee, Toral R. Patel, Zabi
Wardak, John Robert Floyd, David Monyak, John
E. Trusheim, Mitesh Shah, David Brachman
P5.9-007
BRAFV600E-mutant glioblastoma responds
to combination BRAF/MEK inhibition with
encorafenib and binimetinib – Elizabeth Coffee,
Thomas J. Kaley, Eli Diamond, Alexandra M. Miller,
Lauren Rhea Schaff
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
10 Cerebrovascular Disease and
Interventional Neurology
Cerebrovascular Disease: Basic and
Translational Science 1
P5.10-001
Microglial IL-1RA ameliorates brain damage after
ischemic stroke via inhibiting astrocyte-derived
CXCL1 – Xiaoyan Huang, Mingyan Guo
P5.10-002
Immunoreactivity and A New Staining Method
of MCT-1 Located in Endothelial Cells of Cerebral
Vessels of Human Brain in Distinguishing Cerebral
Venules from Arterioles – Yuan Cao, Dong-Hui Ao,
Chao Ma, Wen-Ying Qiu, Yi-Cheng Zhu
P5.10-003
Analysis of Protein Networks Associated with
Hemorrhagic Conversion In Emergent Large
Vessel Occlusion Patients Undergoing Mechanical
Thrombectomy – Madison Sands, Chintan K.
Rupareliya, Jacqueline A. Frank, Christopher
McLouth, Benton Maglinger, Amanda L. Trout,
Jadwiga Turchan, David Dornbos, Shivani Pahwa,
Lila Emily Sheikhi, Ann Stowe, Keith Pennypacker,
Justin Fraser
Interventional Neurology and
Thrombolytic Therapy 2
P5.10-004
Identification of Cerebrovascular Events in an
Inpatient Setting – Adriana Naomi Sari, Faddi
Ghassan M. Saleh Velez, Shyam Prabhakaran
P5.10-005
Identifying Delays Associated with Door-to-
Device Time for Potential Large Vessel Occlucion
Thrombectomy Patients in the Emergency
Department – Anirudh Sreekrishnan, Nirali Vora
P5.10-006
Acute stroke reperfusion therapies in patients
with Posterior Reversible Encephalopathy
Syndrome – Monica Sarkar, Vivien H. Lee
P5.10-007
Stent Retrievers Utilization in Endovascular
treatment of Cerebral Venous Sinus Thrombosis
– Abdallah Omar Amireh, Hassan M. Ali,
Muhammad Nagy, Siddhart Kumar Mehta,
Haralabos Zacharatos, Farah Yolanda Fourcand,
Jawad F. Kirmani
P5.10-008
Risk of Distal Embolization in Large Vessel
Occlusion Strokes Treated with Tenecteplase –
Siddhart Kumar Mehta, Nasar Ali, Teye Aniefiok
Umanah, Arifa Ghori, Rafia Jawed, Spozhmy
Panezai, Ilya Dubinsky, Haralabos Zacharatos,
Farah Yolanda Fourcand, Jawad F. Kirmani
 Poster Session 5
11
Movement Disorders
Movement Disorders: Deep Brain
Stimulation in Parkinson’s Disease 1
P5.11-001
Patient Preferences for Deep Brain Stimulation
Products in Parkinson’s Disease: What Really
Matters to Them? – Teresa Lee, Michelle Fullard,
Tammy Rogers, Steven Ojemann, Drew S. Kern
P5.11-002
Impact of pre-existing small vessel disease on
Motor Outcomes after Deep Brain Stimulation in
Parkinson’s Disease – Heather Martin, Rushna Ali,
Morgan Maley, Muhib Khan
P5.11-003
Subthalamic Peak Beta RatioPower is Asymmetric
in Glucocerebrosidase Mutation Carriers with
Parkinson’s Disease: A Pilot Study – Fabian David,
Miranda Munoz, Jay Shils, Michael Pauciulo, Philip
Hale, William C. Nichols, Mitra Afshari, Sepehr
Sani, Leonard Verhagen Metman, Daniel Corcos,
Gian D. Pal
P5.11-004
Subthalamic tremor related oscillatory neuron
plays a role in the generation of Parkinson’s
tremor – Ping Zhuang, Mark Hallett, Yuqing Zhang,
Jianyu LI, Jiping Li
P5.11-005
Algorithm-Guided Deep Brain Stimulation
Programming Using Automated Motion Sensor-
Based Functional Mapping Improves Programming
Efficiency – Aaron Hadley, Vibhor Krishna, Aristide
Merola, Rozena Davis, Danielle Englert, Nicholas
James Fleming, Benjamin L. Walter, Erica Hennigs,
Dustin A. Heldman
P5.11-006
Programming Time and the Use of a Visualization
Tool for DBS Programming of a Multiple-Source,
Constant-Current System – Jason Lamar
Aldred, Theresa A. Zesiewicz, Juan Ramirez
Castaneda, Michael S. Okun, Corneliu C. Luca,
Ritesh Ramdhani, Leonard Verhagen Metman,
Jennifer Lyn Durphy, Mustafa S. Siddiqui, Yarema
B Bezchlibnyk, Jonathan Carlson, Kelly D. Foote,
Sepehr Sani, Alexander M. Papanastassiou, David
Weintraub, Jonathan Jagid, Julie Pilitsis, Lilly
Chen, Roshini Jain
Movement Disorders: PD Non-Motor
Symptoms or Parkinsonism and NMS 2
P5.11-007
Severity of Depressive and Motor Symptoms
Impacts Quality of Life in Parkinson’s Disease
Patients of High Socioeconomic Status – Brianne
Lacy, Hien Piotrowski, Mustafa Husain
P5.11-008
Real-world digital driving profiles in PD index
motor and non-motor clinical symptom severity
– Jun Ha Chang, Danish Bhatti, Matthew Rizzo,
Jennifer Merickel
Information is accurate as of February 8, 2022, and is subject to change.
Sunday, April 3 11:45 a.m.–12:45 p.m.
12
General Neurology
General Neurology: Clinical Practice and
Telemedicine 2
P5.12-001
Neurological findings in sickle cell disease
patients without a history of neurological insult:
prevalence, risk factors and practice implications
– Ahmed Moh’d Yassin, Mohammed Bassam
Nawaiseh, Mohammed Qussay Ali Al-Sabbagh,
Ahmad Al Nawaiseh, Mohammad Abu-Rub
P5.12-002
Clover-Leaf Curling Recovery in Functional Tongue
Weakness – Michael Patrick Harlan Stanley
P5.12-003
A Clinical Decision Rule Predicting Outcomes of
Emergency Department Patients with Altered
Mental Status – Tyrell Jonathan Simkins, David P.
Bissig, Gabriel M. Moreno, Nimar Kahlon, Fredric
A. Gorin, Alexandra O’Neill Duffy
P5.12-004
Psychotherapeutic approach for the treatment
of generalized anxiety disorder (GAD) improves
outcome when delivered under specific (narrow
band) green light condition. – Raul J. Rodriguez,
Paul Hart, Brittany Lipinski, Lacey Burkett, Skyler
Rosen, Erica Sanes, Cara Harbaugh, Agustin Melo
Carrillo, Rami Burstein
P5.12-005
Gender and decistion making in Neurology, an
Argentinian study. – Maria Gaitan, Celica Ysrraelit,
Laura Negrotto, Veronica A. Bruno, Maria Cecilia
Fernandez, María Del Carmen García, Carolina
Laura Azcona, Maria Justich, Mariela Cabrera,
Maria Soledad Rodriguez Perez, Maia Gomez
Schneider, Marina Romano, Viviana Andrea Ibarra,
Jimena Miguez, Lucia Derosa, Guadalupe Bruera,
Lucia Jimena Zavala
13 Neuromuscular and Clinical
Neurophysiology (EMG)
Diagnostic Techniques, Biomarkers and
Therapies in Neuromuscular Disease 2
P5.13-001
Genetic Testing Analysis in Patients with
Neuromuscular Disorders: A Single Health System
Experience – Madelyn Kay Smiley, J. David Avila,
Scott M. Friedenberg, Madeline Williamson
P5.13-002
Dermal Nerve Bundles Offer a Comprehensive,
Accessible, Cutaneous Nerve Analysis – Kendall
Nichols, Brian McAdams, Adam Loavenbruck
P5.13-003
Refining Compound Muscle Action Potential
as a Translational Biomarker of Neuromuscular
Integrity – Sindhuja Ayyagari, Hallie Harris,
William D. Arnold
P5.13-004
Does High Resolution Ultrasound Guided Femoral
Nerve Conduction Study Makes a Difference
When Compared To Conventional Technique? –
Abhinay Kumar Gattu, Yerasu Muralidhar Reddy,
Shyam Krishnakumar Jaiswal, Pidaparthi Lalitha,
kiran Erranki, Ravi Nulaka, P Anusha, Jagarlapudi
Murali Krishna Murthy
P5.13-005
Value of Diaphragm Electromyography and
Phrenic Nerve Conduction Studies in Suspected
Diaphragm Paresis – Divya Rahul Shah, Steven
Vernino, Shaida Khan
P5.13-006
Electrodiagnostic Findings in Covid patients: A
single center experience – Sajid Hameed Shaikh,
Sara Khan
P5.13-007
A pilot study of neuromuscular ultrasound as a
biomarker for spinal-bulbar muscular atrophy –
Abdullah Zahi Alqahtani, Katharine Alter, Joseph
Shrader, Galen Joe, Angela Kokkinis, Christopher
Grunseich, Kenneth H. Fischbeck
Neuromuscular Disease: Spinal Muscular
Atrophy and Other Motor Neuron
Disorders 2
P5.13-008
Quantitative muscle strength changes in
adults with Spinal Muscular Atrophy receiving
Nusinersen – Dana McDonnell, Sally Dunaway,
Whitney Tang, Connie Wolford, Zihuai He, John W.
Day, Tina Duong
P5.13-009
Real-World Data of Nusinersen in Adults
with Spinal Muscular Atrophy: A Single
Center Experience – Doruk Arslan, Berin Inan,
Muhammed Kilinc, Can Ebru Kurt, Sevim Ozdamar,
Ersin Tan
P5.13-010
LOTS in the Needle Examination – Zara Abigail
Togher, Sue Zann Gan, John C. McHugh, Sean
O’Dowd, Sinead Murphy
AAN.com/AM 45
 Poster Session 6
1
Autoimmune Neurology
Autoimmune Neurology:
Neurosarcoidosis and Vasculitis
P6.1-001
Characterization of Neurosarcoid Myelitis and
Assessment of Treatment Response in a Single-
Hospital System. – Giovanna Manzano, Denis Tan
Kerim Balaban, Ahya Sajawal Ali, Brian Curran
Healy, Bart Chwalisz, Michael Levy, Shamik
Bhattacharyya
P6.1-002
Identification of Brain and Spinal Cord
Abscesses in a Patient with Recently Diagnosed
Neurosarcoidosis – Karishma Anjuli Popli, Ryan
Tyler Lamb, Yasir Al-Khalili, Neel Dixit
P6.1-003
Stroke in Patients with Sarcoidosis: A
Comprehensive Review of 42 Reported
Cases – Danielle Kei Pua, Pria Anand, Shamik
Bhattacharyya
P6.1-004
“String of pearls” in the spinal cord: a novel
magnetic resonance imaging sign in necrotizing
sarcoid granulomatosis myelitis – Xiaoyang Li,
Leonardo Morantes Gomez, Mahmoud Al Masry,
Irena Dujmovic Basuroski
P6.1-005
Neurosarcoidosis after infection with COVID-19, a
case report and review of the literature – Daniel
Esteban Mafla Delgado, Sharon G. Lynch, Maryam
Matloub
P6.1-006
Primary angitis of the central nervous system
(PANCS) mimicking Glioblastoma in a pediatric
patient – Alfred Balasa, Elizabeth McQuade
P6.1-007
Susac Syndrome with a Unique Involvement of the
Thoracic Spinal Cord – Robert Evan Ungerer, Rola
Mahmoud, Michael J. Schwartzman
2 Headache
Headache and Population Health 2
P6.2-001
Migraine and the Risk of Venous
Thromboembolism among Women – Pamela M.
Rist, Flora Chang, Julie E. Buring, Daniel Chasman,
Robert J. Glynn, Tobias Kurth
P6.2-002
Factors Associated With Seeking Care For
Migraine: Results Of The OVERCOME (US) Study
– Sait Ashina, Eva Jolanda Muenzel, Robert
A. Nicholson, Anthony J Zagar, Dawn C. Buse,
Michael L. Reed, Susan Hutchinson, Robert E.
Shapiro, Eric M. Pearlman, Richard B. Lipton
46 2022 AAN Annual Meeting
Sunday, April 3 5:30 p.m.–6:30 p.m.
Headache Validation and Education
Research 1
P6.2-003
Validation of Measures of Treatment Expectancy
in Children & Adolescents with Headache –
Christina Lynch Szperka, Danielle Joy Kellier,
Nichelle Raj, Blanca Marquez de Prado, Steven L.
Kugler, Jocelyn Kalkbrenner, Naomi Hughes, Kevin
Pettijohn, Dana Haagen, Gerardo Velasquez, Jesse
Yenchih Hsu, Andrew D. Hershey, John T. Farrar
P6.2-004
Translation and validation to Spanish of the
diagnostic test ID-Migraine ® – Roberto
Rodriguez, Carlos Alberto Moreno Martinez
P6.2-005
Pediatric Pain Neuroscience Education: Pilot Trial
in Primary Headache Patients – Isidora Rose
Beach, Rachel Munik Madhur, Peter M. Bingham
P6.2-006
The Migraine Disability Assessment (MIDAS)
as an Indicator of Resilience in Patients with
Headaches – Deborah I. Friedman, Avneet Hans,
Cynthia M. Stonnington
3
Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Clinical Trials 2
P6.3-001
Allopregnanolone as a Regenerative Therapeutic
for Early Alzheimer’s Disease: Phase 1b/2a Clinical
Trial Outcomes – Gerson David Hernandez Rivera,
Claudia Lopez, Wendy Mack, Sonia Pawluczyk,
Dawn Matthews, Yonggang Shi, Meng Law,
Michael A. Rogawski, Lon Schneider, Roberta Diaz
Brinton
P6.3-002
PostGraduate Open-label Rollover Study:
Evaluation of Subcutaneous Gantenerumab
Long-term Safety, Tolerability, and Efficacy
in Participants with Alzheimer’s Disease –
Christopher Lane, Angeliki Thanasopoulou, Paul
Delmar, Alison Searle, Francesca Mazzo, Patricia
Ehrhard, Paulo Pacheco Fontoura, Monika Baudler,
Geoffrey A. Kerchner, Rachelle Doody
P6.3-003
Development of the Monoclonal Antibody AL101
to block the Sortilin/Progranulin Interaction as a
Potential Therapy for Neurodegenerative Diseases
– Ananya Mitra, Robert Paul, Hua Long, Guang Tu,
Cheryl Barner, Michael Ward, Stella McCaughey,
Nadine Anne Tatton, Michael Kurnellas
P6.3-004
Integrated Alzheimer’s Disease Rating Scale
(iADRS): Clinically Meaningful Change Estimates –
Ellen Dennehy, Dorene M. Rentz, Alette Wessels,
Michael G. Case, John R. Sims
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P6.3-005
Design and methods of a Phase 2a
study evaluating the safety, tolerability,
pharmacokinetics, and CNS activity of CY6463
in participants with Alzheimer’s disease with
vascular pathology – Chad E Glasser, Jennifer
Chickering, Phebe Wilson, Emily Florine,
Christopher Wright, Christopher Winrow
4 MS and CNS Inflammatory
Disease
MS Clinical Trials and Therapeutics 2
P6.4-001
Effect of Siponimod on Disability Progression as
Measured by the Ambulation Score, a Subscore of
the Neurostatus-EDSS: Post hoc Analysis of the
EXPAND Trial in SPMS – Marcus D`Souza, Gavin
Giovannoni, Patrick Vermersch, Jeff Maca, Soudeh
Ansari, Goeril Karlsson, Daniela Piani Meier,
Ludwig Kappos
P6.4-002
Long-Term Suppression of MRI Disease Activity
and Reduction of Global/Regional Volume Loss:
Results from OPERA I/II and ORATORIO Open-
Label Extension – Douglas L. Arnold, Anthony
Traboulsee, Jerry S. Wolinsky, Stephen L. Hauser,
Ludwig Kappos, Xavier Montalban, Frederik
Barkhof, Ulrike Bonati, Wei Wei, Laura Gaetano
P6.4-003
Efficacy and safety of proposed natalizumab
biosimilar PB006 versus Tysabri® in patients with
relapsing remitting multiple sclerosis: Primary
data from the Phase III Antelope study – Bernhard
Hemmer, Heinz Wiendl, Karsten Roth, Hendrik
Wessels, Josef Hoefler, Cyrill Hornuss, Bernd
Liedert, Krzysztof W. Selmaj
P6.4-004
Estimating long-term effect of siponimod on
disability progression versus virtual placebo in
SPMS using RPSFT model: EXPAND data up to 7
years – Bruce A. C. Cree, Nicolas Rouyrre, Robert
J. Fox, Patrick Vermersch, Gavin Giovannoni, Amit
Bar-Or, Ralf Gold, Jeff Maca, Daniela Piani Meier,
Goeril Karlsson, Ludwig Kappos
P6.4-005
Ublituximab Treatment Is Associated With a
Significant Proportion of Patients Achieving No
Evidence of Disease Activity (NEDA): Results From
the Ultimate I and Ultimate II Phase 3 Studies of
Ublituximab vs Teriflunomide in Relapsing Multiple
Sclerosis (RMS) – Enrique Alvarez, Lawrence
Steinman, Edward J. Fox, Hans-Peter Hartung,
Peiqing Qian, Sibyl E. Wray, Derrick Robertson,
Deren Huang, Krzysztof W. Selmaj, Daniel R.
Wynn, Michael S. Weiss, Jenna Bosco, Sean
Power, Koby Mok, Lily Lee, Bruce A. C. Cree
 Poster Session 6 Sunday, April 3 5:30 p.m.–6:30 p.m.

MS Therapeutics MOA and Safety 1
P6.4-006
Effectiveness of Natalizumab Treatment
Inpatients With Early Relapsing-Remitting
Multiple Sclerosis (RRMS) who were Treatment-
Naive Versus Those Who Had Prior Disease-
Modifying Therapy (DMT) Use – Jai Perumal,
Roumen D. Balabanov, Roger Chang, Laura J.
Balcer, Steven Galetta, Robin L. Avila, Danette J.
Rutledge, Robert J. Fox
P6.5-002
Variants in PNPLA8 are Associated with
Developmental Epileptic Encephalopathy and
Cerebellar Atrophy. – Cheryl Fields, Elissa
Yozawitz, Margo Sheck Breilyn, Indirapriya
Avulakunta, Supriya Bisht, Nagma Dalvi, Leslie
D. Delfiner, Donya Eizadkhah, Solomon L. Moshe,
Sarah Alexandra Nitka, Kimberly O’Neill, Aparna
Polavarapu Ramarao, Orna Rosen, Apirada
Thongsing, Solomon L. Moshe
P6.6-004
Wernicke-Korsakoff syndrome and catatonia: a
case report – Alexandra Seide Cardoso, Viviane
Tavares Carvalho, Matheus Castro, Caroline Bittar
Braune, Isadora Versiani de Lemos, Gabriel R.
Freitas, Marcia Cristina Antu Ribas
P6.6-005
Psychogenic Non-Epileptic Seizures in the Elderly
– Maheen Islam, Shanti S. Thirumalai, Reid D.
Taylor, Coleman Cabe, Tasha Denise Frye
P6.6-006

P6.4-007
Innovative Comparative Study Assessing the
Effect of Siponimod on Reactive Microglia/
Astrocytes in Patients With Secondary
Progressive Multiple Sclerosis: Study Design –
Robert Zivadinov, Bianca Weinstock-Guttman,
Ralph H. B. Benedict, Michael G. Dwyer, Ferdinand
Schweser, Dejan Jakimovski, Niels Bergsland,
Daniela Piani Meier, Harald Kropshofer
P6.4-008
Humoral immunological memory is retained
in patients with multiple sclerosis receiving
cladribine therapy – Tobias Moser, Georg Pilz,
Peter Wipfler
P6.4-009
Autologous HSCT Outside of Clinical Trials in
Patients with Multiple Sclerosis – Jennifer Lord,
John W. Rose, M. Mateo Paz Soldan
P6.4-010
Infusion-Related Reactions (IRRs) With
Ublituximab in Patients With Relapsing Multiple
Sclerosis (RMS): Post Hoc Analyses From the
Phase 3 ULTIMATE I and II Studies – Edward J.
5
General Neurology
Neuroepidemiology 3
P6.5-003
Trends in Diagnosis of Post-Stroke Depression in
the U.S. (2003 – 2019) – Holly Elser, Michelle Rae
Caunca, David Rehkopf, Rebecca F. Gottesman,
Kristine Yaffe, Andrea Lauren Christman Schneider
P6.5-004
Sex Differences in Inpatient Outcomes following
Hospitalization for Myasthenic Crisis – Maryam
Jamil Syed, Ayaz M. Khawaja
P6.5-005
Neurocysticercosis in Mexico. A persistent health
problem or on-track to eradication? – Roberto
Rodriguez, Agnès Fleury
6 Aging, Dementia, Cognitive, and
Behavioral Neurology
Psychological Outcome after Hemorrhagic Stroke
is related to Functional Status – Sarah Ecker,
Aaron S. Lord, Lindsey Gurin, Koto Ishida, Kara R.
Melmed, Jose L. Torres, Barry M. Czeisler, Cen
Zhang, Jennifer A. Frontera, Ariane Lewis
P6.6-007
Piperlongumine and Piperlonguminine Mitigate
Rotenone Induced Neurotoxicity: Implications for
a Novel Parkinson’s Disease Treatment– Jessica
Guo
P6.6-008
A Novel Strategy for the Reversal of Glioblastoma
Tumor Cell Immortality – Samuel Wu
P6.6-009
An Integrated Genome and Phenome-Wide
Association Study Approach to Understand
Alzheimer’s Disease Predisposition – Archita
Khaire

Fox, Lawrence Steinman, Hans-Peter Hartung, Behavioral and Cognitive Neurology:

Enrique Alvarez, Peiqing Qian, Sibyl E. Wray,
Derrick Robertson, Deren Huang, Krzysztof W.
Selmaj, Daniel R. Wynn, Michael S. Weiss, Jenna
Bosco, Sean Power, Koby Mok, Lily Lee, Bruce A.
C. Cree
P6.4-011
Guillain-Barré Syndrome After Alemtuzumab
Treatment in a Patient with Multiple Sclerosis: a
Case Report – Hasim Gezegen, Ozgu Kizek, Tuncay
Gunduz, Mefkure Eraksoy, Murat Kurtuncu
5 Child Neurology and
Developmental Neurology
Child Neurology: Seizures/Genetic
Syndromes 1
P6.5-001
Use of Lacosamide in Neonatal Seizures –
Abdullah Bin Shoaib, Alison M. Dolce, Michelle
Machie, Jennifer Lauren Thomas
Neuropsychiatry 1
P6.6-001
Outcomes of tailored psychotherapy for
dissociative seizures in a developing functional
neurology service – James William Mitchell, Katie
Robb, Mariana Decheva, Jayne Martlew, Christine
Emma Burness
P6.6-002
Emotional and Behavioral Dyscontrol Is More
Likely After Intracerebral Hemorrhage than
Subarachnoid Hemorrhage – Daniel Talmasov,
Sarah Ecker, Anlys Olivera, Aaron S. Lord, Lindsey
Gurin, Koto Ishida, Kara R. Melmed, Jose L. Torres,
Barry M. Czeisler, Cen Zhang, Jennifer A. Frontera,
Ariane Lewis
P6.6-003
Professional Exhaustion Syndrome and
Depression in Two Cohorts of Medical Residents
Before and After the Covid-19 Pandemic – Carla
Florencia Bolano Diaz, jesica Pszenyckyj, Franco
Emanuel Appiani, Daiana Micucci, Guido David
Vazquez, Carlos Santiago Claverie, Santiago
O’Neill, Alfredo Thomson

Information is accurate as of February 8, 2022, and is subject to change. AAN.com/AM 47

 Poster Session 6
7
Neuro Trauma and Critical Care
Neurocritical Care: ICH, SAH, Ischemic
Stroke and Other Topics 1
P6.7-001
Cerebral hypoperfusion after nimodipine
administration is associated with worse functional
outcomes in subarachnoid hemorrhage patients
– David Bartolome, Yelyzaveta Begunova, Ayush
Prasad, Alexandria Soto, Jessica Kobsa, Ilayda Top,
Darko Ernesto Quispe Orozco, Mudassir Farooqui,
Cynthia Zevallos, Jennifer A. Kim, Emily Jean
Gilmore, Rachel Beekman, Adam De Havenon,
Charles Matouk, Kevin N. Sheth, Santiago Ortega
Gutierrez, Nils Petersen
P6.7-002
Exploring the Role of Perihematomal Edema in
Delirium after Intracerebral Hemorrhage – Jesse
Menville, Nathaniel Rex, Mikaela Springsteen,
Scott Collins, Elizabeth Chen, Olga Boukrina,
Lori Daiello, Karen L. Furie, Richard Jones, Jesse
Menville
P6.7-003
National Trends In Utilization And Outcomes
Of Acute Ischemic Stroke And Intracerebral
Hemorrhage Patients Undergoing Gastrostomy
Tube Placement – Mohammad Rauf A. Chaudhry,
Kahtan Fadah, Danish Kherani, Baljinder Singh,
Mohammad Ghatali, Saqib A. Chaudhry, Faheem
Gulamabbas Sheriff, Anantha Ramana Vellipuram,
Alberto Maud, Paisith Piriyawat, Gustavo J.
Rodriguez, Isabel Victoria Narvaez- Correa, Adnan
I. Qureshi
P6.7-004
A Quality Improvement Project to improve the
Standardization of Hospital-wide Initiation of
chemical VTE Prophylaxis in ICH Patients – Sang
Han, Vi Tran, Zachary Thomas Lazzari, Peter Soh,
William A. Kilgo, Rebecca L. Sugg
8 Epilepsy/Clinical Neurophysiology
(EEG)
Epilepsy and Clinical Neurophysiology
(EEG): Epilepsy Others 1
P6.8-001
Serotonin and Focal Epilepsy: A Therapeutic Role?
– William H. Theodore, Irene Dustin, Edythe Wiggs
P6.8-002
Predictors of 30-day Readmission Post Index
Hospitalization With Epilepsy: 5 Years National
Estimate – Parisha Bhatia, Varun Singh, Neena
Viswanathan, Tejinder Singh, Tanushri Bhushan
P6.8-003
Improved Access to Rapid Electroencephalography
at a Community Hospital Reduces Inter-Hospital
Transfers for Suspected Non-Convulsive Seizures
– Kapil Gururangan, Evan Madill, Prashanth
Krishnamohan
48 2022 AAN Annual Meeting
Sunday, April 3 5:30 p.m.–6:30 p.m.
Epilepsy/Clinical Neurophysiology (EEG):
Epilepsy Genetics and Surgery 2
P6.8-004
Quality of Life in Elderly Epilepsy Patients
implanted with Vagus Nerve Stimulator – Ana
Suller Marti, Keith MacDougall, Jonathan C. Lau,
Jorge G. Burneo
P6.8-005
Insular Involvement in Cases of Epilepsy Surgery
Failure – Jimmy Li, Sandra Reiter-Campeau, Dina
Namiranian, Denahin Hinnoutondji Toffa, Alain
Bouthillier, Francois Dubeau, Dang Khoa Nguyen
P6.8-006
Suspected SCN1A gain of function mutation
causing refractory neonatal seizures responsive
to sodium channel blocking antiepileptics – Kelly
Landry Angelle, Jeremy Toler, Rachel Evans, Julie
Gallois, Anne Tufton
P6.8-007
The Language of Seizure Identification: A
Qualitative Investigation – Jacob Pellinen, Ellen
Snyder, Kelly G. Knupp
9 Neuro-oncology
Neuro-oncology: Therapies and Toxicities
2
P6.9-001
Assessing the Impact of Adjuvant Temozolomide
Duration on Survival in Patients with IDH-Mutant
Low-Grade Gliomas – Isabella Densmore, Tresa
McGranahan
P6.9-002
Sarcopenia Measured by Temporalis Muscle
Thickness Independently Predicts Early Relapse
and Short Survival in Primary CNS Lymphoma –
Anthony Michael Menghini, Alipi Bonm, Jerome
J. Graber
P6.9-003
Single Center Experience of Dopamine Antagonist
ONC-201 for Recurrent H3K27M-mutant
Glioblastoma in Adults – Chukwuyem Ekhator,
Ramin Rak, Jai Grewal
P6.9-004
Treatment Outcomes In Patients With H3K27 M
Variant Glioma – Tejas Ranade, Sami Kaldawi,
Zain Ashary, Huiam Mubarak, Ekokobe Fonkem
P6.9-005
Cognitive Sequelae of Radiotherapy in Primary
Brain Tumors – Sofia Ramirez Guerrero, María
Paula Vargas-Cuellar, Jesus David Charry Sanchez,
Claudia Talero-Gutierrez
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P6.9-006
Piedmont Brain Tumor Center’s Experience
with GammaTile Intracranial Brachytherapy for
Malignant Intracranial Tumors – Erin M. Dunbar,
Adam Wayne Nowlan, Tyler Kenning, Courtney
Pollard III, David Jason McCracken
10
Cerebrovascular Disease and
Interventional Neurology
Cerebrovascular Disease: Basic and
Translational Science 2
P6.10-001
Leukocyte Count and Neutrophil-to-Lymphocyte
Ratio as Simple Hematologic Predictors of
Stroke Severity and Functional Outcome in Acute
Ischemic Stroke Patients – Vanessa Veronica,
Rizaldy Taslim Pinzon
P6.10-002
Endoplasmic Reticulum Stress exacerbate Stroke
outcome in Chronic Kidney Disease – Pallab
Bhattacharya, Aishika Datta, Deepaneeta Sarmah,
Antra Chaudhary, Priya Jagtap, Priti Madhavrao
Patale, Debarati Ghosh, Dileep R. Yavagal
P6.10-003
Correlation Between Plasma Glutamate Levels
and Post Stroke Depression – Lea Colantonio,
Jessica Frey, Nicholas Koenig, Amelia Karen
Adcock
Cerebrovascular Disease: Clinical
Science 1
P6.10-004
Intracerebral Hemorrhage as a Marker for Mycotic
Aneurysm in Patients with Infective Endocarditis
– Thomas James Williams, Zach Porterfield, Sami
El-Dalati
P6.10-005
Safety and Efficacy of Sphenopalatine Ganglion
Block in Post-Stroke Headache Cohort: A Single
Center Experience – Cecilia Peterson, Ka-Ho
Wong, Marissa Marie Castillo, Varsha Muddasani,
Nazanin Sheibani, Lourdes Peralta, Kayla Navarro,
Gauri Garg, Seniha N. Ozudogru, Adam De
Havenon
P6.10-006
Predictors of cortical surface subarachnoid
hemorrhage in reversible cerebral
vasoconstriction syndrome – Oscar Emanuel
Garat, Julieta Rosales, Ismael Calandri, Mario
Emiliano Ricciardi, Virginia Andrea Pujol Lereis,
Sebastian F. Ameriso
P6.10-007
Cannabis Use and Outcomes in Spontaneous
Aneurysmal Subarachnoid Hemorrhage: A
Descriptive Study – Julianne Hall, Asad Rehman,
Caitlin Radnis, Anjali Asthana, Ivan Da Silva
 Poster Session 6
P6.10-008
Characteristics of Strokes in Down Syndrome
Patients, A single center decade experience
– Anam Syed, Jasmine Singh, Michael Joel
Schneck, Jose Biller
P6.10-009
Hypertension Associated with Functional Status
Early After Hospitalization for Ischemic Stroke: a
Cohort Study – Megan Elizabeth Pudlo, Kathryn
Cote, Emma Jost-Price, Lester Y. Leung
11 Movement Disorders
Movement Disorders: Tardive Dyskinesia
and PD Imaging 1
P6.11-001
Long-Term Efficacy and Safety of
Deutetrabenazine in Patients With Tardive
Dyskinesia by Concomitant Dopamine-Receptor
Antagonist Use – Hadas Barkay, Robert A. Hauser,
Hubert H. Fernandez, Stewart A. Factor, Joohi
Jimenez Shahed, Nicholas Gross, Leslie Marinelli,
Amanda Wilhelm, Mark Forrest Gordon, Juha M.
Savola, Karen E. Anderson
P6.11-002
Genotype-specific white matter microstructural
alterations in prodromal Parkinson’s disease –
Amgad Droby, Avital Yoffe Vasiliev, Moran Artzi,
Nir Giladi, Anat Mirelman, Avner Thaler
P6.11-003
Association between Parkinson’s disease and
Acute or Subacute Subdural Hemorrhage, a
Retrospective Study – Amna Imran, Saif Ullah,
Alexis Lea Finer
P6.11-004
Once-Daily Valbenazine Is Effective for Tardive
Dyskinesia in Elderly Patients (=65 Years) –
Martha Sajatovic, Khody Farahmand, Chirag Shah,
Leslie Lundt
P6.11-005
Impact of Tardive Dyskinesia on Physical,
Psychological, and Social Aspects of Patient Lives:
A Survey of Patients and Caregivers in the United
States – Rakesh Jain, Rajeev Ayyagari, Sarah
King, Georgia Grace Keller Edwards, Amanda
Wilhelm, Sam Leo
P6.11-006
Using PSMD, a novel DTI measure, to assess
the role of white matter disease on structural
connectivity in Parkinson’s disease. – Isaac
Goldszer, Leonardo F. G. Bonilha, Christine Cooper
Information is accurate as of February 8, 2022, and is subject to change.
Sunday, April 3 5:30 p.m.–6:30 p.m.
Movement Disorders: PD Non-Motor P6.13-004
Symptoms or Parkinsonism and NMS 3 Myasthenic crisis patient characteristics,
P6.11-007 readmissions, treatments, and outcomes: A single
Palliative Care for Parkinson’s Disease: center analysis – Jeffrey Mullen, Ali A. Habib
Literature Review – Wendy Gaztanaga, Jason H. P6.13-005
Margolesky, Danielle Spengler Shpiner, Melissa A prospective natural history study and
Ann Fellman biorepository for patients with myasthenia gravis
(EXPLORE-MG2) – Jeff Guptill, Richard J. Nowak,
Amanda C. Guidon, James F. Howard, Betty C.
12 General Neurology
Soliven, Alex Hammett, Bailey Munro Sheldon,
Yingkai Li, Taylor Meece, Immaculada Aban, Gary
Raymond Cutter, Henry J. Kaminski, Jeff Guptill
General Neurology: Neuropathy and
Myopathy 1
P6.12-001
P6.13-006
Emergent Comorbid Events in First Year of
Immunomodulatory Treatment in Adults With
Peripheral Neuropathy May Be the Major Cause Generalized Myasthenia Gravis treated in a
of Imbalance in Older Patients – Akhand Pratap Neurology Clinic: A Retrospective Review – Nakul
Singh, Karen Stephenson, Ahmed Osameh Katyal, Naureen Narula, Raghav Govindarajan
Alwahaidy, Jennifer L. Cox, Lixin Zhang
P6.13-007
P6.12-002
Clinical and Laboratory Remission with Rituximab
Isolated Hypoglossal Nerve Palsy: Two Case Treatment in anti-MuSK-positive Myasthenia
Reports – Iftekhar Ahmed, Robert Evan Ungerer
Gravis Patients – Berin Inan, Can Ebru Kurt, Sevim
P6.12-003 Ozdamar, Ersin Tan
Multiple Cranial Neuropathies; A Diagnostic P6.13-008
Challenge – Mohammad Ali Shahab, Grace Marie Treatment Burden According to Patients with
Nicole Biso, Muthu Kuzhali Ganapathy, Carolina Generalized Myasthenia Gravis – Katherine
Cuello-Oderiz Ruzhansky, Neelam Goyal, Suraj Muley, Tuan
P6.12-004 Hoang Vu
A Rare Case of Giant Cell Arteritis Presenting P6.13-009
With Transient Polycranial Neuropathies – A Case of Lambert Eaton Myasthenic Syndrome
Harinoor Mann, Troy Desai with Cerebellar Ataxia Complicated by
P6.12-005 Encephalopathy and Confounded by Generalized
Hypokalemic periodic palsy masquerading as Pain – Marissa Urbano, Sandeep Singh, Antonio
Guillaine Barrè syndrome – Sahil Naik, Vivek Moya, Margaret Adler
Varun, Nivedita Jha P6.13-010
Pembrolizumab Associated Myasthenia Gravis
and Myocarditis Associated with Anti-striational
13 Neuromuscular and Clinical
Neurophysiology (EMG)
Antibody – Swaroopa Pulivarthi, Warda Faridi,
Jordan Lee Preston, Jared Scott Hollinger
Neuromuscular Disease: Myasthenia
Gravis 1
P6.13-001
Efficacy of Apraclonidine in Treating Ptosis
Secondary to Myasthenia Gravis – Mohamad
Khodr Agha, Helen Ismail, Raja Sawaya, Johnny
Salameh
P6.13-002
Measuring Adverse Event Burden in Myasthenia
Gravis: Single Center Prospective Evaluation of
the Adverse Event Unit (AEU) – Michael K. Hehir,
Mark Conaway, Avery Berit St Sauveur, Noah A.
Kolb, Waqar Waheed, Brendan Lee McNeish,
Nicole Lucie Tweedy, Donald B. Sanders, Pushpa
Narayanaswami, Ted M. Burns
P6.13-003
Comparison of clinical and electrophysiological
characteristics in Myasthenia Gravis patients with
favorable and unfavorable outcomes – Gabriel
Pina Paiva, Joao Aris Kouyoumdjian
AAN.com/AM 49
 Poster Session 7
1
Autoimmune Neurology
Autoimmune Neurology: Treatment-
associated Neuroinflammatory
Syndromes 1
P7.1-001
Paraneoplastic Sensorimotor Neuropathy and
Ventral Cauda Equina Nerve Root Enhancement as
Initial Presentation of Small Cell Lung Carcinoma:
a Case Study – Meshari Alsaeed, Ah Ryung Lim,
Alyson Rylie Plecash, Tychicus Chen
P7.1-002
New-Onset GFAP Astrocytopathy And DRESS
Syndrome – Mattia Rosso, Muayad Abdulaziz
Alzuabi, Charles Francis Palmer, Mini Singh
P7.1-003
Severe Discoid Lupus Erythematosus Associated
with Eculizumab: A Case Report and Review –
Rishi Sharma, Moises Adrian Romo Sanchez,
Flavia Nelson
P7.1-004
CNS and PNS Manifestation in Immune
Checkpoint Inhibitors: A Systematic Review –
Erum Khan, Ashish Kumar Shrestha, Hannah
Elizabeth Wilson, Shitiz K. Sriwastava
Autoimmune Neurology: NMOSD and
MOGAD 1
P7.1-005
Neuromyelitis Optica Spectrum Disorder With
Comorbid Complex 1 Mitochondrial Disease,
Leukopenia And Neutropenia, A Challenging Case
With Difficult Management – Gina Susana Perez-
Giraldo, Edith Graham, Stephen A. VanHaerents,
Roumen D. Balabanov
P7.1-006
Severe Presentation of Neuromyelitis Optica with
Positive Antibody Following COVID-19 Vaccination
– Afra Janarious, Saif Ullah
P7.1-007
Seronegative Neuromyelitis Optica Spectrum
Disorder (NMOSD) Or Neuro-Behcet’s? Do
Complement Inhibitors Effectively Control Neuro-
Behcet’s Disease? – Negar Molazadeh, Michael
Levy
2
Headache
Headache: Innovation and Technology 1
P7.2-001
Acute Treatment of Migraine in Adolescents:
Post Hoc Analysis of Remote Electrical
Neuromodulation (REN) vs. Standard-care
Medications Efficacy – Andrew D. Hershey,
Samantha Lee Irwin, Liron Rabany, Yaron Gruper,
Alon Ironi, Dagan Harris, Roni Sharon, Jennifer
McVige
50 2022 AAN Annual Meeting
Monday, April 4 8:00 a.m.–9:00 a.m.
P7.2-002
Efficacy of Relivion® MG in the Acute and
Preventive Treatment of Migraine. Findings from
Two Recent Studies. – Roni Sharon, Oved Daniel,
Stewart J. Tepper
P7.2-003
Exposure to narrow band green light (nbGL)
reduces migraineous headache and photophobia:
Large open-label study conducted online using
daily headache diary – Richard B. Lipton, Mark
Severs, Agustin Melo Carrillo, Michael L. Reed,
Rami Burstein
P7.2-004
The Effects of a Digital Mental Health
Intervention in Migraine Patients: A Pilot Study –
Lauren S. Weiner, Eliane Boucher, Murray Zucker,
Acacia C. Parks
P7.2-005
The Impact of Telehealth During the COVID-19
Pandemic on the Clinical Evaluation and Outcome
of Headache in Children and Adolescents –
Michaela Reuter, Tate Reuter, Paul Horn, Andrew
D. Hershey, Marielle Kabbouche
3 Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Frontotemporal
Dementia and Primary Progressive
Aphasia 1
P7.3-001
Automated Analysis of Functional Written
Communication in the Three Variants of Primary
Progressive Aphasia – Sylvia Josephy, Neguine
Rezaii, Amelia Belle Jones, Daisy Hochberg,
Megan Quimby, Bonnie Wong, Bradford Dickerson
P7.3-002
Development of a novel digital speech composite
measure for Frontotemporal Dementia – Jessica
Robin, Mengdan Xu, Liam D. Kaufman, Bill
Simpson, Stella McCaughey, Charles Wolfus, Sam
Jackson, Michael Ward
P7.3-003
Loss of speech and functional impairment in
Alzheimer’s disease-related primary progressive
aphasia: predictive factors of decline – Salvatore
Mazzeo, Cristina Polito, Silvia Bagnoli, Marta
Mattei, Sonia Padiglioni, Valentina Berti, Gemma
Lombardi, Giulia Giacomucci, Maria Teresa De
Cristofaro, Camilla Ferrari, Benedetta Nacmias,
Sandro Sorbi, Valentina Bessi
P7.3-004
Unraveling globular glial tauopathy: a clinical
and neuroimaging study – Marina Buciuc, Nha
Trang Thu Pham, Joseph Duffy, Farwa Ali, David
S. Knopman, Bradley F. Boeve, Jonathan Graff-
Radford, Val John Lowe, Dennis W. Dickson,
Jennifer Louise Whitwell, Keith A. Josephs
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P7.3-005
Novel Chinese Linguistic Markers for Semantic
variant Primary Progressive Aphasia – Boon
Lead Tee, Lorinda Li Ying Kwan-Chen, Ta-fu Chen,
Joshua Tsoh, Andrew Lung Tat Chan, Raymond Y.
Lo, Chien Long Lu, Pei-Ning Wang, Yu Sun, Maria
Gorno Tempini
4 MS and CNS Inflammatory
Disease
MS Clinical Trials & Therapeutics 3
P7.4-001
Glatiramer Acetate Depot (Extended-Release)
Phase IIa Study in Patients with Primary
Progressive Multiple Sclerosis: Safety and
Efficacy Snapshot – Shlomo Flechter, Laura
Popper, Nadav Bleich Kimelman, Shai Rubnov,
Uri Danon, Ehud Marom, Ron E. Milo, Ronit
Gilad, Boaz Weller, Adi Vaknin-Dembinsky, Mark
Hellman, Alla Shifrin, Arnon Karni
P7.4-002
Repeated Confirmed Disability Progressions
Analyses of the OPERA and ORATORIO Studies
and Their Open-Label Extensions – Ludwig
Kappos, Hans-Peter Hartung, Stephen L. Hauser,
Robert T. Naismith, Hans-Martin Schneble, Ben
Townsend, Qing Wang, Jerry S. Wolinsky
P7.4-003
Phase 3 REMODEL I/II Trials: Effectiveness,
Safety, and Tolerability of Remibrutinib in Patients
with Relapsing Multiple Sclerosis – Heinz Wiendl,
Laura Airas, Tanuja Chitnis, Mitzi Joi Williams,
Jin Nakahara, Robert A. Bermel, Allison Mann,
Marina Ollervides Ziehn, Alit Bhatt, Brian Hunter,
Ying Zhang, Rajesh Karan, Bernd C. Kieseier,
Xavier Montalban
P7.4-004
High-dose biotin for Multiple Sclerosis: A
Systematic Review and Meta-Analyses of
Randomized Controlled Trials – Adrian Isidoro
Espiritu, Patricia Remalante-Rayco
P7.4-005
Comparative Effectiveness of Cladribine versus
Fingolimod in the Treatment of Highly Active
Relapsing Multiple Sclerosis: The MERLYN
(MavEnclad Real worLd comparative efficacY
non-iNterventional) Study – Wallace Brownlee,
Aiden Haghikia, Brooke Hayward, Nathalie Waser,
Sheena Kayaniyil, Zaeem Khan, Julie Duncan,
Stefanie Millar, Gerard Harty
 Poster Session 7
MS Therapeutics MOA and Safety 2
P7.4-006
Duration of B-cell depletion in patients receiving
ocrelizumab or rituximab for Multiple Sclerosis
or Neuromyelitis Optica Spectrum Disorders
– Mahmoud A. AbdelRazek, Marcel Casasola,
Roohallah Mollashahi, Alexander Brodski, Scott
James Morin, Aleksandra Augustynowicz, Sarmad
Jassim, Marcelo Matiello, Jacob Alexander Sloane
P7.4-007
Safety and Tolerability of Conversion to Siponimod
With and Without Titration in Patients with
Advancing Forms of Relapsing Multiple Sclerosis:
Interim Results of the Phase 3b EXCHANGE Study
– Amit Bar-Or, Bianca Weinstock-Guttman, Yang
Mao-Draayer, Linda-Ali Cruz, Xiangyi Meng, Gina
Cox, Stanley L. Cohan
P7.4-008
Diroximel Fumarate in Patients with Relapsing-
Remitting Multiple Sclerosis: Interim Safety and
Efficacy Results from the Phase 3 EVOLVE-MS-1
Study – Sibyl E. Wray, Barry A. Singer, Jelena
Drulovic, Hailu Chen, Jennifer Lyons, Florian Then
Bergh, Donald Negroski, Shivani Kapadia
P7.4-009
Long-Term Safety and Effectiveness of Delayed-
release Dimethyl Fumarate in Multiple Sclerosis
Patients Treated in Routine Medical Practice
– Krupa Pandey, Kathryn Giles, Konstantin
E. Balashov, Richard A L Macdonell, Jorg
Windsheimer, Mikel Ander Martinez Oyarzabal,
Ivan Bozin, Nydije Grimes, Phoebe Jiang, Shivani
Kapadia, Jennifer Lyons, Oksana Mokliatchouk,
Annette Okai
P7.4-010
Comparative Effectiveness, Discontinuation, and
Safety of Ocrelizumab and Rituximab in Two Years
of Treatment in Multiple Sclerosis – Brandi L.
Vollmer, Michlene Passeri, Nassim Ijadi, Anthony
Declusin, Stefan Sillau, Kavita Nair, John Corboy,
Timothy L. Vollmer, Enrique Alvarez
P7.4-011
Injection-Related Reactions with Subcutaneous
Administration of Ofatumumab in Relapsing
Multiple Sclerosis: Data from Clinical Studies
and Post Marketing Experience – John F. Kramer,
Ratnakar Pingili, Ronald Zielman, Ayan Das Gupta,
Pranava Reddy Katkuri, Wendy Su, Elisabeth Braun
Lucassen, Dee Stoneman, Olaf Hoffmann
Information is accurate as of February 8, 2022, and is subject to change.
Monday, April 4 8:00 a.m.–9:00 a.m.
P7.4-012
Evaluating No Evidence of Disease Activity in
Patients With Relapsing Multiple Sclerosis:
Post Hoc Analysis of the Phase 3 RADIANCE
and Open-Label Extension Studies of Ozanimod
– Ludwig Kappos, Giancarlo Comi, Krzysztof W.
Selmaj, Lawrence Steinman, Amit Bar-Or, Douglas
L. Arnold, Hans-Peter Hartung, Xavier Montalban,
Eva Havrdova, Chahin Pachai, James K. Sheffield,
Chun-Yen Cheng, Diego Silva, John Vaile, Jean-
Pierre Morello, Jeffrey Alan Cohen, Bruce A. C.
Cree
5
Child Neurology and
Developmental Neurology
Child Neurology: Infectious Disease/
COVID-19 2
P7.5-001
A rare pediatric case of hemichorea-
hemiballismus secondary to vein of Galen
thrombosis – Hemani Ticku, Gaurav Chenji, Ankita
Prasad, Neel Fotedar
P7.5-002
Assessing the Impact of COVID-19 in Healthcare
Providers Treating Spinal Muscular Atrophy (SMA)
– Mary Curry, Ilse Peterson, Lisa Belter, Mary K.
Schroth, Jill Jarecki
Child Neurology: Neurovascular/Critical
Care/Quality 2
P7.5-003
Characterization of Neuropsychological Outcomes
in a Cohort of Pediatric Patients with Moyamoya
Arteriopathy – John Richard Gatti, Alicia Cannon,
Rachel Peterson, Laura Malone, Lisa Sun
P7.5-004
Fetal Neurology Consultation and Institutional
Review of Neonatal Outcomes – Rae Leonor Ferrer
Gumayan, Brett Klamer, Margie A. Ream
P7.5-005
Evidence of Locked-in-Syndrome in Pediatric
Nonfatal Drowning: Results of a Family Caregiver
Survey. – Muslima Sonia Razaqyar, Jonathan
Michael Towne, Mariam Ishaque, Florence Chiang,
Peter T. Fox
6
Aging, Dementia, Cognitive, and
Behavioral Neurology
Behavioral and Cognitive Neurology:
Neuropsychiatry 2
P7.6-001
Calming Effect of Clinically Designed
Improvisatory Music for Patients Admitted
to Epilepsy Monitoring Unit during COVID-19
Pandemic – Borna Bonakdarpour, Guangyu Zhou,
Daniel Huang, Christina Zelano, Clara Takarabe
P7.6-002
Cognitive disorder and depression screening in
acute stroke. – A. M. Barrett, Janice Convoy-
Hellmann, David W. Loring, Jessica Saurman,
Karima Benameur, Felicia Goldstein, Shilpa
Krishnan, Fadi B. Nahab
P7.6-003
Examining Levels of Catecholamine
Neurotransmitter Regulatory Proteins Within the
Prefrontal Cortex of Rodents Following Traumatic
Brain Injury – Eleni Papadopoulos, Christopher
Knapp, Claire M. Corbett, Jessica A. Loweth,
Rachel L. Navarra
P7.6-004
The Clock Drawing Test as a Predictor of
Postoperative Delirium After Urgent Hip Fracture
Surgery – Benjamin Chapin, Katie Rodriguez, Erin
Formanski, Nila Radhakrishnan, Patrick James
Tighe, Catherine Price
6 Research Methodology and
Education
Medical Education to Improve Clinical
Experience 1
P7.6-005
Prevention and acute treatment of migraine:
Evaluating the impacts of education in
empowering clinicians and their patients into
shared decision making – Carole Drexel, Angelique
Vinther, Nim Lalvani, Stewart J. Tepper
P7.6-006
Preparing for a New Era in SMA Care with
Disease Modifying Therapies: The Role of
Tethered, Aligned, Patient/Caregiver and Clinician
Education – Carole Drexel, Mary K. Schroth, Katie
Kowalski, Julie Anne Parsons
AAN.com/AM 51
 Poster Session 7
7 10
Neuro Trauma and Critical Care
Neurocritical Care: ICH, SAH, Ischemic
Stroke and Other Topics 2
P7.7-001
A Single Center Retrospective Review of Long
Term Outcomes in Spontaneous Intracranial
Hemorrhage Patients Who Received
Hyperosmolar Therapy – Anna Whitham, Sonora
Andromeda Windermere, Asim Zia Mian, Courtney
Takahashi
P7.7-002
Intracranial Dermoid/Epidermoid Cyst Mimicking
acute cerebellar hemorrhage – Maryum Shoukat,
Hammad Naeem, Maria Shoaib, Ahmad Al-
Awwad
P7.7-003
Computational Analysis of Subarachnoid
Hemorrhage Pattern Can Indicate the Presence
of Aneurysm – Daniel Mandel, Kelly Pan, Scott
Moody, Bradford B. Thompson, Linda C. Wendell,
Jesse Menville, Karen L. Furie, Ali Mahta
P7.7-004
Hypereosinophilic Syndrome Presenting as an
Acute Stroke – Kenneth Riley Dalton, Todd Looney,
Nawaz Hack
P7.7-005
Assessment of Cerebral Autoregulation during
Head of Bed Maneuvers in Acute Large Vessel
Occlusions – Catherine Hassett, Moein Amin,
Madihah Amima Hepburn, Joao Antonio Gomes
8 Epilepsy/Clinical Neurophysiology
(EEG)
Epilepsy/Clinical Neurophysiology
(EEG): Neuromodulation and
Electrocorticography 1
P7.8-001
Neurostimulation in People with Drug-Resistant
Epilepsy: Systematic Review and Meta-Analysis
from the ILAE Surgical Therapies Commission –
Benedicte Dansereau, Lahoud Touma, Alvin Chan,
Nathalie Jette, Churl-Su Kwon, Kees Braun, Daniel
Friedman, Lara Jehi, John D. Rolston, Sumeet
Vadera, Lily Wong-Kisiel, Dario Englot, Mark
Robert Keezer
P7.8-002
Propagation of Epileptiform Discharge along the
Papez Circuit Demonstrated with Stereotactic EEG
in a Patient with Temporal Lobe Epilepsy – Brian
Joseph Coffey, Giridhar P. Kalamangalam, Maria
J. Bruzzone
P7.8-003
An Acquisition Infrastructure for High-Resolution
Intracranial Electroencephalography – Lisa
Yamada, Tomiko Oskotsky, Paul Nuyujukian
52 2022 AAN Annual Meeting
Monday, April 4 8:00 a.m.–9:00 a.m.
P7.8-004
Responsive Neurostimulation vs. Vagus Nerve
Stimulation in Epilepsy – Henry Skrehot, Dario
Englot, Zulfi Haneef
P7.8-005
The Potential of Invasive and Non-invasive Vagus
Nerve Stimulation to Improve Verbal Memory
Performance in Epilepsy Patients – Ann Mertens,
Stefanie Gadeyne, Emma Lescrauwaet, Evelien
Carrette, Alfred Meurs, Veerle De Herdt, Frank
Dewaele, Robrecht Raedt, Marijke Miatton, Paul
A.J.M. Boon, Kristl Vonck
P7.8-006
Investigation of Neuroplasticity with the
Responsive Neurostimulation (RNS) System during
Battery Failure – Alexandra Vallera, Ryan Ward,
Cemal Karakas, Henry Skrehot, Stephen Cleboski,
Zulfi Haneef
P7.8-007
Dual Device Neurostimulation in Drug Resistant
Epilepsy – Brin Freund, Diogo Garcia, Anteneh
Mekonnen Feyissa, Anthony L. Ritaccio, Joseph
I. Sirven, Erik Middlebrooks, Sanjeet S. Grewal,
William O. Tatum
9 Infectious Disease
Infectious Disease: Acute and Subacute
Responses to COVID-19 3
P7.9-001
Retrospective Multihospital Prevalence Study
of COVID-19 Acute Neurological Manifestations
– Wan Yee Kong, Mihir Kakara, Mahsa Sadeghi,
Hossein Salimnia, Anthony R. Seely, Robert
Mitchell, Jerry L. Chen, Kumar Rajamani, Ayaz M.
Khawaja
P7.9-002
A Single Center, Retrospective Analysis of
Inpatient Neurologic Consultations of Patients
Infected with SARS-CoV-2 – Brian Edward
Emmert, Stephanie Gandelman, David Do,
Matthew K. Schindler
P7.9-003
Pediatric COVID Encephalitis: A Case Report –
Nelson Donovan Gonzalez, Dustin Jacob Paul,
Ana Hernandez Almeda, Samuel Serna, Linette C.
Linsangan
P7.9-004
COVID-19 Related Hashimoto’s and VGKC
Encephalitis – Mohammad Ali Shahab, Kehan
Zhao, Sutanaya Pal
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
Cerebrovascular Disease and
Interventional Neurology
Cerebrovascular Disease: Clinical
Science 2
P7.10-001
Downstream Impact of an Inpatient Telemedicine-
based Stroke Care Delivery Model – Solmaz
Ramezani Hashtjin, Shayan Khan, Adam R.
Lipschultz, Savannah Gabrielle Novy, Cynthia
Zheng, Monica Ngo, Kathryn Bard, Sarah A.
Engkjer, Christopher Streib
P7.10-002
Predictive Factors for Depressive Symptoms in the
Stroke Recovery Follow-Up Period – Julie Sunjoo
Yi, Justin Lu, Annie Yang, Elisabeth B. Marsh
P7.10-003
Prevalence and Overlap of Potential Embolic
Sources in Embolic Stroke of Undetermined
Source in Tunisia – Mouna Naguez, Mouna Aissi,
Mariem Mhiri, Mahouba Frih
P7.10-004
Walk Your Dizzy Patients! Gait Assessment in the
Initial Evaluation of Posterior Circulation Stroke
– Isaac Smith, Eduard Humberto Valdes, Kara R.
Melmed
P7.10-005
Depression after the first stroke not only in the
affected patients but also in their caregivers
– Majdi Al Qawasmeh, Mays Khweileh, Belal
Adel Aldabbour, Ahmed Moh’d Yassin, Khalid I.
El-Salem
P7.10-006
Characteristics and short-term outcomes of
delirium after acute ischemic stroke – Mohammad
Jamil Ahmad, Sahar Anjum, Aditya Kumar, Jacob
Sebaugh, Michele Joseph, Bethany Williams,
Alicia Zha
P7.10-007
Prevalence and Risk Factors of Polyvascular
Disease in Patients with Cerebrovascular or
Ischemic Heart Diseases Undergoing Diagnostic
Angiography – Yi Shen, Jian Wu, Xiaofeng Zhang
P7.10-008
Embolic Stroke in Setting of Iliac Vein Stenosis
in an Avid Cyclist – Nikita Chhabra, Benzion
Blech, F David Fortuin, Susan Wilansky, Bart M.
Demaerschalk, Oana Maria Dumitrascu
P7.10-009
Characteristics of Cerebral Cavernous
Malformations in a Large Multiethnic Cohort – N.
Abimbola Sunmonu, Chad Aldridge, Bradford B.
Worrall
 Poster Session 7
P7.10-010
Identification of Thrombophilia in Cerebral
Infarction, and Potential Effect of Antithrombotic
Therapy on Outcome of Cerebral Infarction
in Association with Hypercoagulability in the
Nationwide Inpatient Sample, 2016-2018 –
Prabandh Reddy Buchhanolla, Shyamal Chandra
Bir, Annie Lewis, Alexis Angelette, Sandeep
Kandregula, Bharat Guthikonda, Vijayakumar
Javalkar, Oleg Y. Chernyshev, Roger E. Kelley
11
Movement Disorders
Movement Disorders: PD Therapeutics 1
P7.11-001
Influence of Istradefylline Treatment on Levodopa
Dose Escalation in PD Patients from over 10 Years
of Experience – Nobutaka Hattori, Daijiro Kabata,
Shinji Asada, Tomoyuki Kanda, Takanobu Nomura,
Ayumi Shintani, Shelby M King, Ross Goldstein,
Akihisa Mori
P7.11-002
Variability of Plasma Levodopa Conveniently
Reduced by More Frequent Administration of
Smaller Doses of Carbidopa/Levodopa Using a
Novel Functionally Scored Formulation – Ahmad
M. Al-Sabbagh, Samuel Testino, Darshana Shah,
Minako Koga, Kathleen E. Clarence-Smith, Thomas
N. Chase
P7.11-003
Novel class of compounds for the treatment of
levodopa-induced dyskinesia – Thomas T. Oh,
Elyas Daadi, Jeffrey Kim, Etienne Daadi, Peng-
Jen Chen, Gourav Roy-Choudhury, Jonathan A.
Bohmann, Benjamin E. Blass, Marcel Daadi
P7.11-004
Levodopa and Dopamine Agonist Medication
Utilization among Patients with Parkinson’s
Disease Enrolled in Commercial and Medicare
Advantage Part D Health Plans – Monica Frazer,
Lisa Le, Steve Arcona, Rahul Sasane
P7.11-005
The clinical and humanistic value of “good on-
time” among patients with advanced Parkinson’s
disease: A real-world study from 7 countries
– Joohi Jimenez Shahed, Aristide Merola, Irene
Malaty, Jean Philippe Azulay, Connie H. Yan, Aditi
Kharat, Ali Alobaidi, Prasanna Lakshmi Kandukuri,
Pavnit Kukreja, Jorge Zamudio, Alexander James
Gillespie, Angelo Antonini
P7.11-006
Transcutaneous Afferent Patterned Stimulation
Provides Upper Limb Motor Symptom Relief
in Patients with Parkinson’s Disease – Salima
Brillman, Pravin Khemani, Stuart H. Isaacson,
Rajesh Pahwa, Ruta Deshpande, Vivien Zraick,
Apoorva Rajagopal, Kathryn Rosenbluth, Dhira
Khosla
Information is accurate as of February 8, 2022, and is subject to change.
Monday, April 4 8:00 a.m.–9:00 a.m.
12
P7.13-004
General Neurology
Coexisting Myasthenia Gravis and Sjogren’s
Syndrome Patients at Virginia Commonwealth
General Neurology: Neurotoxicity University – Kelly G. Gwathmey, Christina Renee
Graley
P7.12-001 P7.13-005
Cefepime-induced Neurotoxicity in the Critically
Concentric Needle Jitter Abnormalities in Patients
Ill: A Modifiable Risk Factor – Mohona Reza, with Ocular and Generalized MG – Gabriel Pina
Bridget A. Bagert, Gregory Reese, Mary Ann
Paiva, Joao Aris Kouyoumdjian
Reeves
P7.13-006
P7.12-002
Poor response to Eculizumab in Caucasian
Nitrous Oxide/’Whippets’ Induced Thoracic Patients with Treatment Refractory Generalized
Spinal Cord Myelopathy and Cognitive Decline Myasthenia Gravis – Nakul Katyal, Raghav
with Normal Serum Vitamin B12 – Bahadar Singh Govindarajan
Srichawla, Kavneet Kaur
P7.13-007
P7.12-003
Immune Checkpoint Inhibitor Associated LRP4
Delayed Neurologic Deterioration after Opioid Positive MG – Sarah Mauney, Joseph Nguyen,
Overdose - an Uncommon Result of a Common James Grogan
Problem – Kathryn Zuchowski, Aaron Stephen
Bower, Nicholas Blondin P7.13-008
Atypical presentation of asymmetric limb dystonia
P7.12-004
in a patient with CHAT gene mutation – Wan Yee
Nitrous Oxide Induced Subacute Combined Kong, Fatema Jahan Serajee, Ahm Mahbubul Huq
Degeneration (SCD) of Spinal Cord. – Shaweta
Khosa, Gurveer Singh Khosa, Shrikant Mishra, P7.13-009
Gyanesh Mani Tripathi Refractory Myasthenia Gravis Exacerbation
associated with Marginal Zone Lymphoma
P7.12-005
– Karan Philip, Christina Xia, Ruham Alshiekh
Effects of Alcohol Use on Mental Health and EQ Nasany, Jenny Meyer
– Francisco Eduardo Ramirez, Jonathan Jensen,
Jordan Tarusenga Jojo, Kylie Northrop P7.13-010
Novel congenital myasthenic syndrome caused
by homozygous mutation in 3’-UTR of low-density
13 Neuromuscular and Clinical lipoprotein receptor-related protein 6 (LRP6) gene
Neurophysiology (EMG) – Xin Ming Shen, Duygu Selcen, Andrew G. Engel
Neuromuscular Disease: Myasthenia
Gravis 2
P7.13-001
12-year trend in utilization of IVIG and
plasmapheresis following acute myasthenia
exacerbation and myasthenic crisis in the United
States and their association with outcome. –
Bhavya Narapureddy, Ahmed Ibrahim, Julius
Latorre, Fadar Oliver Otite
P7.13-002
Measuring Adverse Event Burden in Myasthenia
Gravis: Retrospective Validation of the Adverse
Event Unit (AEU) – Michael K. Hehir, Mark
Conaway, Avery Berit St Sauveur, Donald B.
Sanders, Pushpa Narayanaswami, Noah A. Kolb,
Waqar Waheed, Brendan Lee McNeish, Nicole
Lucie Tweedy, Ted M. Burns
P7.13-003
Spatial Association between Myasthenia Gravis
and Hazardous Waste Sites: A Statewide Planning
and Research Cooperative System (SPARCS)
Study (2002-2014) – Sanjila Islam, Yueqing Zhang,
Mustafa Jaffry, Kranthi Kiran Mandava, Nizar
Souayah
AAN.com/AM 53
 Poster Session 8
1 2
Autoimmune Neurology
Autoimmune Neurology: Treatment-
associated Neuroinflammatory
Syndromes 2
P8.1-001
AMPA-receptor encephalitis in a patient with
metastatic breast cancer receiving palbociclib
– Elizabeth Matthews, Jordan Gallegos, Barrie
Schmitt, Dana Coutts, Karen Dianne Orjuela,
Amanda Lee Piquet
P8.1-002
Immune Checkpoint Inhibitor Rechallenge
Following Neurologic Immune-Related Adverse
Events in Cancer Patients: A Systematic Review
– Mahsa Eskian, Balwant-Amrit V. Singh, Leyre
Zubiri, Leeann Brigham Burton, Lisa Philpotts,
Kerry Reynolds, Amanda C. Guidon
P8.1-003
Nivolumab-Induced Limbic Encephalitis
Associated with Glutamic Acid Decarboxylase 65
Antibodies – Al-alya Alsabah, Robert Altman
P8.1-004
Acute Onset, Rapidly Progressive Anti-Yo
Positive Paraneoplastic Cerebellar Degeneration,
Associated with Ovarian Cancer, in the Setting of
Immune Checkpoint Inhibitor Pembrolizumab Use:
a Case Report – Yoon Jae Choi, Jerica Lomax,
Xiao-Tang Kong
P8.1-005
Rapidly Progressive Dementia from treatment
with a novel IGF-1R inhibitor – Zoe Olga Marinides,
Casey Christopher Gower, Charles J. Kidd, John
Kent Werner
Autoimmune Neurology: NMOSD and
MOGAD 2
P8.1-006
Immune Reconstitution Therapy in NMOSD –
Staley A. Brod
P8.1-007
Very-late Onset Neuromyelitis Optica Spectrum
Disorder – Alexander Besser, Brandi Baker, Sean
T. Kenniff
54 2022 AAN Annual Meeting
Monday, April 4 11:45 a.m.–12:45 p.m.
Headache
Headache Validation and Education
Research 2
P8.2-001
Non-Neurologist Perspectives on Migraine:
Results of a cross-sectional advisory board survey
– Edward Kim, Gilbert J. L’Italien, Ali Mohajer
P8.2-002
Choosing Multiple Headache Preventive
Medications Wisely: A Comprehensive Analysis
Of Reported Versus Theoretical Drug-Drug
Interactions – Ian Hakkinen, Jay Dave, Pengfei
Zhang
P8.2-003
Expert Consensus on the Benefits and Limitations
of the Diagnostic Criteria for Post-Traumatic
Headache as Defined by the International
Classification of Headache Disorders-3rd Edition:
A Qualitative Study – Emily Lane L. Schlitz
Fortenberry, Jason J. Sico
P8.2-004
Trivializing Migraines – Karthik Meda
Secondary Headache 1
P8.2-005
Gorham-Stout Disease of the Skull and the
Delicate Balance Between Intracranial Hyper- and
Hypotension – Mark Cohen, Gian Carlo Rossi
P8.2-006
Treatment of Thoracic Outlet Syndrome in
Outcome of Chronic Headaches – Lindsey Randall,
Yoon-Hee Cha
3 Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Frontotemporal
Dementia and Primary Progressive
Aphasia 2
P8.3-001
Understanding the lived experience of persons
affected by frontotemporal degeneration (FTD):
perceptions from persons diagnosed, their families
and caregivers via the FTD Disorders Registry
(FTDDR) Disease Impact Survey – Diana Wheaton,
Sherry Harlass, Sweatha Reddy, Lakecia Vincent,
Nadine Anne Tatton
P8.3-002
Social cognition and behavioral assessments
improve the diagnosis of behavioral variant of
frontotemporal dementia in older Peruvians with
low educational levels – Nilton Custodio Capunay,
Rosa Montesinos, Lizardo Cruzado, Eder Herrera-
Perez, Virgilio E. Failoc-Rojas, Maritza Pintado-
Caipa, Wendy Seminario, José Cuenca, Carlos
Alberto Gamboa Acasiete, Monica M. Diaz
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P8.3-003
Anomalous Language Lateralization in Semantic
Dementia: a Neurodevelopmental Hypothesis
– Zachary Miller, Leighton Hinkley, Rian Bogley,
Valentina Borghesani, Danielle Mizuiri, Maxime
Montembeault, Isabel Allen, David C. Perry, Bill
Seeley, Bruce L. Miller, Srikatan Nagarajan, Maria
Gorno Tempini
P8.3-004
Insights on FTD: An Externally-Led Patient-
Focused Drug Development Meeting – Debra
Niehoff, Shana Dodge, Elizabeth Graham, Megan
Barker, Stephanie Cosentino, Diana Wheaton,
Sharon Denny, Penny Dacks, Susan Dickinson
P8.3-005
Expanding the clinical presentations of primary
progressive aphasia: evidence of progressive
dynamic aphasia – Petronilla Battista, Valentina
Borghesani, Michael G. Erkkinen, Maxime
Montembeault, Boon Lead Tee, Eduardo Europa,
Ariane E. Welch, Suzee Lee, Bruce L. Miller, Maria
Luisa Mandelli, Maria Gorno Tempini, Zachary
Miller
4
MS and CNS Inflammatory
Disease
MS Clinical Practice & Decision Making 2
P8.4-001
Quantifying Subclinical Square Wave Jerks
(SWJs) in Multiple Sclerosis (MS). – Luigi Pesce
Ibarra, Christy Stefano Sheehy, Calen Walshe, Ari
Green, Shivany Condor Montes, Daniel Bennett
P8.4-002
Screening for differential diagnoses in MS:
Evaluation of inclusion criteria for extensive
diagnostic workup – Richard Schmidt, Sarah
Haars, Astrid Unterlauft, Rami Jamra, Florian Then
Bergh
P8.4-003
B-cell CNS Lymphoma Disguised as Tumefactive
Multiple Sclerosis Relapse in Patient on
Ocrelizumab – Kelsey H. Carr, Mary Alissa Willis,
Sameer Sharma
P8.4-004
Differences in quality of care between neurology
clinics - do they correlate to patient outcomes? A
nationwide observational study. – Anna He, Ali
Manouchehrinia, Jan A. Hillert, Kyla A. McKay
 Poster Session 8
MS Therapeutics MOA and Safety 3
P8.4-005
Post-approval Safety of Subcutaneous Interferon
ß-1a in the Treatment of Multiple Sclerosis,
With Particular Reference to Respiratory Viral
Infections – Mark S. Freedman, Milorad Todorovic,
Zuzana Murgasova, Dominic Jack
P8.4-006
Safety and Tolerability of Conversion to Siponimod
in Patients with Advancing Relapsing Multiple
Sclerosis: A Subgroup Analysis by Race and
Ethnicity of EXCHANGE Interim Data – Amit
Bar-Or, Bianca Weinstock-Guttman, Yang Mao-
Draayer, Angel R. Chinea, Gina Cox, Linda-Ali Cruz,
Xiangyi Meng, Stanley L. Cohan
P8.4-007
Safety and Efficacy of Siponimod in Patients with
Active Secondary Progressive Multiple Sclerosis
Identifying as Hispanic from the Phase 3 EXPAND
Study – Stanley L. Cohan, Le Hua, Amit Bar-Or,
Fred D. Lublin, Xiangyi Meng, Gina Cox, Patricia K.
Coyle, Robert J. Fox
P8.4-008
Real-world data on cladribine effectiveness
and safety: a two-year follow-up study – Maria
Petracca, Elisabetta Signoriello, Elena Barbuti,
Antonio Ianniello, Rosanna Missione, Simona
Bonavita, Giovanna Borriello, Giacomo Lus, Carlo
Pozzilli, Serena Ruggieri
MS Special Populations 2
P8.4-009
INFORM – Interferon beta Exposure in the 2nd
and 3rd Trimester of Pregnancy - a Register-based
Drug Utilisation Study in Finland and Sweden –
Meritxell Sabidó Espin, Kiliana Suzart-Woischnik,
Nydije Grimes, Lisa Prach, Liwei Zhao, Katja
Hakkarainen
P8.4-010
Case of Leber Hereditary Optic Neuropathy
Mimicking Neuromyelitis Optica Spectrum
Disorder – Keli Tahara, Nina Maithi Long, Diana
Yang, Niki Maki, Kimberly L. Pargeon
P8.4-011
Clinical Features and Course of Cerebral Amyloid
Angiopathy-Related Inflammation – Moein Amin,
Albert Aboseif, Ken Uchino, Ghulam Abbas Kharal
Information is accurate as of February 8, 2022, and is subject to change.
Monday, April 4 11:45 a.m.–12:45 p.m.
5 Child Neurology and
Developmental Neurology
Child Neurology: Infectious Disease/
COVID-19 1
P8.5-001
Impact of the COVID-19 Pandemic on Behavioral
Health of People with Intellectual and/or
Developmental Disabilities – Jessica Sanders,
Rachel Sturley, Rajapillai Pillai, Miya Asato,
Stefan Sillau, Bhooma Rajagopalan Aravamuthan,
Mackenzie Cervenka, Nancy Hammond, Karen
Bonuck, joanne siegel, Vincent Siasoco, Benjamin
Alexander Margolis
P8.5-002
Assessing the Fatality Rate of Congenital Zika
Syndrome Since the 2015 Zika Outbreak – Nilson
Nogueira Mendes Neto, Jessika Thais da Silva
Maia, Marcelo Rodrigues Zacarkim
P8.5-003
A Pediatric Case of Severe, Treatment-Resistant,
COVID-19 Associated Acute Longitudinally
Extensive Transverse Myelitis with Masquerading
Confounding Variables – Tasneem Fatema Hasan,
Rachel E. Triay, Maroun J. Mhanna, Sheila Joyce
Asghar, Rosario Maria S. Riel-Romero
P8.5-004
Anosmia and Ageusia after COVID-19 vaccination
in Pediatrics Population: A Vaccine Adverse Event
Reporting System (VAERS) Study – Jeffrey M.
Kornitzer, Mustafa Jaffry, Kranthi Kiran Mandava,
Tarek Elshourbagy, Nizar Souayah
P8.5-005
A Pediatric Case of Sensory Predominant Guillain-
Barré Syndrome Following COVID-19 Vaccination
– Yunsung Kim, Zahra Zhu, Ashutosh Kumar
6 Research Methodology and
Education
Medical Education to Improve Clinical
Experience 2
P8.6-001
Continuity Clinic Experience in Neurology
Residency – Aman Dabir, Vincent Arnone, Umer
Najib, Gauri V. Pawar
P8.6-002
Caring for Women with Neurologic Disease:
A Single Center Survey Exploring Neurology
Residents Knowledge, Perception, and Practices –
Areeba Siddiqui, Ayra Siddiqui, Mona Sazgar
P8.6-003
Harnessing Continuing Education to Address
Advances in the Management of Patients with
NMOSD While Elucidating Persisting Educational
Needs for Future Programs – Katie Robinson,
Simon Cooper, Nick Nowotarski, Jennifer
Frederick, Jenna Gentile, Robert Esgro
P8.6-004
Creating and Implementing a Virtual Simulation
for Neurology Trainees – Rebecca Stainman, Steve
Choongheon Han, Scott Grossman, Neil A. Busis,
Arielle Marisa Kurzweil
P8.6-005
High Fidelity Simulation of Acute Neurology
Enhances Confidence and Knowledge of Rising
Residents – Zahari Tchopev, Alexis E. Nelson,
Morgan Christina Jordan
P8.6-006
Driving Shared Decision-Making and Best
Practices for Insomnia: The Impact of Tethered,
Aligned Education on Clinicians, Patients, and
Caregivers – Carole Drexel, Angelique Vinther,
William Christopher Winter, Russell Rosenberg
7 Neuro Trauma and Critical Care
Neurocritical Care: ICH, SAH, Ischemic
Stroke and Other Topics 3
P8.7-001
A rare mechanism of Acute Ischemic Stroke
following Intrathecal Methotrexate – Navreet
Kaur, Christina Xia, Karan Philip, Hesham Masoud,
Fadar Oliver Otite
P8.7-002
Sinking Skin Flap Syndrome Presenting as
Paradoxical Herniation Syndrome – Leonid
Groysman, Daniel Ilchoong Ro
P8.7-003
Acute Ischemic Leukoencephalopathy Secondary
to Circulatory Shock and Metabolic Acidosis –
Sharanya Ramakrishnan, Neha Sharma, Moin Ud
Din, Muhammad Faisal Khan
P8.7-004
Neuropsychiatric Manifestations of Shiga Toxin
Producing E Coli Induced Hemolytic Uremic
Syndrome in an Adult: A Case Report – Nefize
Turan, Valeria Ariza Hutchinson, Steve Bibu,
Deborah M. Green-LaRoche, Joshua A. Kornbluth
P8.7-005
Ciliospinal Reflex – A Clinical Clue to Avoid
Unnecessary Procedures in a Barbiturate Coma
Patient – Negar Moheb, Ramiro Gabriel Castro
Apolo, Cleo Zarina Alejo Reyes, Jaspreet Johal,
Preet M. Varade
AAN.com/AM 55
 Poster Session 8
8 Epilepsy/Clinical Neurophysiology
(EEG)
Epilepsy and Clinical Neurophysiology
(EEG): Neuromodulation and
Electrocorticography 2
P8.8-001
Stereo-EEG Seizure Localization in Epilepsy
Patients with History of Viral Brain Infection –
Irina Podkorytova, Kan Ding, Ryan Hays, Ghazala
Perven
P8.8-002
Decreasing VNS Settings Improves Seizure
Control in a Patient with VNS-induced OSA –
Rebecca Stainman, Mackenzie Cervenka, Grace
Pien, Christopher Carosella
Epilepsy/Clinical Neurophysiology (EEG):
Status Epilepticus and Autoimmune
Epilepsy 1
P8.8-003
Status Epilepticus: Analysis of the Time to Follow
Up; A Retrospective cohort study – Jasmine
Policherla, Muhammad Irshad Khan, Rohit Ajay
Marawar, Maysaa Merhi Basha
P8.8-004
An Autoimmune Epilepsy Case Series: Atypical
Presentations with Atypical Autoimmune
Antibodies. – Samir Sadik Al-Ghazawi, Saleem
Mohamad Al Mawed, Gaurav Kathuria, Adnan
Subei, Tarek Zakaria
P8.8-005
Withdrawal of Antiepileptic Drugs After MRI–
Guided Laser Interstitial Thermal Therapy in Extra-
Temporal Lobe Epilepsy – Arjun Athreya, Rebecca
E. Fasano, Daniel L. Drane, Jon T. Willie, Robert E.
Gross, Ioannis Karakis
P8.8-006
De novo KCND3 Causing Encephalopathy and
Cardiac Arrhythmias: A Case Report – Eiman Ali,
Imane Abdelmoumen, Melanie Ortiz, Stephen
Falchek
9
Infectious Disease
Infectious Disease: Bacteria, Fungi, and
Parasites on the Mind and Body 1
P8.9-001
Nonconvulsive Status Epilepticus - A Potentially
Underrecognized Consequence of Infant Botulism
– Rachel Pauley, Levi Dygert, Aaron Lane Nelson,
Heather Lau
P8.9-002
Case Report of Central Nervous System
Cryptococcosis Mimicking Stroke –
Mangayarkarasi Thandampallayam Ajjeya, Kara Jo
Swafford
56 2022 AAN Annual Meeting
Monday, April 4 11:45 a.m.–12:45 p.m.
P8.9-003
Pseudomonas Meningoencephalitis Stemming
From Occult Chronic Sacral Abscess – Connor
David Welsh, Tejas Ranade, Elizabeth Anderson
P8.9-004
Acute Ischemic Stroke In Patients With
Tuberculous Meningitis – Akshay Deepak, Shankar
Venkatasubramanian
P8.9-005
Cryptococcal Meningitis and Suspected Small
Vessel Vasculitis in an Immunocompetent Patient:
A Case Report – Richa Mehta Thakkar, Kyle R.
Marden, Cyrus Mowdawalla, Alvin Mercado,
James E. Siegler
P8.9-006
Case Report: Hemorrhagic Septic Emboli
Secondary to disseminated Listeria
monocytogenes in a Patient with a St. Jude aortic
Prosthetic Valve – Vi Tran, Sang Han, William A.
Kilgo, Rebecca L. Sugg, Juan G. Ochoa
P8.9-007
A rare case of Meningitis due to Streptococcus
suis in an immunocompetent patient – Roseliny
Martins Batista, Carlos Correia
10 Cerebrovascular Disease and
Interventional Neurology
Cerebrovascular Disease: Clinical
Science 3
P8.10-001
Acute Hypotension and Bradycardia Due to
Unilateral Carotid Artery Dissection: A Case
Report – Cleo Zarina Alejo Reyes, Ramiro Gabriel
Castro Apolo, Tsneem Mbydeen, Preet M. Varade
P8.10-002
Necessity of Universal Echocardiograms in
First-Time Stroke: A Retrospective Chart Review –
Anthony Michael Harrington, Stefan Sillau, Sharon
Poisson
P8.10-003
Characterization and Comparison of
Hospitalization Outcomes Between Symptomatic
and Asymptomatic Urinary Tract Infection in Acute
Ischemic Stroke Patients. – Wenyang Li, Elif Pinar
Coskun, Jessica Doyle Lee
P8.10-004
Post Stroke Delirium Does Not Predict Poor
Cognitive Outcome at Discharge in Patients with
Acute Ischemic Stroke – Sahar Anjum, Jacob
Sebaugh, Bethany Williams, Alicia Zha
P8.10-005
Intracerebral Hemorrhage Severity Predicts Long-
Term Functional Outcomes After Anticoagulation
Reversal with Andexanet alfa – Nikita Chhabra,
Johnny Cebak, Molly Catherine Klanderman, Kara
A. Sands, Harn Shiue
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P8.10-006
Admission rates, time-trends, risk factors and
outcomes of ischaemic and haemorrhagic stroke
in German nationwide data – Dearbhla Kelly,
Jeanette Koeppe, Peter Rothwell, Holger Reinecke
P8.10-007
Comparison of Probable Cerebral Amyloid
Angiopathy Diagnosed by Clinical Versus Imaging
Features of Previous Hemorrhage – Varun Jain,
Yoram Roman Casul, Nandakumar Nagaraja
P8.10-008
NIHSS-SAAD (Skew deviation, truncal Ataxia,
nystAgmus, abnormal saccaDes) score a better
predictor of posterior circulation stroke – Saad
Hasan, John M Hourihane
P8.10-009
Initiation of Anti-Seizure Medications in Atrial
Fibrillation-Related Stroke – Colby Allen
Richardson, David Z. Rose, Wei Deng, Nhi Tran,
Swetha Renati
P8.10-010
Functional Neurological Disorders in Telestroke
– Attitudes and Practice Patterns – Johanna L.
Morton, Jaime Hatcher-Martin, Eric Anderson,
Robert Jason Hallock
11 Movement Disorders
Movement Disorders: Deep Brain
Stimulation in Parkinson’s Disease 2
P8.11-001
Apathy Following Bilateral Subthalamic Deep
Brain Stimulation for Parkinson’s Disease: The
INTREPID Randomized Controlled Trial – Tamara
Stiep, Adolfo Ramirez Zamora, Alexander I. Troster,
Roshini Jain, Lilly Chen, Mahsa Malekmohammadi,
Michael S. Okun
P8.11-002
Impulse Control Disorders Following Bilateral
Subthalamic Deep Brain Stimulation for
Parkinson’s Disease: The INTREPID Randomized
Controlled Trial – Tamara Stiep, Alexander I.
Troster, Adolfo Ramirez Zamora, Roshini Jain, Lilly
Chen, Michael S. Okun
P8.11-003
Deep Brain Stimulation Parameter Prediction using
GuideXT and Traditional Monopolar Survey in
Parkinson’s Disease Patients – Alina Shub, Donald
A. Smith, Theresa A. Zesiewicz, Teresita Malapira,
Chase Michael Kingsbury, Roshini Jain, Yarema B
Bezchlibnyk
 Poster Session 8 Monday, April 4 11:45 a.m.–12:45 p.m.

General Neurology: Neuropathy and P8.13-006

Movement Disorders: Genetics 1
P8.11-004
Heterogenous neuropathology in a pedigree with
RAB39B-related Parkinson’s disease – Kimmy
Su, Caitlin Shannon Latimer, Marika Bogdani, Dirk
Keene, Cyrus P. Zabetian
P8.11-005
Attitudes Regarding Genetic and Risk Factor
Screening for Parkinson’s Disease (PD) among
Research Study Participants in the Parkinson’s
Progression Markers Initiative (PPMI) – Adrienne
Lange Clark, Cheryl Meng, Brenda Valerie Luan,
Ethan G. Brown, Jill L. Ostrem, Lana Chahine, Nijee
Sharma Luthra, Marta San Luciano, Kenneth L.
Marek, Caroline M. Tanner
P8.11-006
Homozygous CADPS2 mutations cause
neurodegenerative disease with Lewy bodies in
amazon parrots – Oswaldo Lorenzo Betancor, Livio
Galosi, Laura Bonfili, Anna Maria Maria Eleuteri,
Valentina Cecarini, Ranieri Verin, Fabrizio Dini,
Anna Rita Attili, Patrizia Robino, Maria Cristina
Stella, Dora Yearout, Michael Dorschner, Cyrus P.
Zabetian, Giacomo Rossi, Debby W. Tsuang
P8.11-007
Eye movement abnormalities in patients with
Parkinson’s disease (PD) and heterozygous GBA
variants versus non-carrier PD – Hannah Marie
Conn, Giulietta Riboldi, Todd Hudson, John Ross
Rizzo, John Martone, Kelly Astudillo, Janet C.
Rucker
P8.11-008
Investigating a Neuroprotective Role for GBA in
Astrocytes – Raja Elizabeth Estes, Bernice Lin,
Jessica Young, Marie Ynez Davis
Myopathy 2
P8.12-004
Red Ear Syndrome – James Christian Hiana,
Adrian Marchidann, Simona Treidler
P8.12-005
A Case of Multiple Diagnoses Contributing to a
Clinical Presentation Consistent with Myopathy
– Rebecca Pratt, Shilpa Haldal, Rohan Sharma,
Rucha Bahekar, Sumera Ali
13
Neuromuscular and Clinical
Neurophysiology (EMG)
Neuromuscular Disease: Peripheral
Neuropathy 1
P8.13-001
Central Nervous System Involvement in HINT1
Neuropathy: An Overlooked Phenotypical Feature?
– Arman Cakar, Ayse Nur Ozdag Acarli, Ayse
Candayan, Serdar Ceylaner, Esra Battaloglu, Hacer
Durmus, Fatma Yesim Parman
P8.13-002
A double-blind, placebo controlled trial
of Gamunex-C in Patient with Small Fiber
Neuropathy Associated with Autoantibodies to
TS-HDS and FGFR3 – Christopher H. Gibbons,
Sharika Rajan, Katherine Senechal, Erin Auriel
Hendry, Brady McCallister, Todd D. Levine
P8.13-003
Autonomic Dysfunction in Patients with Guillain-
Barré Syndrome and Related Prognosis: From the
Clinic to the Electrophysiology. – Anna Lisette
Bazan, Jesus Alberto Ruiz Avalos, Eunice Martínez
Jiménez, Adib Jorge De Sarachaga, Juan Carlos
Lopez, Elizabeth Leon, Edwin S. Vargas
P8.13-004
Treatment Response in Patients with Clinical
and Supportive Laboratory Features of Chronic
Inflammatory Demyelinating Polyneuropathy
(CIDP) Without Demyelinative Findings on Nerve
Conduction Studies – Patrick Curry, David N.
Herrmann, Michael Stanton, Phillip C. Mongiovi,
Eric L. Logigian
P8.13-007
Long-term Outcome in Chronic Inflammatory
Demyelinating Polyneuropathy: A Systematic
Review and Meta-analysis – Ali Al-Zuhairy,
Johannes Jakobsen
P8.13-008
Pre-treatment Axonal Loss as Biomarker for Long-
term Disability in CIDP – Ali Al-Zuhairy, Johannes
Jakobsen, Christian Krarup
P8.13-009
The Motor Axon Threshold Variability Is
Increased in Chronic Inflammatory Demyelinating
Polyneuropathy – Christian Krarup, Ali Al-Zuhairy,
Johannes Jakobsen, Mihai Moldovan
P8.13-010
Poly-nutritional Deficiency in Acute to Subacute
Polyneuropathy in Patients with Weight Loss – Ian
Bakk, Mamatha Pasnoor, Mazen M. Dimachkie,
Constantine Farmakidis

12 General Neurology Hereditary Transthretin Amyloidosis (hATTR)

General Neurology: Clinical Practice and
Telemedicine 3
P8.12-001
Effect of Neuro-hospitalist Program on Health
Care Outcomes: An Observational Cohort Study
& Narrative Review – Justin Mikhail Tiongson,
Krystal Hunter, James E. Siegler
P8.12-002
Effects of Flexible Scheduling and Virtual Visits
on Burnout for Clinicians – Amy B. Sullivan, Sara
Davin, Brittany Lapin, Andrew Schuster, Raed
Dweik, Karen F. Murray, Susan Rehm, Andre
Machado
P8.12-003
Assessing Medical Student Competency in the
Teleneurology Examination – Stephen Esguerra,
Alyssa J. Espinoza, Robert S. Allen, Tarun Girotra,
Sharon Czech-Siewert, Sarah Grant, Daniel Devitt
Barnett, Asad Ikram, Deirdre Hill
V142I Polyneuropathy Characteristics: A Multi-
Center Perspective – Urvi G. Desai, Hristelina S.
Ilieva, James Eyer, Amanda C. Peltier
P8.13-005
Guillain-Barré Syndrome after the ZIKV Epidemic
in Colombia: A Multicenter, Prospective, Case-
control Study – Susana Carolina Dominguez
Penuela, Martha Moyano, Jose Enrique Vargas
Manotas, Jorge Andres Jimenez-Arango,
Guillermo Gonzalez-Manrique, Jairo Francisco
Lizarazo Nino, Jorge Angarita, Andres Felipe
Zea-Vera, Reydmar Lopez, Daniela Zuluaga Lotero,
David Orlando Acero-Garces, Maria Alejandra
Garcia-Dominguez, Jose Miguel Enciso, Maria
Fernanda Ramos Sanchez, Julie Benavides,
Katherine V Claros, Jaime Quintero, Jonathan
Urrego, Christian Rojas, Juan Pablo Rojas,
Fernando Rosso, Gustavo Eduardo Ramos, Luis
Carlos Quintero, Mario Llanos, Angela Catalina
Vallejo Cajigas, Viviana Martinez, Carlos A. Pardo-
Villamizar, Beatriz Parra, Lyda Osorio

Information is accurate as of February 8, 2022, and is subject to change. AAN.com/AM 57

 Poster Session 9
1 2
Autoimmune Neurology
Autoimmune Neurology: MOGAD 1
P9.1-001
A case of a 14 year old male with MOGAD
(Myelin Oligocyte Glycoprotein Antibody Disease)
post-COVID-19 infection responsive to high dose
corticosteroids and intravenous immunoglobulin
(IVIG) therapy – Alfred Balasa, Brandon Neely,
Sara A. McGuire
P9.1-002
MOG Antibody Myelitis Following HIV
Seroconversion – Tejas Ranade, Zain Ashary, Sami
Kaldawi
P9.1-003
Initial Presentation of MOGAD Masquerading as
Acute Para-infectious Flaccid Myelitis – Raissa
Aoun, Doris Xia, Elina Zakin
P9.1-004
Should we test anti-MOG in probable autoimmune
encephalitis? Results from a large Brazilian cohort
– Bruna Dias, Fabio Fieni Toso, Rene De Araújo
Gleizer, Maria Eduarda Slhessarenko, Orlando
Povoas Barsottini, Mariana Braatz Krueger,
Valéria Granja, Alessandra Dellavance, Andressa
Maldonado, Luiz Eduardo Andrade, Romana
Hoeftberger, Livia Almeida Dutra Antonio
P9.1-005
MOG-IgG associated disease is uncommon
during treatment with TNF inhibitors – Vyanka
Redenbaugh, Eoin P. Flanagan, Valentina Floris,
Pietro Zara, M. Tariq Bhatti, Francisco Roberto
Sanchez Moreno, Matthew Koster, Sara Mariotto,
Sean J. Pittock, John Chen, Alberto Cauli, Paolo
Solla, Elia Sechi
P9.1-006
A Case of MOG-associated Encephalomyelitis in
the Setting of Post-COVID-19 Infection – Ali-Musa
R. Jaffer, Muhammad Hasanayn Jaffer, Sheyar
Amin, Ushtar Amin
P9.1-007
The Role of Socioeconomic, Demographic, and
Serologic Factors in Determining the Differential
Pathogenesis of Myelin Oligodendrocyte
Glycoprotein Antibody Disorder versus Multiple
Sclerosis in Pediatric Patients – Brian Christopher
Florenzo, James Nick Brenton
58 2022 AAN Annual Meeting
Monday, April 4 5:30 p.m.–6:30 p.m.
P9.3-005
Headache
Computational modeling of tau pathology spread
reveals genetic correlates of regional vulnerability
Secondary Headache 2 and the impact of a LRRK2 mutation – Eli
Cornblath, Howard Liu Li, Lakshmi Changolkar,
P9.2-001 Bin Zhang, Hannah Jean Brown, Ronald James
Fear of Brain Tumor in Patients with Migraine in an Gathagan, Modupe Folaranmi Olufemi, John Q.
Academic Headache Clinic – Derek J. Notch, Daniel Trojanowski, Danielle Smith Bassett, Virginia Lee,
Krashin, Ami Zarrillo Cuneo, Sau Mui Chan-Goh, Michael Henderson
Marcel Budica, Natalia Murinova
P9.2-002
Cerebral Venous Sinus Thrombosis (CVST) As A
Complication Of COVID-19 Infection Presenting As
4 MS and CNS Inflammatory
Disease
Post COVID-19 Headache – Mohammad Dibs, Ram
MS Clinical Practice & Decision Making 3
Mohan R. Sankaraneni
P9.2-003 P9.4-001
Headache Frequency and Quality of Life in Patients Diagnosis of myotonia congenita and multiple
with Post-Acute Sequelae of COVID-19 – Sujata P. sclerosis in a patient with a familial history –
Thawani, Peyton Meyer, Lisena Hasanaj, Jennifer Alexander Abud, Kara Stavros, Syed Rizvi
A. Frontera, Steven Galetta, Laura J. Balcer P9.4-002
P9.2-004 Disease activity after cladribine immune
Occipital Neuralgia Secondary to an Occipital reconstitution therapy: To repeat or to retreat? –
Bone Lesion Revealing Multiple Myeloma – Anvita Kimberley Allen-Philbey, Monica Marta, Sharmilee
Suneja, Maryann Mays, Aarushi Suneja Gnanapavan, David Baker, Klaus Schmierer
P9.2-005 P9.4-003
A case of cerebral vasculitis mimicking RCVS Clinical-pathological correlation of progressive
– Valentina Poretto, Valeria Bignamini, Bruno solitary sclerosis: a case report – Nathan Chu,
Giometto, Sabrina Marangoni Sumit Das, Penelope Sybol Smyth
P9.4-004
Rapidly Progressive Demyelinating Disease
3
Aging, Dementia, Cognitive, and
Secondary to the Marburg Variant of Multiple
Behavioral Neurology Sclerosis: A Case Report – David M. Anson, Natalie
Aging and Dementia: Neuroimaging: Aging Bartnik, Daniah Shamim, Yunxia Wang
and Alzheimer’s Disease 1 P9.4-005
P9.3-001 Small Fiber Neuropathy in People with MS with
Neuropathic Pain and Dysautonomia: A Case Series
Exploratory Imaging Outcomes of a Phase 1b/2a
Clinical Trial of Allopreganolone as a Regenerative – Mary Kelley, Leorah Aude Emmanuelle Freeman,
Therapeutic for Alzheimer’s Disease: Structural and Ethan Isaac Meltzer, Ashlea Lucas, Helen Onuorah
Functional Connectivity Outcomes – Roberta Diaz
Brinton, Adam Raikes, Gerson David Hernandez
Rivera, Dawn Matthews, Ana Lukic, Yonggang Shi,
Meng Law, Lon Schneider
P9.3-002
WITHDRAWN
P9.3-003
Cross-sectional and longitudinal effects of APOE
genotype on atrophy and tau burden in atypical
Alzheimer’s disease – Neha Atulkumar Singh,
Nirubol Tosakulwong, Jonathan Graff-Radford,
Mary M. Machulda, Stephen Weigand, Nilufer
Taner, Christopher Schwarz, Matthew Senjem,
Clifford R. Jack, Val John Lowe, Keith A. Josephs,
Jennifer Louise Whitwell
P9.3-004
Longitudinal hypothalamic atrophy and its
association with amyloid-ß and tau pathology in
Alzheimer’s disease – Alice Tao, Zachary Myslinski,
Yushan Pan, Costantino Iadecola, Jonathan Dyke,
Gloria Chiang, Makoto Ishii
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
 Poster Session 9
MS Therapeutics MOA and Safety 4
P9.4-006
Two-Year Interim Analysis of the TREAT-MS
Alemtuzumab Study in Germany Differentiated
by Direct Pretreatment – Tjalf Ziemssen, Stephan
Richter, Frank Hoffmann, Angeliki Konstantinidou,
Laura Quint
P9.4-007
Updated Real-World Analysis Affirms the High
Persistence and Adherence Observed with
Diroximel Fumarate in Patients with Multiple
Sclerosis – Brittney Lager, Jacob Liseno, Catherine
Miller, Sai Shankar, Jason P. Mendoza, James B.
Lewin
P9.4-008
Diroximel Fumarate (DRF) Has High Rates of
Real-World Adherence and Persistence in Patients
with Multiple Sclerosis (MS): Retrospective Claims
Analysis – Nicholas PharmD Belviso, Carl DeMoor,
Sai Shankar, Changyu Shen, Catherine Miller
MS Special Populations 3
P9.4-009
Patients with Multiple Sclerosis Attempting
Conception: Interim Analysis from PREG-MS and
CANPREG-MS Prospective Pregnancy Registries.
– Maria K. Houtchens, Preksha Kukreja, Irene Yee,
Jeta Pol-Patil, Adele Sadovnick
P9.4-010
Association of Epigenetic Biomarkers of Neoplasia
with Multiple Sclerosis in an Underrepresented
Minority Population – Jeremy Michael Bingen,
Lindsay Virginia Clark, Mark Band, Rajeev Ranjan,
Michael D. Carrithers
P9.4-011
Impact of symptomatic MS therapy on pregnancy
course and outcome – Laura Witt, Sandra Thiel,
Andrea Ines Ciplea, Ralf Gold, Kerstin Hellwig
Information is accurate as of February 8, 2022, and is subject to change.
Monday, April 4 5:30 p.m.–6:30 p.m.
5 Child Neurology and
Developmental Neurology
Child Neurology: Neurovascular/Critical
Care/Quality 1
P9.5-001
Rett-like phenotypes in HNRNPH2-Related
Neurodevelopmental Disorder – Joseph Gonzalez,
Olivia Thornburg, Sylvie Goldman, Melissa T.
Carter, Jennifer M. Bain
P9.5-002
Psychophysiological Markers Predict the Effect
of Propranolol on Conversational Reciprocity in
Autism Spectrum Disorder – David Q. Beversdorf,
Bradley Ferguson, Carrina Appling, Nanan Nuraini,
Samantha Hunter, Kathy Hirst, Bridget Lolli, Julie
Muckerman, Ryan Holem, Nicole Takahashi
P9.5-003
Utility of General Movement Assessment (GMA)
in predicting the neurodevelopmental outcomes
of term and late preterm infants exposed to
severe hyperbilirubinemia in the neonatal period
– Chandana Bhagwat, Lokesh Saini, Arushi Gahlot
Saini, Naveen Sankhyan, Praveen Kumar, Rajni
Sharma, Christa Einspieler
P9.5-004
PFO Closure Following Childhood Stroke – Laurel
Rose Persa, Catherine M. Amlie-Lefond
P9.5-005
Shunting Prevalence in Patients with Moyamoya –
Lori Xu, Wilmot Bonnet, Michael M. Dowling
6 Research Methodology and
Education
Curriculum Development in Neurology
Medical Education 1
P9.6-001
Longitudinally Integrated Clerkships and
Interwoven Learning Experiences: Adapting
Neuroscience Education to Evolving Medical
School Curricula – Aaron M. Carlson, Trevor
Hawkins, Pearce Korb, C. Alan Anderson, Hannah
R. Daniels, Chad Stickrath, Shanta Mary Zimmer,
Maureen Estevez Stabio
P9.6-002
The Journey with Our Evolving Neurology
Residency Curriculum in Molding Humanistic
Neurology Graduates – Aileen Antonio,
Christopher Morgan, Emily C. Johnson, Taylor R.
Anderson
P9.6-003
The impact of an X+Y schedule model on
Neurology residency training – Shuvro Roy,
Katherine Fu, Timothy Edward Ryan, Yvette
Bordelon, Charles C. Flippen, Adrienne M. Keener
P9.6-004
A Novel Approach to Orientation for Incoming
Neurology Residency through Simulation-Based
Education – Madeline Louise Singer, Huiam
Mubarak, Tejas Ranade, Sami Kaldawi, Tejas
Ranade, Kelly Breaux, Valerie Sharf, Justin Hoskin
P9.6-005
Retrospective Study of an Adult Neurology
Residency’s Implementation of an Academic Half
Day Curriculum – Sonali Sharma, Mohamed Ridha,
Mohammed Al-Dulaimi, Cristie S. Draconi, Joshua
A. Kornbluth
P9.6-006
Resident Driven Quality Improvement: A Self-
Sustaining Model for New Milestones – Micaela
Rose Owens, Alyssa Marie Smith, Cynthia Correll,
Anthony Noto, Megan E. Esch, Joseph C. Alario
7 Neuro Trauma and Critical Care
Neurocritical Care: COVID-19, TBI and
Other Topics 1
P9.7-001
Underutilization of Neuro Critical Care during the
COVID-19 Pandemic – Shubham Biyani, Naren
Raj Arulprakash, Abhilash Thatikala, Krishna
Nalleballe, Sanjeeva Reddy Onteddu, Vishank Arun
Shah
P9.7-002
Delivery of Neurocritical Care Services to Critically
Ill Patients with Altered Mental Status Before and
During the COVID-19 Pandemic: A Single Center
Study – Jonathan Reid Crowe, Rajesh Amerineni,
Lidia Maria Veras Rocha Moura, Michael Brandon
Westover, Sahar Fatima Zafar
P9.7-003
COVID-19 Associated Aortic Thrombosis
Mimicking Transverse Myelitis – Anand Kumar,
Deepika Joshi, Varun Kumar Singh
P9.7-004
Dysautonomia in Guillain-Barré Syndrome:
Prevalence, Clinical Spectrum, and Outcomes –
Tia Chakraborty, Christopher Lawrence Kramer,
Eelco F. M. Wijdicks, Alejandro A. Rabinstein
P9.7-005
Comparison of Invasive and Non-Invasive Brain
Tissue Oximetry after Pediatric Traumatic Brain
Injury – Ann Oh, M’hamed Temkit, Michael
Kuwabara, P. David Adelson, Brian L. Appavu
AAN.com/AM 59
 Poster Session 9
8 9
Epilepsy/Clinical Neurophysiology
(EEG)
Epilepsy/Clinical Neurophysiology (EEG):
Status Epilepticus and Autoimmune
Epilepsy 2
P9.8-001
Faciobrachial seizures in LGI1 encephalitis are
not always dystonic. – Noushin Chini Foroush,
Subramanian Muthusamy, Udaya K. Seneviratne
P9.8-002
Incidence and Predictors of in-hospital mortality
associated with Status Epilepticus using
Nationwide inpatient population cohort database
(2011-2014) – Tejinder Singh, Parisha Bhatia,
Neena Viswanathan, Varun Kumar, Tanushri
Bhushan, Ashmeet Kaur, Chirag Narshibhai Savani
P9.8-003
Epileptic spasms and neurodevelopmental
regression: a rare presentation of Anti-NMDA-
receptor encephalitis – Valentina Stephen Joseph,
Paul E. Youssef, Jan-Mendelt Tillema, Anthony L.
Fine, Katherine C. Nickels, Lily Wong-Kisiel
P9.8-004
National estimate of incidence and predictors
of generalized convulsive status epilepticus
following traumatic brain injury (TBI) using
Nationwide inpatient sample database.(2011-
2014) – Tejinder Singh, Neena Viswanathan,
Parisha Bhatia, Varun Kumar, Tanushri Bhushan,
Ashmeet Kaur, Chirag Narshibhai Savani
P9.8-005
Continuous Renal Replacement Therapy versus
Peritoneal Dialysis in reversing Cefepime-Induced
Non-Convulsive Status Epilepticus: A Case Report
– Noor Mahmoud, Veronica Astrid Moreno Gomez,
Maria Shoaib, Sameera Siddiqui, Sarah R. Durica
P9.8-006
Use of Ketogenic Diet in New-Onset Super-
Refractory Status Epilepticus (NOSRSE): A Case
Report with Literature Review – Daniel Li, Daniel
Mandel, Jason B. Richards
P9.8-007
Hashimoto Encephalopathy Presenting with
Seizures and Uncommon EEG pattern - Case
Report – Hasmik Amirjanyan, Shivanee Sodani,
Musab Zorlu, Jose Antonio Montes-Rivera, Marie
C. Eugene
60 2022 AAN Annual Meeting
Monday, April 4 5:30 p.m.–6:30 p.m.
Infectious Disease
Infectious Disease: Peripheral
Manifestations Take Center Stage in
COVID-19 1
P9.9-001
Peripheral Nervous System Complications of
SARS-CoV-2 – Chelsea Schmoll, Stefanie Jordan
Rodenbeck
P9.9-002
Case Series: Post-COVID Small Fiber Neuropathy
– Lindsay Sarah McAlpine, Adeel Zubair, Serena
Spudich
P9.9-003
Vestibular Dysfunctions Related to COVID-19
Infection: A Clinical Case Report – Rebecca Potts,
Hongyan Li
P9.9-004
Dysautonomia in Long Haul Covid-19 Infection
Impairs Activities of Daily Living and Mental
Health: The Patient Perspective – Emma Reford,
Nicki Mohammadi, Natalia Romano Spica, Jenna
Tosto, Laura Rosenbaum Tabacof, David Putrino,
Christopher Kellner
P9.9-005
Sensory Neuronopathy Following COVID-19
Infection: a Case Series – Venkatraman Thulasi,
Shaul Shaulov, Rijul Asri, Machteld E. Hillen
P9.9-006
COVID-19?associated myositis with severe
proximal and bulbar weakness – Hui Zhang,
Zeinab Charmchi, Roberta J. Seidman, Yaacov
Anziska, Vinodkumar Velayudhan, Jonathan Perk
P9.9-007
Guillain-Barre and Miller Fisher Overlap Syndrome:
A Masked Neurological Consequence of COVID-19
– Reha Rabbani, Stephen Vetter, Bradley Moore
10 Cerebrovascular Disease and
Interventional Neurology
Cerebrovascular Disease: Clinical
Science 4
P9.10-001
Increased Prevalence of Autoimmune Disease in
Individuals with Down Syndrome and Moyamoya
Disease – Jonathan Santoro, Sarah Lee, Anthony
C. Wang, Eugenia Ho, Deepti Nagesh, Runi Tanna,
Mellad Khoshnood, Ramon A Angel Durazo
Arvizu, Melanie Manning, Brian Gary Skotko, Gary
Steinberg, Michael S. Rafii
P9.10-002
A Case of Atrioesophageal Fistula as a Rare
Complication of Atrial Fibrillation Ablation Leading
to Multifocal Embolic Ischemic Strokes – Merry
Huang, Eric Dunn, Ghulam Abbas Kharal
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P9.10-003
Early Onset Cerebral Amyloid Angiopathy in the
Context of Perinatal Hydrocephalus and VP Shunt
Instrumentation – Joshua Augustin Modeste,
Isabelle Snider, Alexis N. Simpkins
P9.10-004
Sex-specific lesion pattern of long-term functional
outcome after stroke – Anna Katharina Bonkhoff,
Martin Bretzner, Sungmin Hong, Markus D.
Schirmer, Christina Jern, Arne Lindgren, Jane
Maguire, Danilo Bzdok, Ona Wu, Natalia Sana Rost
P9.10-005
P2RX7 stimulates Mac-1/ICAM-1-dependent
leukocyte-endothelial Adhesion through
promotion of Neurovascular Insult during Septic
Encephalopathy – Muhammad Masood Ahmed,
Huan Wang, Shumaila Andleeb, Rong-Rong Tao,
Syed Nisar Hussain Shah
P9.10-006
Thrombotic Thrombocytopenic Purpura Atypically
Presenting as Acute Ischemic Stroke – Kelsey H.
Carr, Ryan Pinosky, Sameer Sharma
P9.10-007
Do Retinal Microvascular Changes Improve TIA
Risk Stratification Scores? ABCD2 vs. ABCDEye
in the FOTO-TIA Study – Beau Benjamin Bruce,
Fadi B. Nahab, Jeffery Siegelman, Nicolas Antonio
Bianchi, Mung Yan Lin, Benjamin Meyer, Michael
Ross, David W. Wright, Nancy J. Newman, Valerie
Biousse
P9.10-008
“Early Mobilization Protocol” Can Be Initiated
in the Intensive Care Unit in Acute Ischemic
Stroke Patients After Receiving Intravenous
Alteplase – Muhammad Fawad Ishfaq, Shruthi HR
Pulimamidi, Megan Sweeney, Anudeep yelam, Eric
T. Lybeck-Brown, Wei Huang, Attiya Jaura, Swathi
Beladakere Ramaswamy, Nakul Katyal, Kunal
Bhatia, Brandi R. French, Camilo Ramiro Gomez,
Adnan I. Qureshi
P9.10-009
Application of Machine Learning Model to
Prognosticate Functional Outcome in Patients
with Acute Ischemic Stroke Secondary to Proximal
Large Vessel Occlusion – Sankar Prasad Gorthi,
Srinivasa Rao Kundeti, Krithishree S.
P9.10-010
Incidence of Access Site Complications in Patients
Receiving Tenecteplase as Bridging Therapy to
Endovascular Treatment – Brigitte Percival, Nasar
Ali, Sindhu Sahito, Abdallah Omar Amireh, Laura
Suhan, Spozhmy Panezai, Haralabos Zacharatos,
Siddhart Kumar Mehta, Farah Yolanda Fourcand,
Jawad F. Kirmani
 Poster Session 9
11
Movement Disorders
Movement Disorders: Tardive Dyskinesia
and PD Imaging 2
P9.11-001
Dose Patterns for Long-Term Deutetrabenazine
Treatment in Patients With Tardive Dyskinesia by
Baseline Abnormal Involuntary Movement Scale
Item 8 Score – Hadas Barkay, Stacy Finkbeiner,
Amanda Wilhelm, Jessica K. Alexander, Nayla
Chaijale, Mark Forrest Gordon
P9.11-002
Effects of Long-Term Deutetrabenazine Treatment
in Patients With Tardive Dyskinesia and
Underlying Psychiatric or Mood Disorders – Mark
Forrest Gordon, Robert A. Hauser, Hadas Barkay,
Hubert H. Fernandez, Stewart A. Factor, Joohi
Jimenez Shahed, Nicholas Gross, Leslie Marinelli,
Amanda Wilhelm, Juha M. Savola, Karen E.
Anderson
P9.11-003
Evaluation of brain SPECT with 99mTc - TRODAT-1
in the differential diagnosis of Parkinsonism –
Giorgio Fabiani, Carlos Henrique Ferreira Camargo,
Rui Kleber Martins-Filho, Gabriel Sampaio
Froehner, Helio Afonso Ghizoni Teive
P9.11-004
Role of Nuclear Imaging (18-Fluro-FDG PET Brain
and 99m-TC-TRODAT-1-SPECT Brain) in Supporting
the Clinical Diagnosis in Patients with Idiopathic
Parkinson’s Disease, Progressive Supranuclear
Palsy and Vascular Parkinsonism , along with
their Characteristic Imaging Findings – Shankar
Balakrishnan, Amruthavarshini Srinivasan
Movement Disorders: Trials 1
P9.11-005
Liraglutide Improves Non-Motor Function
and Activities of Daily Living in Patients with
Parkinson’s disease: A Randomized, Double-Blind,
Placebo-Controlled Trial – Camille Malatt, Tina
Wu, Catherine Bresee, Elliot James Hogg, Jeffrey
C. Wertheimer, Echo Tan, Hayley Pomeroy, Gloria
Obialisi, Michele Tagliati
P9.11-006
Parkinson’s Progression Markers Initiative (PPMI)
Online expands biomarker research in Parkinson’s
disease (PD) – Ethan G. Brown, Dave Alonso,
Lana Chahine, Christopher Coffey, Roseanne D.
Dobkin, Monica Korell, Ana Lorenzo, Connie C.
Marras, Werner Poewe, Todd Sherer, Andrew D.
Siderowf, Tanya Simuni, Eduardo S. Tolosa, Daniel
Weintraub, Sohini Chowdhury, Kenneth L. Marek,
Caroline M. Tanner
Information is accurate as of February 8, 2022, and is subject to change.
Monday, April 4 5:30 p.m.–6:30 p.m.
P9.11-007
Real-world Effect of Age on Long-term
Effectiveness and Safety of Levodopa-Carbidopa
Intestinal Gel: A Post Hoc Analysis From the
Prospective, Multinational, Observational
DUOGLOBE Study – Mihaela A. Simu, Ray
Chaudhuri, Norbert Kovacs, Francesco Pontieri,
Jason Lamar Aldred, Paul M. Bourgeois, Thomas
L. Davis, Marieta Anca-Herschkovitsch, Robert
Iansek, Mustafa S. Siddiqui, Lars Bergmann, Omar
Ladhani, Tianming Gao, David G. Standaert, Esther
Cubo Delgado
12
General Neurology
General Neurology: COVID-related
Conditions and Outcomes 1
P9.12-001
A systemic review of neurological manifestations
of COVID-19 infection – Sahil Naik, Nivedita Jha,
Varsha Muddasani, Shivani Naik
P9.12-002
Cerebral Venous Sinus Thrombosis (CSVT) and
Bilateral Thalamic Infarcts Following Pfizer-
BioNTech mRNA Vaccine in a Patient with
Ulcerative Colitis – Akshaya Prabhakaran Sudha,
Natalie Bartnik, Arpan Patel
P9.12-003
Acute Inflammatory Demyelinating
Polyneuropathy as the first presenting feature
of COVID 19 infection – Praveen Ramani, Jose
Ricardo Lopez-Castellanos, Joshua K. Walls, Lucas
H. Nalley, Nidhi Kapoor
General Neurology: Neuropathy and
Myopathy 3
P9.12-004
69-Year-Old with Flaccid Paraplegia Immediately
Post Epidural Steroid Injection – Hayden Wisely,
Spencer Nam, Zoe Olga Marinides, Charles J.
Kidd, Kenneth Riley Dalton
P9.12-005
Single Neuron Recruitment during Direct Electrical
Stimulation in the Human Cortex – Oludamilola
Ademoyero, Angelique Christine Paulk, Sydney
Cash
13 Neuromuscular and Clinical
Neurophysiology (EMG)
Neuromuscular Disease: Peripheral
Neuropathy 2
P9.13-001
Amyloidosis Presenting as Mononeuropathy
Multiplex – Michael D. Weiss, Priyank Patel,
George Banks, P. James B. Dyck
P9.13-002
Chronic Inflammatory Demyelinating
Polyneuropathy at a reference center in a low
income country: Eleven year’s experience – Marco
Antonio Alvarado, Mitzi Gabriela Marquez Vargas,
Jesus Millan-Padilla, Anna Lisette Bazan
P9.13-003
Idiopathic Brachial Plexopathy Presenting with
Unilateral Vocal Cord Paresis – Marjorie Anne
Dela Cruz Bagnas
P9.13-004
Carpal and Cubital Tunnel Surgical Release
in HNPP and CMT1A: Success Predictors and
Outcomes – Pitcha Chompoopong, Zhiyv Niu,
Kamal Shouman, Nicolas N. Madigan, Paola
Sandroni, Sarah E. Berini, Alexander Y. Shin,
Jeffrey Brault, Andrea Boon, Ruple S. Laughlin,
Thorland Erik, Jayawant Narayan Mandrekar,
Christopher J. Klein
P9.13-005
Conus Medullaris Damage by West Nile Virus
Infection – Ghadeer Fatani, Wan Yee Kong, James
F. Selwa, Maher Fakhouri, Neha Venkatesh, Jun Li
P9.13-006
Chronic Inflammatory Demyelinating
Polyradiculoneuropathy associated with
Enfortumab Vedotin – Ali Ebrahim, Kevin Elmore,
Susan Shin
P9.13-007
A Unique Presentation of Amyloid-like IgM
Deposition Neuropathy with Microvasculitis.
– Pannathat Soontrapa, Christopher J. Klein,
P. James B. Dyck, Sarah E. Berini, Pitcha
Chompoopong, JaNean Engelstad, Kamal
Shouman
P9.13-008
Acute and Chronic Demyelinating Neuropathies
following COVID-19 Vaccination: A Report of Four
Cases – Erin Dennis, Elizabeth A. Hartman, Nicolas
W. Cortes-Penfield, Ezequiel A. Piccione, Pariwat
Thaisetthawatkul
P9.13-009
A rare case of bilateral Bell’s Palsy in the setting
of SARS-CoV-2 – Ameen Fahad, Manali Desai,
Yulia Salamatova, Shannon M. LaBoy
P9.13-010
Association between Sarcopenia and Diabetic
Peripheral Neuropathy: A Systematic Review
and Meta-Analysis. – Thapat Wannarong, Persen
Sukpornchairak, Christopher D. Geiger, Patompong
Ungprasert
AAN.com/AM 61
 Poster Session 10
1
Autoimmune Neurology
Autoimmune Neurology: Clinical
Observations 1
P10.1-001
Adult-onset MELAS Syndrome Mimicking
Autoimmune Encephalitis – Rumyar Vojdanian
Ardakani, Lauren Tardo, Benjamin M. Greenberg,
Jaya Raghav Trivedi, Paula Hardeman, Elisabeth
Golden
P10.1-002
DiGeorge Syndrome Associated with
Longitudinally Extensive Transverse Myelitis –
Jenelle Raynowska, Jennifer H. Yang, Anastasie
M. Dunn-Pirio
P10.1-003
Transverse Myelitis Secondary to Insect Bite:
A Case Series and Proposed Pathophysiologic
Mechanism – Evan Madill, Shawn J. Lee, Julia
Sumera, Neda Sattarnezhad, May Han
P10.1-004
Title: Faciobrachial Dystonic Seizures in a patient
with NMDAR (N Methyl D aspartate receptor)
Encephalitis – Naga Krishnakanth Madireddy,
Shivani Naik, Zarmina Mufti, Vishwanath Sagi
P10.1-005
Cerebral Calcifications in Systemic Lupus
Erythematosus – Rishika Singh, Andrew N. Wilner,
Jessica Lynn Bertram, Hunter Leigh Mitchell, Syed
Raza
P10.1-006
A Subacute Neurologic Presentation of Fibrosing
Inflammatory Pseudotumor – Mattia Rosso, Cori
Afton Cummings, Mini Singh
2 Headache
Headache: Migraine in the Real World 1
P10.2-001
Treatment Satisfaction and Optimization With
Real-World Use of Ubrogepant for the Acute
Treatment of Migraine in Combination With
an Anti-Calcitonin Gene–Related Peptide
Monoclonal Antibody Preventive: Results From
the COURAGE Study – Janette Contreras-De
Lama, Aubrey Manack Adams, Daniel Serrano, Ella
Engstrom, Weijie Poh, Francois Cadiou, Richard B.
Lipton
P10.2-002
A Real-World, Observational Study of Erenumab
for Migraine Prevention in Canadian Patients With
Prior Prophylactic Treatment Failure – Werner J.
Becker, Sian D. Spacey, Elizabeth Leroux, Rose
A. M. Giammarco, Christine L. Lay, Jonathan P.
Gladstone, Suzanne N. Christie, Sarah Power,
Jagdeep Kaur Minhas, Johanna Mancini, Driss
Rochdi, Ayca Filiz, Natacha Bastien
62 2022 AAN Annual Meeting
Tuesday, April 5 8:00 a.m.–9:00 a.m.
P10.2-003
Real-World Effectiveness of Ubrogepant for
the Acute Treatment of Migraine When Used
in Combination With an Anti-Calcitonin Gene–
Related Peptide Monoclonal Antibody Preventive:
Results From the COURAGE Study – Aubrey
Manack Adams, Janette Contreras-De Lama,
Daniel Serrano, Ella Engstrom, Weijie Poh, Francois
Cadiou, Richard B. Lipton
P10.2-004
Real-World Persistence and Costs Among
Patients With Chronic Migraine Treated
With OnabotulinumtoxinA or CGRP mAbs: A
Retrospective Claims Analysis Study – Todd J.
Schwedt, Jae Hyun Lee, Kerry Louise Knievel,
Jennifer McVige, Weiying Wang, Zheng Wu,
Patrick J. Gillard, Darshini Shah, Andrew M.
Blumenfeld
Secondary Headache 3
P10.2-005
Bridging the Gap With Gift Bags: A Mullti-
Departmental, Multidisciplinary Approach to
Headache in the EmergencyDepartment – Ellen
Michelle Gibson, Courtney Sarah White, Brittany
Lynn Heckel
P10.2-006
Use of Anti-CGRP Monoclonal Antibodies to Treat
Headache in Patients with Idiopathic Intracranial
Hypertension: A Retrospective Study – Lindsay
Frerichs, Karabi Nandy, Deborah I. Friedman
3 Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Neuroimaging: Aging
and Alzheimer’s Disease 2
P10.3-001
Cognitive Screening Subscores and Cortical
Thickness in Amnestic and Non-Amnestic Mild
Cognitive Impairment – Carolyn Parsey, Daniel
Jon Peterson, Roy Seo, Annika Noreen, Thomas J.
Grabowski
P10.3-002
Disrupted white matter microstructural integrity
and network connectivity are related to poor
cognition functions: data from a large community-
based aging population – Zi-Yue Liu, Feifei Zhai,
Fei Han, Ming-Li Li, Li-Xin Zhou, Jun Ni, Ming
Yao, Shu-Yang Zhang, Li-Ying Cui, Zheng-Yu Jin,
Yi-Cheng Zhu
P10.3-003
MRI Investigation of Caudate Networks in
the Normal Aging – Federica Agosta, Silvia
Basaia, Giacomo Sferruzza, Matteo Zavarella,
Camilla Cividini, Maria Antonietta Magno, Laura
Cacciaguerra, Marco Bacigaluppi, Gianvito
Martino, Massimo Filippi
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P10.3-004
Greater Functional Connectivity in Right Temporal
Cortex was Associated with SuperAging – Soo-
Hyun Kim, Hyung Ho Kim, Bori R. Kim, Geon Ha
Kim
P10.3-005
Longitudinal changes of subcortical volumes in
SuperAgers – Hyung Ho Kim, Soo-Hyun Kim, Bori
R. Kim, Geon Ha Kim
4
MS and CNS Inflammatory
Disease
MS Symptom Assessment & Management
1
P10.4-001
Impact of Vaginal estriol on urogenital symptoms
in Relapsing Remitting Multiple Sclerosis – Mirla
L. Avila, Roberto Hernandez Quintana, Jie Pan,
Smathorn Thakolwiboon, Dargelis Chi, Alan Peiris,
Charles D. Thompson, John Matthew Garza
P10.4-002
Reduced Reward Responsiveness: A Unique
Phenotypic Presentation of Depressive Symptoms
in Multiple Sclerosis – Tali R. Sorets, Jordyn
Anderson, James F. Sumowski
P10.4-003
Sources of Cannabis Information and Medical
Guidance Among People With Multiple Sclerosis:
NARCOMS Survey Results – Robert J. Fox,
Amber Salter, Gary Raymond Cutter, Joshua R.
Steinerman, Kathryn Nichol, Karry Smith
P10.4-004
Discordance between Neurologists and People
With Multiple Sclerosis on the Perception of the
Presence and Burden of Cognitive Impairment –
Iris Katharina Penner, Virginia De Las Heras Revilla,
Eddie Jones, Suzannah Ryan, Patricia Dominguez
Castro, Emma Houchen, Shruti Narasimham,
Himanshu Karu, Rahul Chetlangia, Sourav
Debsarma Biswas, Vladimir Bezlyak, Daniela Piani
Meier, Carol Lines
P10.4-005
Validation of Novel Semantic Word-Retrieval
Tasks as Sensitive to Word-Finding Difficulty
in Multiple Sclerosis – Emily Dvorak, James F.
Sumowski
P10.4-006
Treating Mild, Moderate, or Severe Spasticity
Matters to People with Multiple Sclerosis - SEEN-
MSS Survey – Ben W. Thrower, Scott Douglas
Newsome, Barry A. Hendin, Robert Chinnapongse,
Sherry R. Danese, Jenifer Patterson
P10.4-007
Heart Rate Variability (HRV) Corresponds to
Multiple Sclerosis Symptom Burden – Giuseppina
Pilloni, Pamela Best, Lauren B. Krupp, Ilya Kister,
Leigh Elkins Charvet
 Poster Session 10
P10.4-008
Sexual dysfunction in multiple sclerosis as
a function of concomitant risk factors: an
intersectional approach – Maria Petracca, Antonio
Carotenuto, Cristiano Scandurra, Marcello Moccia,
Laura Rosa, Sebastiano Arena, Antonio Ianniello,
Agostino Nozzolillo, Mariavittoria Turrini, Lidia
Mislin Streito, Gianmarco Abbadessa, Maria
Cellerino, Sebastiano Bucello, Elisabetta Ferraro,
Manuela Mattioli, Alessandro Chiodi, Matilde
Inglese, Simona Bonavita, Marinella Clerico,
Cinzia Cordioli, Lucia Moiola, Francesco Patti, Luigi
Lavorgna, Giovanna Borriello, Emanuele D’Amico,
Vincenzo Brescia Morra, Roberta Lanzillo
P10.4-009
Subcortical brain volumes are sexually dimorphic
and related to neurofunctional outcomes in MS –
Victoria Leavitt, Claire Riley, James F. Sumowski,
Korhan Buyukturkoglu
P10.4-010
Impact of Social Distancing during the COVID-19
Pandemic on Longitudinal Severity of Depression
in Patients with Multiple Sclerosis – A Single Site
Analysis – Magdalena Lana, Alexis Ahmad, Myra
Lewontin, Carlo S. Tornatore
P10.4-011
Beyond the Physical Symptoms of Spasticity
for People With MS Spasticity: Results From
SEEN-MSS, a Large-scale, Self-reported Survey
– Scott Douglas Newsome, Ben W. Thrower, Barry
A. Hendin, Joanne M. Wagner, Sherry Danese,
Jenifer Patterson
5 Child Neurology and
Developmental Neurology
Child Neurology: Seizures/Genetic
Syndromes 2
P10.5-001
Eladocagene Exuparvovec Improves Body Weight
and Reduces Respiratory Infections in Patients
With Aromatic L-Amino Acid Decarboxylase
Deficiency – Paul Wuh-Liang Hwu, Yin-Hsiu
Chien, Sheng-Hong Tseng, Antonia Wang, Traci B.
Schilling, Chun-Hwei Tai
P10.5-002
Early Psychotherapy in Post-Concussion
Syndrome. A Study in the Pediatric Population and
Young Adults. – Alcy Torres, Relfa Proano, Joyce
Antonella Jimenez-Zambrano, Jose F. OrtegaTola
P10.5-003
Design and Rationale of SMART, a Phase IIIb
Study Evaluating Intravenous Onasemnogene
Abeparvovec in Spinal Muscular Atrophy –
Arseniy Lavrov, Richelle Randazzo, Florencia Segal
P10.5-004
Therapeutic Hypothermia in Neonatal
Encephalopathy: Creating a Post-Pandemic
Playbook – Justin Rosati, Jennifer ToTran Nguyen
Information is accurate as of February 8, 2022, and is subject to change.
Tuesday, April 5 8:00 a.m.–9:00 a.m.
P10.5-005
Decision Support for AAN Quality Measures –
Stephen Downs, Katie Hentges, Nicky Young, Ann
Clark, Anup D. Patel
6
Research Methodology and
Education
Curriculum Development in Neurology
Medical Education 2
P10.6-001
Standardized Site Description Template Meeting
LCME Elements – Celia Linton Walker, Stephen A.
Berman
P10.6-002
Leadership and Professional Development
Innovation in a Military Adult Neurology
Residency Program to Enhance Medical Readiness
– Zahari Tchopev, Alexis E. Nelson
P10.6-003
Implementing Collaborative, Innovative Trainee-
Centered Strategies to Enhance the Mayo
Clinic Arizona Neurology Residency Educational
Experience – Sara Dawit, Benzion Blech, Marlene
Girardo, Erika Driver-Dunckley
P10.6-004
A Single-Center Study Surveying Neurology
Trainees and Faculty’s Perceptions of the Impact
of the COVID-19 Pandemic on Residents’ Medical
Education – Hisham Alhajala, Ahmad Riad
Ramadan, Aarushi Suneja, Lonni Schultz, Iram
Zaman
7 History of Neurology
History of Neurology 1
P10.7-001
Were the Incas Skilled Surgeons? A Comparison of
Survival Rates Between Incan and Contemporary
Cranial Procedures – Jorge Arturo Cespedes, John
Vargas, Matthew Grady, David Fonseca
P10.7-002
The Neurology in Shakespeare – Lance Fogan
P10.7-003
“Stranger than fiction”: the nineteenth-century
media coverage of the case of Phineas Gage –
Manon Auffret
P10.7-004
Babinski and His Sign – Sanem Pinar Uysal
8
Neuro Trauma and Critical Care
Neuro Trauma 1
P10.8-001
Does Tranexamic Acid (TXA) post Traumatic
Brain Injury (TBI) return Service Members to the
Battlefield? – Matthew Donald Holtkamp
P10.8-002
Influence of Ethnoracial and Sociodemographic
Variables on Incidence and Management of
Traumatic Brain Injury Patients in Hawaii – Kayti
Luu, Michelle Pang, Rachel Gorenflo, Frances
Tiffany Morden, Ariel Ma, Nicholas Lee Sims,
Lauren Keiko Fujii, Kent Yamamoto, Enrique
Carrazana, Jason Viereck, Kore K. Liow
P10.8-003
Clinical Profiles of Concussed U.S. Soldiers Injured
During the January 8th, 2020 Iranian Theatre
Ballistic Missile Attack on Al Asad Air Base, Iraq:
A Real World, Chaotic, Blast-related TBI Mass
Causality Event – Jeffrey Brian Hainsworth,
Alan Paul Johnson, Shana Godfred-Cato, George
Smolinski, Kendra Wagers
8 Sports Neurology
Sports Neurology 1
P10.8-004
Standardized Neurologic Exam Findings Following
Sports Related Concussion – Nicholas Samuel
Streicher, Andrea Almeida, Bara Alsalaheen,
Michael Popovich, James T. Eckner, Matthew T.
Lorincz
P10.8-005
Traumatic Encephalopathy Syndrome in a cohort
of Professional Fighters – Charles Bernick, Guogen
Shan, Aaron Ritter
P10.8-006
Menstrual Cycle Function Following Concussion
in Adolescent Patients. – Patricia Rhys Roby, Adda
Grimberg, Christina Master, Kristy Arbogast
P10.8-007
Stratifying Risk for Failure to Receive Concussion
Care – Jonathan Davidow, Andrew John Carlson,
Paige Buddenhagen, Kate M. Essad
AAN.com/AM 63
 Poster Session 10
9
Infectious Disease
Infectious Disease: Tricky Viruses 2
P10.9-001
New Onset Refractory Status Epilepticus
secondary to HIV CNS Syndrome – Mustafa
Al-Chalabi, Jennifer Amsdell, Mehmood Rashid,
Ajaz Sheikh
P10.9-002
WITHDRAWN
P10.9-003
A Rare Case of Postherpetic Wallerian
Degeneration of the Trigeminal nerve – Ademilola
Tejuoso, Erik Seroogy, Mehyar Mehrizi, Ranjit
Bagga
P10.9-004
West Nile Virus Encephalitis with Flaccid Myelitis
and Atypical T1 Hyperintensities on Brain
Magnetic Resonance Images after Transplant
– Ada Breitenbucher, Rebecca Anne Silverstein,
Meredith Wicklund, Ruchira M. Jha
P10.9-005
Progressive Multifocal Leukoencephalopathy as
the Initial Presenting Sign of Underlying Immune
Abnormalities: A Series of 3 Cases. – Busranur
Agac, Mouaz Alsawas, Kyle Conway, Marco Hefti,
Tracey Cho
10 Cerebrovascular Disease and
Interventional Neurology
Cerebrovascular Disease: Clinical
Science 5
P10.10-001
The Bulbar Imposter: A Case Presentation of
Foix-Chavany-Marie Syndrome – Christina Xia,
Raja Rama Godasi, Ahmed Ibrahim, Navreet Kaur,
Rashid Ali Ahmed, Neil Suryadevara, Cornelia
Mihai
P10.10-002
Association of Cerebral Microbleeds in ARDS
and Acute Vascular Pathology on MRI – Aron
Gedansky, Merry Huang, Catherine Hassett, Aaron
Shoskes, Abhijit Duggal, Pravin George, Andrew
Blake Buletko, Sung Min Cho, Ken Uchino
P10.10-003
When to suspect depression among patients who
suffered from stroke – Mays Khweileh, Majdi Al
Qawasmeh, Belal Adel Aldabbour, Khalid I. El-
Salem, Haneen Faisal Al Refa’i, Raid M. Kofahi
P10.10-004
Consider Holding DAPT Acutely for Patients with
Large Strokes Who May Need Procedures –
Elisabeth B. Marsh, Elma Chowdhury
64 2022 AAN Annual Meeting
Tuesday, April 5 8:00 a.m.–9:00 a.m.
P10.10-005
Effect of non-invasive vagus nerve stimulation in
hemorrhagic brain injury and permanent ischemic
stroke in rats – Ilknur Ay, Eric J. Liebler, Hakan Ay
P10.10-006
Postpartum Risk of Cerebral Venous Thrombosis –
Tehniyat Baig, Hamza Chaudhry, Santosh Bhaskar
Murthy, Neal S. Parikh, Ava L. Liberman, Hooman
Kamel, Cenai Zhang, Alexander Merkler
P10.10-007
Venous Thromboembolism Development in Stroke
Patients: A Retrospective Analysis of Predictors
– Youssra Hany Saqr, Hera Ashraf Kamdar, Juan
Peng, Archana Hinduja
P10.10-008
Management and Outcomes of Stroke in Patients
with Parkinson’s Disease – Lynda Nwabuobi,
Chenel Morrison, Aryeh Zolin, Cenai Zhang, Babak
Navi, Hooman Kamel
P10.10-009
Clinical and Demographic Characteristics
Associated With Poor Posterior Circulation
Stroke Outcomes: Greater Cincinnati/Northern
Kentucky Stroke Study – Lina Chervak, Stacie
Leigh Demel, Heidi Sucharew, Adam S. Jasne,
Daniel Woo, Sharyl R. Martini, Tracy E Madsen,
Eva Akshitkumar Mistry, Dawn O. Kleindorfer, Brett
M. Kissela
P10.10-010
Reversible Ischaemia Without Infarction
Presenting as Progressive Hemichorea – Sarah
Wrigley, Ronan Killeen, Sean O’Riordan
P10.10-011
Early-onset delirium after spontaneous
intracerebral hemorrhage – Federico Marrama,
Maéva Kyheng, Marco Pasi, Mathieu Rutgers,
Solene Moulin, Didier Leys, Charlotte Cordonnier,
Hilde Henon, Barbara Casolla
11 Movement Disorders
Movement Disorders: Trials 2
P10.11-001
Pharmacokinetics, Pharmacodynamics, and Safety
of the Highly Selective Dopamine D1/D5 Agonist
Tavapadon: Summary of Phase 1 Clinical Studies –
Gina Pastino, Josh Yuan, Sridhar Duvvuri, Matthew
Leoni, Kimberly Largay, Ih Chang, Amy Giugliano,
Stacey Versavel, David Gray, Raymond Sanchez,
John Renger
P10.11-002
Duration of Benefit Per Dose: Post Hoc Analysis of
”Good On” Time Per Dose for IPX203 vs CD-LD IR
in the RISE-PD Phase 3 Trial – Robert A. Hauser,
Hubert H. Fernandez, Kevin J. Klos, Susan Criswell,
Neepa J. Patel, Ghazal Banisadr, Stanley Fisher
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P10.11-003
Long-Term Motor Function and Quality of Life
Outcomes from a Prospective, International DBS
Registry – Guenther Deuschl, Roshini Jain, Heleen
Scholtes, Alex Wang, Michael Barbe, Steffen
Paschen, Chong S. Lee, Andrea Kuehn, Jan Vesper
P10.11-004
SAGE-718 in Parkinson’s Disease Mild Cognitive
Impairment: Results from the Phase 2 PARADIGM
Study (Part A) – Aaron Koenig, Jason K.
Johannesen, Emily Freitag, Sigui Li, Jennifer Billet,
Jeffrey Wald, Steve Kanes, Michael Quirk, James
Doherty
P10.11-005
SPAN-PD: Subgroup Analyses by Baseline
Characteristics of Patients Treated With Levodopa
Inhalation Powder 84mg or Placebo to Treat OFF
Symptoms in Patients With Parkinson’s Disease
(PD) as Measured by Unified Parkinson’s Disease
Rating Scale Part III (UPDRS-III) Score and Patient
Global Impression of Change (PGIC) – Stuart H.
Isaacson, Ping Zhao, Burkhard Blank
P10.11-006
Long-term safety of continuous levodopa/
carbidopa infusion with ND0612: Results from the
ongoing BeyoND study – Stuart H. Isaacson, Tanya
Simuni, Laurence Salin, Ryan J. Case, Liat Adar,
Nissim Sasson, Tamar Yardeni, Werner Poewe
P10.11-007
Monoclonal Antibodies Targeting Alpha
Synuclein- a revolutionary treatment for
Parkinson’s Disease – Harshadayani Jagadish
Kumar, Bina Patel, Ivonne De la Hoz, Lordstrong
Akano
12 General Neurology
General Neurology: COVID-related
Conditions and Outcomes 2
P10.12-001
Hospital-based Observational Study of
Neurological Disorders in Patients Recently
Vaccinated with COVID-19 mRNA Vaccines –
Jasmine Koh, Rebecca Hui Min Hoe, Ming Hui
Yong, Hui Jin Chiew, Yihui Goh, Kok Pin Yong,
Tian Ming Tu, Derrick WS Chan, Benjamin Yong
Qiang Tan, Leonard Leonard Yeo, Amy May Lin
Quek, Isabel Siow, Monica Saini, Jasmyn De Leon,
Sharmini Rathakrishnan, Geraldine Chen, Andrew
C-F Hui, Aftab Ahmad, Moe Pearl Shwe, Kevin Tan,
Chee Seong Seet, Mingshi Cai, Simin Kuo, Ling Li
Foo, Umapathi Thirunagnam
P10.12-002
Machine Learning Analysis of Anosmia and
Ageusia after COVID-19 Vaccination: A Vaccine
Adverse Event Reporting System (VAERS) Study
– Kranthi Kiran Mandava, Mustafa Jaffry, GM
Fahad Bin Mostafa, Kazim Jaffry, Hafiz Khan, Nizar
Souayah
 Poster Session 10
P10.12-003
Dizziness After COVID-19 Infections or
Vaccinations – Maxwell Graham Kahn, Karen
Stephenson, Jennifer L. Cox, Lixin Zhang
P10.12-004
Assessing the Impact of COVID-19 on Clinical
Trials within Neurology – Annabella R. Strathman,
Julie Cannon, Joy Lin, Veronica E. Santini
P10.12-005
A Case of Chronic Inflammatory Demyelinating
Polyneuropathy after Pfizer COVID-19 Vaccination.
– Irma Nora Duncan, Alexander Steve Renpenning,
Roberto Alejandro Cruz
13 Neuromuscular and Clinical
Neurophysiology (EMG)
COVID-19 Related Neuromuscular
Complications and Care 1
P10.13-001
No Significant Increase of Guillain-Barré
Syndrome after COVID-19 Vaccination in Adults: A
Vaccine Adverse Event Reporting System (VAERS)
Study – Mustafa Jaffry, Tarek Elshourbagy, Kranthi
Kiran Mandava, Samar Eldahtoury, Mawj Al-Ani,
Ayatalla Ahmed, Jeffrey M. Kornitzer, Nizar
Souayah
P10.13-002
Retrospective Cohort Study Evaluating Outcomes
in Myasthenia Gravis Patients with COVID-19 –
Minseon Kim, Youngran Kim, Xiaojin Li, Guo-Qiang
Zhang, Aziz I. Shaibani, Thy Nguyen
Experience the Takeda Neuroscience
Medical Affairs Booth in Augmented Reality!
Visit the Takeda Neuroscience Medical Affairs booth #234
Copyright © 2022 Takeda Pharmaceutical Company Limited. All Rights Reserved.
TAKEDA and the TAKEDA logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-60076 . 02/2022.
Information is accurate as of February 8, 2022, and is subject to change.
Tuesday, April 5 8:00 a.m.–9:00 a.m.
Neuromuscular Disease: Peripheral P10.13-007
Neuropathy 3 Compound Mutations in IGHMBP2 are Associated
P10.13-003 with a Demyelinating Polyneuropathy – Xue
Herpes Zoster may be a trigger for Lumbosacral Yang, Sadaf Saba, Karen Krajewski, Ryan Castoro,
Radiculoplexus Neuropathy – Catarina Aragon Yongsheng Chen, Bo Hu, Jun Li
Pinto, Marcus Vinicius Rocha Pinto, P. James B. P10.13-008
Dyck Hereditary TTR amyloid neuropathy unmasked by
P10.13-004 bortezomib chemotherapy for multiple myeloma –
Electrodiagnostic characteristics of hereditary Xiaoyang Li, Rebecca Traub
(hATTR) and wild-type amyloid (wt-TTR) P10.13-009
neuropathy – Akhil Shivaprasad, Melody Badii, Use of Botulinum Toxin in the Treatment of
Sheetal Shroff Neuropathic Pain: A Case Series – XinLi Du, Deep
P10.13-005 Patel
Small Fiber Neuropathy Incidence, Prevalence, P10.13-010
Longitudinal Impairments, and Disability – Adult-Onset Krabbe Disease Presenting as
Stephen A. Johnson, Kamal Shouman, Shahar
Shelly, Paola Sandroni, Sarah E. Berini, P. James
B. Dyck, E. Matthew Hoffman, Jayawant Narayan
Demyelinating Neuropathy in a Much Older Adult:
A Case Report – Aparna Nutakki, Ryan David
Jacobson
Mandrekar, Zhiyv Niu, Christopher Lamb, Phillip A.
Low, Wolfgang Singer, Michelle L. Mauermann,
John R. Mills, Divyanshu Dubey, Nathan P. Staff,
Christopher J. Klein
P10.13-006
Demyelinating Features More Common in
Recurrent Guillain-Barré Syndrome: is Monophasic
GBS a Different Disease? – Adib Jorge De
Sarachaga, Juan Carlos Lopez, Eunice Martínez
Jiménez, Anna Lisette Bazan, Elizabeth Leon,
Edwin S. Vargas
AAN.com/AM 65
 Poster Session 11
1 Autoimmune Neurology
Autoimmune Neurology: Clinical
Observations 2
P11.1-001
A Case of Paraneoplastic Cerebellar Degeneration
and Autonomic Neuropathy in a Patient with P/Q
Type Calcium Channel and CRMP-5 Antibodies
and Prostate Adenocarcinoma – Jennifer Amsdell,
Mehmood Rashid
P11.1-002
A Devastating Neurologic Disorder: Anti-
Dipeptidyl Peptidase like Protein-6 Encephalitis
Mimicking Creutzfeldt-Jakob Disease – Neeharika
Thottempudi, Aimalohi Esechie, Chilvana V. Patel,
Elena Shanina, Xiangping Li
P11.1-003
Unusual Presentation of Paraneoplastic Limbic-
Encephalitis (PLE) with Acute Retrograde-Amnesia
as Presenting Symptom. – Madiha Tariq, Barbara
O’Brien
P11.1-004
New-onset Headache in Neurosarcoidosis: An
Early Sign of Leptomeningeal Involvement. –
Danwei Wu, Anna Tomczak, Neda Sattarnezhad,
Jamie C. McDonald, Julia Sumera, Lucas Kipp,
Christopher Lock, Jeffrey E. Dunn, May Han
P11.1-005
The First Ever Report of Morvan’s Syndrome
associated with a Pseudopapillary Pancreatic
Tumor. – Rajinder Kumar Dhamija, Alvee Saluja
2
Headache
Headache: Innovation and Technology 2
P11.2-001
Direct-To-Consumer Asynchronous Telemedicine
as a Solution to Improve Health Access for
Underrepresented Minorities in Migraine Care
– Sara C. Crystal, Alexander Mauskop, Alan M.
Rapoport, Robert Cowan, Philip Arthur Bain,
Elizabeth Faust Murdoch, Alexander Grigorenko,
Kristen Miranda, Adam B. Cohen, Neil Parikh
P11.2-002
A Cognitive Behavioral Therapy Pilot Program
Delivered via Telemedicine Is Associated with
Reduced Headache Disability in Patients with
Migraine – Sara C. Crystal, Alexander Mauskop,
Alan M. Rapoport, Robert Cowan, Philip Arthur
Bain, Kristen Miranda, Adam B. Cohen, Neil Parikh,
Chelsea Orcutt, Laura Berk, Jeffrey Janata
66 2022 AAN Annual Meeting
Tuesday, April 5 11:45 a.m.–12:45 p.m.
Headache: Migraine Therapeutics 1
P11.2-003
Long-Term Efficacy and Safety of AXS-07 (MoSEIC
Meloxicam-Rizatriptan) for the Acute Treatment of
Migraine: Results from the MOVEMENT Phase 3
Trial – Amanda Jones, Herriot Tabuteau
P11.2-004
The Effect of Pharmacogenomic Data on Adequate
Dosages of Verapamil for The Prevention of
Primary Headache Disorders- a pilot exploratory
study – Yi-Chieh Chen, Han Wang, Jayawant
Narayan Mandrekar, Carrie E. Robertson, Amaal J.
Starling, F. Michael Cutrer, Chia-Chun Chiang
P11.2-005
A Phase 3 randomized, double-blind, sham-
controlled Trial of e-TNS for the Acute treatment
of Migraine (TEAM) – Deena Kuruvilla, Amaal
J. Starling, Stewart J. Tepper, Joseph I. Mann,
Gregory Panza, Michael Johnson
3
Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Non-Alzheimer’s
Dementia: Genetics and Neuroimaging 1
P11.3-001
Prevalence and Phenotype of TBK1 Mutations:
an In-Depth Description – Helena Gossye, Sara
Van Mossevelde, Jan L. De Bleecker, Patrick Cras,
Sebastiaan Engelborghs, Peter P. De Deyn, Tim Van
Langenhove, Christine Van Broeckhoven
P11.3-002
Genotype–phenotype correlations in adult-
onset leukoencephalopathy with axonal
spheroids and pigmented glia (ALSP) – Spyridon
Papapetropoulos, Angela Pontius, Matthew
Brennan, Ryan O’Mara
P11.3-003
Diagnostic whole-exome sequencing and C9orf72
repeat expansion testing in an Austrian cohort
with early onset dementia – Sara Silvaieh,
Theresa Koenig, Tandis Parvizi, Raphael Wurm,
Evelyn Berger-Sieczkowski, Alexander Zimprich,
Elisabeth Stogmann
P11.3-004
CAG repeats within the non-pathological range
in the HTT gene influence personality traits in
patients with Subjective Cognitive Decline –
Valentina Moschini, Filippo Emiliani, Assunta
Ingannato, Camilla Ferrari, Valentina Bessi,
Sandro Sorbi, Benedetta Nacmias, Silvia Bagnoli,
Salvatore Mazzeo, Sonia Padiglioni
P11.3-005
Multimodal Imaging and Perceptual Features
in Two Patient with Anterior Versus Posterior
Primary Progressive Prosopagnosia – Kathleen
Bradbury, Madison N. Shyer, Johanna Evans
Appleton, Quentin Funk, Victoria Arbones, Joseph
C. Masdeu, Belen Pascual
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
4 MS and CNS Inflammatory
Disease
MS COVID 2
P11.4-001
Post-vaccination Central Nervous System
Inflammation at a Tertiary Neuroimmunology
Clinic: Impact of Influenza, SARS-CoV-2, and Other
Vaccines – Hannah Marie Kelly, Collin Jakubecz,
Alessandro Serra, Hesham Ahmed Abboud
P11.4-002
Survey of Immune Response to SARS-CoV-2
mRNA Vaccines in Patients on anti-CD20 Therapy
for Multiple Sclerosis and Neuromyelitis Optica
Spectrum Disorder. – Toluwalase Oluwakemi
Tofade, Pratibha Surathi, Jorge Luis Rodriguez Lee,
Machteld E. Hillen
P11.4-003
Neutralizing Antibody Response to SARS-CoV-2
Vaccination in Multiple Sclerosis – Tirisham
Gyang, John Evans, Joseph Scott Miller, Kariss
Michelle Alcorn, Juan Peng, Erica Bell, Cong Zeng,
Richard Gumina, Shan-Lu Liu, Benjamin M. Segal
P11.4-004
Longitudinal Myelitis as a COVID-19 Neurological
Manifestation – Lindsay Celentano, Alexander
Besser, Amaris Alayon, Adnan Subei
P11.4-005
Clinical Outcomes in Patients With COVID-19
During Two Phase IV Studies of Cladribine Tablets
for Treatment of Multiple Sclerosis: An Update –
Victoria Yavorskaya, Radmila Karan, Laszlo Borsi,
Nektaria Alexandri
P11.4-006
Case Series of New-Onset CNS Immunological
Disorders Temporally Associated with mRNA-
based COVID-19 Vaccines – Ahmad A. Ballout,
Anna Babaie, Michael Dmitriy Kolesnik, Natasha
Hameed, Glenn E. Waldman, Frasat Chaudhry,
Sami Saba, Asaff Harel, Souhel Najjar
P11.4-007
SARS-CoV-2 specific T cell immunity in Spike
Protein Antibody negative MS patients after
vaccination – Clemens Goedel, Anna Bartalis,
Andreas Boldt, Ulrich Sack, Florian Then Bergh
P11.4-008
Corpus Callosum in COVID-19 Cytokinopathy. –
Vilakshan Alambyan, Yan Zhang, Brooke Devenney,
Aparna M. Prabhu, George C. Newman
P11.4-009
COVID-19 mRNA vaccines associated with MOG-
Ab disease and transverse myelitis: Two case
reports – Jonathan Morena, Tirisham Gyang
 Poster Session 11 Tuesday, April 5 11:45 a.m.–12:45 p.m.

6 7
P11.4-010 Research Methodology and
Sleep
Anti-SARS-Cov-2 neutralizing antibodies in Education
subjects with multiple sclerosis: an Italian
monocentric study – Marinella Clerico, Alessandro Social Media and Technology in Medical
Sleep: Focus on Insomnia and TBI 2
Maglione, Marta Morra, Rachele Francese, Andrea Education 1
Civra, David Lembo, Simona Rolla P11.6-001 P11.7-003
P11.4-011 Neurology Virtual Morning Report: An online PTSD Effects on Sleep in Active Duty Service
Covid19 in Multiple Sclerosis Patients in Dubai : Campaign to #EndNeurophobia – Maria Jimena Members – Brent Jacobus
Observational Study – Mona Chetan Thakre, Jihad Aleman, Gabriela Figueiredo Pucci, Valeria Roldan, P11.7-004
Said Inshasi Aaron L. Berkowitz
REM-Sleep: Remote Monitoring for Sleep
P11.6-002 Promotion – Hannah Beaman, Vanja C. Douglas,
Podcasting for Exam Preparation: Tuning into Sara LaHue

5 Child Neurology and

Developmental Neurology
Alternative Study Strategies for Residents – Safa
Abdelhakim, Aaron Stephen Bower, Jeremy

Child Neurology: Neurodevelopmental
Disorders/CP/ASD 4
P11.5-001
Patient Journey and Clinical Burden of Rett
Syndrome in the United States – Damian Michael
May, Kalé Kponee-Shovein, Malena Mahendran,
Nathaniel Downes, Kristy Sheng, Patrick Lefebvre,
Wendy Cheng
P11.5-002
Longitudinal Case Series of Development and
Behavior among Children with Dup15q Syndrome
– Maya Christina Ayoub, Carly Hyde, Shafali Jeste,
Charlotte Distefano
P11.5-003
Impact of Insurance Status, Hospital Ownership
Type, and Children’s Hospital Designation on
Outcomes for Pediatric Neurosurgery Patients
Following Spasticity Procedures in the United
States – Amaris Alayon, Vivian Hagerty, James
Botros, Tamar Leah Levene, Shenae Samuels,
Heather S. Spader
Child Neurology: Seizures/Genetic
Moeller
P11.6-003
Piloting Teleneurology Simulations for Adult
Neurology Residents – Alicia Zha, Rohini D.
Samudralwar, Shivika Chandra, Amanda L.
Jagolino-Cole
P11.6-004
Online Modules Support a Neurology Resident
Teleneurology Curriculum - Pilot Data – Shivika
Chandra, Alicia Zha, Rohini D. Samudralwar,
Amanda L. Jagolino-Cole
P11.6-005
Reported levels of comfort and experience with
interprofessional and telehealth skills in a cohort
of neurology faculty – Cen Zhang, Arielle Marisa
Kurzweil, Perrin A. Pleninger, Aaron Lane Nelson,
Lindsey Gurin, Sondra Zabar, Steven Galetta, Laura
J. Balcer, Ariane Lewis
P11.6-006
Group Text Messaging as a Residency Teaching
Tool in Outpatient Neurology – Anjeli Song,
Joseph E. Safdieh, Matthew S. Robbins
8
Neuro Trauma and Critical Care
Neuro Trauma 2
P11.8-001
Associations Between Inpatient mTBI Patient
Cognitive Profile and Outpatient Functional Status
at 6 Months Post-Injury, a University of California
Davis Cognitive Screener (UCD-Cog) Study. –
Wentao Li, Matthew Nedjat-Haiem, Erin D. Bigler,
Dana Farias, Rejane A. Wittmann, Ryan M. Martin
P11.8-002
Determining the molecular drivers of
neurodegeneration using a novel in vitro model
of secondary brain injury – Gabriel Reynaldo
Arismendi, Josh Karp, Julian Klein, Bruce A. Citron,
Vedad Delic
P11.8-003
Systematic Comparison of Diffusion MRI-Derived
Conventional Single-Tensor and Advanced Voxel-
Wise Metrics Towards Understanding White
Matter Tract Disorganization Due to Repeated
Head Impacts – Virendra R. Mishra, Aaron Ritter,
Charles Bernick

Syndromes 3
P11.5-004
Safety & Feasibility of Responsive
Neurostimulation in Children with Refractory
Epilepsy – Maria El-Hallal, Shefali Karkare, Shaun
Rodgers, Sanjeev V. Kothare
P11.5-005
Patient-focused Remote Study Design in a Natural
History Study for KCNT1-related Epilepsy – Viet
Nguyen, Sarah Hubbard, Marco A. Rizzo, Heather
Adams, Laurie Eileen Seltzer, Carolyn Dickinson,
Courtney Aponte, Jonathan J. Cherry, David
Bearden
7
History of Neurology
History of Neurology 2
P11.7-001
Ketogenic Diet and Pediatric Epilepsy – A
Historical Review (1920 – 1964) – Joseph Mark
Maes, Ram Mohan R. Sankaraneni, Sanjay P.
Singh
P11.7-002
Contemporary Representation of African
American Female Physicians in Vascular
Neurology Clinical Leadership Positions – Melanie
Marcille, Tiyannah Everett, Devin Pranay Patel,
Rishubh Hitesh Shah, Sherita Chapman, Alison L.
Christy, Richard T. Benson, Alexis N. Simpkins

Information is accurate as of February 8, 2022, and is subject to change. AAN.com/AM 67

 Poster Session 11 Tuesday, April 5 11:45 a.m.–12:45 p.m.

8
Sports Neurology
Sports Neurology 2
P11.8-004
Tolerance of Supervised Exercise Among
Concussed Adolescents with Potential Risk
Factors for Prolonged Recovery – Cory Kathleen
Dodson, Jennifer Andrea Fokas, Matthew T.
Lorincz, Andrea Almeida, James T. Eckner,
Jeremiah Freeman, Brooke Ernst, Michael
Popovich
P11.8-005
Resting-State Connectivity Between the Insula
and Prefrontal Cortex Is Sensitive to Acute Injury
P11.9-004
Clinical Characteristics and Outcomes of
Neuroinvasive West Nile virus infection in
Immunosuppressed and Immunocompetent
individuals treated at the Mayo Clinic Hospitals
– David Gritsch, Ehab Yaser Khaled Harahsheh,
Sabirah Kasule, Shemonti Hasan, Angela Parsons,
Cynthia M. Stonnington, Richard Butterfield, Harn
Shiue, Kathryn Norville, Jenna Reynolds, Brian
Chong, Marie Francisca Grill
P11.9-005
A Wolf in Sheep’s Clothing: West Nile Virus
presenting as Guillain Barre Variant – Subhan
Tabba, Asif Amin Kabani
P11.10-007
Characteristics and Outcomes of Stroke Patients
with Concurrent SARS-CoV-2 Infection from
March 1, 2020 to February 28, 2021: An Analysis
from the N3C Database – Jackson Narrett, Ethan
D. Assefa, Arti Patel, Indika Mallawaarachchi,
Johanna Loomba, Sarah Ratcliffe, Ofer Sadan,
Teshamae Monteith, Bradford B. Worrall, Donald
Brown, Karen C. Johnston, Andrew Mebane
Southerland
Interventional Neurology and
Thrombolytic Therapy 3
P11.10-008
Differences in Time to Presentation, Initial

and Symptom Persistence After Sport-Related
Concussion – Christopher Andrew Sheridan, Kevin
Bickart, Corey M. Thibeault, Christopher Giza,
Christopher Thomas Whitlow, Robert Hamilton,
Meeryo Choe
P11.8-006
Pediatric Femoral Nerve Palsy Due to Traumatic
Iliacus Muscle Hematoma – Robert Samuel
Sacks, Sabrina Bulancea, Kathryn Zapata, Simona
Treidler, Jason Wong
P11.8-007
Second Impact Syndrome in Adults: a case report
and review of the literature – Bryce Sarcar, Jiping
Zhou, Philip Mark Ross, Murali Guthikonda, Wazim
Mohamed
9
Infectious Disease
Infectious Disease: Tricky Viruses 3
P11.9-001
Neuroinvasive West Nile Virus Presenting with
Anton Syndrome – Bahadar Singh Srichawla,
Jonathan Min
P11.9-002
Adult-onset Neurodegeneration in XMEN –
Anusha Ebrahim, Daniel Benavides, Michael
Leonardo, William Gahl, Lynne Wolfe, Juan Carlos
Ravell Aumaitre, Camilo Toro
P11.9-003
Mycophenolate Mofetil for the Treatment of
HTLV-1 Associated Myelopathy: A Case Report
– Alexandra Aria Mandel, Sofia Chernet, Pritha
Ghosh, Henry J. Kaminski
68 2022 AAN Annual Meeting
10
Cerebrovascular Disease and Imaging and Revascularization Between Right and
Interventional Neurology Left Hemisphere Acute Ischemic Stroke – John
Henry Erdman, Parul Agarwal, Naomi Mayman,
Cerebrovascular Disease: COVID-19 1 Danielle Wheelwright, Connor Mensching,
Nathalie Jette, Mandip Singh Dhamoon, Laura
P11.10-001 Stein
Delays in thrombolysis during COVID-19 are P11.10-009
associated with worse neurological outcomes: the OR-Converted Angiography Suite in Mechanical
Society of Vascular and Interventional Neurology Thrombectomy Case with Difficult Access – Adam
Multicenter Collaboration – Sitara Koneru, Dinesh T. Mierzwa, Sumayya Naz, Mustafa Al-Chalabi,
V. Jillella, Fadi B. Nahab, Thanh Ngoc Nguyen, Mouhammad A. Jumaa
Mohamad Abdalkader, David S. Liebeskind, Nirav
P11.10-010
Vora, Vivek Rai, Diogo Casarin Haussen, Raul G.
Nogueira, Shashvat Desai, Ashutosh P. Jadhav, Is Neutrophilia a Risk Factor for Fast Stroke
Alexandra L. Czap, Alicia Zha, Italo Linfante, Ameer Progression in Large Vessel Occlusion? – Jawad F.
Hassan, Darko Ernesto Quispe Orozco, Santiago Kirmani, Farah Yolanda Fourcand, Nancy Gadallah,
Ortega Gutierrez, Priyank Khandelwal, Pratit Arifa Ghori, Danisette Torres, Abdallah Omar
Dhirajlal Patel, Osama O. Zaidat, Tudor G. Jovin, Amireh, Haralabos Zacharatos, Siddhart Kumar
Mehta
Scott Kamen, James E. Siegler
P11.10-002
Predicting Risk of Stroke in Hospitalized Patients
with COVID-19: A Machine Learning Approach –
Vikraant Kohli, Danny Truong, Ethan Isaac Meltzer
P11.10-003
Telestroke Care for Acute Ischemic Stroke
Patients Admitted to a Comprehensive Stroke
Center During the COVID-19 Pandemic: TELECAST-
CSC – Solmaz Ramezani Hashtjin, Adam R.
Lipschultz, Monica Ngo, Jodi Mueller-Hussein,
Apameh Salari, Collin Daniel Gradin, Kathryn Bard,
Amelia Solei, Nasima Omar, Sarah A. Engkjer,
Oladi Sedjio Bentho, Christine Elizabeth Yeager,
Benjamin Robert Miller, Christopher Streib
P11.10-004
COVID-19 and Seasonal Temperature’s Influence
on Cerebral Venous Thrombosis – Natalie ANN
Ivey, Lauren A. Fowler, Joseph P. Hanna
P11.10-005
Evidence of Ischemic Stroke in Pediatric Patient
with Post-COVID-19 Syndrome – Chandler
Harrison Lichtefeld, Michael K. Sowell
P11.10-006
Investigating Cerebral Sinus Venous Thrombosis
after COVID-19 Vaccination in Adults – Kazim
Jaffry, Kranthi Kiran Mandava, Mustafa Jaffry,
Sanjana Rosario, Kamel Jedidi, Nizar Souayah
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
 Poster Session 11
11
Movement Disorders
Movement Disorders: Outcomes in DBS
and PD 2
P11.11-001
Dry Cleaning & Parkinson’s Disease: Evaluation
of a Potential Cluster – Meghan Elizabeth Pawlik,
Maryam Zafar, Samantha Lettenberger, Madeleine
Coffey, Aayush Sarkar, Caroline M. Tanner, Samuel
Goldman, Briana De Miranda, Karl D. Kieburtz,
Daniel R. Kinel, E. Ray Dorsey
P11.11-002
Prescribing Patterns for Patients With Parkinson’s
Disease in Long-Term Care Facilities – Andrew
Thach, Andrew J. Epstein, Dom Nunag, Jennifer
Wilbanks, Darshan Mehta
Movement Disorders: PD Therapeutics 2
P11.11-003
Amantadine DR/ER Efficacy as Early Add-On for
Motor Complications in Parkinson’s Disease –
Caroline M. Tanner, Judy Lytle, Andrea Formella
P11.11-004
Amantadine DR/ER Improved OFF-State Dystonia
Motor Complications in PD – Caroline M. Tanner,
Jill L. Ostrem, Judy Lytle, Andrea Formella, Alberto
J. Espay
P11.11-005
Potential Utility of Amantadine DR/ER for Persons
with Parkinson’s Disease Under Consideration for
Device-Aided Therapy – Andrea Formella, Santosh
Mahadevana Goud, Robert A. Hauser
P11.11-006
Pharmacokinetic–pharmacodynamics of
levodopa/carbidopa following subcutaneous
infusion with ND0612 – Tal Birnberg, Ryan J.
Case, Liat Adar, Werner Poewe, Marcus Björnsson,
Mats Karlsson
P11.11-007
Patients’ Preferences for Adjunctive Parkinson’s
Disease Treatments: A Discrete-Choice
Experiment – Michael Serbin, Carol Mansfield,
Colton Leach, Chuck Yonan, Olga Klepitskaya,
Margaret Sheehan, Anne Donnelly
P11.11-008
Adverse drug reactions to apomorphine: a
worldwide pharmacovigilance database analysis
– Manon Auffret, Claire Le Corre, Marc Verin,
Elisabeth Polard
Information is accurate as of February 8, 2022, and is subject to change.
Tuesday, April 5 11:45 a.m.–12:45 p.m.
12
General Neurology
General Neurology: Neurogenetics
P11.12-001
Impact of neurofibromatosis type 1 in an adult
community population – Timothy Gregory, Gregory
Douglas Phillips, John W. Henson
P11.12-002
Vitamin D defiency as Neurological manifestation
of Neurofibromatosis Type1 – Hans H. Shuhaiber
P11.12-003
Management and Progression of Arginase
1 Deficiency Over 2 Decades of Follow-up –
Deborah Marsden, Alexandra Eaton
P11.12-004
Arginine: The Key Driver of Pathophysiology and
Progression in Arginase 1 Deficiency – George A.
Diaz, Mark Bechter, Stephen David Cederbaum
General Neurology: Neurodegeneration
P11.12-005
Two Probable Creutzfeldt-Jakob Disease Cases
Within One Month in a Single Hospital in Grand
Rapids, Michigan – Lingling Rong, Philip Michael
McCarthy, Jessica Feistel, Dania Mallick
13
Neuromuscular and Clinical
Neurophysiology (EMG)
COVID-19 Related Neuromuscular
Complications and Care 2
P11.13-001
Guillain-Barré Syndrome During the COVID-19
Pandemic – Yigit Karasozen, Andrew A. Collins,
Xiaojin Li, Youngran Kim, Guo-Qiang Zhang, Kazim
Ali Sheikh, Thy Nguyen
P11.13-002
Is COVID-19 Vaccination Associated with an
Increased Reporting Rate of Myasthenia Gravis? A
Vaccine Adverse Event Reporting System (VAERS)
Study – Jorge Luis Rodriguez Lee, Mustafa Jaffry,
Kranthi Kiran Mandava, Sanjana Rosario, Kazim
Jaffry, Kamel Jedidi, Nizar Souayah
P11.13-003
Safety and Tolerability of SARS-Cov-2 Vaccination
in Patients with Neuromuscular Disorders: A
Single Center Experience – David Stevens,
Melanie Meton, Jeffrey Mullen, Shadi Milani,
Manisha Kak Korb, Namita Goyal, Tahseen
Mozaffar, Ali A. Habib
P11.13-004
Understanding the Resiliency of the Muscular
Dystrophy Community One-Year into the COVID-19
Pandemic – Leann Lewis, Katy Eichinger, Nuran
Dilek, Kiley Higgs, Michaela Walker, David Palmer,
John Cooley, Nicholas Elwood Johnson, Alrabi
Tawil, Jeffrey Statland
P11.13-005
COVID Spike antibodies in neuromuscular
condition: KU experience – Ameen Khalid
Tajuddin, Mazen M. Dimachkie, Omar
Jawdat, Duaa Jabari, Erik R. Ensrud, Swathy
Chandrashekhar, Constantine Farmakidis,
Mamatha Pasnoor
P11.13-006
Is Rhabdomyolysis after SARS-CoV-2 infection a
Factor of Poor Prognosis? – Steve N. Gad, Mohsen
Ahmed, Mustafa Jaffry, Kranthi Kiran Mandava,
Kazim Jaffry, Nizar Souayah
P11.13-007
Small Fiber Neuropathy Associated with
SAR-CoV-2 Infection – Rory Abrams, Saritha
Kosarussavadi, David M. Simpson, Allison P. Navis,
Nathalie Jette, Lan Zhou, Susan Shin
P11.13-008
COVID-19 Associated Guillain-Barre Syndrome:
Comparing Six Cases of This Rare Presentation –
Shaily Patel, Rachana Gandhi
P11.13-009
Factors associated with utilization of telemedicine
during the COVID-19 pandemic among patients
with myasthenia gravis: A retrospective regional
cohort study – Amanda C. Guidon, Jeff Guptill,
Michael K. Hehir, David Bates, Julie Fiskio, Ximin
Jessica Sun, Mahsa Eskian, William S. David,
James F. Howard
P11.13-010
Immune Mediated Bulbar Myasthenia Gravis
Incited by SARS-CoV2 mRNA Vaccination. –
Jarrett Leech, Monica Petluru, Thomas E. Ragole,
Brian M. Sauer
AAN.com/AM 69
 Poster Session 12
1
Autoimmune Neurology
Autoimmune Neurology: Clinical
Observations 3
P12.1-001
Acute Hemorrhagic Leukoencephalitis as a
Primary Presentation in an Immunocompromised
Patient With Cerebral Toxoplasmosis – Lindsey
Ladd, Max Keeling, Maryam Zulfiqar, Anand
Mamdani
P12.1-002
A case report of Granulomatous angiitis
associated with Cogan syndrome. – Praveen
Ramani, Hira Zafar, Nayana Prabhu, Salman
Zahoor, Sisira Yadala
P12.1-003
HSV-2 Encephalitis Presenting with Immune-
Responsive Chorea – Michael Dmitriy Kolesnik,
Ahmad A. Ballout, Natasha Hameed, Souhel Najjar
P12.1-004
NMDAR-Antibody Encephalitis Presenting
with Faciobrachial Dystonic Seizues in a Gravid
Nigerian Woman – Fatima Ilemona Abdulai,
Gerald Awele Onwuegbuzie, Peter Alabi, Nkechi
Obianozie
P12.1-005
Primary Brain Tumours Masquerading as
Autoimmune Neurological Disorders- A Possible
Paraneoplastic Association? A Retrospective Case
Series – Harini Pavuluri, KP Divya, Bejoy Thomas,
George C. Vilanilam, Rajalakshmi Poyuran, Ajith
Cherian
P12.1-006
Spectrum of Combined Central and Peripheral
Demyelination: A Case Report – Reya Marie
Hayek, Maryam Zulfiqar, Clara Adele Thiel
P12.1-007
Pediatric AMPA Receptor Encephalitis (AMPARE):
A Case Report and Literature Review – Ezgi
Saylam, Alexandra Estelle Sankovic, Brenda Shen,
Lauren Hurst, Setty Magana
2 Edoardo G. Spinelli, Francesco Falbo, Silvia Basaia,
Headache
Headache: Migraine in the Real World 2
P12.2-001
Real-World Effectiveness of Ubrogepant Among
Participants With Prior Treatment Failure:
Subgroup Analysis From the UNIVERSE Study –
Anand R. Shewale, Weijie Poh, Michael L. Reed,
Jinjie Liu, Francois Cadiou, Kate Burslem, Richard
B. Lipton
70 2022 AAN Annual Meeting
Tuesday, April 5 5:30 p.m.–6:30 p.m.
P12.2-002
Reductions in Migraine-related Health Care
Resource Utilization and Costs for Patients
Initiating Fremanezumab: Results of a Long-term
US Claims Database Analysis – Maurice Driessen,
Lynda Krasenbaum, Verena Ramirez Campos,
Robert DiEgidio, Marc Tian, Michael Seminerio
P12.2-003
Reduction in Period Prevalence of Medication
Overuse Headache Following Initiation of Nurtec
ODT Treatment – A Real World Administrative
Claims Study – Gilbert J. L’Italien, Linda Harris,
Ali Mohajer, Jared Scripture, Vladimir Coric, Noah
Rosen
Headache: Migraine Therapeutics 2
P12.2-004
Early Prediction of Response to INP104 for the
Acute Treatment of Migraine – Sara E. Sacco,
Robert Vann, Sutapa Ray, Stephen Bevan
Shrewsbury, Sheena K. Aurora
P12.2-005
Efficacy and Safety of Subcutaneous Sumatriptan
for Acute Migraine Attacks Compared with
other treatments: A Systematic Review and
Network Meta-analysis. – Mohamed Sayed
Zaazouee, Walid Abdel-Aziz, Gena M. ELassall,
Yasmine Adel Mohammed, Mohamed Ibrahim
Gbreel, Abdelrahman M. Attia, Alaa Elshanbary,
Hagar Rohim, Mariam Alsayd Alsayd, Asmaa
Khaled Alsiouty, Anas Zakarya Nourelden, Khaled
Mohamed Ragab, Ahmed Sayed, Mohamed Fahmy
Doheim
3 Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Non-Alzheimer’s
Dementia: Genetics and Neuroimaging 2
P12.3-001
Functional Connectivity Rearrangements
Propagating from Disease Epicenters in
Frontotemporal Lobar Degeneration Variants –
Camilla Cividini, Nilo Riva, Elisa Canu, Veronica
Castelnovo, Giuseppe Magnani, Francesca Caso,
Paola Caroppo, Sara Prioni, Giacomina Rossi, Lucio
Tremolizzo, Ildebrando H. Appollonio, Vincenzo
Silani, Massimo Filippi, Federica Agosta
P12.3-002
Neuroinflammation biomarker in non-fluent/
agrammatic variant of primary progressive
aphasia and/or apraxia of speech – Belen Pascual,
Quentin Funk, Kathleen Bradbury, Johanna Evans
Appleton, Paolo Zanotti Fregonara, Mohammad
Obadah Nakawah, David Robert Beers, Alirexa
Faridar, Stanley H. Appel, Masahiro Fujita, Joseph
C. Masdeu
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P12.3-003
Active elite rugby participation predicts
alterations in right precentral cortical thickness
– Thomas David Parker, Karl Zimmerman, Niall
Bourke, Etienne Laverse, Neil Samuel Nyholm
Graham, Amanda Heslegrave, Henrik Zetterberg,
Simon Kemp, Huw R. Morris, Sharp James David
P12.3-004
White Matter Hyperintensity on Cholinergic
Pathways is Associated with Dementia Severity in
e4 Carriers, not in Non-carriers – Tracy Ming-Chun
Yu, Shu Ching Wu, Chia-Ju Chou, Yi-Chien Liu
P12.3-005
Neuronal intranuclear inclusion disease
(NIID) showing positive results on Pittsburgh
Compound-B PET imaging – Pu-Tien Chiang, Hsin-
Hsi Tsai
4
MS and CNS Inflammatory
Disease
MS Clinical Practice & Decision Making 4
P12.4-001
Neurological Disease Burden in Females with
X-linked Adrenoleukodystrophy – Natalie Grant,
Yedda Li, Claudia Maria Brito Pires, Reza Sadjadi,
Florian Eichler
P12.4-002
Imaging Features of Adult-Onset Genetic
Leukodystrophies Misdiagnosed as Multiple
Sclerosis in Clinical Practice – Alise Carlson,
Emmanuel Obusez, Natalia Shor, Yann Nadjar,
Jeffrey Alan Cohen, Gabrielle Macaron
P12.4-003
Real-world Comparative Effectiveness and
Persistence of Cladribine Tablets and Other Oral
Disease-Modifying Treatments for Multiple
Sclerosis from GLIMPSE: Results from the
MSBase Registry – Helmut Butzkueven, Timothy
Spelman, Serkan Ozakbas, Raed Alroughani, Murat
Terzi, Suzanne J. Hodgkinson, Guy Laureys, Tomas
Kalincik, Anneke Van Der Walt, Bassem I. Yamout,
Jeannette Lechner-Scott, Aysun Soysal, Jens
Kuhle, Jose Luis Sanchez Menoyo, Yolanda Blanco
Morgado, Daniele Litterio A. Spitaleri, Vincent Van
Pesch, Dana Horakova, Radek Ampapa, Francesco
Patti, Richard A L Macdonell, Abdullah Al-Asmi,
Oliver Gerlach, Jiwon Oh, Ayse Altintas, Namita
Tundia, Schiffon Wong, MSBase Study Group
P12.4-004
A retrospective evaluation of people with Multiple
Sclerosis, to determine factors predicting who
declines Disease Modifying Therapies – Thomas
Jackson, Gagana Mallawaarachchi, Jack
Grimshaw, Joyutpal Das, David Rog
P12.4-005
Outcomes and prognostic factors in myelopathies
– Maria Alejandra Garcia-Dominguez, Paula
Barreras, Carlos A. Pardo-Villamizar
 Poster Session 12
P12.4-006
Knowledge, skills, and confidence of healthcare
professionals participating in the ECHO MS
program – Kevin Alschuler, Darren Ball, Annette
Wundes, Salim Chahin, Mark B. Skeen, Gloria Von
Geldern
MS Neuroimaging 1
P12.4-007
Regional Atrophy of the Thalamus as a Biomarker
for Progressive Multiple Sclerosis – Showly
Nicholson, Andrew Russo, Kristina Brewer, Heidi
Bien, Ani Eloyan, Eric Klawiter, Sean Tobyne
P12.4-008
Choroid plexus enlargement in multiple sclerosis
is associated with decreased brain volume – Niels
Bergsland, Michael G. Dwyer, Dejan Jakimovski,
Bianca Weinstock-Guttman, Robert Zivadinov
P12.4-009
DeepGRAI (Deep Gray Rating via Artificial
Intelligence) Provides Feasible and Clinically
Meaningful Thalamic Volume Measurement on
Multi-Center Clinical-Quality T2-FLAIR Images
– Robert Zivadinov, Niels Bergsland, Dejan
Jakimovski, Bianca Weinstock-Guttman, Ralph H.
B. Benedict, Jon V. Riolo, Diego Silva, Michael G.
Dwyer
P12.4-010
White Matter Binding in PET: Pittsburgh
Compound-B and Flutemetamol – Burcu Zeydan,
Christopher Schwarz, Scott Przybelski, Timothy
Lesnick, Walter Kremers, Matthew Senjem, Hoon-
Ki Min, Brad Kemp, Clifford R. Jack, Orhun H.
Kantarci, Kejal Kantarci, Val John Lowe
P12.4-011
Brain Network Centrality Abnormalities
Underpin Multiple Sclerosis Disease Course –
Antonio Carotenuto, Paola Valsasina, Menno M
Schoonheim, Jeroen JG Geurts, Frederik Barkhof,
Antonio Gallo, Gioacchino Tedeschi, Nikolaos
Petsas, Patrizia Pantano, Massimo Filippi, Maria
Assunta Rocca
5 Child Neurology and
Developmental Neurology
Child Neurology: Seizures/Genetic
Syndromes 4
P12.5-001
Intractable Epilepsy and Ischemic Strokes in Two
Children, both with CACNA1A Gene Mutations
– Kristen Bolte, Melissa Assaf, Tamara Zach,
Shubhangi Shahaji Peche
P12.5-002
Hemiconvulsion-Hemiplegia-Epilepsy Syndrome in
the Setting of COVID-19 Infection and Multisystem
Inflammatory Syndrome in Children – Paul Gong,
Bethanie N. Morgan, Cemal Karakas
Information is accurate as of February 8, 2022, and is subject to change.
Tuesday, April 5 5:30 p.m.–6:30 p.m.
P12.5-003
Successful remission with ACTH after early
therapeutic pyridoxine fails to prevent the
development of infantile spasms in ALDH7A-
1-related epilepsy – Darrah Haffner, Jorge A.
Vidaurre, John R. Mytinger
P12.5-004
Diurnal Periodicity in Spontaneously Occurring
High-Frequency Oscillations in Intracranial EEG
– Gabrielle Taylor Petito, Jeremy Housekeeper,
Jason Buroker, Craig William Scholle, Brian Ervin,
Ravindra Arya
P12.5-005
Epilepsy Characteristics in Children With
Neurofibromatosis type 1, What We Have Learnt
From a Tertiary Center Five Years’ Experience –
Abdulhafeez Khair, Gurcharanjeet Kaur, Stephen
Falchek
6 Research Methodology and
Education
Social Media and Technology in Medical
Education 2
P12.6-001
Online CME-Certified Expert Panel Discussion
Improved Knowledge of Clinically-Relevant
Information Regarding Cannabinoids Among
Neurologists – Thomas Finnegan, Kathy Merlo,
Michael Targowski, Barry E. Gidal
P12.6-002
A SIGN Group’s Diverse Virtual Neurology
Education Programs: Successes, Barriers, and
Future Directions – Sophia Gillian Musacchio,
Ahmed Z. Obeidat
P12.6-003
A Simulated Hospital in a COVID-19 Pandemic
Environment for Undergraduate Neurology
Students. – Jaime Toro, Juan Sebastian Rivera
Perez, Daniela Sofia Rodriguez, Laura Andrea
Serna, Jairo Alejandro Gaitan Alfonso, Thomas
Felipe Medina Ramirez, Fabián Cortés, Manuel S.
Yepes
P12.6-004
Online CME-certified Case Challenges in Migraine
Increase Knowledge and Competence Among
Neurologists and PCPs – John Maeglin, Thomas
Finnegan, Kathy Merlo, Deborah I. Friedman
7
Neuro Trauma and Critical Care
Neurocritical Care: COVID-19, TBI and
Other Topics 2
P12.7-001
Advanced Practice Providers in Neurocritical Care:
Model for Orientation and Onboarding to Ensure
Quality of Patient Care, APP Autonomy, Retention
and Job Satisfaction – Tyler John Schaefer, Blair
Cotton, Benjamin Carroll Grant, Danielle Diekevers,
Elizabeth Michel, Kyla Beckman, Chelsea Borta,
Bridget Russell, Sarah Nava, Kaitlin Schoder,
Trisha Raelynn Dickey, Hildalicia Guerra, Tia
Chakraborty, Joseph Zachariah, Muhib Khan
P12.7-002
RLS-0071-101 a study in healthy human
volunteers demonstrates safety, complement and
inflammatory effector target engagement activity
of this novel peptide – Kenji Mason Cunnion,
Parvathi Kumar, Neel Krishna, Ulrich Thienel, L
Matthew Frank
P12.7-003
Diabetic Striatopathy, a rare complication of
uncontrolled diabetes: A review of distinct clinical
presentations of three different cases – Navreet
Kaur, Kehan Zhao, Rashid Ali Ahmed, Julius
Latorre, Elena Schmidt
P12.7-004
Feasibility and safety of the Metaneb® System
in neurocritical care patients – Evien Albazi, Azam
Tolla, Aaron Abramovitz, Tracy J. Koehler, Meredith
A. Kriger, Rajit Pahwa, Brandon Francis
P12.7-005
A Rare Case of Acute Toxic Leukoencephalopathy:
Is Sevoflurane the Culprit? – Saleem Mohamad Al
Mawed, Samir Sadik Al-Ghazawi, Niral K. Patel
P12.7-006
Guillain-Barre Syndrome after Influenza
Vaccination in Adults – Tarek Elshourbagy,
Mustafa Jaffry, Kranthi Kiran Mandava, Kazim
Jaffry, Jorge Luis Rodriguez Lee, Mawj Al-Ani,
Mustafa Turkmani, Samar Eldahtoury, Ayatalla
Ahmed, Ahmed Ezzeldein Omran, Youssef Ahmed
Ragab Ali, Hagar Adel Abuelazm, Nizar Souayah
AAN.com/AM 71
 Poster Session 12
8 9
Epilepsy/Clinical Neurophysiology
(EEG)
Epilepsy/Clinical Neurophysiology (EEG):
ASM Clinical Trials 1
P12.8-001
Sustainability of Seizure Control With Adjunctive
Cenobamate in the Phase 3 C021 Study – David G.
Vossler, William E. Rosenfeld, Sean Stern, Robert
T. Wechsler
P12.8-002
Phase 2 Open-label Clinical Study Evaluating
Oral Ganaxolone for the Treatment of Seizures
Associated with Tuberous Sclerosis Complex
– Mary Kay Koenig, Rajeshwari Mahalingam,
Jurriaan Peters, Brenda E. Porter, Rajsekar R.
Rajaraman, Muhammad Shahzad Zafar, Alex
Aimetti, Ian Miller, Joseph Hulihan, Darcy Krueger
P12.8-003
An Open-Label Pilot Trial Assessing the Safety
and Efficacy of SPN-817 (Huperzine A Extended-
Release) in Adults with Treatment-Resistant Focal
Impaired Awareness Seizures – Jeanelle Portelli,
Lovingly Q. Park, Brendan Lujan, Gregory Busse,
Jonathan Rubin, Azmi Nasser
P12.8-004
Fenfluramine Improves Everyday Executive
Functioning in Patients With Lennox-Gastaut
Syndrome: Analysis of Phase 3 Data – Kim I.
Bishop, Peter Isquith, Gerard A. Gioia, Kelly G.
Knupp, Joseph Sullivan, Rima Nabbout, Gail M
Farfel, Bradley Galer, Arnold Gammaitoni
P12.8-005
Effect of Add-on Cannabidiol (CBD) on Seizure
Frequency and Seizure-Free Intervals in
Patients With Seizures Associated With
Tuberous Sclerosis Complex (TSC): Phase 3 Trial
GWPCARE6 Post Hoc Analysis – Elizabeth Thiele,
E Martina Bebin, Finbar O’Callaghan, Steven Paul
Sparagana, Floor Jansen, Ashley Schreiber, Farhad
Sahebkar-Moghaddam
P12.8-006
Phase 2b Efficacy and Safety of XEN1101, a
Novel Potassium Channel Opener, in Adults with
Focal Epilepsy (X-TOLE) – Jacqueline French,
Roger J. Porter, Emilio Perucca, Martin Brodie,
Michael A. Rogawski, Simon Pimstone, Ernesto
Aycardi, Cynthia L. Harden, Yi Xu, Constanza Luzon,
Christopher J. Kenney, Gregory N. Beatch
P12.8-007
Efficacy and Safety of Cannabidiol (CBD) Dose
Adjustment in Patients With Lennox-Gastaut
Syndrome (LGS): Post Hoc Analysis of Phase 3
Randomized Controlled Trial (RCT) GWPCARE3
and Open-Label Extension (OLE) Trial GWPCARE5
– Elaine C. Wirrell, Ashley Schreiber, Timothy B.
Saurer, Robert T. Wechsler
72 2022 AAN Annual Meeting
Tuesday, April 5 5:30 p.m.–6:30 p.m.
Neuro-oncology
Advancing Care in Neuro-oncology 2
P12.9-001
Modified Frailty Index (mFI) in Elderly Patients
with Glioblastoma Correlates with Survival – Amy
Khine Chang, Alissa Ashley Thomas
P12.9-002
Feasibility of an Electronic Patient Reported
Steroid Toxicity Monitoring Program in Patients
with Malignant Gliomas – Jared Macher, Andrea
C. Wasilewski
P12.9-003
Disparities in Pediatric Medulloblastoma: A Large
Center’s Outcomes and Review of the Literature –
Karthik Jagannath
P12.9-004
Summary of virtual tumor board platforms and
implementation in Neuro-Oncology – Chukwuyem
Ekhator, Santosh Kesari, Jai Grewal
P12.9-005
Disparities in Enrollment of Primary CNS
Lymphoma Trials in the US – Camille Stevenson,
Nimish A. Mohile
P12.9-006
Validation of the Chimeric Antigen Receptor (CAR)
T-cell Therapy Neurotoxicity: A Single Center
Study – Carlen Amy Yuen, Kourosh Rezania,
Thomas J. Kelly, Michael Bishop
P12.9-007
The Impact of COVID-19 on Neuro-Oncology
Clinical Trials During Wave 1 and Wave 2 at a
Frontline Detroit Healthcare System – Carmen
Griffin, Joshua Alton, James Snyder, James
Snyder, Tobias Walbert
10
Cerebrovascular Disease and
Interventional Neurology
Interventional Neurology 1
P12.10-001
Acute Ischemic Stroke Patients Receiving
Reperfusion Therapy Do Not Have Worse 90-day
Outcomes After Delirium – Mohammad Jamil
Ahmad, Sahar Anjum, Aditya Kumar, Jacob
Sebaugh, Michele Joseph, Bethany Williams,
Alicia Zha
P12.10-002
Predicting Aneurysmal Etiology Using Admission
Head CT in Patients with Aneurysmal Pattern
Subarachnoid Hemorrhage – Karl Viktor
Baumgartner, Aiden Meyer, Daniel Mandel, Scott
Moody, Linda C. Wendell, Bradford B. Thompson,
Jesse Menville, Karen L. Furie, Ali Mahta
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P12.10-003
Association of External Ventricular Drain Duration
and Outcomes in Aneurysmal Subarachnoid
Hemorrhage: a Single Center Study – Wendy
Elizabeth Gonzalez, Elyse Forman, Nicholas S.
Potter, Christoph Stretz, Linda C. Wendell, Jesse
Menville, Karen L. Furie, Bradford B. Thompson,
Ali Mahta
P12.10-004
Association Between Asymptomatic Cerebral
Vasospasm and Outcomes in Aneurysmal
Subarachnoid Hemorrhage – Alizeh Shamshad,
Ali Mahta, Elijah Malik Persad-Paisley, Christoph
Stretz, Linda C. Wendell, Nicholas S. Potter
P12.10-005
Assessing Thrombectomy Capacity and
Characteristics of Thrombectomy Capable
Centers World-wide Using the MT2020+ Global
Thrombectomy Tracking Smartphone App ? – Syed
F. Zaidi, Alicia Castonguay, Kaiz Shabbar Asif,
Santiago Ortega Gutierrez, Violiza A. Inoa, Nabeel
Herial, Fawaz Al-Mufti, Viktor Szeder, Dileep R.
Yavagal
P12.10-006
Induction of Vasodilation to Prevent Ophthalmic
Complications Before Middle Meningeal Artery
Embolization – Kiana Moussavi, Mohammad
Moussavi
P12.10-007
Identification of large vessel occlusion on CTA
head using artificial intelligence – James Michael
Hillis, Bernardo Canedo Bizzo, Charles J. Lu,
Christopher Philip Bridge, John Kent Chin, Stuart
Robert Pomerantz, Keith Dreyer, Katherine Patricia
Andriole, Michael H. Lev, Ramon Gilberto Gonzalez
P12.10-008
Early Neurological Improvement Can Reduce
Intensive Care Unit Length of Stay in Aneurysmal
Subarachnoid Hemorrhage – Ryan Snow, Alizeh
Shamshad, Alexandra Helliwell, Nicholas S. Potter,
Linda C. Wendell, Bradford B. Thompson, Jesse
Menville, Christoph Stretz, Karen L. Furie, Ali
Mahta
P12.10-009
Post-Thrombectomy Outcome is Not Associated
with Administration of Intravenous Thrombolysis
– Amanda Jin Zhao, Penina Krieger, Leah Croll,
Hannah Irvine, Jose L. Torres, Kara R. Melmed,
Aaron S. Lord, Koto Ishida, Jennifer A. Frontera,
Ariane Lewis
Cerebrovascular Disease: Neuroimaging 1
P12.10-010
Blood Pressure Changes Impact Corticospinal
Connectivity and Downstream Gait and Balance
Control – Elizabeth A. Coon, Anna Castillo, Timothy
Lesnick, Michelle M. Mielke, Robert I. Reid, B.
Gwen Windham, Ronald C. Petersen, Jonathan
Graff-Radford, Prashanthi Vemuri
 Poster Session 12 Tuesday, April 5 5:30 p.m.–6:30 p.m.

11
Movement Disorders
Movement Disorders: Dystonia and
Botulinum Toxin 1
P12.11-001
Treatment of Camptocormia in Parkinsonism: A
Comparison of Different Interventions in a Single
Center – Carly Jo Olszewski, Jessica Tate, Mark A.
Hirsch, Erwin Van Wegen, Mustafa S. Siddiqui
P12.11-002
A Phase 3, Open-Label, Multi-Center Trial to
Evaluate the Long-Term Safety and Efficacy of
Repeat Treatments of DaxibotulinumtoxinA for
Injection in Adults with Isolated Cervical Dystonia
– Jaroslaw Slawek, Peter J. McAllister, Sebastian
Paus, Daniel D. Truong, Todd Gross, Roman Rubio,
James P. Kesslak, Domenico Vitarella
Movement Disorders: Genetics 2
P12.11-003
Rare Variants In ARSA Are Associated With
Parkinson’s Disease – Konstantin Senkevich, Aliza
Dworkind, Eric Yu, Jamil Ahmad, Jennifer Ruskey,
Farnaz Asayesh, Dan Spiegelman, Stanley Fahn,
Cheryl H. Waters, Oury Monchi, Yves Dauvilliers,
Nicolas Dupre, Lior Greenbaum, Sharon Hassin,
Roy Alcalay, Ziv Gan-Or
P12.11-004
VCP Mutations and Parkinsonism: An Emerging
Link – Ashley Mary Paul, Jumana Tariq A Alshaikh,
Emile Sami Moukheiber, Sonja Waltraud Scholz,
Alexander Pantelyat
P12.11-005
DNA Methylation-based Surrogates of Plasma
12
General Neurology
General Neurology: Neuro-Immunology
and Neuro-Infectious diseases
P12.12-001
Neurological Outcomes of Organ Transplantation:
A Systematic Review – Jenny Paola Garzon,
Ana Garcia, Maria Paula Silva Sanchez, Lizeth
Rodriguez, Marcela Cardona, Federico Silva
P12.12-002
Progressive Multifocal Leukoencephalopathy
in immunocompetent a case report and review
of literature – Syed Hassan Khalid, Erum Khan,
Durgesh Chaudhary, Shitiz K. Sriwastava
P12.12-003
Treatment Challenges of Active Multiple Sclerosis
in the Setting of Cryptococcal Meningitis: A Case
Report and Review of the Literature – Crystal A.
Honold, Brandi Anderson, Andrea Loggini, Jonatan
Hornik, Alejandro Hornik, Hope Merkley, Tiffany
Ward, Abdelhameed Nawwar
P12.12-004
Bannwarth Syndrome Mimicking
Neurolymphomatosis – Sanem Pinar Uysal, John
A. Morren
General Neurology: Neuro-oncology
P12.12-005
Brainstem Gliomatosis Cerebri Presenting as
a Cerebellopontine Angle Tumor – Anthony
Thompson, Kayla Schusterman, Julianne Lee,
Charles Maitland, Isabella Canut
P12.13-004
Pharmacokinetics, Biodistribution, and Exploration
of the Mechanism of Central Nervous System
Penetration of a PATrOL™-Enabled Investigational
Genetic Therapy for Myotonic Dystrophy, Type
1 after a Single Subcutaneous or Intravenous
Administration in the BALB/c Murine Model –
Renta Hutabarat, Barry A. Badeau, Dani Stoltzfus,
William Mann, Dietrich A. Stephan, Sandra
Rojas-Caro
Neuromuscular Disease: Peripheral
Neuropathy 4
P12.13-005
Creatine kinase A Novel Prognostic Marker
in GBS – Kaushik S, Lakshmi N. Ranganathan,
Balasubramanian Samivel, Uma Maheswari E
P12.13-006
Sciatic Nerve Mononeuropathy After An
Uncomplicated Vaginal Delivery – Nader Gamil
Boutros, Milad Sabouri, Mark Girgis, Bhavesh
Trikamji
P12.13-007
Super Slow Conduction Velocities in Chronic
Inflammatory Demyelinating Polyneuropathy
(CIDP) – Jeremy Zung, Kunal V. Desai
P12.13-008
Optimization of intrathecal delivery of an infused
AAV9 vector for delivery of a gene therapy
candidate for Adrenomyeloneuropathy (AMN)
in Non-Human Primates (NHP) – Vidyullatha
Vasireddy, Sean W. Clark, Karen Kozarsky, David
William Anderson
P12.13-009
Understanding the Adrenomyeloneuropathy
(AMN) Patient Journey – Rohan Gandhi, Emma

Proteins are associated with Parkinson’s Disease
Risk – Katherine Fu, Kimberly C. Paul, Ake TzuHui
Lu, Steve Horvath, Adrienne M. Keener, Yvette
Bordelon, Jeff M. Bronstein, Beate Ritz
P12.11-006
Transcriptome patterns and their regulation by
alternative splicing in Parkinson’s disease. – Krithi
Irmady, Caryn R. Hale, Rizwana Qadri, John Fak,
Serge Przedborski, Thomas Samuel Carroll, Robert
B. Darnell
P12.11-007
Remote follow up of prodromal Parkinson’s
disease in a LRRK2 G2019S cohort – Ruth
Schneider, Taylor Myers, Stella Jensen-Roberts,
Meghan Elizabeth Pawlik, Emily Hartman,
Samantha Lettenberger, Alexandra N. Kaplan,
Renee Wilson, Peggy Auinger, E. Ray Dorsey,
Blanca Yvette Valdovinos, Katherine D. Amodeo,
Saloni Sharma, Robert G. Holloway, Caroline M.
Tanner, Roy Alcalay, Julia Marie Soto
Information is accurate as of February 8, 2022, and is subject to change.
13
Neuromuscular and Clinical Drysdale, Gregory Brooks, Jessica Lee, Chan
Neurophysiology (EMG) Beals, Florian Eichler
Neuromuscular Disease: Inherited Muscle P12.13-010
Disorders 1 Gender Differences in the Development of
P12.13-001 Cardiomyopathy in Friedreich’s Ataxia Patients: A
Retrospective Study. – Yoona Lee, Jaya Raghav
Quantitative muscle analysis in FSHD Trivedi, Pradeep Mammen
using Whole-Body MRI: Composite Muscle
Measurements for Cross-Sectional Analysis –
Per Wildholm, Markus Karlsson, Olof Dahlqvist
Leinhard, Alrabi Tawil, Katy Eichinger, Leo Hong-Li
Wang, Perry Shieh, Baziel G M van Engelen,
Diego Cadavid, Lucienne Ronco, Adefowope
Odueyungbo, Jay Han, Maya Hatch, Michelle L.
Mellion
P12.13-002
Regional Body Composition in Myotonic Dystrophy
Type 2: Associations of Lower Extremity Lean
Mass Index and Clinical Endpoints – Carolyn
Foster Aldendail, Diana Alejandra Madrid,
Rebecca Knapp, Delanie Lynch, Ashley A. Weaver,
Paula R. Clemens, Araya Puwanant
P12.13-003
ADSSL1 Myopathy: A Case Report – David
Atherton, Megan Leitch
AAN.com/AM 73
 Poster Session 13
1 2
Autoimmune Neurology
Autoimmune Neurology: COVID-19 and
Autoimmune Neurologic Disorders 1
P13.1-001
Immunosuppression in Chronic Autoimmune
Neurological Disorders during the COVID-19
Pandemic – Shubham Biyani, Abhilash Thatikala,
Rohan Sharma, Sukanthi Kovvuru, Krishna
Nalleballe, Sanjeeva Reddy Onteddu, Nidhi
Kapoor, Karthika Durga Veerapaneni, Sisira Yadala,
Robert L. Archer
P13.1-002
The Impact of COVID-19 in Patients With Stiff
Person Syndrome – Alexandra Christina Simpson,
Sarah Snoops, Scott Douglas Newsome
P13.1-003
A case of Optic neuropathy post COVID-19
vaccination – Badria Munir, Shitiz K. Sriwastava
P13.1-004
Acute disseminated encephalomyelitis after
COVID-19 vaccination: A case report – Monica He,
Christopher Joseph Bondoc, Robert Fekete
P13.1-005
Neurologic Sequela of COVID-19. Guillain Barré
Syndrome Following Johnson and Johnson
COVID-19 Vaccination; A Case report – Octavio
Carranza-Renteria, Sadia Waheed, Denis Babici,
Fawad Yousuf
Autoimmune Neurology: Clinical
Observations 4
P13.1-006
Systemic Lupus Erythematous Flare Up Presenting
as Myelitis – Deema Sawass Najjar, Kush Sharma,
Adrian Marchidann, Elizabeth Chernyak, Simona
Treidler
P13.1-007
Uncovering the putative pathogenesis of
Stiff Person Syndrome (SPS): is there a
neuroinflammatory mechanism? – Maria Isabel
Reyes, Samantha Hao, Susana Carolina Dominguez
Penuela, David Orlando Acero-Garces, Carlos A.
Pardo-Villamizar, Scott Douglas Newsome
74 2022 AAN Annual Meeting
Wednesday, April 6 8:00 a.m.–9:00 a.m.
Headache
Headache: Migraine Therapeutics 3
P13.2-001
Exploratory Efficacy of INP104 in Migraine
Patients By Prior Treatment – Tanya Rochelle
Bilchik, Robert Vann, Sutapa Ray, Stephen Bevan
Shrewsbury, Sheena K. Aurora
P13.2-002
Long-Term Safety and Tolerability of STS101, A
Novel Investigational Dihydroergotamine Nasal
Powder: Initial Data from the ASCEND Study –
Stewart J. Tepper, Shannon Strom, Detlef Albrecht
P13.2-003
Pharmacokinetics and Safety of STS101, A Novel
Investigational Dihydroergotamine Powder Drug-
Device Combination in Healthy Subjects – Detlef
Albrecht, Richard B. Lipton, Shannon Strom
P13.2-004
Pharmacokinetic Comparison of STS101 (A
Novel Investigational DHE Nasal Powder) with
Liquid Nasal, Injectable and Oral Inhaled DHE
Formulations – Shannon Strom, Detlef Albrecht
P13.2-005
Efficacy and Safety of AXS-07 (MoSEIC
Meloxicam-Rizatriptan) for the Acute Treatment of
Migraine: Results from the MOMENTUM Phase 3,
Randomized, Double-blind, Active- and Placebo-
controlled Trial – Amanda Jones, Stewart J.
Tepper, Richard B. Lipton, Herriot Tabuteau
3
Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Neuropsychology
and Remote Assessments 1
P13.3-001
Clusters of Cognitive Performance among
Aging People Living with HIV: the Application
of Unsupervised Machine Learning – Akarin
Hiransuthikul, Thanapoom Rattananupong,
Waragon Phusuwan, Chaipat Chunharas, Tanakorn
Apornpong, Vitool Lohsoonthorn, Anchalee
Avihingsanon
P13.3-002
Next Generation Tablet-based Digital Clock
Drawing Task for Characterizing Change to
Cognitive Status – Timothy Helbig, William A.
Souillard-Mandar, Connor Patrick Higgins, Anthony
Le, Sadhvi Saxena, Joyce Rios Gomes-Osman,
Alvaro Pascual-Leone, David James Bates, John
Langton, Sean Tobyne
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P13.3-003
Empathy deficit along Alzheimer’s Disease
continuum: from Subjective Cognitive Decline
to dementia. – Giulia Giacomucci, Giulia Galdo,
Cristina Polito, Valentina Berti, Sonia Padiglioni,
Salvatore Mazzeo, Maria Teresa De Cristofaro,
Benedetta Nacmias, Sandro Sorbi, Valentina Bessi
P13.3-004
The Brain Health Champion Study: A Health
Coaching Intervention with Mobile Technology
in Older Adults with Mild Cognitive Impairment
or Risk Factors for Dementia – Sergio Ramirez-
Salazar, Taylor Krivanek, Brittany McFeeley, Casey
Nicastri, Demsina Babazadeh, Kirk R. Daffner, Seth
Gale
P13.3-005
Initial Validity Evidence for the Mobile Toolbox
(MTB): A Completely Remote Platform for
Cognitive Research – Zahra Hosseinian, Aaron
Kaat, Sarah Pila, Cindy Nowinski, Jerry Slotkin,
Yusuke Shono, Miriam Novack, Maria Varela Diaz,
Saki Amagai, Hubert Adam, Lara Mangravite,
Sonia Carlson, Larsson Omberg, Michael Kellen,
Jonathan King, Richard Gershon
4 MS and CNS Inflammatory
Disease
MS Special Populations 4
P13.4-001
Pregnancy in women with Multiple Sclerosis:
Recommendations from the French Multiple
Sclerosis Society – Sandra Vukusic, Jonathan
Ciron, Clarisse Carra-Dalliere, Elisabeth Maillart,
Laure Michel, Emmanuelle Leray, Anne Marie
Guennoc, Bertrand Bourre, David Laplaud,
Geraldine Androdias-Condemine, Caroline Bensa,
Kevin Bigaut, Damien Biotti, Pierre Branger, Olivier
Casez, Mikael Cohen, Elodie Daval Imbert, Romain
Deschamps, Cécile Donzé, Anne-Laure Dubessy,
Cécile Dulau-Metras, Francoise Durand Dubief,
Maxime Guillaume, Benjamin Hebant, Laurent D.
Kremer, Arnaud Kwiatkowski, Julien Lannoy, Adil
Maarouf, Eric Manchon, Guillaume Mathey, Xavier
Moisset, Alexis Montcuquet, Julie Pique, Thomas
Roux, Romain Marignier, Beverly Aagard-Kienitz
P13.4-002
MOGAD Atypical Presentations in Pediatric
Patients – Victoria A. Adeseye, Grace Reynolds,
Nikita Shukla
P13.4-003
Incidence and Prevalence of MS in Indigenous
Populations of the Americas: A systematic review
– Michael Vincent Robers, Brigitte Furth Hurtubise,
Melissa H. Roberts, Hollie K. Schmidt, Lilyana M.
Amezcua, Brigitte Furth Hurtubise
P13.4-004
Eculizumab Induces Remission of Highly Active
Aquaporin-4 Neuromyelitis Optica Spectrum
Disorder (AQP-4 NMOSD) in a Pediatric Patient –
Cynthia X. Wang
 Poster Session 13
P13.4-005
Anti-Neurofascin Antibodies, White Matter
Abnormalities and Cancer: Caught in the Act or
Innocent By-Stander? – Rana K. Zabad, Navnika
Gupta, Afsaneh Shirani
P13.4-006
Pregnancy in women with Neuromyelitis Optica
Spectrum Disorders: Recommendations from
the French Multiple Sclerosis Society – Sandra
Vukusic, Jonathan Ciron, Clarisse Carra-Dalliere,
Elisabeth Maillart, Laure Michel, Emmanuelle
Leray, Anne Marie Guennoc, Bertrand Bourre,
David Laplaud, Geraldine Androdias-Condemine,
Caroline Bensa, Kevin Bigaut, Damien Biotti, Pierre
Branger, Olivier Casez, Mikael Cohen, Elodie Daval
Imbert, Romain Deschamps, Cécile Donzé, Anne-
Laure Dubessy, Cécile Dulau-Metras, Francoise
Durand Dubief, Maxime Guillaume, Benjamin
Hebant, Laurent D. Kremer, Arnaud Kwiatkowski,
Julien Lannoy, Adil Maarouf, Eric Manchon,
Guillaume Mathey, Xavier Moisset, Alexis
Montcuquet, Julie Pique, Thomas Roux, Romain
Marignier, Beverly Aagard-Kienitz
P13.4-007
Validation of MRI radiological reports in pediatric
MS according to the McDonald 2017 criteria: A
Danish nationwide multicenter cohort study –
Magnus Spangsberg Boesen, Annika Langkilde,
Jurgita Ilginiene, Melinda Magyari, Morten Bjorn
Blinkenberg
MS Symptom Assessment & Management
2 – Laura Gilbert, Darcy L. Fehlings, Paul Gross,
P13.4-008
SARS-CoV-2 vaccine response in RMS patients
treated with ozanimod and other DMTs – Daniel
Kantor
P13.4-009
Distinct immune repertoire characteristics
are associated with secondary autoimmunity
following LEMTRADA® therapy – Sumanta
Barman, Tobias Ruck, Christoph Lehrich, Hans-
Peter Hartung, Nico Melzer, Heinz Wiendl, Sven G.
Meuth, Norbert Goebels
P13.4-010
Natalizumab Extended Interval Dosing (EID) is
Associated with a Reduced Risk of Progressive
Multifocal Leukoencephalopathy (PML) Compared
With Every-4-Week (Q4W) Dosing: Updated
Analysis of the TOUCH® Prescribing Program
Database – Lana Zhovtis Ryerson, John F. Foley,
Ilya Kister, Gary Raymond Cutter, Ryan Metzger,
Judith Goldberg, Xiaochun Li, Karen Smirnakis,
Liesel DSilva, Wai Chin, Evan Riddle
P13.4-011
Risks of Minor and Severe Infections in Multiple
Sclerosis Patients Treated with Long-term B-cell
Depletion – John Peters, Erin Longbrake
Information is accurate as of February 8, 2022, and is subject to change.
Wednesday, April 6 8:00 a.m.–9:00 a.m.
5
Child Neurology and
Developmental Neurology
Child Neurology: Neurodevelopmental
Disorders/CP/ASD 3
P13.5-001
Evaluation of an Artificial Intelligence-Based
Medical Device Designed to Aid in the Diagnosis
of Autism Spectrum Disorder in the Primary Care
Setting – Jonathan Thomas Megerian, Sangeeta
Dey, Ruan Melmed, Daniel Coury, Marc Alan
Lerner, Christopher John Nicholls, Kristin Sohl,
Rambod Rouhbakhsh, Anandhi Narasimhan,
Jonathan Romain, Sailaja Golla, Safiullah Shareef,
Andrey Ostrovsky, Jennifer Shannon, Colleen Kraft,
Stuart Liu-Mayo, Halim Abbas, Diana Elena Gal-
Szabo, Dennis Wall, Sharief Taraman
P13.5-002
A Phase IV, Prospective, Observational,
Multicenter Study Evaluating the Effectiveness
and Safety of AbobotulinumtoxinA in Pediatric
Lower Limb Spasticity (PLLS) – Mark Gormley,
Edward R. Dabrowski, Mauricio R. Delgado, Ann
H. Tilton, Asare Christian, Sarah Helen Evans,
Francoise Calvi-Gries, Jumaah Goldberg
P13.5-003
Predictors of Resident Physician Comfort with
Individuals with Intellectual and Developmental
Disabilities – Jessica Sanders, Hannah Johnson
P13.5-004
Top Ten Research Themes for Dystonia in Cerebral
Palsy: A community-driven research agenda
Michael C. Kruer, Wendy Kwan, Jonathan W.
Mink, Michele Shusterman, Bhooma Rajagopalan
Aravamuthan
P13.5-005
Altered Gut Bacteriome and Mycobiome in
Neurodevelopmental Disorders – Ibrahim Laswi,
Ameena Shafiq, Dana Al-Ali, Zain Ali Burney,
Krishnadev Vijaykumar Pillai, Mohammad
Salameh, Nada Mhaimeed, Dalia Zakaria, Ali
Chaari, Noha Yousri, Ghizlane Bendriss
6
Research Methodology and
Education
Teaching Across the Spectrum of Medical
Education in Neurology 1
P13.6-001
Diversity of Grand Rounds Presentations at Large
Academic Medical Centers – Trusha Shah, Alec
Gibson, Jerome J. Graber
P13.6-002
NeuroLytes: Developing Clinical Reasoning for
Medical Students on the Neurology Clerkship
– Muhammad Suhaib Qasim, Michael Zachary
Moore, Catherine R Garcia, Alexander Sellers,
Ramneek Manchanda, Ibrahim Noorbhai, Rebecca
Eleanor Fenelon, Fabio Nascimento, Doris Kung
P13.6-003
Evaluation of a Novel Clinical Training Program for
Medical Students on their Neurology Clerkship
– Caitlin Mulligan, Chris Cannavino, Shannon
O’Donnell, Jamie LaBuzetta
P13.6-004
Review of Neuroscience and Neurology Education
in Physician Assistant Programs – Daniel Steven
Harrison, Margaret Naclerio, Kathryn Swider,
Andrew Busler, Lena Liu, Andrew Tien-Wai Yu,
Christopher T. Doughty
P13.6-005
Neurology Residents as Teachers of
Undergraduate Neuroscience - an Untapped
Resource! – Alyssa Marie Smith, Sandeep Gill,
Micaela Rose Owens, Scott M. Friedenberg,
Robert Waldeck, Madelyn Kay Smiley
P13.6-006
Online Medical Education Improves Knowledge
of Recent Data in Epilepsy and Related Clinical
Applicability Among General Neurologists and
Epileptologists – Thomas Finnegan, Kathy Merlo,
Jovana Lubarda, Louis Ferrari, Gregory L. Krauss,
Michael R. Sperling
7 Neuro Trauma and Critical Care
Neurocritical Care: Status Epilepticus,
Brain Death and Cardiac Arrest 1
P13.7-001
Super Refractory Status Epilepticus in
Seronegative Autoimmune Encephalitis – Steven
Yang, Kelsey Curd Ladt, Venkataditya Dugyala
P13.7-002
Assessment of Adherence to Status Epilepticus
Treatment Guidelines at a Single Institution
– Steven Yang, Michelle Lan, Victoria Lily Wu,
William Cang, Navaz Karanjia
P13.7-003
Massive Cerebral Edema and Super-Refractory
Status Epilepticus: A Rare Postsurgical
Complication of Cranioplasty – Ramiro Gabriel
Castro Apolo, Erafat Rehim, Jaspreet Johal,
Christopher Melinosky, Preet M. Varade
P13.7-004
Hyperammonemia and Status Epilepticus after
Lung Transplant – Jonathan Rosenthal, Alexa
Dessy, Samantha Smalley, Cherisse Berry, Serena
Arnouk, Luis Angel, Kara R. Melmed
AAN.com/AM 75
 Poster Session 13
8 9
Epilepsy/Clinical Neurophysiology
(EEG)
Epilepsy/Clinical Neurophysiology (EEG):
ASM Clinical Trials 2
P13.8-001
Results for the Quality of Life in Epilepsy Scale
From a Long-Term Safety Study of Diazepam
Nasal Spray for Seizure Clusters – Sunita N.
Misra, R Edward Faught, Enrique Carrazana, Adrian
Rabinowicz
P13.8-002
12-month effectiveness and tolerability of
brivaracetam in the real-world: interim analysis of
the international, non-interventional EXPERIENCE
study – Vicente Villanueva, Wendyl J. D’Souza, R
Edward Faught, Pavel Klein, Markus Reuber, Felix
Rosenow, Javier Salas-Puig, Adam Strzelczyk,
Jerzy P. Szaflarski, Kristen Ricchetti-Masterson,
Cedric Laloyaux, Veronica Sendersky, Sophia Zhou,
Florin Floricel, Tony Daniels, Bernhard Steinhoff
P13.8-003
Cenobamate for Uncontrolled Focal Seizures in
Patients With Previous Epilepsy-Related Surgery:
A Post-hoc Analysis – Bassel W. Abou-Khalil,
Sami M. Aboumatar, Pavel Klein, Gregory L.
Krauss, Michael R. Sperling, William E. Rosenfeld
P13.8-004
Cognitive and Behavioral Effects and Tolerability
of Adjunctive Brivaracetam in Children and
Adolescents with Focal Seizures: Pooled Interim
Analysis – Jan-Peer Elshoff, Sofia Grigory
Fleyshman, Christine M De la Loge, Xavier
Nondonfaz, Christoph Reichel, Florin Floricel,
Patricia Maria Smeyers
P13.8-005
Cognitive and Psychiatric Adverse Events During
Adjunctive Cenobamate Treatment in Phase 2 and
Phase 3 Clinical Studies – Gregory L. Krauss, Steve
S. Chung, Louis Ferrari, William E. Rosenfeld
P13.8-006
Seizure-Related Outcomes With Real-World Use
of Cannabidiol (CBD) in Lennox-Gastaut Syndrome
and Dravet Syndrome: BECOME, A Caregiver
Survey – Tracy Dixon-Salazar, Anne T. Berg, Sherry
Danese, M. Scott Perry, Mary Anne Meskis, Ngoc
Minh Dang Le
P13.8-007
Early Intervention with Midazolam Nasal Spray
and Efficacy in Patients with Seizure Clusters:
Post-hoc Analysis of an Open-label Extension
Trial – James W. Wheless, Marcus Brunnert, Florin
Floricel, Svetlana Dimova, Brandi Fannon
76 2022 AAN Annual Meeting
Wednesday, April 6 8:00 a.m.–9:00 a.m.
Neuro-oncology
Molecular Determinants of Neuro-
oncology 1
P13.9-001
An IDH Wildtype, EGFR Amplified and TERT
Promoter Mutated Astrocytoma that is Clinically
and Molecularly Incompatible with the Diagnosis
of Glioblastoma, IDH Wildtype. – Marina
Kushnirsky, Richard Hickman, Lauren Rhea Schaff,
Brandon Stuart Imber, Jamal Benhamida, Andrew
L. Lin
P13.9-002
Alpha-Synucleinopathy is a Potential Modifier of
Neuro-Oncologic Outcome – Eric Tai-Lee Wong,
Huan Yang, Lan Luo, Roy L. Freeman, Christopher
H. Gibbons
P13.9-003
Cloning and overexpression of multi-domain
enhancer protein p300, to study its involvement
in childhood-diffuse intrinsic pontine glioma
(DIPG) cell proliferation. – Steven Summers, Pinki
Chowdhury
P13.9-004
STING is silenced by DNA methylation in primary
brain tumors and is rescued by methyltransferase
inhibition – Justin Thomas Low, Vidyalakshmi
Chandramohan, Michelle Bowie, Michael Brown,
Matthew Waitkus, Aaron Briley, Kevin Stevenson,
Rebecca Fuller, Zachary J. Reitman, Andrea
M. Muscat, Seethalakshmi Hariharan, Janell
Hostettler, Nick Wong, Matthias Gromeier, David
Ashley
P13.9-005
BRAT1 Associated Leukodystrophy exacerbated
by Lymphoma directed Chemotherapy – Sara J
Hooshmand, Karan Chohan, Michael Wren Ruff
P13.9-006
Using Cerebrospinal Fluid (CSF) tumor cells to
track disease burden and treatment response
in patients with Leptomeningeal Disease (LMD)
from solid cancers – Akanksha Sharma, Nathan
Sweed, Barbara Blouw, Lan Huynh, Deanna Fisher,
Kaitlyn S. Armijo, Smitha Boorgula, Steven Hsiao,
Tony Pircher, Julie Mayer, Naveed Wagle, Jose A.
Carrillo, Minhdan Nguyen, Judy Dang Truong, Eve
J. Landa, Michael J. Dugan, Santosh Kesari
10 Cerebrovascular Disease and
Interventional Neurology
Interventional Neurology 2
P13.10-001
Markers of Inflammation Predict Post-
Thrombectomy Mortality in Acute Stroke –
Hannah Irvine, Leah Croll, Penina Krieger, Amanda
Jin Zhao, Jose L. Torres, Kara R. Melmed, Koto
Ishida, Aaron S. Lord, Jennifer A. Frontera, Ariane
Lewis
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P13.10-002
Impaired Cerebral Autoregulation Related Blood
Pressure Reductions After Nimodipine Are
Associated with Ischemic Changes on EEG After
Subarachnoid Hemorrhage – Ilayda Top, Yilun
Chen, David Bartolome, Amedeo Rapuano, Emily
Jean Gilmore, Kevin N. Sheth, Charles Matouk,
Nils Petersen, Jennifer A. Kim
P13.10-003
Double-Stent Retrieval Thrombectomy Technique
For MCA Bifurcation Thrombus: A Case Report –
Milagros Galecio-Castillo, Cynthia Zevallos, Juan
A. Vivanco-Suarez, Mudassir Farooqui, Santiago
Ortega Gutierrez
P13.10-004
Endovascular Therapy Delay for Acute Large
Vessel Occlusion (LVO) is Associated with Worse
Functional Outcome and Increased Mortality
- Quantified – Julian David Carrion-Penagos,
Sonam Thind, Elisheva Ruth Coleman, James R.
Brorson, Cedric McKoy, Scott J Mendelson, Shyam
Prabhakaran, Ali Mansour, Tareq Kass-Hout
P13.10-005
Predictors of Favorable Functional Outcome
Following Acute Ischemic Stroke Secondary to
M1/ICA Occlusion in the Extended Thrombectomy
Time Window – Quinn Steiner, Thomas Andrew
Reher, Qianqian Zhao, Alexey Samsonov, John
W. Garrett, Nicole Bennett, Vivek Prabhakaran,
Beverly Aagard-Kienitz, Bolanle Famakin
P13.10-006
Cerebral Venous Sinus Thrombosis in the Setting
of an AVM While on Anticoagulation: A Case
Report – Milena Lobaina, Laura J. Wu, Hashem M.
Shaltoni, Arun Singh Chhabra
P13.10-007
Low NIHSS Large Vessel Occlusion: Impact of
Treatment Modality on Early Outcomes – Sung
Jeon, Sharon Poisson
P13.10-008
Reducing Unnecessary Hospital Transfers for
Patients Not Taken for Thrombectomy – Kelsey
Duncan, Julie Fussner, Kelly M. Montgomery,
Cathy A. Sila
P13.10-009
Risk Factors, Treatments, and Outcomes of
Ischemic Stroke Associated with Basilar Artery
Occlusion – Mona Al Banna, Melissa Mariscal,
Sweta Rao, Fadar Oliver Otite, Richa Sharma
P13.10-010
Moyamoya Syndrome in the Setting of Sturge
Weber: A Case Report – Aaisha Mozumder,
Michael Gaub, Richard Cody Simon, Jonathan
Fisher, Firas Kaddouh
 Poster Session 13
11
Movement Disorders
Movement Disorders: PD Gut and Lung
and PD Biomarkers 1
P13.11-001
Mediterranean Diet Impacts Gastrointestinal
Symptoms and Modulates Gut Microbiota in
People with Parkinson’s Disease – Carley Rusch,
Matthew Beke, Lily Tucciarone, Carmelo Nieves,
Maria Ukhanova, Massimiliano S. Tagliamonte,
Volker Mai, Joon Hyuk Suh, Yu Wang, Shannon
Chiu, Bhavana U. Patel, Adolfo Ramirez Zamora,
Bobbi Langkamp-Henken
P13.11-002
Proof of Concept Study of Prebiotics to Modulate
Gut Microbiome in Parkinson’s Disease – Deborah
Hall, Robin Voigt, Thaisa Cantu-Jungles, Bruce R.
Hamaker, Shohreh Raeisi, Maliha Shaikh, Stefan
Joshua Green, Phillip Andrew Engen, Bichum
Ouyang, Ankur Naqib, Christopher Forsyth, Heather
Rasmussen, Shahriar Sedghi, Christopher Goetz,
Ali Keshavarzian
P13.11-003
Effects of probiotic, prebiotic or synbiotic
supplementation on Parkinson’s Disease: A
systematic review with meta-analysis – Miguel
Francisco Cabanillas Lazo, Milagros Del Pilar
Pascual-Guevara, Carlos S. Mamani-García, Victor
Andrés Velasquez Rimachi, Nicanor Mori, Carlos
Alva-Diaz
P13.11-004
Early biochemical changes in a-synuclein in the
central and enteric nervous system in Parkinson’s
disease – Virginia Gao, Lauren Komer, Juan
Antonio Briano, Carl Crawford, Claire Henchcliffe,
Andrea P. Lee, Jacqueline Burré
P13.11-005
Genetic Overlap between Parkinson’s Disease
and Inflammatory Bowel Disease – Xiaoying
Kang, Alexander Ploner, Yunzhang Wang, Dylan
Williams, Nancy Pedersen, Karin Wirdefeldt
P13.11-006
Lifelong Constipation in Synucleinopathies: An
Incident Cohort Study in Olmsted County, MN
(1991-2010). – Pierpaolo Turcano, Emanuele
Camerucci, Aidan Mullan, Cole Daniel Stang, Adil
Bharucha, Delana Weis, Bradley F. Boeve, James
H. Bower, J. Eric Ahlskog, Rodolfo Savica
P13.11-007
Pyridostigmine as an Effective Treatment for
Atonic Colon in Parkinson’s Disease – Ann Nguyen
Ly, Mahrin Rahman, David D. Song
P13.11-008
Respiratory Comorbidities in Patients With
Parkinson’s Disease – Andrew Thach, Rajat
Chandra, Jingjun Wang, Yifei Wang, Samuel
Croset, Eric Pappert, Pinky Agarwal
Information is accurate as of February 8, 2022, and is subject to change.
Wednesday, April 6 8:00 a.m.–9:00 a.m.
12 Neuro-ophthalmology/Neuro-
otology
Neuro-ophthalmology and Neuro-otology
Cases 1
P13.12-001
Acute Posterior Multifocal Placoid Pigment
Epitheliopathy as the presenting feature of
Sarcoid – Audrey Reynolds, Karen Curtin, Andrea
Ryan, Conor Murphy, Eamonn Molloy, Justin
Kinsella
P13.12-002
Vestibular Paroxysmia Successfully Treated with
N-acetylcysteine: A Case Report – Courtney Iser,
Karissa Arca, David W. Dodick, Jamie Bogle
P13.12-003
Recurrent Progressive Peripheral Vertigo:
Revisiting Vestibular Paroxysmia – Bryan Paulo
Lopez Canlas, Julia Morrow Kerrigan
P13.12-004
Atypical Optic Neuritis Associated with
golimumab – Smathorn Thakolwiboon, Praelada
Wongsirimeteekul, Mirla L. Avila
P13.12-005
A case of pediatric Idiopathic intracranial
hypertension associated with aplastic anemia –
Usama Tariq, Apoorva Jagadish, Rosario Maria S.
Riel-Romero
13 Neuromuscular and Clinical
Neurophysiology (EMG)
Neuromuscular Disease: Inherited Muscle
Disorders 2
P13.13-001
Strength is Associated with Functional Abilities
and Changes over a 12 Month Period in Individuals
with Facioscapulohumeral Dystrophy (FSHD) –
Katy Eichinger, Michael McDermott, Kiley Higgs,
Michaela Walker, Leann Lewis, William Martens,
Doris G. Leung, Sabrina Sacconi, Karlien Mul,
Valeria A. Sansone, Elena Carraro, Leo Hong-Li
Wang, Perry Shieh, Bakri Elsheikh, Samantha
Jo LoRusso, Nicholas Elwood Johnson, Russell
Butterfield, Maria Chiara Frisoni, Alrabi Tawil,
Jeffrey Statland
P13.13-002
Reliability of Reachable Workspace (RWS)
Measurement System in a Large, Multi-Site,
International FSHD Clinical Study – Maya Hatch,
Jay Han, Gregorij Kurillo, Leo Hong-Li Wang,
Katy Eichinger, Michael McDermott, Kiley Higgs,
Michaela Walker, Leann Lewis, William Martens,
Doris G. Leung, Sabrina Sacconi, Karlien Mul,
Valeria A. Sansone, Elena Carraro, Perry Shieh,
Bakri Elsheikh, Samantha Jo LoRusso, Russell
Butterfield, Nicholas Elwood Johnson, Alrabi
Tawil, Jeffrey Statland
P13.13-003
A Concisely Recorded Ambulatory Assessment
for Enhancing Real-World Outcomes Research in
Duchenne Muscular Dystrophy: Development and
Validation – Anna Mayhew, James Signorovitch,
Volker Straub, Chiara Marini-Bettolo, Chiara
Marini-Bettolo, Amritpal Sodhi, Adnan Manzur,
Vandana Ayyar Gupta, Victoria Selby, Francesco
Muntoni
P13.13-004
High-throughput Variant Resolution Utilizing Deep
Mutational Scanning in Sarcoglycanopathies –
Conrad Weihl, Chengcheng Li, Jackson Wilborn, Jil
Daw, Okechukwu Obidike, Katy Eichinger, Nicholas
Elwood Johnson, Gabriel Haller
P13.13-005
Preliminary Twelve-Month Functional Change in
Limb Girdle Muscular DystrophyR9/2I – Jeffrey
Statland, Kameron Bates, Han Xie, Lindsay N.
Alfano, John Vissing, Tahseen Mozaffar, Katherine
D. Mathews, Linda Pax Lowes, Matthew P.
Wicklund, Conrad Weihl, Doris G. Leung, Peter
B. Kang, Carla D. Zingariello, Urvi G. Desai, Erin
DeSpain, Jessica St Romain, Douglas M. Sproule,
Nicholas Elwood Johnson, The GRASP Consortium
P13.13-006
Predicting Trajectories of Ambulatory Function in
Duchenne Muscular Dystrophy (DMD) – Francesco
Muntoni, James Signorovitch, Nathalie M.
Goemans, Adnan Manzur, Nicolae Done, Henry
Lane, Gautam Sajeev, Susan J. Ward, Craig
McDonald
P13.13-007
The Cognitive Profile of Congenital Myotonic
Dystrophy and the Impact of Sleep Quality –
Namita Patel, Kiera Berggren, Man Hung, Kameron
Bates, Karen Ann Bax, Craig Gordon Campbell,
Nicholas Elwood Johnson
P13.13-008
Expanding the clinical spectrum of CLCN1
mutations – Nivedita Jerath
P13.13-009
Novel KCNA1 Variant Associated Syndrome
of Episodic Dystonia and Electrophysiologic
Myokymia - A Case Report – Lauren Ashley Major,
Robert Lebel, Steven M. Rothman, Ai Sakonju
AAN.com/AM 77
 Poster Session 14
1 2
Autoimmune Neurology
Autoimmune Neurology: Neuromyelitis
Optica Spectrum Disorder 1
P14.1-001
Quantifying the Economic Burden of
Hospitalization from Neuromyelitis Optica: Results
of a Cross-sectional Survey – Dylan R. Rice,
Kathryn Holroyd, Danielle Kei Pua, Michael Levy,
Farrah J. Mateen, Shamik Bhattacharyya
P14.1-002
Tumefactive Demyelinating Lesions due to NMO
treated with Eculizumab – Kimberly O’Neill, Lauren
Gluck
Autoimmune Neurology: COVID-19 and
Autoimmune Neurologic Disorders 2
P14.1-003
Multiple Cranial Neuropathies After COVID-19
Vaccination – Hemali Patel, George T. Savvides,
Yin Allison Liu, Michelle Apperson
P14.1-004
A Case of Transverse Myelitis After Moderna
SARS-CoV-2 Vaccination – Bahram Rabbani,
Danny Samkutty, Ahmad Al-Awwad, Nidhiben A.
Anadani
P14.1-005
A Case of an 83 Year Old Male with Acute
Disseminated Encephalomyelitis-like Presentation
Post COVID-19 Vaccination – Teye Aniefiok
Umanah, Suman Bharath, Ming He
P14.1-006
Severe Multifocal Cortical Encephalopathy
Following COVID-19 Vaccination: A Case Report –
Michael Saad, Xin Yang, Sabeena Iqbal Malik
P14.1-007
Autoimmune gastrointestinal dysmotility following
SARS-CoV-2 infection successfully treated with
intravenous immunoglobulin – Mayra Montalvo
Perero, Padmini Nallapaneni, Sara Hassan, Samuel
Nurko, Julie Khlevner, Sean J. Pittock
78 2022 AAN Annual Meeting
Wednesday, April 6 11:45 a.m.–12:45 p.m.
Headache
Headache: Migraine Therapeutics 4
P14.2-001
Combined Prophylactic Treatment of Chronic
Migraine with OnabotulinumtoxinA and Anti-
CGRP Monoclonal Antibodies – Audrey Marie
Blazek, Rima Dafer, Christopher P. Rhyne, Ivan
Rocha Ferreria Da Silva
P14.2-002
A Novel Approach to Defining Success in the
Acute Treatment of Migraine: Demonstrating
Therapeutic Benefit at 1-Hour Post-Dose in the
Pooled ACHIEVE I and ACHIEVE II Trials – Charles
Iaconangelo, Daniel Serrano, Aubrey Manack
Adams, Joel M. Trugman, Richard B. Lipton
P14.2-003
PREDICT: PREEMPT fixed-dose, fixed-site and
follow the pain – Corrie Graboski, May Ong-Lam,
Werner J. Becker, Julia Ma, Katherine Sommer,
Ian Finkelstein
P14.2-004
Efficacy and Safety of AXS-07 (MoSEIC
Meloxicam-Rizatriptan) for the Acute Treatment
of Migraine: Results from the INTERCEPT Phase
3, Randomized, Double-blind, Placebo-controlled
Trial – Amanda Jones, Stewart J. Tepper, Richard
B. Lipton, Herriot Tabuteau
P14.2-005
Efficacy of memantine compared to sodium
valproate as prophylactic treatment for migraine:
A pilot clinical trial – Damaris Daniela Vazquez
Guevara, Ildefonso Rodriguez-Leyva
P14.2-006
Cardiovascular Safety of STS101, A Novel
Investigational DHE Nasal Powder Product: Initial
Data from the ASCEND Study – Alan M. Rapoport,
Shannon Strom, Detlef Albrecht
3 Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Neuropsychology
and Remote Assessments 2
P14.3-001
Validation of MyCog: A Self-Administered Rapid
Detection Tool for Cognitive Impairment in
Everyday Clinical Settings – Zahra Hosseinian,
Laura M. Curtis, Yusuke Shono, Saki Amagai,
Julia N Yoshino Benavente, Michael Bass, Maria
Varela Diaz, Stephanie Batio, Cindy Nowinski, Mr.
Michael Wolf, Richard Gershon
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P14.3-002
Quantification of Cognitive Impairments in
Preclinical and Early Alzheimer’s Disease: A Proof
of Concept Study to Investigate the Feasibility,
Adherence and Preliminary Clinical Validity of
Remote Smartphone Based Self-Assessments
of Cognition, Function and Behavior – Thanneer
Malai Perumal, Arnaud Marc Wolfer, Florian
Lipsmeier, Michael Lindemann, Foteini Orfaniotou,
Simone Rey, Irma Kurniawan, David Watson,
Merce Boada Rovira, Kirsten I. Taylor
P14.3-003
Figure-Ground Testing as an Accurate and
Efficient Tool For Clinical Screening of Posterior
Cortical Atrophy – Golnoush Akhlaghipour, Mario
F. Mendez, Youssef I. Khattab, Oleg Yerokhin
Yerstein
P14.3-004
Predicting behind-the-wheel driving behavior
in PD through motor and cognitive testing in
outpatient clinics – Nikolaos Andronas, Elissaios
Karageorgiou, Ion Beratis, Stella Fragkiadaki,
Dionysia Kontaxopoulou, George Yannis, Leonidas
Stefanis, Sokratis Papageorgiou
P14.3-005
Characterization of Mild Cognitive Impairment
with a Digital Cognitive Assessment Tool –
Nandor K. Pinter, Erica S. Westphal, Mandy
Spaltman, Maxwell Daniel Yargeau, Ryu Platinum
Dorn, Sarah Harlock, Gijs Van Elswijk, Bela Ajtai,
Ben Schmand, Willem Huijbers
4
MS and CNS Inflammatory
Disease
MS Symptom Assessment & Management
3
P14.4-001
The Predictors of Fatigue in Multiple Sclerosis
– Harriet Louisa Johanna Moore, Krishnan
Padmakumari S Nair, Kathleen Baster, Rod
Middleton
P14.4-002
NODDI Microstructural Abnormalities in
Normal-Appearing Gray Matter and White
Matter Contribute to Cognitive Impairment in
Multiple Sclerosis – Paolo Preziosa, Lorenzo Conti,
Elisabetta Pagani, Olga Marchesi, Damiano Mistri,
Andrea Falini, Maria Assunta Rocca, Massimo
Filippi
P14.4-003
A Prospective, Open Label, Single Center Study
of Patients With Multiple Sclerosis With Lower
Extremity Spasticity who are Treated With
abobotulinumtoxin A – Salvatore Napoli, Donna
Bradley, Dianna Sullivan, Olivia Parsons, Sarah B.
Cardoso, Rachel ODonnell
 There’s a
smarter way to
treat epilepsy.

The RNS System is the only

epilepsy therapy that…

Delivers Personalized Neuromodulation Therapy

Recognizes and responds to each patient’s unique brain patterns,
providing personalized stimulation to prevent seizures before they start.

Gives You A Window to the Brain®

Records EEG data while patients live their normal lives, providing
unprecedented visibility into real-world brain activity that can help you
optimize patient treatment plans.

82% Life Changing Seizure Reductions

seizure Greatest reductions in seizure frequency seen in any published
reduction
at ≥ 3 years neuromodulation study for focal epilepsy.1, 2

WEBINAR Learn more from the experts!

April 27th Join us for a webinar to learn more about the RNS System,
how to identify potential patients, and how to build successful connections
3:30 – 4:30 PT with L4 Comprehensive Epilepsy Centers for effective patient management.

REGISTER

1. Elliott, et al., Epilepsy Behav, 2011. 2. Salanova, et al., Neurology, 2015.

Learn More About the RNS System Rx Only. The RNS® System is an adjunctive therapy for adults with refractory, partial onset seizures with no
www.neuropace.com more than 2 epileptogenic foci. See important safety information at http://www.neuropace.com/safety/.
©2022 NeuroPace, Inc. All rights reserved. NeuroPace and RNS are trademarks of NeuroPace, Inc.
NP 220018 Rev1 / Rev. Date: 2022-02
NeuroPace® RNS® System Brief
Statement
Indication for Use
The RNS® System is an adjunctive therapy in reducing the frequency of seizures
in individuals 18 years of age or older with partial onset seizures who have
undergone diagnostic testing that localized no more than 2 epileptogenic foci,
are refractory to two or more antiepileptic medications, and currently have
frequent and disabling seizures (motor partial seizures, complex partial seizures
and / or secondarily generalized seizures). The RNS® System has demonstrated safety
and effectiveness in patients who average 3 or more disabling seizures
per month over the three most recent months (with no month with fewer than
two seizures), and has not been evaluated in patients with less frequent
seizures.
Contraindications
The RNS® System is contraindicated for patients at high risk for surgical
complications, with medical devices implanted that deliver electrical energy to
the brain, and those who are unable (or do not have the necessary assistance)
to properly operate the NeuroPace® Remote Monitor or Magnet. For patients
with an implanted RNS® System the following medical procedures are contraindicated:
• Electroconvulsive Therapy (ECT)
• Transcranial Magnetic Stimulation (TMS)
• Diathermy procedures (any treatment that uses high-
frequency electromagnetic radiation, electric currents or
ultrasonic waves to produce heat in body tissues)
Warnings and Precautions
The RNS® System is not compatible with non-NeuroPace leads and/or pulse
generators. Electrical shock may occur with incorrect use of the Programmer
or Remote Monitor. Do Not Resterilize and Do Not Reuse the implantable
products.
MRI Safety Information
RNS® Neurostimulator model RNS-320: An MRI scan may be safely performed
on patients with the RNS® System (with RNS Neurostimulator model RNS-320)
only under the specific conditions of safe use detailed in the MRI Guidelines for
the RNS® System. Scanning under different conditions may result in device
damage or malfunction and serious patient risks including permanent brain
damage which may cause severe injury, coma, or death.
RNS® Neurostimulator model RNS-300M of the RNS® System is MR Unsafe.
Having an MRI scan with a model RNS-300M neurostimulator implanted may
result in serious injury or possible death.
RNS® System External Components: All external components and accessories
of the RNS® System such as the Magnet, RNS® Tablet, NeuroPace® Programmer,
NeuroPace® Remote Monitor, and Wand are MR Unsafe and can pose a
projectile hazard in the MR environment, and therefore, must be kept out of
the MRI scanner room.
Clinical Use
The RNS® System should only be implanted at Comprehensive Epilepsy
Centers by neurosurgeons with adequate experience in the implantation of
subdural and stereotactic implantation of intraparenchymal electrodes and in
the surgical treatment of intractable epilepsy. The RNS® System should only be
used by neurologists and neurosurgeons with adequate experience in the
management of intractable epilepsy and in the localization of epileptic foci.
They must complete a NeuroPace® RNS® System training program and
demonstrate specific expertise related to epilepsy, video-EEG monitoring,
interpretation of electrocorticograms (ECoGs), the pharmacology of
antiepileptic medications and selection of patients for epilepsy surgery. In
some instances Neurologists who meet the experience and certification
requirements but do not practice at Comprehensive Epilepsy Centers could be
qualified by NeuroPace to provide post-implant programming.
Surgical
Implantation of the RNS® System and associated surgical procedure risks may
cause, but are not limited to, infection, intracranial hemorrhage, tissue damage,
temporary pain at the implant site, CSF leakage, seroma, and paralysis.
RNS® System and Therapy
The safety and effectiveness has not been studied in pregnant women. The
effects of long-term brain stimulation are not completely known. Strong
electromagnetic interferences (EMI) can result in serious patient injury or
death, damaged brain tissue, loss or change in symptom control, reoperation,
stimulation to turn on or off, a return of symptoms, or a momentary increase in
stimulation felt by the patient. In addition EMI, such as security screening
devices and radio frequency identification, can result in delivering the
programmed stimulation to the patient and appear as sensing artifacts on the
ECoG recordings. The RNS® System could interact with implanted cardiac
devices and result in inappropriate device response or device damage.
Additional surgical procedures can result from battery malfunction, electrical
short, open circuit, lead fracture, lead insulation failure, damage as a result of
head trauma, or lead migration. Severe brain tissue damage can result from
exposure to battery chemicals if the Neurostimulator is ruptured or pierced due
to outside forces. The patient must collect data from the Neurostimulator once
a day and send data to the PDMS once a week.
Medical Environment
Electrolysis on the head and neck should be avoided. Prior to the
administration of Extracorporeal Shock Wave Lithotripsy or high radiation
sources the administering physician should consult with the physician
prescribing the RNS® System. Read the user manual to understand the steps to
be taken before, during and after computerizedTomography (CT) scans.
Potential Adverse Events
Serious adverse events occurring in ≥ 2.5% of patients and those of particular
relevance reported during the RNS® System clinical studies include EEG
monitoring, infection, change in seizures, medical device removal, death, device
lead damage or revision, antiepileptic drug toxicity, hemorrhage, psychiatric
events, status epilepticus and seizure-related injury. Refer to the product
labeling for a detailed disclosure of other reported adverse events.
Rx Only. Refer to the product labeling for a detailed disclosure of specific
indications, contraindications, warnings, precautions and adverse events.
DN 1014760 Rev 4
Rev. Date: 2020-03
©2022 NeuroPace, Inc. All rights reserved. NeuroPace and RNS are trademarks
of NeuroPace, Inc. NeuroPace, Inc., 455 N. Bernardo Ave., Mountain View, CA
94043. www.NeuroPace.com
NP 220018 Rev. 1 Rev. Date: 2022-02
 Poster Session 14
P14.4-004
The humoral response to SARS-COV-2 vaccines
in MS patients: Impact of DMT, lymphocyte
count, immunoglobulins, and vaccine type –
Hesham Ahmed Abboud, Collin Jakubecz, Sophia
Woodson, Alessandro Serra
P14.4-005
Persistently Impaired Antibody Response of
Ocrelizumab-treated Multiple Sclerosis Patients to
Third (“Booster”) mRNA Vaccine Against SARS-
CoV-2 – Pavle Repovic
P14.4-006
Temporal Trends in Humoral and Cellular Immune
Responses to SARS-CoV-2 mRNA Vaccines
Among Multiple Sclerosis Patients Treated
With Natalizumab, Ocrelizumab or Fumarates
– Pavle Repovic, Jongchan Choi, Sunga Hong,
Jennifer Umali Reola, Kelly Chun, Christos John
Petropoulos, James D. Bowen, Peiqing Qian,
Simon Evans, Rick Edmark, Jason P. Mendoza,
Robin L. Avila, James Richard Heath, Jason D.
Goldman
MS Neuroimaging 2
P14.4-007
TSPO-PET-measurable Microglial Activation
Associates with Serum 3-hydroxykynurenine
Levels in Multiple Sclerosis Patients – Maija
Saraste, Markus Matilainen, Marcus Sucksdorff,
Cecilia Rajda, Zsolt Galla, Laszlo Imre Vecsei, Laura
Airas
P14.4-008
Cerebral Blood Flow Dependency on Systemic
Arterial Circulation in Progressive Multiple
Sclerosis – Dejan Jakimovski, Brianna Gibney,
Karen L. Marr, Deepa Ramasamy, Michael G.
Dwyer, Niels Bergsland, Bianca Weinstock-
Guttman, Murali Ramanathan, Robert Zivadinov
P14.4-009
Exploring in-vivo brain microstructural damage
in multiple sclerosis through T1w/T2w-ratio
mapping: a multicenter study – Monica Margoni,
Elisabetta Pagani, Alessandro Meani, Loredana
Storelli, Sarlota Mesaros, Jelena Drulovic, Frederik
Barkhof, Hugo Vrenken, Antonio Gallo, Alvino
Bisecco, Debora Pareto, Jaume Sastre-Garriga,
Olga Ciccarelli, Marios Yiannakas, Jacqueline
Palace, Paolo Preziosa, Maria Assunta Rocca,
Massimo Filippi
P14.4-010
Thalamic Volume Predicts Recovery from
Cognitive Relapse – Zachary Weinstock, Michael
G. Dwyer, Niels Bergsland, Dejan Jakimovski,
Sarah Anne Morrow, Devon Conway, Tom Fuchs,
Curtis Wojcik, Robert Zivadinov, Bianca Weinstock-
Guttman, Ralph H. B. Benedict
Information is accurate as of February 8, 2022, and is subject to change.
Wednesday, April 6 11:45 a.m.–12:45 p.m.
P14.4-011
Prospective Characterization of Brain T2 Lesions
Suggestive of Demyelination in Asymptomatic
Patients diagnosed as Radiologically Isolated
Syndrome – Cassandre Landes-Chateau,
Lydiane Mondot, Mikael Cohen, Celine Callier,
Helene Zephir, Celine Louapre, Francoise Durand
Dubief, Clarisse Carra-Dalliere, Eric Thouvenot,
Emmanuelle Le Page, Aurelie Ruet, Eric Berger,
Nathalie Derache, Pierre Clavelou, Thibault
Moreau, Olivier Casez, Olivier F. Gout, Jerome
De Seze, Jonathan Ciron, Sandrine Wiertlewski,
Bertrand Bourre, Laurent Magy, Philippe Cabre,
Jean Pelletier, Marc Debouverie, Bruno Stankoff,
Alain Creange, Ombeline Fagniez, Corinne
Pottier, Jean Philippe Neau, Jean-Phillippe
Camdessanche, Carole Henry, Stephane Beltran,
Anne Marie Guennoc, Ayman Poincaré Tourbah,
Fatai Radji, Nathalie Morel, Karine Boyer,
Abdullatif Al Khedr, Aksel Siva, Orhun H. Kantarci,
Daniel Pelletier, Darin T. Okuda, Beverly Aagard-
Kienitz, SFSEP
5 Child Neurology and
Developmental Neurology
Child Neurology: Neurovascular/Critical
Care/Quality 3
P14.5-001
Reliability and Validity of a Novel Quick Neurologic
Exam Tool for Assessing Patients in the Pediatric
Intensive Care Unit (PICU) – Apirada Thongsing,
Susan Erin Duberstein Coad, Michael Miksa
P14.5-002
Use of intra-dural thrombolysis in a case of
extensive pediatric Cerebral Sinus Venous
Thrombosis (CSVT) and Venous infarction – Aya A.
Ouf, Jaims Lim, Gull Sial, Kathleen Sellick, Renee
Reynolds, Veetai Li, Leon A. Weinstock
P14.5-003
Quantitative Cerebrovascular Reactivity Atlas In
Children – Kenda Alhadid, Amanda Robertson,
Kirsten Walker, Andrea Kassner, William J. Logan,
Gabrielle A. DeVeber, Nomazulu Dlamini
Child Neurology: Seizures/Genetic
Syndromes 5
P14.5-004
Presence and Predictive Value of Midline Vertex
Discharges on EEG in Children with Complex
Febrile Seizures – Purva Choudhari, Alison M.
Dolce, Andrea R. Lowden
P14.5-005
A Case of CHD2 Epileptic Encephalopathy
– Megan Bone, Kimberly Goodspeed, Dallas
Armstrong
6
Research Methodology and
Education
Teaching Across the Spectrum of Medical
Education in Neurology 2
P14.6-001
Experiences with a virtual nationwide seminar
series for neuroimmunology trainees – John
Peters, John Corboy, Sarah E. Hopkins, Le
Hua, Ahmed Z. Obeidat, Vijayshree Yadav, Erin
Longbrake
P14.6-002
Global Uptake of a Virtual Neurology Clinical
Reasoning Conference: Live versus Asynchronous
Learning – Valeria Roldan, Gabriela Figueiredo
Pucci, Maria Jimena Aleman, Aaron L. Berkowitz
P14.6-003
Fun with Physiology: Improving resident
neurophysiology education with interactive
quizzes – Jonathan Donnelly, Leila Saadatpour,
Alejandro Tobon
P14.6-004
Neurology and Child Neurology Training Program
First Attempt Pass Data on the ABPN Certification
Examinations – Dorthea Juul, Jaffar Khan, Larry
R. Faulkner
7 Neuro Trauma and Critical Care
Neurocritical Care: Status Epilepticus,
Brain Death and Cardiac Arrest 2
P14.7-001
Perspectives on the use of ancillary tests for
determining neurological death: a survey of
Canadian intensivists – Joel Neves Briard,
Michael Yu, Livia Pinheiro Carvalho, Shane
English, Frederick Daragon, Francois Lauzier, Alexis
Turgeon, Sonny Dhanani, Lauralyn McIntyre, Sam
Shemie, Greg Knoll, Dean Fergusson, Samantha
Anthony, Matthew Weiss, Michael Chasse
P14.7-002
Recognition of Unilateral Eye Opening as Spinal
Motor Reflex in Brain Death – Eesha Oza, Nilufer
Yalcin, Klepper A. Garcia, Manan Shah
P14.7-003
Unilateral Spontaneous Pupillary Activity in Brain
Death: A Case Report – Atef Kokash, Erafat Rehim,
Tsneem Mbydeen, Preet M. Varade
P14.7-004
Neurological Injury and Outcomes in Fentanyl-
related Cardiac Arrest – Matheus Otero, Jonathan
Shih, Edilberto Amorim De Cerquiera Filho
P14.7-005
Diagnostic Accuracy of GCS Score compared
to CRS-r for Consciousness – Greer Waldrop,
Sachin Agarwal, Jerina Carmona, Kevin Doyle,
Shivani Ghoshal, Soojin Park, David J. Roh, Qi
Shen, Angela M. Velazquez, Athina Vrosgou, Jan
Claassen
AAN.com/AM 81
 Poster Session 14
8 Epilepsy/Clinical Neurophysiology
(EEG)
Epilepsy/Clinical Neurophysiology (EEG):
ASM Clinical Trials 3
P14.8-001
Single Ascending Dose Pharmacokinetics (PK),
Pharmacodynamics (PD), and Tolerability of LP352
in Healthy Subjects – Dolly A Parasrampuria, Ian
Mills, Gale O’Connell, Archana Chaudhary, Jon
Leslie Ruckle, Chad Orevillo, Philip Perera
P14.8-002
A Randomized, Double-Blind, Placebo-Controlled,
Multiple Ascending Dose Pharmacokinetics (PK),
Pharmacodynamics (PD), and Tolerability of LP352
in Healthy Subjects – Dolly A Parasrampuria, Ian
Mills, Gale O’Connell, Archana Chaudhary, Jon
Leslie Ruckle, Chad Orevillo, Philip Perera
P14.8-003
Safety of a Second Dose of Diazepam Nasal
Spray Within 4 Hours in Patients With Seizure
Clusters: Final Results From a Long-Term, Phase 3,
Open-Label, Repeat-Dose Safety Study – Gregory
D. Cascino, Jay D. Desai, Daniel C. Tarquinio,
James W. Wheless, Robert E. Hogan, Michael R.
Sperling, Kore K. Liow, Sunita N. Misra, Adrian
Rabinowicz, Enrique Carrazana
Epilepsy and Clinical Neurophysiology
(EEG): EEG 1
P14.8-004
Association of EEG Findings with Clinical Outcome
in Patients with Encephalitis – Shirin Jamal Omidi,
Rohini D. Samudralwar, Katherine Marie Johns
Harris, Shivika Chandra, Rodrigo Hasbun
P14.8-005
Meta-analysis of EEG Findings in Patients with
PRES – Sihyeong Park, Arsalan Anwar, Sidra
Saleem, Imran I. Ali
P14.8-006
Utilization and findings of out-patient EEG in
routine clinical care of patients with acute
symptomatic seizure concern after acute stroke –
Pradeep Chandan, Vineet Punia
P14.8-007
Continuous EEG During ECMO: A Single-Center
Retrospective Cohort Study – Jennifer Marie
Olson, Brandon P. Foreman, Moshe Albert Mizrahi
82 2022 AAN Annual Meeting
Wednesday, April 6 11:45 a.m.–12:45 p.m.
9 Neuro-oncology
Neuro-oncology: Neuroimaging and
Informatics 2
P14.9-001
Semi-Automated Longitudinal Lesion Tracking
In PACS Reveals High Proportion of Metastatic
Lesions Showing Mixed Response To
Radiosurgery – Gabriel Ignacio Cassinelli Petersen,
Tej Verma, Khaled Bousabarah, Leon Jekel, Sara
Merkaj, Ryan C. Bahar, Sandra Abi Fadel, Ichiro
Ikuta, MingDe Lin, Antonio M. P. Omuro, Mariam
Aboian
P14.9-002
Integration of Machine Learning Into Clinical
Radiology Practice – Development of a Machine
Learning Tool for Preoperative Glioma Grade
Prediction – Sara Merkaj, Tal Zeevi, Khaled
Bousabarah, Eve Kazarian, MingDe Lin, Andrej
Pala, Gabriel Ignacio Cassinelli Petersen, Leon
Jekel, Ryan C. Bahar, Niklas Joern Tillmanns, Jin
Cui, Ichiro Ikuta, Richard A. Bronen, Sandra Abi
Fadel, Malte Westerhoff, Antonio M. P. Omuro,
Mariam Aboian
P14.9-003
Cancer informatics survey of different grades and
subtypes of glioma – Parampreet Kaur
P14.9-004
Comparing Deep Learning and Classical Machine
Learning Methods For Differentiating Primary
CNS Lymphomas From Gliomas – A Systematic
Review – Gabriel Ignacio Cassinelli Petersen,
Julia Shatalov, Tej Verma, Waverly Rose Brim,
Sara Merkaj, Ryan C. Bahar, Harry Subramanian,
Jin Cui, Michele Hackley Johnson, Ajay Malhotra,
Antonio M. P. Omuro, Mariam Aboian
P14.9-005
Bias assessment of Artificial Intelligence papers
in Glioma segmentation using TRIPOD – Avery
Lum, Waverly Rose Brim, Harry Subramanian,
Sam Payabvash, Ichiro Ikuta, MingDe Lin, Khaled
Bousabarah, Michele Hackley Johnson, Ajay
Malhotra, Mariam Aboian
P14.9-006
Systematic Review of Machine Learning
Models for Differentiation of Glioma from Brain
Metastasis – Leon Jekel, Waverly Rose Brim,
Gabriel Ignacio Cassinelli Petersen, Sara Merkaj,
Harry Subramanian, Tal Zeevi, Sam Payabvash,
Khaled Bousabarah, MingDe Lin, Jin Cui,
Alexandria Brackett, Michele Hackley Johnson,
Antonio M. P. Omuro, Bjorn Scheffler, Mariam
Aboian
P14.9-007
Differential Prevalence of Developmental Venous
Anomalies in Glioma Subtypes – Jacob William
Benson, Jerome J. Graber
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
10 Cerebrovascular Disease and
Interventional Neurology
Interventional Neurology 3
P14.10-001
Outcomes in Acute Ischemic Stroke Patients
with Metastatic Cancer Undergoing Mechanical
Endovascular Revascularization: Analysis of the
National Readmission Database – Hassan Osama
Mostafa Aboul Nour, Ahmed Maraey, Mahmoud
Khalil, Ahmed Elzanaty, Hadeer Rafat Elsharnoby,
Daniel Miller, Stephan A. Mayer
P14.10-002
Peri-embolization Use of Stent Retrievers as
a Rescue Tool in Patients with Subarachnoid
Hemorrhage – Abdallah Omar Amireh,
Muhammad Nagy, Hassan M. Ali, Siddhart Kumar
Mehta, Haralabos Zacharatos, Farah Yolanda
Fourcand, Jawad F. Kirmani
P14.10-003
Tachycardia is Associated with Mortality after
Thrombectomy for Acute Ischemic Stroke – Penina
Krieger, Amanda Jin Zhao, Leah Croll, Hannah
Irvine, Jose L. Torres, Kara R. Melmed, Aaron S.
Lord, Koto Ishida, Jennifer A. Frontera, Ariane
Lewis
P14.10-004
Effects of blood pressure management after
endovascular thrombectomy on short term
outcomes in patients with acute ischemic stroke
– Jiping Zhou, Heba Samara, Ali Ebrahim, Jay
Kinariwala, Wazim Mohamed
P14.10-005
Novel Endovascular Method for Chronic Total
Occlusion (CTO) of the Internal Carotid Artery
(ICA) – Nicholas Ravindra Mulchan, Philip Yeung,
Ambooj Tiwari, Jennifer A. Frontera, Ketevan
Berekashvili, Jeffrey Farkas, Jose L. Torres,
Matthew D. Sanger
P14.10-006
Utility of IV thrombolysis and mechanical
thrombectomy in nonagenarians with acute
ischemic stroke – Tasha Ann Tombo, Anam Syed,
Michael Wesolowski, Michael Joel Schneck
P14.10-007
Reversible focal neurologic deficits as a
complication of diagnostic cerebral angiogram –
Anusha Mangalampalli, Sri Raghav Seshu Sista,
Elias Samaha
P14.10-008
Middle meningeal artery embolization performed
through a transcarotid artery revascularization
stent (TCAR) – Christopher Medina, Elie E.
Dancour, Paul Wright
P14.10-009
Hypoperfusion Intensity Ratio May Predict
Cerebral Edema After Endovascular
Thrombectomy – Caitlin Radnis, Anjali Asthana,
Rima Dafer
 Poster Session 14
P14.10-010
Anomalous Right Vertebral Artery Origin from
the Right Common Carotid Artery: A Rare
Angiographic Finding – Sara Habib, Ahmer Asif,
Maria Shoaib, Sameera Siddiqui, Robert Alan
Hamilton
11 Movement Disorders
Movement Disorders: PD Gut and Lung
and PD Biomarkers 2
P14.11-001
No Accumulation of Glucosylceramide in PD
Cerebrospinal Fluid – Tatsuro Mutoh, Yoshiki
Niimi, Hisako Akiyama, Hirohisa Watanabe, Yoshio
Hirabayashi
P14.11-002
Poly (ADP-Ribose) and a–synuclein extracellular
vesicles in patients with Parkinson disease: A
possible biomarker of disease severity – Fabrice
Lucien, Eduardo E. Benarroch, Aidan Mullan,
Farwa Ali, Bradley F. Boeve, Michelle M. Mielke,
Ronald C. Petersen, Cole Daniel Stang, Emanuele
Camerucci, Owen A Ross, Zbigniew K. Wszolek,
David S. Knopman, James H. Bower, Wolfgang
Singer, Rodolfo Savica
Movement Disorders: Tremor 1
P14.11-003
Type 2 Diabetes and the Risk of Parkinson’s
Disease in an Essential Tremor Population – Julia
Hendricks, Mary Taglieri, Mudit Gupta, Mihai
Cosmin Sandulescu
P14.11-004
WITHDRAWN
P14.11-005
Patient-Specific Outcomes of Transcutaneous
Afferent Patterned Stimulation with Varying
Frequencies for Essential Tremor – Alexander
Kent, Han Biehn Kim, Vedanshi Bhargava, Dhira
Khosla, Kathryn Rosenbluth
P14.11-006
Tremor and Quality of Life Following Thalamic
Deep Brain Stimulation for Essential Tremor:
5-Year Outcomes. – Ka Loong Kelvin Au, Kelly E.
Lyons, Michael T. Frassica, Binith Cheeran, Rajesh
Pahwa
P14.11-007
Low Initial Stimulation Amplitude Is Associated
With Improved Tremor Outcome in Clinical
Responders To VIM DBS For ET – Salman
Ikramuddin, Rebecca Doran Butler, Jerrold L. Vitek,
Lauren E. Schrock, Scott E. Cooper, Matthew
Johnson, Joseph Y. Matsumoto
Information is accurate as of February 8, 2022, and is subject to change.
Wednesday, April 6 11:45 a.m.–12:45 p.m.
12
Neuro-ophthalmology/Neuro-
otology
Neuro-ophthalmology and Neuro-otology
Cases 2
P14.12-001
An Unusual Case of Bilateral Orbital Hemorrhage
– Sanem Pinar Uysal, Catherine Hassett, Dhimant
Dani
P14.12-002
An Unusual Case of Isolated Bilateral Papillitis
– Molly Rachel Fensterwald, Angela Jinsook Oh,
Perry Shieh, Samuel Spiegel
P14.12-003
Postoperative Diffusion Restriction in Proximal
Optic Nerve – Parth Pranav Parikh, Oana Maria
Dumitrascu
P14.12-004
Double trouble: A Unique Case of Herpes Zoster
Ophthalmicus with Concomitant Abducens Nerve
Palsy – Roberto Gomez, Anthony Fam, Machteld
E. Hillen
P14.12-005
A young female with acute onset visual
disturbance: a case report – Jonathan Donnelly,
Leila Saadatpour, Ali E. Kaabi, John E. Carter
13 Neuromuscular and Clinical
Neurophysiology (EMG)
Neuromuscular Disease: Inherited Muscle
Disorders 3
P14.13-001
Cardiac MRI in Duchenne and Becker Muscular
Dystrophy – Manu S S. G, Atchayaram Nalini,
Ashita Barthur, Seena Vengalil, Saraswati Nashi
P14.13-002
Prevalence and impact on quality of life of
gastrointestinal and genitourinary symptoms
in facioscapulohumeral muscular dystrophy –
Michael Cole, June Kinoshita, Bridget Zimmerman,
Katherine D. Mathews
P14.13-003
Prevalence of healthcare conditions and services
used by patients with myotonic dystrophy (DM1
and DM2) prior to diagnosis; a real-world data
analysis – John W. Day, Kathryn Munoz, Richard
A. Brook, Bradley W. McEvoy, Li-Jung Tai, Kelly
Ditrapani, Nathan Kleinman, Mohita Kumar, Chao-
Yin Chen, Mark Stahl
P14.13-004
Development of Validated Clinical Outcome
Assessments in Limb Girdle Muscular Dystrophy
R1/2A – Nicholas Elwood Johnson, Kameron
Bates, Han Xie, Lindsay N. Alfano, Conrad Weihl,
Linda Pax Lowes, Matthew P. Wicklund, Katherine
D. Mathews, Tahseen Mozaffar, Jessica St
Romain, Erin DeSpain, Katy Eichinger, The GRASP
Consortium
P14.13-005
Evaluation of Total Binding Antibodies Against
rAAVrh74 in Patients with Duchenne Muscular
Dystrophy – Natalie Goedeker, Danielle A. Griffin,
Sachi Dharia, Sourav Santra, Jesantha Coy, Nicole
Yocum, Craig M. Zaidman
P14.13-006
Understanding the patients’ journey to the
diagnosis of Facioscapulohumeral Muscular
Dystrophy (FSHD): a real-world retrospective
data analysis – Chamindra G. Konersman, Kathryn
Munoz, Richard A. Brook, Nathan Kleinman, Kelly
Ditrapani, Bradley W. McEvoy, Alissa N. Peters,
Trista Hardin, Chao-Yin Chen, Mark Stahl
P14.13-007
Understanding Falls in FSHD – Enrico Bugiardini,
Katy Eichinger, Michael George Hanna, Gita
Ramdharry, Michael McDermott, Kiley Higgs,
Michaela Walker, Leann Lewis, William Martens,
Doris G. Leung, Sabrina Sacconi, Karlien Mul,
Valeria A. Sansone, Elena Carraro, Leo Hong-Li
Wang, Perry Shieh, Bakri Elsheikh, Samantha Jo
LoRusso, Russell Butterfield, Nicholas Elwood
Johnson, Maria Chiara Frisoni, Alrabi Tawil,
Jeffrey Statland
P14.13-008
Developmental changes of the axon initial
segment in animal model of Duchenne Muscular
Dystrophy – Samantha Lee Shallop, Tytus Bernas,
Mathula Thangarajh
P14.13-009
Facioscapulohumeral muscular dystrophy
myopathologic dissection in 22 patients shows
highly variable morphologic findings – Lisanne
Hubregtse, Karlijn Bouman, Chéryane Lama,
Saskia Lassche, Benno Kusters, Baptiste Periou,
Francois Jerome Authier, Nicol Voermans, Edoardo
Malfatti
P14.13-010
Inherited Myopathy Plus: Double-Trouble from
Rare Neuromuscular Disorders – Andre Granger,
Grayson Bernard Beecher, Teerin Liewluck, Ruple
S. Laughlin, Margherita Milone
AAN.com/AM 83
 Poster Session 15
1 2
Autoimmune Neurology
Autoimmune Neurology: Neuromyelitis
Optica Spectrum Disorder 2
P15.1-001
Inebilizumab Improves Pain Outcomes and Quality
of Life in Neuromyelitis Optica Spectrum Disorder
– Ho Jin Kim, Michael Smith, William Rees,
Michele Gunsior, Eliezer Katz, Friedemann Paul
P15.1-002
SAkuraBONSAI: A Prospective, Open-label Study
of Satralizumab Investigating Novel Imaging,
Biomarker, and Clinical Outcomes in Patients
with Aquaporin-4-IgG-seropositive (AQP4-IgG+)
Neuromyelitis Optica Spectrum Disorder (NMOSD)
– Anthony Traboulsee, Kazuo Fujihara, Ho Jin
Kim, Romain Marignier, Kevin O’Connor, Robert
C. Sergott, Heinz Wiendl, Jens Wuerfel, Scott S.
Zamvil, Sean J. Pittock, Veronica Anania, Regine
Buffels, Thomas Kuenzel, Sian Lennon-Chrimes,
Jeffrey L. Bennett
P15.1-003
Cognitive Impairment in Neuromyelitis Optica
Spectrum Disorder (NMOSD) – Luka Vlahovic,
Jamie C. McDonald, Jessica Hinman, Anna
Tomczak, Christopher Lock, Gayle Deutsch, Lorene
M. Nelson, May Han
P15.1-004
Safety and Efficacy of Inebilizumab as Treatment
for Newly Presenting Neuromyelitis Optica
Spectrum Disorder – John William Lindsey,
Evanthia Bernitsas, Dewei She, Eliezer Katz, Bruce
A. C. Cree
P15.1-005
Neuromyelitis optica / Neuromyelitis optica
spectrum disorders: pattern of clinical
presentation, radiological characteristics, and
AQP4 serological status among Sudanese patients
– Etedal Ahmed Ibrahim, Eiman Hamid
P15.1-006
Long-term Efficacy and Safety of Rituximab in
Neuromyelitis Optica Spectrum Disorder and
MOG Antibody Disease – Eleni Vasileiou, Paula
Barreras, Angeliki Filippatou, Kathryn Fitzgerald,
Michael Levy, Ellen M. Mowry, Peter A. Calabresi,
Elias S. Sotirchos
P15.1-007
Indirect Comparison Analysis of FDA-Approved
Treatment Options for Adults with Aquaporin-4
Immunoglobulin G-positive Neuromyelitis Optica
Spectrum Disorder – Dean M. Wingerchuk, Sean
J. Pittock, Michael Levy, Kazuo Fujihara, Ichiro
Nakashima, Friedemann Paul, Adrian Kielhorn,
Minying Royston, Imran Tanvir, Inar Zhang
84 2022 AAN Annual Meeting
Wednesday, April 6 5:30 p.m.–6:30 p.m.
Headache
Headache: Migraine Therapeutics 5
P15.2-001
Efficacy of Intravenous Valproic Acid and Oral
Valproic Acid Tapers for Treatment of Pediatric
Headaches in the Emergency Department – Scott
Rosenthal, Emma Lynn Mazzio, Hannah Wellman,
Jill Marks, Jerry Jewell, Sarah Guistolisi, Jan A.
Martin, Ricka Messer, Rakesh Mistry, Marcy E.
Yonker, Craig A. Press
P15.2-002
The Efficacy of Transdiagnostic Cognitive
Behavioral Therapy on Migraine Headache: A
Randomized Clinical Trial – Negin Badihian,
Forouzandeh Soleimanian Boroujeni, Shervin
Badihian, Vahid Shaygannejad, Yousef Gorji
P15.2-003
Exploratory Efficacy of INP104 by Migraine
Attack Severity and Time of Dosing: Results From
the Phase 3 STOP 301 Study – Brian D. Loftus,
Michelle Murphy, Christopher J. Fitzpatrick, Sutapa
Ray, Stephen Bevan Shrewsbury, Sheena K. Aurora
P15.2-004
Celecoxib Oral Solution in the Acute Treatment of
Migraine: Pooled Efficacy and Safety Results From
2 Randomized Placebo-controlled Trials – Stewart
J. Tepper, Harvey Kushner, Mancia M. Ko, Todd
Kunkel, Richard B. Lipton
P15.2-005
Improvements in Disability, Migraine Frequency,
and the Interictal Period with INP104: Results
from the Phase 3 STOP 301 Study – Cynthia Emilie
Armand, Dawn C. Buse, Robert Vann, Sutapa Ray,
Stephen Bevan Shrewsbury, Sheena K. Aurora
P15.2-006
Impact of Celecoxib Oral Solution on Symptomatic
Improvements in the Acute Treatment of Migraine
– Stewart J. Tepper, Harvey Kushner, Mancia M.
Ko, Todd Kunkel, Richard B. Lipton
3
Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Clinical Aspects 1
P15.3-001
The Diagnostic Utility of the Motor Perseveration
Sign for the Identification of Mild Neurocognitive
Disorder and Dementia – Brad Tyson, Puneet
Kainth, Pinky Agarwal
P15.3-002
Q-RUDAS: A Cognitive Test Adapted To The
Indigenous Cuzco Quechua Language, Pilot
Study – Nilton Custodio Capunay, Marco Moises
Malaga, Enrique Choquenaira Imata, Victor Andrés
Velasquez Rimachi, Aaron Rodriguez, Carlos Alva-
Diaz, Rosa Montesinos
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P15.3-003
A Review of Posterior Cortical Atrophy over 25
Years – Golnoush Akhlaghipour, Oleg Yerokhin
Yerstein, Leila Parand, Li-Jung Liang, Adrienne
Isaac, Youssef I. Khattab
P15.3-004
WITHDRAWN
P15.3-005
Prevalence of Comorbidities in a National Sample
of Lewy Body Dementia Caregivers – Anna
Moshkovich, Melissa Levin, Faizan Akram, Serena
Hess, Jori Fleisher
4 MS and CNS Inflammatory
Disease
MS Neuroimaging 3
P15.4-001
Contrast enhancement sources on post-
Gadolinium “black-blood” 3D T1-weighted
Turbo-Spin-Echo images in patients with
multiple sclerosis. – Claudio Gobbi, Lucia Danieli,
Daniela Distefano, Alessandro Cianfoni, Luca
Roccatagliata, Emanuele Pravatà, Chiara Zecca
P15.4-002
Predicting Treatment Response with MRI-Based
Subtyping in Relapsing and Secondary Progressive
MS – Arie Gafson, Phoebe Jiang, Changyu Shen,
Dawei Liu, Rodrigo Perea, Douglas L. Arnold, Colm
Elliott, Bing Zhu, Elizabeth Fisher, Olga Ciccarelli,
Declan Chard, Frederik Barkhof, Arman Eshaghi,
Shibeshih Belachew
P15.4-003
Myelin Mapping in Trigeminal Neuralgia:
Standardizing Conventional MR Images Enables
Quantitative Comparison of Myelin Content –
Meng Fei Li, Powell Chu, Peter Shih-Ping Hung,
David J. Mikulis, Moji Hodaie
P15.4-004
Assessment of cervical spinal cord volume
in pediatric-onset multiple sclerosis – Saher
Suleman, Matthew Harwood, Paul Kang, Ram
Narendra Narayan, Jeremy Hughes
P15.4-005
An imaging signature in choroid plexuses in
pre-symptomatic multiple sclerosis – Vito Antonio
Gerardo Ricigliano, Arya Yazdan Panah, Andrea
Lazzarotto, Michel Bottlaender, Benedetta Bodini,
Celine Louapre, Bruno Stankoff
P15.4-006
Quantitative Analysis of MS Lesion in Cervical
Spinal Cord (CSC) using Ultrahigh-b DWI (UHb-
DWI) – Kyle E. Jeong, Lubdha Shah, Sophie Lee,
Bijaya Thapa, Nabraj Sapkota, Erica Bisson, Noel
Carlson, Eun-Kee Jeong, John W. Rose
 Poster Session 15
P15.4-007
Cerebrospinal Fluid Lymphocytic Pleocytosis is
Associated With Enhanced Blood-Brain Barrier
Breakdown at the Time of Multiple Sclerosis
Diagnosis – Dinesh Keran Sivakolundu, Miriyam
Kopyto, Katherine Hill, Hebatalla Elhusseiny,
Robert K. Fulbright, David A. Hafler, Erin Longbrake
P15.4-008
Automated MRI features of MS and common
radiological mimickers – Moein Amin, Kunio
Nakamura, Daniel Ontaneda
P15.4-009
Longitudinal Assessment of Optical Coherence
Tomography in Patients with Relapsing-Remitting
Multiple Sclerosis on Interferon beta-1a – Ka-Ho
Wong, Rae E. Bacharach, Anette Fjeldstad, Julia
Klein, M. Mateo Paz Soldan, John W. Rose
P15.4-010
Examining Regional Brain Volume Differences
in Radiologically Isolated Syndrome – Jeffrey
Glaister, Melanie Guenette, Adelia Adelia, Scott
Patten, Alexandre Prat, Roger Tam, Anthony
Traboulsee, Shannon Kolind, Jiwon Oh
5 Child Neurology and
Developmental Neurology
Child Neurology: SMA/DMD/Muscle 1
P15.5-001
Onasemnogene Abeparvovec in Presymptomatic
Spinal Muscular Atrophy (SMA): SPR1NT Study
Update in Children with Three Copies of SMN2
– Kevin Strauss, Francesco Muntoni, Michelle
A. Farrar, Kyoko Saito, Jerry R. Mendell, Laurent
Servais, Hugh John McMillan, Richard S. Finkel,
Kathryn J. Swoboda, Jennifer M. Kwon, Craig
M. Zaidman, Claudia A. Chiriboga, Susan T.
Iannaccone, Jena M. Krueger, Julie Anne Parsons,
Perry Shieh, Sarah Kavanagh, Deepa Chand, Sitra
Tauscher-Wisniewski, Bryan McGill, Thomas
Macek
P15.5-002
The RESTORE Registry: Real-World Assessments
of Interventions and Long-Term Outcomes in
Patients with Spinal Muscular Atrophy (SMA) –
Richard Finkel, John W. Day, Darryl C. De Vivo,
Eugenio Mercuri, Francesco Muntoni, Perry Shieh,
Eduardo Tizzano, Isabelle Desguerre, Kyoko Saito,
Melissa Menier, Nicole LaMarca, Fred Anderson,
Omar Dabbous, Laurent Servais
P15.5-003
The RESTORE Registry: Comparative Outcomes
in Patients with Spinal Muscular Atrophy (SMA)
in the United States Identified by Newborn
Screening (NBS) or Clinical Diagnosis – Laurent
Servais, Darryl C. De Vivo, Janbernd Kirschner,
Eugenio Mercuri, Francesco Muntoni, Eduardo
Tizzano, Susana Quijano-Roy, Kyoko Saito, Melissa
Menier, Nicole LaMarca, Fred Anderson, Omar
Dabbous, Richard S. Finkel
Information is accurate as of February 8, 2022, and is subject to change.
Wednesday, April 6 5:30 p.m.–6:30 p.m.
7
P15.5-004
Practice, Policy, and Ethics
JEWELFISH: Safety, Pharmacodynamic and
Exploratory Efficacy Data in Non-Naïve Patients
with Spinal Muscular Atrophy (SMA) Receiving Practice, Pitfalls, and Innovation 2
Treatment with Risdiplam – Claudia A. Chiriboga,
Claudio Bruno, Tina Duong, Dirk Fischer, Janbernd P15.7-001
Kirschner, Eugenio Mercuri, Marianne Gerber, Challenges in Deploying Low-Field and Ultra-Low
Ksenija Gorni, Heidemarie Kletzl, Imogen Field MRI in Research, Clinical Care, Population
Carruthers, Carmen Martin, Francis Warren, Screening, and Direct-to-Consumer Use – Francis
Mariacristina Scoto
X. Shen, Susan Wolf, Michael Garwood, Duke Han,
P15.5-005 Judy Illes, W. Taylor Kimberly, Eran P. Klein, Karen
Apitegromab in Spinal Muscular Atrophy (SMA): Rommelfanger, Matthew Rosen, Kevin N. Sheth,
Efrain Torres, Paul J. Tuite, John Thomas Vaughan
An Analysis of Multiple Efficacy Endpoints in the
TOPAZ Trial – Thomas O. Crawford, Basil T. Darras, P15.7-002
John W. Day, Guochen Song, Georgios Nomikos,
Updates and Improvements to the American
Amy Place, Doreen Barrett, Sanela Bilic, Janet Academy of Neurology Guideline Dissemination
ONeil, Nathalie Kertesz, Shaun Cote, Jagdish
Practices – Sarah Tanveer, Sonja Potrebic, Mark
Patel, Yung Chyung Robert Keezer, Navdeep Sangha, Vishwanath Sagi,
Scott A. Heller, Mia T. Minen, Anne Encarnacion
Agraviador Constantino, Mark Douglas Johnson,
6 Neuro-rehabilitation Benzi Kluger, Kelly Sullivan, Scott Wessels
P15.7-003
Hospital Teleneurology Role Leads to Significant
General Neuro-rehabilitation 1
Wait Time Reduction for Follow Up Appointments
P15.6-001 and Increased Access to Subspecialists –
Matthew Hart, Sandeep Gill, Sukhraj Gill, Julianne
Loss of Regained or Spared Function after SCI
(Neuroworsening): Evidence and Dimension –
Markus Harrigan, Marcel Kopp, Juan Peng, YuYing
Leah Gay, Scott M. Friedenberg, Anthony Noto
P15.7-004
Chen, Clayton Peterson, Jan M. Schwab Patient Response to Telephonic follow up In
P15.6-002 Neurology: A Hospital Based Study – Anand
Kumar, Varun Kumar Singh, Deepika Joshi,
Nabiximols Efficacy in Multiple Sclerosis (MS) Abhishek Pathak, Rameshwar Nath Chaurasia,
Spasticity: Treatment Effects on Spasticity
Vijaya Nath Mishra, Neha Lall, Pratishtha Sengar
Numeric Rating Scale (NRS) and Muscle Spasm
Frequency in 2 Randomized Clinical Trials – P15.7-005
Sajida Javaid, Fred D. Lublin, Jacqueline Ann Characterization of General Neurology Emergency
Nicholas, Sylvia Klineova, Joris Berwaerts, Robert Department Discharge Consultations: A Pilot
Chinnapongse, Daniel Checketts, Joshua R. Study into Potentially Avoidable Neurological ED
Steinerman Visits – Anik Amin
P15.6-003
Impact of Cerebral Small Vessel Disease on
Neurological Outcomes Following Traumatic Brain
Injury – Gary Robert Salomon, Kevin M. Barrett
P15.6-004
Width of Tissue Bridges Predicts Neurologic
Recovery 3 Months After Spinal Cord Injury:
a Multi-Center Study – Dario Pfyffer, Andrew
Craig Smith, Kenneth Arnold Weber, Christina
Draganich, Jeffrey Berliner, Candace Tefertiller,
Torsten Hothorn, Jan M. Schwab, Armin Curt,
Patrick Freund
AAN.com/AM 85
 Poster Session 15
8 Epilepsy/Clinical Neurophysiology
(EEG)
Epilepsy/Clinical Neurophysiology (EEG):
ASM Clinical Trials 4
P15.8-001
Timing to Administration and Ease of Dosing of
Diazepam Nasal Spray Rescue Therapy for Seizure
Clusters: Results From a Phase 3, Long-Term
Open-Label, Repeat-Dose Safety Study – Jay
D. Desai, Robert E. Hogan, James W. Wheless,
Michael R. Sperling, Kore K. Liow, Daniel C.
Tarquinio, Dennis J. Dlugos, Gregory D. Cascino,
Sunita N. Misra, Adrian Rabinowicz, Enrique
Carrazana
P15.8-002
Real-World Experience of Perampanel
Monotherapy in Epilepsy Patients with Focal-
Onset and Generalized-Onset Seizures – Taoufik
Alsaadi, Manuel Toledo, Fernando Ayuga Loro,
Eugen Trinka, Tony Wu, Manoj Malhotra, Stella
Leock Ngo, Antonio Gil-Nagel, Vicente Villanueva
P15.8-003
Effectiveness and Tolerability of Brivaracetam by
Reason for Initiation in Adults with Focal Seizures:
Post-hoc Analysis of a Real-world, US Study –
Heidi L. Henninger, Michael R. Sperling, Hamada
Hamid Altalib, Hina N. Dave, Michael Gelfand,
Roger J. Porter, Melinda S. Martin, Sami Elmoufti,
Anne-Liv Schulz, Prashant Dongre, Jacqueline
French
Epilepsy and Clinical Neurophysiology
(EEG): Epilepsy Co-morbidities 1
P15.8-004
Clinical Correlates of Cyclic Alternating Pattern of
Encephalopathy (CAPE) – Crystal Jing Yu, Christine
Smith, Taylor Maxwell Parker, Karly A. Landvay,
Calvin Hu, Stephan Eisenschenk, Yue Wang, Maria
J. Bruzzone, Carolina B. Maciel
P15.8-005
The Management of Patients with Epilepsy Taking
Anti-Epileptic Drugs Associated with Metabolic
Bone Disease – Ma Su Su Aung, Shreeja Kadakia,
Brian James Hanrahan
P15.8-006
Seizure Incidence in Lung Transplant Patients
– Maria Kristina Casanova Dorotan, Robert
Bodroghy, Zachariah Dorey-Stein, Ching Tsao
P15.8-007
Cognitive Deterioration in a Patient with Down
Syndrome Presenting as Epileptic Encephalopathy
– Annika Daya, Vinita J. Acharya, Jayant N.
Acharya
86 2022 AAN Annual Meeting
Wednesday, April 6 5:30 p.m.–6:30 p.m.
9 Neuro-oncology
Observations in Neuro-oncology 1
P15.9-001
Clinical Reasoning: A 65-year-old Woman with
Cancer History and Wrist Drop – Rebecca Merrill,
Meaghan Puckett, William Patrick Morrow, Jason
Powell, Eric Hsi, Rakhee Vaidya, Roy E. Strowd
P15.9-002
Small Lymphocytic Lymphoma Causing
Probable Vasculitic Neuropathy: A Distinctive
Neurologic Manifestation of a Rare Hematologic
Entity – Nishika Karbhari, Molly Perkins, Arati
Gangadharan, Sean Soorena Zadeh, George
Zanazzi
P15.9-003
Erdheim-Chester Disease with Isolated CNS
Involvement: A Case Report and Systematic
Review of Literature – Anam Qamar Haque, Carlos
Alberto Perez, Thejasvi Anantasagar Reddy, Rajesh
K. Gupta
P15.9-004
Anaplastic Pleomorphic Xanthoastrocytoma with
Extracranial Bone Metastasis: A Case Report and
Literature Review – Edith Jia-Jiun Yuan, Emily
T. Lo, Tania Vartanians, Thomas Chen, Frances E.
Chow
P15.9-005
Brainstem Small Lymphocytic Lymphoma
(SLL) Presenting as Serpiginous Small Vessel
Enhancement and Peduncular Hallucinosis: A First
Case Report – Brigitte Reina, Amy Chan
P15.9-006
Erdheim-Chester Disease: A rare case with
central nervous system involvement – José Maria
Bandeira Costa, Joana Marques
P15.9-007
A Fatal Case of Primary Diffuse Leptomeningeal
Melanomatosis – Ramiro Gabriel Castro Apolo,
Negar Moheb, Cleo Zarina Alejo Reyes, Sayyeda
Zahra, Preet M. Varade
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
10 Cerebrovascular Disease and
Interventional Neurology
Cerebrovascular Disease: Neuroimaging 2
P15.10-001
Associations of Intracranial Vascular Features
on Non-contrast Enhanced MRA with Cognitive
Impairment – Anders Gould, Zhensen Chen, Duygu
Baylam Geleri, Niranjan Balu, Li Chen, Xu Peng,
Kristi Pimentel, Gador Canton, Thomas Hatsukami,
Chun Yuan
P15.10-002
Clinical Utility of Intravascular Ultrasound (IVUS)
in Carotid Artery Interventions – A systematic
review and meta-analysis. – Awadh K. Pandit,
Biswamohan Mishra, Venugopalan Y Vishnu,
Shubham Misra, M.V.Padma Srivastava, Achal K.
Srivastava, Shashank Sharad Kale
P15.10-003
CT Perfusion Parameters for Early Prediction
of Malignant Cerebral Edema in Hemispheric
Infarction – Eesha Oza, Brian Alexander Tong, Dan
Victor Giurgiutiu, Nilufer Yalcin, Klepper A. Garcia,
Deepak Nag Ayyala, Askiel Bruno, Manan Shah
P15.10-004
Deep medullary veins are associated with
widespread brain structural abnormalities – Zi-Yue
Liu, Feifei Zhai, Dong-Hui Ao, Fei Han, Ming-Li Li,
Li-Xin Zhou, Jun Ni, Ming Yao, Shu-Yang Zhang,
Li-Ying Cui, Zheng-Yu Jin, Yi-Cheng Zhu
P15.10-005
Ultra High-field MRI Versus 1.5/3 T MRI in the
Detection of Cerebrovascular Disease – David
T. Krist, Rachael Tessem, Anant Naik, Tracy
Kao, Victoria Andrea Blaiotta-Vazquez, Wael
Ali Hassaneen Mostafa, Tracey Wszalek, Aaron
Thomas Anderson, Paul Arnold
P15.10-006
The Predictive Value of Multimodal Intraoperative
Neuromonitoring Techniques for Periprocedural
Preventive Interventions during Carotid Surgery
– Brandon Trang Nguyen, Cara Joyce, Bernadette
Aulivola, Michael Joel Schneck
P15.10-007
Motor Tract Variations and Walking Recovery
after Thalamic Hemorrhage: Analyses by Diffusion
Tensor Tractography – Aki Arai
P15.10-008
Unusual Multicompartmental Intracranial
Hemorrhage After Tenecteplase Administration –
Abdallah Omar Amireh, Muhammad Nagy, Hassan
M. Ali, Haralabos Zacharatos, Siddhart Kumar
Mehta, Farah Yolanda Fourcand, Jawad F. Kirmani
P15.10-009
Illustration of exacerbating cortical superficial
siderosis on close-up MRIs after resumption of
anticoagulant therapy. – Bianca Oana Pîrlog,
Augustin Gaudemer, Pierre Amarenco, Celine
Guidoux
 Poster Session 15
P15.10-010
Intracranial Hemorrhage due to Arteriovenous
Malformations in Hepatic Cirrhosis – Maya
Mounir Ramy, Kiely Whitham, Denny Joseph,
Orlando Diaz, Tanu Garg
11 Movement Disorders
Movement Disorders: Atypical Movement
Disorders 1
P15.11-001
Acute Parkinsonism Secondary to CHANTER
Syndrome – Dharti Dua, Cody Magnuson, Amir
Adeli
P15.11-002
Iron accumulation correlates with disease severity
in patients with Multiple System Atrophy – Daniel
O. Claassen, Paula Trujillo Diaz, Jessie Iregui, Amy
Wynn, Kilian Hett, James Silverman, Yan Yan,
Hakmook Kang, David A. Stamler
P15.11-003
Primary Familial Brain Calcification with
Leukoencephalopathy Associated with a Novel
Variant in PDGFB – Jack Shen, Alberto J. Espay,
Emily J. Hill
P15.11-004
Spectrum of Movement disorders of late-onset
Niemann- Pick disease type C – Jasmine Parihar,
Deepa Dash, Bhawana Aggarwal, Madhulika
Kabra, Roopa Rajan, Deepti Vibha, Rajesh Kumar
Singh, Rohit Bhatia, Neerja Gupta, Manjari Tripathi
Movement Disorders: Tremor 2
P15.11-005
Prospective, Multicenter, International Registry of
Deep Brain Stimulation for Essential Tremor – P.R.
Schuurman, Guenther Deuschl, Lilly Chen, Roshini
Jain
P15.11-006
Annual Health Care Costs Among Medicare
Beneficiaries with Essential Tremor – Elan D.
Louis, Kandice A. Kapinos
P15.11-007
Increased Healthcare Cost and Mental Health
Burden among Patients with Essential Tremor: A
Retrospective Observational Study in A Large US
Commercially Insured and Medicare Advantage
Population – Dingwei Dai, Ali Samiian, Henriette
Coetzer, Joaquim Fernandes
Information is accurate as of February 8, 2022, and is subject to change.
Wednesday, April 6 5:30 p.m.–6:30 p.m.
12
Neuro-ophthalmology/Neuro- P15.13-004
otology Immune-mediated rippling muscle disease
(iRMD): Clinical-electrophysiological-pathological
Neuro-ophthalmology and Neuro-otology spectrum and long-term outcomes – Grayson
Research: Ocular Motor and Vestibular 1 Bernard Beecher, Divyanshu Dubey, James
P15.12-001 Douglas Triplett, Teerin Liewluck, William J. Litchy,
Effect of Convergence on the Horizontal Vestibulo- Margherita Milone
Ocular Reflex in Normal Volunteers, Unilateral
Acute and Subacute Peripheral Vestibulopathy
and in One Patient with an Unilateral Pontine
P15.13-005
A comparison study of different imaging
technologies in Inclusion Body Myositis – Anthony
Tegmentum Lesion – Ammar Lamak Ujjainwala, K. Ma, Bhaskar Roy
Cal Dewar, Laurel Donaldson, Caroline Marie
Rayburn, Emily Buenting, Jordan Noelle Boyle, P15.13-006
Jorge C. Kattah Less fatty infiltration of the quadriceps muscles
in dysphagic inclusion body myositis – Kenichiro
P15.12-002
Taira, Madoka Mori-Yoshimura, Toshiyuki
Delineating the anatomical basis of Yamamoto, Yasushi Oya, Ichizo Nishino, Yuji
microsaccades using an ultrasensitive technique Takahashi
for detection of deficits in patients with MS –
Christy Kathleen Sheehy, Eduardo Caverzasi, P15.13-007
Christian Cordano, Ari Green Anti (3-Hydroxy-3-Methylglutaryl-Coenzyme A
Reductase Myopathy: A Muscular Dystrophy
P15.12-003
Mimicker In Pediatric Patient – Rocio Delgado
Mobile Integrated Cognitive Kit (MICK): A Diaz, Brenda Deliz Roldan, Alexandra M. Montalvo
Digitized Visual Rapid Automatized Naming (RAN) Acevedo, Ivonne Arroyo
Task for Concussion on the Sidelines – Scott
Grossman, George Park, Lisena Hasanaj, Marc P15.13-008
Balcer, Todd Hudson, John-Ross Rizzo, Janet C. Dysphagia in patients with Inclusion Body
Rucker, Steven Galetta, Laura J. Balcer Myositis: A national inpatient sample-based study
– Anthony K. Ma, Bhaskar Roy
P15.12-004
Quality of Life in Classical (infratentorial) P15.13-009
Superficial Siderosis – Natallia Kharytaniuk, Amir Diagnostic delay and challenges in a case of
Mazaheri, Menelaos Pavlou, David Werring, Doris- sarcoid myositis – Maria Elisa Samaniego, Paul T.
Eva Bamiou Twydell, Anvita Potluri
P15.12-005 P15.13-010
Usefulness 3 tesla magnetic resonance imaging Improving Patient Outcomes through Standardized
in the evaluation of central acute vestibular Protocols when prescribing Glucocorticoids. –
syndrome – Florencia Wainberg, Alfredo H. Laffue, Tiffany Chang, David Post, Neelam Goyal
Francisco Gualtieri
13 Neuromuscular and Clinical
Neurophysiology (EMG)
Neuromuscular Disease: Acquired
Myopathies 1
P15.13-001
Proteomic profiling of sporadic late-onset
nemaline myopathy – Elie Naddaf, Surendra
Dasari, Duygu Selcen, Cristine Charlesworth, Ken
L. Johnson, Michelle L. Mauermann, Taxiarchis
Kourelis
P15.13-002
Atypical Presentations of Inclusion Body Myositis
– Mazen S. Alamr, Marcus Vinicius Rocha Pinto,
Elie Naddaf
P15.13-003
Myopathies associated with large granular
lymphocytic (LGL) leukemia – Pritikanta Paul,
Margherita Milone, Min Shi, Mithun Shah, Teerin
Liewluck
AAN.com/AM 87
 Poster Session 16
1 2
Autoimmune Neurology
Autoimmune Neurology: NMOSD and
MOGAD 3
P16.1-001
WITHDRAWN
P16.1-002
Cerebral cortical encephalitis in Myelin
Oligodendrocyte Glycoprotein Antibody-
associated Disease – Cristina Valencia Sanchez,
John Chen, Jan-Mendelt Tillema, Claudia F.
Lucchinetti, Mayra Montalvo Perero, Paul Martin
Elsbernd, Alfonso Sebastian Lopez, Adrian
Budhram, Elia Sechi, Amy Kunchok, Divyanshu
Dubey, Sean J. Pittock, Eoin P. Flanagan
P16.1-003
MOGAD in the Mountain West: Epidemiology and
Outcomes in Pediatric and Adult Patients at Two
Large Academic Referral Centers – Suzanne Liu,
Melissa Wright, Ka-Ho Wong, Christopher Steven
Mizenko, Ryan Kammeyer, Teri Schreiner, Robert
Kadish, Tammy L. Smith, Jonathan Ross Galli, Julia
Klein, John E. Greenlee, John W. Rose, M. Mateo
Paz Soldan, Jeffrey L. Bennett, Joshua Bonkowsky,
Lisa Kay Peterson, Amanda Lee Piquet, Stacey
Clardy
Autoimmune Neurology: MOGAD 2
P16.1-004
MOG Antibody-Associated Disease Manifesting
as MRI-Negative Encephalitis: A Case Report and
Literature Review – David M. Anson, Akshaya
Prabhakaran Sudha, Natalie Bartnik, Arpan Patel
P16.1-005
A Case of MOGAD Optic Neuritis Initially Mis-
classified As CLIPPERS – Ethan Daniel Zerpa-
Blanco, Stan C. Kunigelis, Stacy Victoria Smith
P16.1-006
A case of MOG antibody disorder with pontine
involvement mimicking CLIPPERS and extensive
transverse myelitis – Mark Keroles, Brian Rogers
Stocksdale, Jessica P. Ng, Sahar Ahadi, Jeffrey E.
Dunn
88 2022 AAN Annual Meeting
Thursday, April 7 8:00 a.m.–9:00 a.m.
Headache
Headache: Advances in CGRP Inhibition
for Precision Medicine 4
P16.2-001
Fremanezumab for Preventive Treatment in
Migraine: The FINESSE Study – Andreas Straube,
Gregor Broessner, Charly Gaul, Xenia Hamann,
Torsten Kraya, Isabel Schauerte, Lars Neeb
P16.2-002
Changes in Acute Headache Medication Use
Among Patients With Chronic Migraine and
Medication-Overuse Headache: An Exploratory
Analysis of PROMISE-2 – Robert Cowan, Michael
J. Marmura, H. Christoph Diener, Amaal J.
Starling, Jack D. Schim, Joe Hirman, Thomas
Brevig, Roger Cady
P16.2-003
Timing and Location of Injection-site Adverse
Events With Fremanezumab in Patients With
Migraine: A Pooled Analysis of Phase 3 Studies
– Holle Lee Dagny, Yoel Kessler, Verena Ramirez
Campos, Xiaoping Ning, Joshua M. Cohen, Steve
Barash, Tim Jürgens
P16.2-004
Erenumab Versus Topiramate for the Prevention of
Migraine: Results of a Post-hoc Efficacy Analysis
– Marc Ehrlich, Monika Maier Peuschel, Christian
Sieder, Christian Hentschke, Uwe Reuter
P16.2-005
Reductions in Acute Medication Use for Patients
with Migraine Initiating Fremanezumab: Results
of a Long-term US Claims Database Analysis –
Lynda Krasenbaum, Maurice Driessen, Michael
Seminerio, Robert DiEgidio, Marc Tian
P16.2-006
Effect of Erenumab on Patient-Reported Outcomes
in Patients With Episodic Migraine From Asia, the
Middle East and Latin America: The EMPOwER
Study – Shuu-Jiun Wang, Artemio A. Roxas,
Bibiana Saravia, Byung-kun Kim, Debashish
Chowdhury, Naji J. Riachi, Sharon Mei Ling Tai,
Surat Tanprawate, Tai Ngoc Tran, Yi Jing Zhao,
Gabriel Paiva da Silva Lima, Shaloo Pandhi, Shihua
Wen, Subhayan Mondal, Laurent Ecochard, Michal
Arkuszewski
3 Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Clinical Aspects 2
P16.3-001
A prospective observational study using
questionnaires on the treatment needs of patients
with dementia with Lewy bodies, their caregivers,
and their physician in Japan – Yuta Manabe,
Mamoru Hashimoto, Takuhiro Yamaguchi, Shunji
Toya, Manabu Ikeda
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P16.3-002
Creutzfeldt-Jakob disease predictors of survival:
a 10 year experience from a reference center in
Argentina – Santiago Crema, Micaela Hernandez,
Juan Ignacio Castiglione, Ismael Calandri, Gustavo
Sevlever, Ricardo F. Allegri
P16.3-003
Exploring Gentrification’s Impact on the Cognitive
Health of Older Black Adults – Ann Wachana,
Sophia Aron, Holly E. Hinson, Raina Croff
P16.3-004
Cognitive and Neuropsychiatric features of an
Alzheimer ´s Disease Cohort in the Peruvian
Population – Mario R. Cornejo Olivas, Pedro Mena,
Maryenela Illanes-Manrique, Larry D. Adams,
Elison Sarapura-Castro, Victoria Marca, Rosario
Isasi, Sheila Castro Suarez, Gary W. Beecham, Koni
Mejia, Jeffery M. Vance, Carla Manrique Enciso,
Michael L. Cuccaro, Maria Meza-Vega, Margaret
A. Pericak-Vance
P16.3-005
Baseline Characteristics of the GRADUATE
Studies: Phase III Randomized, Placebo-
Controlled Studies Investigating Subcutaneous
Gantenerumab in Participants with Early
Alzheimer’s Disease – Christopher Lane, Szofia
S. Bullain, Angeliki Thanasopoulou, Paul Delmar,
Merce Boada Rovira, Timo Grimmer, Diana Kerwin,
Paulo Pacheco Fontoura, Monika Baudler, Geoffrey
A. Kerchner, Rachelle Doody
4
MS and CNS Inflammatory
Disease
MS Clinical Assessments & Outcome
Measures
P16.4-001
Temporal Mapping of Trigeminal Neuralgia
Lesions to Symptom Onset in Multiple Sclerosis:
When Do the Lesions Occur and What Do They
Tell Us? – Sonam Dilwali, Ian Mark, Emmanuelle
Waubant
P16.4-002
Automatic rating of the neurological examination
in multiple sclerosis: a proof of concept – Mikael
Cohen, Christine Lebrun Frenay
P16.4-003
Assessing treatment response in pediatric
multiple sclerosis patients – Ermelinda De
Meo, Massimo Filippi, Vincenzo Brescia Morra,
Francesco Patti, Giorgia Teresa Maniscalco,
Valentina Torri Clerici, Giuseppe Salemi, Marco
Onofrj, Giacomo Lus, Marta Simone, Maria
Trojano, Maria Pia Amato
 Poster Session 16
P16.4-004
Spinal Cord Lesions and Brain Grey Matter
Atrophy Independently Predict Clinical Worsening
in Multiple Sclerosis: A 5-Year, Multicentre
Study – Maria Assunta Rocca, Paola Valsasina,
Alessandro Meani, Claudio Gobbi, Chiara Zecca,
Frederik Barkhof, Menno M Schoonheim, Eva
Strijbis, Hugo Vrenken, Antonio Gallo, Alvino
Bisecco, Olga Ciccarelli, Marios Yiannakas, Alex
Rovira, Jaume Sastre-Garriga, Jacqueline Palace,
Lucy Matthews, Achim Gass, Philipp Eisele,
Carsten Lukas, Barbara Bellenberg, Monica
Margoni, Paolo Preziosa, Massimo Filippi
P16.4-005
Evaluating the Impact of Administration of
Ocrelizumab via Home Infusion on Safety and
Patient Reported Outcomes – Britney Barrera,
Haley Simpson, Eric Engebretson, Stefan Sillau,
Brooke L. Valdez, Britney Barrera, Ryan Christopher
Winger, Enrique Alvarez, Robert H. Gross, Amanda
Lee Piquet, Teri Schreiner, John Corboy, Jinglan
Pei, Timothy L. Vollmer, Kavita Nair
P16.4-006
Cognitive performance and health-related quality
of life in patients with neuromyelitis optica
spectrum disorder – Elisabet Lopez-Soley, Sara
Llufriu, Rocio Gomez, Jorge Maurino, Francisco
Perez Miralles, Lucia Forero Diaz, Maria Sepúlveda,
Carmen Calles, Maria Luisa Martinez Gines, Ines
Gonzalez, Sabas Boyero, Lucía Romero-Pinel,
Angel Perez Sempere, Virginia Meca Lallana, Luis
Querol, Lucienne Costa Costa-Frossard Franca,
Albert Saiz, Jose Meca Lallana, Elisabeth Solana
P16.4-007
Evaluation of NEDA as a Predictor of Disease
Progression in Patients With RMS and PPMS
Treated With Ocrelizumab: Post-Hoc Analyses
From the OPERA I/OPERA II and ORATORIO Trials
– Xavier Montalban, Maria Pia Sormani, Harold
Koendgen, Fabian Model, James Overell, Hans-
Martin Schneble, Qing Wang, Dalia Rotstein
P16.4-008
Estimating the profile of responders to treatment
in the phase 3 EXPAND trial: do different patients
show benefits on different outcomes? – Francesca
Bovis, Ludwig Kappos, Sophie Arnould, Goeril
Karlsson, Daniela Piani Meier, Maria Pia Sormani
P16.4-009
High Efficacy Agents as First Line Treatment
of Relapsing Forms of MS – Chiara Bellomo,
Alexander Abud, Jonathan Cahill, Saima Chaudhry,
Syed Rizvi
P16.4-010
“The missing-piece sign” located in the cervical
spinal cord in sDAVF – Jonathan Morena
Information is accurate as of February 8, 2022, and is subject to change.
Thursday, April 7 8:00 a.m.–9:00 a.m.
5
Child Neurology and
Developmental Neurology
Child Neurology: SMA/DMD/Muscle 2
P16.5-001
Implementation of Spinal Muscular Atrophy
Newborn Screening across the US – Mary K.
Schroth, Maynard Friesz, Lisa Belter, Mary Curry,
Jacqueline Glascock
P16.5-002
MANATEE: A Study of RO7204239 in Combination
with Risdiplam Treatment in Pediatric Patients
with SMA – Tina Duong, Basil T. Darras, Jasper
Morrow, Francesco Muntoni, Laurent Servais,
Imogen Carruthers, Marianne Gerber, Heidemarie
Kletzl, Carmen Martin, Becca Zhang, Renata
Scalco, Eugenio Mercuri
P16.5-003
Scurvy as a forgotten cause of pseudo-ataxia
child; A Case Report with muscle pathology
and musculoskeletal MRI findings. – Pitchamol
Vilaisaktipakorn, Montida Veeravigrom
P16.5-004
Health Care Resource Utilization in Spinal
Muscular Atrophy Type 1 Patients in Japan:
Results of a Global Caregiver Survey – Walter
Toro Jimenez, Satoru Tanaka, Anish Patel, Omar
Dabbous, Anastasiia Motrunich, Amir Amin,
Mondher Toumi, Imen Touati, Kyoko Saito
P16.5-005
Preferences Related to Treatment of Spinal
Muscular Atrophy (SMA): Qualitative Study of
SMA Caregivers and Health Care Professionals
Treating SMA Types 1 and 2 in the United States
– Anish Patel, Natalia Hawken-Hakimi, Samuel
Aballea, Magdalena Bebrysz, Walter Toro Jimenez,
Nicole LaMarca, Omar Dabbous, Mondher Toumi
6
Neuro-rehabilitation
General Neuro-rehabilitation 2
P16.6-001
Need for Medical Student Education in
Rehabilitation and Post-Acute Care to Support
Patients with Neurologic Illness and Injury –
Dorothy Weiss Tolchin, Michael Young
P16.6-002
Post Hoc Analysis of Nabiximols Efficacy by
Concomitant Medication Use in 2 Enriched
Placebo-Controlled Randomized Clinical Trials
(RCTs) – Faria S. Amjad, Aaron L. Boster, Francisco
Javier Carod-Artal, Robert Chinnapongse,
Daniel Checketts, Peyman Adjamian, Joshua R.
Steinerman
P16.6-003
Axial Diffusivity of the Left Anterior Limb of the
Internal Capsule Associated with Slow Wave
Sleep in Warfighters with Traumatic Brain Injury
– Allen Bell, Brian Gerstenslager, Ping Hong Yeh,
Rujirutana Srikanchana, Kimbra L. Kenney, John
Ollinger, John Kent Werner
P16.6-004
WITHDRAWN
P16.6-005
Motor Cortex Inhibition: A Marker of Motor
Function in Neurofibromatosis Type 1 – Alexander
Doherty, David Huddleston, Hannah Jackson, Paul
Horn, Donald Gilbert
P16.6-006
Healthcare Resource Utilization and Costs Among
Patients With Stroke-related Spasticity Before
and After Treatment With OnabotulinumtoxinA
– Lisa Bloudek, Kristen Migliaccio-Walle, David
Oliveri, Amy Tung, Patrick J. Gillard
7 Practice, Policy, and Ethics
Practice, Pitfalls, and Innovation 3
P16.7-001
Optimizing Hypercoagulable Testing After
Ischemic Stroke in the Acute Setting – Barbara S.
Gordon-Kundu, Jennifer Picagli, Babar Khokhar
P16.7-002
Identifying Gaps and Closing Loops: A Process
Analysis of Neurology Resident Clinic Referrals –
Devin Kyle Leslie, Santiago Diaz, Susan K. Dubois,
Justin F. Rousseau
P16.7-003
Real-World Healthcare Costs and Resource
Utilization Among Patients Treated With
Erenumab in the United States: A Retrospective
Claims Database Study – Stewart J. Tepper, Todd
J. Schwedt, Pamela Vo, Parth Joshi, Mrudula
Glassberg, Ahmad Abdrabboh, Matias Ferraris,
Santosh Tiwari, Jeffrey Thompson
P16.7-004
B-Cell therapy Shared Medical Appointments
(BCSMA) lead to faster time to treatment and
less indirect care – Desiree Chizmadia, Deja Rose,
Jennifer Stack, Ambar Liriano, Jessica Glaser,
Mary R. Rensel
P16.7-005
Where Does the Search End? A Cost Analysis
of a Patient-Driven Work-Up of Potential
Dysautonomia – Danielle M. Stember
AAN.com/AM 89
 Poster Session 16
8 Epilepsy/Clinical Neurophysiology
(EEG)
Epilepsy/Clinical Neurophysiology (EEG):
EEG 2
P16.8-001
An EEG-Based Machine Learning Classifier
To Differentiate Hippocampal-Coupled Sleep
Spindles In Humans – Bryan Baxter, Sheraz Khan,
Megan Thompson, Kristi Kwok, Bailey Driscoll,
Rudra Patel, Matti Hamalainen, Catherine J Chu,
Dara Sue Manoach
P16.8-002
Localization of Inter-ictally Silent (IIS) Drug
Resistant Focal Epilepsies (DRE) – Ifrah Zawar,
Ping Liu, Richard C. Burgess, Andreas V.
Alexopoulos, Vineet Punia
P16.8-003
Benign Variants on Intracranial EEG- A Systemic
Review. – Rawan Mahgoub, Ahmed S Taha, Efe
Fakir, Rafeed Alkawadri
P16.8-004
EEG Signatures of Delirium and Coma in
Mechanically Ventilated ICU Patients –
Shawniqua Williams Roberson, Kevin C. Zhang,
Fei Ye, Pratik P Pandharipande, Nathan Brummel,
Mayur Patel, James C. Jackson, E. Wesley Ely
P16.8-005
Role of EEG in the diagnosis of spells of elevated
intracranial pressure – Mohamed Nasser, Zubeda
B. Sheikh
P16.8-006
The Efficacy of CERIBELL in Acute Neurological
Conditions in the Emergency Room – Iftekhar
Ahmed, Ramya Chilappa
P16.8-007
Cefalexin-Induced Electroencephalography
Changes Mimicking Creutzfeldt-Jakob disease –
Siobhan Delaney, Padraigin O’Sullivan, Jennifer
Margaret Dineen, Brian McNamara, Orna O’Toole
9
Neuro-oncology
Observations in Neuro-oncology 2
P16.9-001
CNS Lymphoma Presenting as Cavernous Sinus
Syndrome – Nathan Lightfoot, Bilaal Sirdar
P16.9-002
Two Rare Cases of Glioma in Total Spine with
Metastases to Brain – Daniel Minsuk Oh, Pegah
Kahaliardabili, Brooke Lauren Guerrero, Frances
E. Chow
P16.9-003
Isolated Oxaliplatin Induced Lhermitte’s sign in
Rectal Cancer – Hadi Mohammad-Khanli
90 2022 AAN Annual Meeting
Thursday, April 7 8:00 a.m.–9:00 a.m.
P16.9-004
Methotrexate Induced CNS Neurotoxicity: Is It
Always Leukoencephalopathy? – Syeda Manahil
Haider Jeoffrey, Muhammad Taqi, Hisham Raza
Alim Salahuddin
P16.9-005
The Concomitant Incidence of Multiple Sclerosis
and Primary CNS Tumors Leading to Treatment
Dilemma. – Sandeep Gill, Muhammad Taimur
Ahmad Malik
P16.9-006
A Case of Myasthenia Gravis and Myositis after
Immunotherapy and COVID Vaccine – Nelitza
Ivemaris Rivera Vega, Karin Woodman
P16.9-007
Efficacy and Safety of Amantadine in Cerebellar
Mutism Syndrome - a Pediatric Case Series –
Sarah Ghattas, Deborah M. Cassidy, Eileen Shieh,
Gurcharanjeet Kaur
10
Cerebrovascular Disease and
Interventional Neurology
Cerebrovascular Disease: Clinical
Science 6
P16.10-001
Living with Children Improved Functional Recovery
Post-Stroke – Dalton Akeim George, Antonio
Bustillo, Adina Zeki Al Hazzouri, Scott Brown,
Carolina Gutierrez, Chuanhui Dong, Kefeng Wang,
Gillian L. Gordon-Perue, Erika Tatiana Marulanda-
Londono, Jose Gabriel Romano, Tatjana Rundek,
Ralph L. Sacco, Hannah Gardener
P16.10-002
Determination of Prevalence of Posterior
Reversible Encephalopathy Syndrome (PRES)
and Its Association with Cerebral Infarction, and
Outcome in the Nationwide Inpatient Sample,
2016-2018 – Prabandh Reddy Buchhanolla,
Shyamal Chandra Bir, Alexis Angelette, Annie
Lewis, Sandeep Kandregula, Bharat Guthikonda,
Vijayakumar Javalkar, Oleg Y. Chernyshev, Roger
E. Kelley
P16.10-003
Cerebral Hemodynamic Evaluation in Children
with Sickle Cell Disease in India – Erum Khan,
Bhakti Gajjar, Pranita Sharma, Pawan Jain, Vikas
Goyal, Arvind Neral, Arvind Sharma, Sanjay
Sharma, Vijay K. Sharma
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
Cerebrovascular Disease: Secondary
Prevention
P16.10-004
The Incidence and Clinical Outcomes of Acute
Ischemic Strokes in Patients with Atrial Fibrillation
on long term Oral Anticoagulation at OLSU-S
– Junaid Ansari, Prabandh Reddy Buchhanolla,
Amir Neshatfar, Arvin Parvathaneni, Rachel E.
Triay, Alexandra Gaudet, Nimer Abushehab,
Hugo Cuellar-Saenz, Roger E. Kelley, Vijayakumar
Javalkar
P16.10-005
Analysis of Ischemic Stroke Cases Eligible for
Novel Treatment of Hypertriglyceridemia – Adam
Peter Klein, Karen Yarbrough, Prachi Mehndiratta,
Carolyn Cronin, John Cole, Marcella A. Wozniak,
Steven J. Kittner, Seemant Chaturvedi
P16.10-006
Cost effectiveness of smoking-cessation
interventions following ischemic stroke and
transient ischemic attack – Paul Wechsler, Ava L.
Liberman, Daniel Restifo, Erika Lauren Abramson,
Babak Navi, Hooman Kamel, Neal S. Parikh
P16.10-007
Antiplatelets Versus Anticoagulants in
Cervical Artery Dissection: A Meta-analysis –
Abdulrahman Ibrahim Hagrass, Bashar Khaled
Almaghary, Amira Abo Hegil Abo Ali, Mohammed
Tarek Elgammal, Mohammed Al-kafarna,
Aboalmagd Hamdallah, Sarah Makram Makram,
Khaled Mohamed Ragab, Mohamed Abdelhady
Abdelsadik Mostafa, Mohamed Fahmy Doheim
P16.10-008
Morbidity and Mortality of Breakthrough Strokes
in Patients on Novel Oral Anticoagulants –
Christina Xia, Bhavya Narapureddy, Christina
Delnero, Allen J. Hoste, Fiorella Guido, Hesham
Masoud
P16.10-009
Predictors of Very Early Stroke Recurrence in
the POINT Trial Population – James R. Brorson,
Natalie Monique Bourand
P16.10-010
Larger Functional Shunts are associated with
greater Cerebrovascular Disease Burden – Nancy
Gadallah, Danisette Torres, Arifa Ghori, Laura
Suhan, Spozhmy Panezai, Siddhart Kumar Mehta,
Farah Yolanda Fourcand, Jawad F. Kirmani
 Poster Session 16
11
Movement Disorders
Movement Disorders: COVID,
Telemedicine, and Community 2
P16.11-001
A pilot study on the effect of a community-based
boxing program on Parkinson’s disease – Roshni
A. Patel, Lucia Blasucci, Abhimanyu Mahajan
P16.11-002
Clinical Trial Recruitment of Individuals with
Parkinson’s Disease in a Community Setting: A
Case Study – Sarah Ingersoll, Brian Alexander
Cohn, Melissa Trieu, Kenneth Hayashida
Movement Disorders: Atypical Movement
Disorders 2
P16.11-003
Sensitivity and Specificity of the 2008 Diagnostic
Criteria for Multiple System Atrophy – A
Clinicopathological Study – Guillaume Lamotte,
Farwa Ali, J. Eric Ahlskog, James H. Bower, Anhar
Hassan, Bradley F. Boeve, William P. Cheshire,
Dennis W. Dickson, Joseph E. Parisi, Keith A.
Josephs, Ann M. Schmeichel, Phillip A. Low,
Wolfgang Singer, Elizabeth A. Coon
P16.11-004
Primary lateral sclerosis presenting as atypical
parkinsonism: a clinical challenge – Aya
Murakami, Shinsuke Fujioka, Shunsuke Koga,
Kevin Bieniek, Masataka Nakamura, Yoshio Tsuboi,
Melissa Murray, Zbigniew K. Wszolek, Dennis W.
Dickson
P16.11-005
Diversity of Ethnic Background among Progressive
Supranuclear Palsy and its Predominant Variants
– Juan Blas Couto, Susan Fox, Carmela Tartaglia,
Gabor G. Kovacs, Anthony E. Lang
P16.11-006
Brain-first Versus Body-first Synucleinopathies:
A Population-based Cohort Study – Pierpaolo
Turcano, Emanuele Camerucci, Aidan Mullan,
Cole Daniel Stang, Delana Weis, Bradley F. Boeve,
James H. Bower, J. Eric Ahlskog, Rodolfo Savica
P16.11-007
Long-term follow-up of “brain-first/body-first”
Lewy body diseases – Abhishek Lenka, David S.
Goldstein
P16.11-008
Manganese-Induced Parkinsonism - A Case Series
– Butchi Raju Garuda, Gopi Seepana, Talabhaktula
Sateesh Kumar, Arunakumari Upputuri
Information is accurate as of February 8, 2022, and is subject to change.
Thursday, April 7 8:00 a.m.–9:00 a.m.
12 Neuro-ophthalmology/Neuro- P16.13-005
otology Dual energy X-ray absorptiometry to measure lean
muscle mass in FSHD – Leo Hong-Li Wang, Anna
Neuro-ophthalmology and Neuro-otology Faino, Sarah J. Lowry, Katy Eichinger, Michael
Research: Ocular Motor and Vestibular 2 McDermott, Kiley Higgs, Michaela Walker, Leann
P16.12-001 Lewis, William Martens, Doris G. Leung, Sabrina
Idiopathic Orbital Inflammatory Syndrome Sacconi, Karlien Mul, Valeria A. Sansone, Perry
Masquerading as Isolate Nerve Palsy, A Case Shieh, Bakri Elsheikh, Samantha Jo LoRusso,
Series – Divya Nayar, Sehneet Grewal, Arvind Russell Butterfield, Nicholas Elwood Johnson,
Prabhu Carmelo Messina, Alrabi Tawil, Jeffrey Statland
P16.12-002 P16.13-006
VRDN-001: a Novel IGF-1R Monoclonal Antibody COL6A2 mutation (G733R) in an Argentine
for Treatment of Thyroid Eye Disease: Adaptive family with Bethlem myopathy diagnosed during
Design Strategy for Clinical Development – Mark adulthood – Micaela Kennedy, Jose M Pastor-
L. Moster, Barrett Katz Rueda, Claudia Cejas, Fabio Adrian Barroso,
Horacio Martinetto, Gustavo Sevlever
P16.12-003
P16.13-007
Migraine and Association of Benign Paroxysmal
Positional Vertigo: A Large Tertiary University RBCK1-Associated Polyglucosan Body Myopathy
Medical Center Review – Sarah Goh, Natalia Presenting with Mild Weakness and Pain: A Case
Murinova, Ami Zarrillo Cuneo, Daniel Krashin Report – Sanket Aggarwal, Ryan David Jacobson,
Richard Dineen, Peter Pytel
P16.12-004
P16.13-008
Extracranial venous compression in persistent
oscillating vertigo – Lindsey Randall, Jeffrey Riley Glycogen Accumulation in GNE Myopathy – Andre
Granger, Margherita Milone, Marcus Vinicius
P16.12-005 Rocha Pinto, Teerin Liewluck
Tele-Neuro-Ophthalmology: An Update One Year
P16.13-009
Into The COVID-19 Pandemic – Adrienne Ng,
Heather Moss, Kevin Lai, Melissa W. Ko Congenital cataracts, slow relaxation of handgrip,
and electrical myotonia; mimicking myotonic
dystrophy. – Melissa Cook, Georgios Manousakis,
Teerin Liewluck, Pitcha Chompoopong
13 Neuromuscular and Clinical
Neurophysiology (EMG) P16.13-010
Importance of Muscle biopsy in a case of
Neuromuscular Disease: Acquired dysferlinopathy with novel gene mutation –
Myopathies 2 Hasnain Arshad, Leila Darki, Said R. Beydoun
P16.13-001
To compare the performance of various
classification criteria in patients of idiopathic
inflammatory myopathies in South Asian
population. – Yogeesh P M, Vishnu VY, Padma
Vasantha Hadakasira, Rohit Bhatia, Mamta
Bhushan Singh, Roopa Rajan, Awadh K. Pandit,
Rajesh Kumar Singh, Mehar Chand Sharma
P16.13-002
Statin Associated Necrotizing Autoimmune
Myositis and p-ANCA Vasculitis: A Rare Case
Report – Chantal Bhan, Paul T. Twydell
P16.13-003
Lower Extremity Muscle Fat Fraction in Myotonic
Dystrophy Type 2 – Associations with Physical
Performance – Diana Alejandra Madrid, Rebecca
Knapp, Delanie Lynch, Paula R. Clemens, Ashley A.
Weaver, Araya Puwanant
P16.13-004
Hereditary myopathies in Mexican population:
experience from a tertiary neuromuscular center.
– Eunice Martínez Jiménez, Juan Carlos Lopez,
Adib Jorge De Sarachaga, Anna Lisette Bazan,
Elizabeth Leon, Edwin S. Vargas
AAN.com/AM 91
TURN LIFE WITH LEMS INTO

WITH FIRDAPSE ® (AMIFAMPRIDINE)

“It’s so easy to do the simple things

again. I can walk, take the stairs,
and do things with the grandkids.”
—Pat, managing her LEMS with FIRDAPSE.
Individual results may vary.

The recommended first-line treatment for adults

with Lambert-Eaton myasthenic syndrome (LEMS)1

Clinically proven to help patients maintain muscle strength and mobility2-4

Learn the hallmark signs of LEMS and the definitive diagnostic

tests that can help you change the lives of undiagnosed patients.

INDICATIONS AND USAGE:

FIRDAPSE is a potassium channel blocker indicated for the treatment of Lambert-Eaton myasthenic
syndrome (LEMS) in adults.

SELECTED IMPORTANT SAFETY INFORMATION

FIRDAPSE can cause seizures. Do not use FIRDAPSE in patients with a history of seizures, or with
a hypersensitivity to amifampridine or another aminopyridine.

Please see Brief Summary of full Prescribing Information on the next page.
References: 1. Yoon CH, Owusu-Guha J, Smith A, Buschur P. Amifampridine for the management of Lambert-Eaton myasthenic syndrome: a new take on an old drug. Ann
Pharmacother. 2020;54(1):56-63. 2. Full Prescribing Information for FIRDAPSE (amifampridine). Catalyst Pharma; 2021. 3. Shieh P, Sharma K, Korhman B, Oh SJ. Amifampridine
phosphate (FIRDAPSE) is effective in a confirmatory phase 3 clinical trial in LEMS. J Clin Neuromuscul Dis. 2019;20(3):111-119. 4. Oh SJ, Scherbakova N, Kostera-Pruszczyk A,
et al; LEMS Study Group. Amifampridine phosphate (FIRDAPSE®) is effective and safe in a phase 3 clinical trial in LEMS. Muscle Nerve. 2016;53(5):717-725.

FIRDAPSE® is a registered trademark of SERB.

© 2022 Catalyst Pharmaceuticals, Inc. All Rights Reserved.
Printed in USA. 22LEM0795 February 2022

FIRDAPSE® (amifampridine) tablets for oral use
BRIEF SUMMARY OF FULL PRESCRIBING
INFORMATION FOR FIRDAPSE
INDICATIONS AND USAGE
FIRDAPSE is a potassium channel blocker indicated
for the treatment of Lambert-Eaton myasthenic
syndrome (LEMS) in adults.
DOSAGE AND ADMINISTRATION
• The recommended starting dosage is 15 mg to
30 mg daily taken orally in divided doses (3 to 4
times daily)
- Starting dosage is 15 mg daily for patients with
renal impairment, hepatic impairment, and
in known N-acetyltransferase 2 (NAT2) poor
metabolizers
• Dosage can be increased by 5 mg daily every
3 to 4 days
• Dosage is not to exceed a maximum of 80 mg daily
• The maximum single dose is 20 mg
CONTRAINDICATIONS
FIRDAPSE is contraindicated in patients with:
• A history of seizures
• Hypersensitivity to amifampridine phosphate or
another aminopyridine.
WARNINGS AND PRECAUTIONS
Seizures
FIRDAPSE can cause seizures. Seizures have been
observed in patients without a history of seizures
taking FIRDAPSE at the recommended doses, at
various times after initiation of treatment, at an
incidence of approximately 2%. Many of the patients
were taking medications or had comorbid medical
conditions that may have lowered the seizure
threshold. Seizures may be dose-dependent. Consider
discontinuation or dose-reduction of FIRDAPSE in
patients who have a seizure while on treatment.
FIRDAPSE is contraindicated in patients with a
history of seizures.
Hypersensitivity
In clinical trials, hypersensitivity reactions and
anaphylaxis associated with FIRDAPSE administration
have not been reported. Anaphylaxis has been
reported in patients taking another aminopyridine;
therefore, it may occur with FIRDAPSE. If anaphylaxis
occurs, administration of FIRDAPSE should be
discontinued and appropriate therapy initiated.
ADVERSE REACTIONS
The following serious adverse reactions are described
elsewhere in the labeling:
• Seizures
• Hypersensitivity
Clinical Trials Experience
Because clinical trials are conducted under widely
varying conditions, adverse reaction rates observed
in the clinical trials of a drug cannot be directly
compared to rates in the clinical trials of another drug
and may not reflect the rates observed in practice.
In controlled and uncontrolled trials (Study 1 and 2)
in patients with LEMS, 63 patients were treated with
FIRDAPSE, including 40 patients treated for more
than 6 months, and 39 patients treated for more
than 12 months. In an expanded access program,
139 patients with LEMS were treated with FIRDAPSE,
including 102 patients treated for more than 6
months, 77 patients treated for more than 12 months,
and 53 patients treated for more than 18 months.
Study 1 was a double-blind, placebo-controlled,
randomized discontinuation study in adults with
LEMS. Following an initial open-label run-in phase
(up to 90 days), patients were randomized to either
continue FIRDAPSE treatment or transition to placebo
for a 14-day double-blind phase. Following final
assessments, patients were allowed to resume
FIRDAPSE treatment for up to 2 years (open-label,
long-term safety phase of the study).
During the open-label run-in phase of Study 1,
53 patients received FIRDAPSE for an average of 81
days at an average daily dosage of 50.5 mg/day. The
average patient age was 52.1 years and 66% were
female. There were 42 patients who had no prior
exposure to FIRDAPSE at the initiation of this study.
Table 1 shows adverse reactions with an incidence
of 5% or greater occurring in the 42 LEMS patients
newly initiated on treatment with FIRDAPSE during
the run-in phase of the study.
Table 1. Adverse Reactions in ≥5% of LEMS
Patients Newly Treated with FIRDAPSE in Study 1
FIRDAPSE
ADVERSE REACTION N=42
% needed based on clinical effect and tolerability.
Paresthesia* 62
Upper respiratory tract infection 33
Abdominal pain 14
Nausea 14
Diarrhea 14
Headache 14
Elevated liver enzymes** 14
Back pain 14
Hypertension 12
Muscle spasms 12
Dizziness 10
Asthenia 10
Muscular weakness 10
Pain in extremity 10
Cataract 10
Constipation 7 (0, 7.5, 22.5, or 75 mg/kg/day) to female rats
Bronchitis 7
Fall 7 increase in stillbirths and pup deaths, reduced pup
Lymphadenopathy 7
*Includes paresthesia, oral paresthesia, oral
hypoesthesia
**Includes elevated alanine aminotransferase
(ALT), aspartate aminotransferase (AST), lactate
dehydrogenase (LDH), and gamma-glutamyl
transferase (GGT)
Other Adverse Reactions
In the overall population treated in Study 1 (n=53),
including the double-blind phase and the 2-year
open-label long-term safety phase, additional
adverse reactions occurring in at least 5% of the
patients included: dyspnea, urinary tract infection,
gastroesophageal reflex, insomnia, peripheral edema,
pyrexia, viral infection, blood creatine phosphokinase
increase, depression, erythema, hypercholesterolemia,
and influenza. These patients received an average
daily dosage of 66 mg of FIRDAPSE.
DRUG INTERACTIONS
Drugs that Lower Seizure Threshold
The concomitant use of FIRDAPSE and drugs that
lower seizure threshold may lead to an increased risk
of seizures. The decision to administer FIRDAPSE
concomitantly with drugs that lower the seizure
threshold should be carefully considered in light of
the severity of the associated risks.
Drugs with Cholinergic Effects
The concomitant use of FIRDAPSE and drugs
with cholinergic effects (e.g., direct or indirect
cholinesterase inhibitors) may increase the
cholinergic effects of FIRDAPSE and of those drugs
and increase the risk of adverse reactions.
USE IN SPECIFIC POPULATIONS
Pregnancy
Pregnancy Exposure Registry
There is a pregnancy exposure registry that monitors
pregnancy outcomes in women exposed to FIRDAPSE
during pregnancy. Physicians are encouraged to
enroll pregnant patients, or pregnant women may
register themselves in the registry by calling
855-212-5856 (toll-free), using the Fax number
877-867-1874 (toll-free), by contacting the
Pregnancy Coordinating Center at
firdapsepregnancyregistry@ubc.com or by visiting the
study website at www.firdapsepregnancystudy.com.
Risk Summary
There are no data on the developmental risk
associated with the use of FIRDAPSE in pregnant
women. In animal studies, administration of
amifampridine phosphate to rats during pregnancy
and lactation resulted in developmental toxicity
(increase in stillbirths and pup deaths, reduced pup
weight, and delayed sexual development) at doses
associated with maternal plasma drug levels lower
than therapeutic drug levels (see Animal Data). In the
U.S. general population, the estimated background
risk of major birth defects and miscarriage in
clinically recognized pregnancies is 2-4% and
15-20%, respectively. The background risk of major
birth defects and miscarriage for the indicated
population is unknown.
Data
Animal Data
Oral administration of amifampridine phosphate
(0, 7.5, 22.5, or 75 mg/kg/day) to female rats prior
to and during mating and continuing throughout
organogenesis produced no adverse effects on
embryofetal development. Plasma amifampridine
exposure (AUC) at the highest dose tested is
approximately 7 times that in humans at the
maximum recommended human dose (MRHD) of
80 mg amifampridine/day. Oral administration of
amifampridine phosphate (0, 9, 30, or 57 mg/kg/day)
to pregnant rabbits throughout organogenesis
produced no adverse effects on embryofetal
development. The highest dose tested is
approximately 7 times the MRHD (80 mg/day
amifampridine) on a body surface area (mg/m2) basis.
Oral administration of amifampridine phosphate
throughout pregnancy and lactation resulted in an
weight, and delayed sexual development in female
pups at the mid and high doses tested. The no-effect
dose (7.5 mg/kg/day amifampridine phosphate) for
adverse developmental effects is associated with a
plasma amifampridine exposure (AUC) less than that
in humans at the MRHD.
Lactation
Risk Summary
There are no data on the presence of FIRDAPSE in
human milk, the effects on the breastfed infant, or
the effects on milk production. The developmental
and health benefits of breastfeeding should be
considered along with the mother’s clinical need
for FIRDAPSE and any potential adverse effects on
the breastfed infant from FIRDAPSE or from the
underlying maternal condition.
In lactating rat, amifampridine was excreted in milk
and reached levels similar to those in maternal plasma.
Pediatric Use
Safety and effectiveness in pediatric patients have
not been established.
Geriatric Use
Clinical studies of FIRDAPSE did not include
sufficient numbers of subjects aged 65 and over
(19 of 63 patients in Studies 1 and 2) to determine
whether they respond differently from younger
subjects. Other reported clinical experience has
not identified differences in responses between
the elderly and younger patients. In general, dose
selection for an elderly patient should be cautious,
usually starting at the low end of the dosing range,
reflecting the greater frequency of decreased hepatic,
renal, or cardiac function, and of concomitant
disease or other drug therapy.
Renal Impairment
Renal clearance is an elimination pathway for
amifampridine and the inactive metabolite,
3-N-acetyl amifampridine, and exposure of
amifampridine is higher in subjects with renal
impairment. Therefore, in patients with renal
impairment, FIRDAPSE should be initiated at the
lowest recommended starting dosage (15 mg/day),
and patients should be closely monitored for
adverse reactions. Consider dosage modification
or discontinuation of FIRDAPSE for patients with
renal impairment as needed based on clinical
effect and tolerability. The safety, efficacy, and
pharmacokinetics of amifampridine have not been
studied in patients with end-stage renal disease
(CLcr <15 mL/min or patients requiring dialysis).
No dosage recommendation for FIRDAPSE can be
made for patients with end-stage renal disease.
Hepatic Impairment
The effects of FIRDAPSE have not been studied in
patients with hepatic impairment. FIRDAPSE is
extensively metabolized by N-acetyltransferase 2
(NAT2) and hepatic impairment may cause an
increase in exposure. Therefore, initiate FIRDAPSE
in patients with any degree of hepatic impairment
at the lowest recommended starting dosage
(15 mg/day) and monitor for adverse reactions.
Consider dosage modification or discontinuation of
FIRDAPSE for patients with hepatic impairment as
NAT2 Poor Metabolizers
Exposure of FIRDAPSE is increased in patients who
are N-acetyltransferase 2 (NAT2) poor metabolizers.
Therefore, initiate FIRDAPSE in patients who
are known NAT2 poor metabolizers at the lowest
recommended starting dosage (15 mg/day) and
monitor for adverse reactions. Consider dosage
modification of FIRDAPSE for patients who are known
NAT2 poor metabolizers as needed based on clinical
effect and tolerability.
PATIENT COUNSELING INFORMATION
Advise the patient and/or caregiver to read the
FDA-approved patient labeling (Medication Guide).
Risk of Seizures
Inform patients that FIRDAPSE can cause seizures,
and to notify their healthcare provider if they
experience a seizure.
Hypersensitivity
Instruct patients to inform their healthcare provider
if they have signs or symptoms of hypersensitivity,
and to seek emergency help if symptoms of
anaphylaxis occur.
FIRDAPSE Dosing
Instruct patients to take FIRDAPSE exactly as
prescribed. Patients should carefully follow the dose
escalation schedule provided by their healthcare
provider to safely achieve the therapeutic dosage.
Inform patients that the tablets may be divided in
half at the score, if needed. Instruct patients not to
take a double dose to make up for a missed dose.
Drug Interactions
Instruct patients to notify their healthcare provider
prior to starting any new medication, including
over-the-counter drugs.
Pregnancy
Instruct patients that if they are pregnant or plan to
become pregnant while taking FIRDAPSE they should
inform their healthcare provider. Advise patients that
there is a pregnancy registry that monitors pregnancy
outcomes in women exposed to FIRDAPSE during
pregnancy and encourage them to enroll if they
become pregnant while taking FIRDAPSE
[see Use in Specific Populations (8.1) of full
Prescribing Information].
Storage
Advise patients to store FIRDAPSE at 68°F to 77°F
(20°C to 25°C).
Distributed by Catalyst Pharmaceuticals, Inc.,
Coral Gables, FL 33134.
FIRDAPSE® is a registered trademark of SERB.
Catalyst and the Catalyst logo are trademarks
of Catalyst Pharmaceuticals, Inc.
© 2022 Catalyst Pharmaceuticals, Inc.
All Rights Reserved.
 Poster Session 17
1 Autoimmune Neurology
Autoimmune Neurology: Clinical
Observations 5
P17.1-001
Anti-hu Associated Encephalomyelitis as a
presentation of Primary Extrapulmonary Small
Cell Carcinoma of the Small Bowel – Vincent
Trung Huu Ngo, Kasim Qureshi, Michael Meyers,
Muhammad Farooq
P17.1-002
A Tale of 2 Leukodystrophies in DOCK8 Deficiency,
a Rare Primary Immunodeficiency – Ariane
Soldatos, Irene CM Cortese, Anita M. Fletcher,
Corina Gonzalez, Alexandra Freeman
P17.1-003
Neurologic manifestations of Degos disease –
Sasha Zivkovic, Tawfiq Al-Lahham, David Lacomis
P17.1-004
Mast cell activation syndrome, Mannose
binding lectin, Ehlers-Danlos syndrome, and
Neuropsychiatric symptoms. – Ilene S. Ruhoy,
Isabelle Brock, Anne Maitland
1 Neuromuscular and Clinical
Neurophysiology (EMG)
Autonomic Disorders 1
P17.1-005
COVID-Long Haulers Can Develop POTS (Postural
Orthostatic Tachycardia Syndrome) with Small
Fiber Neuropathy and Abnormal Autonomic
Testing – Christopher John Cantrell, Robert G.
Wilson
P17.1-006
Case series: A review of three patients with
autonomic dysfunction and positive TS-HDS or
FGFR3 antibodies – Raeann Bourscheid, Sonesh
Dilip Amin, Peter Eric Hauer, Melissa M. Cortez,
Kelsey Rachel Juster-Switlyk
P17.1-007
Demonstrating New-onset or Worsened
Sudomotor Function post COVID-19. – Aditi Vian
Varma-Doyle, Nicole Villemarette-Pittman, Paul
Andrew LeLorier, Noah Blackstone Reeves, John
D. England
94 2022 AAN Annual Meeting
Thursday, April 7 11:45 a.m.–12:45 p.m.
2 Headache
Headache and Population Health 3
P17.2-001
Prescription Opioids in Patients With Migraine
in Southern Israel: a Retrospective Database
Analysis – Mohnnad Asla, Iso Peles, Mariya
Abayev, Michal Gordon, Victor Novack, Rinat
Ribalov, Tamar Lengil, Ron Maor, Mayera Elizur,
Gal Ifergane
P17.2-002
Unmet Treatment Needs in Migraine Among
Those Seeking Care from Neurologists or
Headache Specialists: Results of the OVERCOME
US study – Michael L. Reed, Elizabeth Johnston,
Robert A. Nicholson, Dawn C. Buse, Anthony J
Zagar, Sait Ashina, Susan Hutchinson, Robert E.
Shapiro, Eric M. Pearlman, Richard B. Lipton
P17.2-003
Perspectives From Members of an Online
Community on Their Communications With Health
Care Professionals About Migraine Treatment: A
Social Listening Analysis – Edward Kim, Heather
Lapidus Glassner, Jaclyn Klepper, Jessica Cirillo
P17.2-004
Migraine Epidemiology in Southern Israel: A
Retrospective Database Study – Iso Peles,
Mohnnad Asla, Mariya Abayev, Michal Gordon,
Victor Novack, Rinat Ribalov, Tamar Lengil, Ron
Maor, Mayera Elizur, Gal Ifergane
P17.2-005
Employability, Work Difficulties and Factors
Impacting Chronic Migraine Patients of Hawaii:
Results of a Quality Improvement Survey –
Michelle Stafford, Tracy Van, Rachel Gorenflo,
Frances Tiffany Morden, Kara Ushijima, Ashley
Ung, Emma Sage Inouye, Uiyeol Yoon, Vimala
Sravanthi Vajjala, Enrique Carrazana, Kore K. Liow
P17.2-006
Direct Health Care Costs of Patients Suffering
With Migraine in Southern Israel: a Retrospective
Database Analysis – Iso Peles, Mariya Abayev,
Michal Gordon, Victor Novack, Rinat Ribalov,
Tamar Lengil, Ron Maor, Mayera Elizur, Lynda
Krasenbaum, Gal Ifergane
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
3 Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Clinical Aspects 3
P17.3-001
Cerebellar infarcts are associated with a
higher frequency of dementia and decreased
performance in cognitive domains of memory,
attention, and language. – Camilo Bermudez,
Sheela Raghavan, Mary M. Machulda, Scott
Przybelski, Ekaterina Hofrenning, Timothy
Lesnick, David S. Knopman, Ronald C. Petersen,
Petrice Mostardi Cogswell, Michelle M. Mielke,
Prashanthi Vemuri, Clifford R. Jack, Jonathan
Graff-Radford
P17.3-002
Assessing the Impact of Older Driver Visual and
Cognitive Impairment on Intersection Stopping
Behavior – Guillermo Basulto-Elias, Ashirwad
Barnwal, Anuj Sharma, Jennifer Merickel,
Matthew Rizzo, Shauna Hallmark
P17.3-003
Improvement of Quality of Life in Individuals with
Cognitive Impairment After Spiritual Support
Group – William G. Buxton, Traci Richelle Lyon,
David Merrill, Verna R. Porter, Mihae Kim, Claudia
Wong, Judy Weintraub, Jennifer Leigh Lisenby,
Anne C. Galbraith
P17.3-004
Bringing Art to Life: Growing Empathy Through Art
Therapy, Life Story and Relationships – Daniel C.
Potts, Neelum T. Aggarwal, Rebecca Mae Allen,
Keisha Carden, Angel Duncan
P17.3-005
INVOKE-2 - A Phase 2 Randomized, Double-Blind,
Placebo-Controlled Study to Evaluate the Efficacy
and Safety of AL002 in Participants with Early
Alzheimer’s Disease – Sam Jackson, Robert Paul,
Aashka Joshi, Yijie Liao, Glenn Morrison, Abe
Castro, Felix Leejia Yeh, Michael Ward
4 MS and CNS Inflammatory
Disease
MS Epidemiology and Prognosis
P17.4-001
Early Predictors of Disability in Paediatric Multiple
Sclerosis: Evidence from a Multi-National Registry
– Sifat Sharmin, Charles Malpas, Izanne Roos,
Ibrahima Diouf, Raed Alroughani, Serkan Ozakbas,
Guillermo Izquierdo Ayuso, Sara Eichau Madueño,
Dana Horakova, Eva Havrdova, Francesco Patti,
Murat Terzi, Cavit Boz, Bassem I. Yamout, Samia
J. Khoury, Marco Onofrj, Alessandra Lugaresi,
Ayse Altintas, Alexandre Prat, J M. Girard, Pierre
Duquette, Maria Jose Marques de Sa, Danielle
Spitareli, Youssef Sidhom, Riadh Gouider, Aysun
Soysal, Recai Turkoglu, Maria Pia Amato, Yara D.
Fragoso, Tomas Kalincik
 Poster Session 17 Thursday, April 7 11:45 a.m.–12:45 p.m.

P17.4-002
Early Treatment Can Postpone the Time to
Disability Pension in Relapsing-Remitting Multiple
Sclerosis – Malthe Faurschou Wandall-Holm,
Mathias Buron, Tine Iskov Kopp, Finn Sellebjerg,
Melinda Magyari
P17.4-003
Trajectories of disability and relapse-rate in
naïve patients on oral drugs: results from the
Italian Multiple Sclerosis Register – Alessia
Manni, Damiano Paolicelli, Giuseppe Lucisano,
Pietro Iaffaldano, Riccardo Sansone, Luca
Bollo, Francesco Patti, Carlo Pozzilli, Claudio
Gasperini, Giovanna De Luca, Vincenzo Brescia
P17.4-009
A Practical Approach to Longitudinal
Neurological Care of Adults With
X-linked Adrenoleukodystrophy and
Adrenomyeloneuropathy (X-ALD/AMN) –
Alexandra Behar Kornbluh, Jennifer Lauren
Orthmann Murphy
P17.4-010
The Diagnosis and Treatment of Epilepsy in
Patients with Multiple Sclerosis: a Case Series
from Argentina – Melanie Lara Sanchez, Abril
Marone, Mariano Marrodan, Jorge D. Correale
6
Neuro-rehabilitation
General Neuro-rehabilitation 3
P17.6-001
The Development of Phelan-McDermid-specific
anchors for the Clinical Global Impression Scales
– Elizabeth M. Berry-Kravis, Sandeep Valluripalli
Soorya, Alexander Kolevzon, Audrey Thurm, Nancy
Jones
Neuromodulation for Rehabilitation 1

Morra, Matilde Inglese, Giacomo Lus, Roberto
Bergamaschi, Ilaria Pesci, Paola Gazzola, Patrizia
Sola, Gioacchino Tedeschi, Massimo Filippi, Maria
Pia Amato, Maria Trojano
P17.4-004
The Impact of BMI on Brain Volume and Cognitive
Function in RRMS: A Secondary Analysis – Aliza
Ben-Zacharia, Malvin Janal, Abraham Brody, Jerry
S. Wolinsky, Fred D. Lublin, Gary Raymond Cutter
P17.4-005
5
Child Neurology and
Developmental Neurology P17.6-002
Decoding Speech from Human Motor Cortex Using
Child Neurology: SMA/DMD/Muscle 3 an Intracortical Brain Computer Interface – Daniel
Rubin, Tommy Hosman, Anastasia Kapitonava,
P17.5-001 John D. Simeral, Sydney Cash, Leigh R. Hochberg
Demographic and Clinical Profiles of Neonates
Diagnosed with Spinal Muscular Atrophy (SMA)
via the Kentucky Newborn Screening (NBS)
Program: A Two-Year Experience – Arpita
Lakhotia, David Toupin, Anna Rachele Thamann,
7 Practice, Policy, and Ethics

Analysis of Fertility Characteristics in Patients
with MS in NARCRMS Database – Celeste Fine,
Amber Peskin, John Gamba, Toni Saldana-King,
Raquel T. Brillante, Coraly Perez-Bajandas, Megan
Vignos
P17.4-006
Patterns of Healthcare Utilization and Expenditure
among People with Multiple Sclerosis in the
Age of Disease-Modifying Therapy: An Analysis
of Claim Data from a Commercially Insured
Population in the United States, 2010-2019 – Wen
Zhu, Zongqi Xia
P17.4-007
Long-term prognosis communication preferences
in early-stage relapsing-remitting multiple
sclerosis – Tamara Castillo-Trivino, Rocio Gomez,
Monica Borges, Jesus Manuel Martin Martinez,
Javier Sotoca, Ana María Alonso Torres, Ana
Belen Caminero Rodriguez, Laura Borrega Canelo,
Jose Luis Sanchez Menoyo, Francisco Barrero-
Hernandez, Carmen Calles, Luis Brieva Ruiz,
Rosario Blasco Quilez, Julio Dotor Garcia-Soto,
Maria Campo Amigo, Laura Navarro, Eduardo
Aguera Morales, Moises Garces Redondo, Olga
Carmona Codina, Gabaldon Torres Laura, Lucía
Forero, Mariona Hervas Pujol, Jorge Maurino,
Susana Sainz de la Maza
P17.4-008
Younger Age at Multiple Sclerosis Onset Is
Associated With Worse Outcomes at Age 50 –
Gauruv Bose, Brian Curran Healy, Bonnie Glanz,
Hrishikesh A. Lokhande, Mariann Polgar-Turcsanyi,
Charles R.G. Guttmann, Rohit Bakshi, Howard L.
Weiner, Tanuja Chitnis
Kelly Elaine Jackson, Darrin Sevier, Angela Ethics, Diversity & Research, Oh My... 1
Crutcher, Sainan Wei, Vaneet Arora, Alexander
Asamoah, William C. Robertson P17.7-001
P17.5-002 Gender Discrepancies in Neurologist
Case of a novel genotypic homozygous missense Compensation – Melissa Yu, Shannon Ashley
Merillat, Allison L. Weathers, David A. Evans,
mutation that disrupts oligomerization of SMN
protein and causes severe SMA Type 0 – Sonia Becky Wolf, John Ney
Ann Varghese, Yael Shiloh-Malawsky, Senyene P17.7-002
Hunter, Elizabeth Jalazo, Cynthia Marion Powell,
Demographic and Subsequent Funding Trends in
AG Matera, Zheng Fan the AAN Research Program (1996-2021) – Daniela
P17.5-003 Arantxa Pimentel Maldonado, Tachira Tavarez,
RAINBOWFISH: Preliminary Efficacy and Alejandro Vargas, Gabriel M. Moreno, Raelle
Tagge, Daniel Thomas Lackland, Bruce I. Ovbiagele
Safety Data in Risdiplam-Treated Infants with
Presymptomatic SMA – Richard S. Finkel, Michelle P17.7-003
A. Farrar, Dmitry Vlodavets, Laurent Servais, Edmar
Examining National Representativeness of the
Zanoteli, Mohammad A. F. Al-Muhaizea, Leslie Axon Registry – Andrew M. Wilson, Kavita Nair,
Nelson, Alexandra Prufer, Yi Wang, Carolyn Fisher,
Sarah M. Benish, Gregory J. Esper, Amanda
Marianne Gerber, Ksenija Gorni, Heidemarie Kletzl, Lien, Aristotle Mante, Karen Lundgren, Becky
Laura Palfreeman, Renata Scalco, Enrico Silvio
Schierman, John Ney
Bertini
P17.7-004
P17.5-004
An Ethical Approach to Detecting Covert
The Burden of Spinal Muscular Atrophy Type 1 Consciousness – Michael Young, Yelena Bodien,
(SMA1) on Caregivers in the United States (US): Leigh R. Hochberg, Brian Edlow
First Results of a Global Survey – Walter Toro
Jimenez, Anish Patel, Samuel Aballea, Anastasiia
Motrunich, Omar Dabbous
P17.5-005
CSF IL-8 as a potential marker for gene therapy
outcomes in Spinal Muscular Atrophy – Sumit
Verma, Kelsey Perry, J. Christina Howell, Raj
Razdan, Alice L. Dawson, William T. Hu

Information is accurate as of February 8, 2022, and is subject to change. AAN.com/AM 95

 Poster Session 17
8 9
Epilepsy/Clinical Neurophysiology
(EEG)
Epilepsy/Clinical Neurophysiology (EEG):
Epilepsy Co-morbidities 2
P17.8-001
Occurrence of cognitive impairment in older adult
patients with epilepsy – Jeongyeon Hwang,
Kristen Lucas, Rohit Ajay Marawar
P17.8-002
Patient-reported Outcomes in Mood, Fatigue,
Sleep Disturbance, and Disability While
on Brivaracetam Treatment: a Prospective
Observational Study – Hamada Hamid Altalib,
Jacqueline French, Michael R. Sperling, Heidi
L. Henninger, Hina N. Dave, Michael Gelfand,
Anne-Liv Schulz, Sami Elmoufti, Prashant Dongre,
Melinda S. Martin
P17.8-003
Time-course of Treatment-emergent Adverse
Events Potentially Associated with Behavioral
Disorders during Adjunctive Brivaracetam
Treatment of Adults with Focal Seizures – Kimford
J. Meador, Svetlana Dimova, Cedric Laloyaux,
Xavier Nondonfaz, Florin Floricel, Sami Elmoufti,
Pavel Klein
P17.8-004
Barriers to Breastfeeding Counseling in Women
with Epilepsy – Abrar Omar Al-Faraj, Jessica
LeClair, Rebecca M. Summit, Deeya Modhwadiya,
Isabelle Messina, Trudy Pang
P17.8-005
Preferences and Experiences of Women with
Epilepsy Regarding Sexual and Reproductive
Health Care – Laura Anne Kirkpatrick, Elizabeth Ivy
Harrison, Sonya Borrero, Anne R. Davis, Elizabeth
Miller, Yoshimi Sogawa, Olivia Stransky, Mehret
Birru, Alexandra Urban, Anne C. Van Cott, Traci
Kazmerski
P17.8-006
Quality of Life in People with Epilepsy:
a Population-Based Study in the Detroit
Metropolitan Area – Kristen Lucas, Maryam Jamil
Syed, Rohit Ajay Marawar, Maysaa Merhi Basha,
Deepti Zutshi
P17.8-007
Factors Associated with Depression in Epilepsy
Patients: a Population-Based Study in the Detroit
Metropolitan Area – Kristen Lucas, Maryam Jamil
Syed, Rohit Ajay Marawar, Maysaa Merhi Basha,
Deepti Zutshi
96 2022 AAN Annual Meeting
Thursday, April 7 11:45 a.m.–12:45 p.m.
Infectious Disease
Infectious Disease: Peripheral
Manifestations Take Center Stage in
COVID-19 2
P17.9-001
Atypical Pharyngo-Cervico-Brachial Variant of
GBS Associated with Covid-19 Antibodies – Butchi
Raju Garuda, Gopi Seepana, Talabhaktula Sateesh
Kumar, Arunakumari Upputuri
P17.9-002
Bilateral facial nerve palsy associated with
COVID-19 infections. – Karan Hingorani, Thomas
Ryan Ford, Pria Anand, Michelle Kaku
Infectious Disease: Bacteria, Fungi, and
Parasites on the Mind and Body 2
P17.9-003
Neurosyphilis: a challenging diagnosis – Blibeche
Hela, Khadija Sonda Moalla, Salma Sakka,
Sawsan Daoud, Yosra Mzid, Nadia Bouattour,
Mariem Damak, Nouha Farhat, Kheireddine Ben
Mahfoudh, Chokri Abdellaziz Mhiri
P17.9-004
CNS Tuberculosis Mimicking as Neurosarcoidosis:
A Diagnostic Quandary – Jacob Lowery, Soukaina
Noor, Laurel Officer
10 Cerebrovascular Disease and
Interventional Neurology
Cerebrovascular Disease: Clinical
Practice 1
P17.10-001
Decreasing Delayed Recognition, Diagnosis,
& Treatment of Ischemic Posterior Circulation
Strokes in The Emergency Department by
Improving Triage Screening in Patients Presenting
with Atypical Stroke Symptoms – Haley Ruth
Hamer, Vanessa Pabon
P17.10-002
Developing a Pilot Program to Increase Stroke
Education Among Internal Medicine Residents
– Gilad Muth, Rebecca Stainman, Triveni Abburi,
Jeffrey Farkas, Richard Libman
P17.10-003
Epidemiological Characteristics of Patients
Received Therapeutic Hypothermia Following
Acute Ischemic Stroke - a Nationwide Perspective
– Greshaben Patel, David Pielykh, Aakash Baskar,
Muhammad Imtiaz Tar, Chetna Dengri, Yogesh
Kothari, Renu Renu, Sogut Turkmen Aksoy,
Mohammed Rifat Shaik, Satish Tadepalli, Syed
Nazeer Mahmood, Amit Munshi Sharma, Appala
Suman Peela, Urvish K Patel, Shamik Shah
P17.10-004
Acute Ischemic Stroke in Young Adults – Narsis
Aminian, Nehaal Ahmed, Vivien H. Lee
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
Cerebrovascular Disease: Systems of Care
Research
P17.10-005
Clinical pharmacy services as part of the
Telehealth After Stroke Care in an underserved
setting: a feasibility study – Yuliya Baratt, Hanlin
Li, Neisha Patel, Kevin Strobino, Ian Kronish,
Mitchell S. V. Elkind, Imama Ali Naqvi
P17.10-006
Inclusion of Asymmetric Bilateral Weakness
Optimizes VAN Pre-hospital LVO Triage – Aaisha
Mozumder, Sujani Bandela, Lee Birnbaum
P17.10-007
Evaluation of A Pre-hospital Stroke Assessment’s
Ability to Identify Patients with Large Vessel
Occlusion (LVO) – Samadhi Thavarajah, Zachary
Langston, Adam Bayne Sarayusa, Shannon
Sternberg, Ashley Pulido, Neel N. Shah
P17.10-008
Completing the NIHSS Score Prior to CT Scan to
Reduce Time to Acute Intervention for Stroke: A
Quality Improvement Project – Paige Sutton, Kyle
Darpel, Margie Campbell, Jessica Doyle Lee, Kara
Jo Swafford
P17.10-009
Impact of Patient Transfer to an External ICU
Hospital for Post-Operative Monitoring after
Endovascular Intervention – Ankita Tripathi, John
Liang, Michael Graff Fara, Alexandra S. Reynolds,
Danielle Wheelwright
P17.10-010
Impact of Artificial Intelligence Stroke Software
on Detection of LVO Transfer Patients – Irma Nora
Duncan, Ermias Mekonnen Aytenfisu, Sohum
Desai, Michael Machiorlatti, Wondwossen G.
Tekle, Ameer Hassan
11 Movement Disorders
Movement Disorders: Ataxia and Tourette
1
P17.11-001
Beliefs about Tourette Syndrome in Adolescent
Patients with Tics – Jessica Frey, Tracy
Tholanikunnel, Heather Simpson, Irene Malaty
P17.11-002
Mini-Child Tourette Syndrome Impairment Scale
Scores in Functional versus Primary Tic Disorders
– Travis Larsh, Steve Wu, Donald Gilbert
 Poster Session 17 Thursday, April 7 11:45 a.m.–12:45 p.m.

Movement Disorders: Dystonia and P17.12-003 P17.13-006

Botulinum Toxin 2
P17.11-003
Real-world Experience with Botulinum Toxin A
for The Treatment of Hemifacial Spasm: A Study
of 1138 Injections – Samantha Anne Gutierrez,
Jeryl Ritzi Tan yu, Patrick Yalung, Roland Dominic
Jamora
P17.11-004
Real-world Botulinum Toxin Type A Treatment
Patterns in Patients with Spasticity – Daniel
Gratie, Daniel Mercer, Jae Hyun Lee, Patrick J.
Gillard
P17.11-005
Real-world Botulinum Toxin Type A Treatment
Patterns in Patients with Cervical Dystonia –
Daniel Gratie, Daniel Mercer, Jae Hyun Lee, Patrick
J. Gillard
P17.11-006
Impact of Disease Severity on Presentation
Subtype and OnabotulinumtoxinA Utilization in
Patients with Cervical Dystonia: Results from the
CD PROBE Completer Population – Pinky Agarwal,
Richard L. Barbano, Henry Paul Moore, Marc
Schwartz, Aleksej Zuzek, Atul T. Patel
P17.11-007
Current Perspectives on the Management of
Cervical Dystonia Among Global Clinicians – H.
A. Jinnah, Henrique Ballalai Ferraz, Stephanie
Standal, Pooia Fattahi, Aleksej Zuzek, Nabilah
Alibhai, Kate Merath
P17.11-008
EEG analysis of social cognition in cervical
dystonia – Rosalie Herings, Shameer Rafee, Sean
O’Riordan, Michael Hutchinson, Richard Reilly
Neurofilament light chain levels differentiate
between ischemic and inflammatory optic
neuropathies – Shailee Samir Shah, Sara
Mariotto, Elia Sechi, Sean J. Pittock, Eoin P.
Flanagan, M. Tariq Bhatti, John Chen
P17.12-004
A Randomized Prospective Trial Comparing
Repository Corticotropin Injection and Intravenous
Methylprednisolone for Neuroprotection in
Acute Optic Neuritis – Jeffrey L. Bennett, Nathan
C. Grove, Ruth K. Johnson, Christopher Steven
Mizenko, Joan DuPont, Brandie Wagner, Anne M.
Lynch, Teresa Frohman, Elliot M. Frohman, Kenneth
Shindler
P17.12-005
Cerebrospinal Fluid Biomarkers in Idiopathic
Intracranial Hypertension: An Exploratory
SWATH Proteomics analysis. – Awadh K. Pandit,
Shubham Misra, Rahul Chakraborty, Praveen
Singh, Gyaninder Pal Singh, Swati Phuljhele, Achal
K. Srivastava, Deepti Vibha, Ajay Garg, Dheeraj
Mohania
13
Health Care Disparities
Racial Disparities in Neurologic Care
P17.13-001
Health Disparities in African American Patients
with Multiple Sclerosis: A Retrospective Chart
Review Study – Elissa Dykes, William R. Meador,
Surachat Ngorsuraches
P17.13-002
Racial differences in trust and risk disclosure
preferences among older research volunteers
The Impact of Race and Ethnicity on Time to
Diagnosis of Multiple Sclerosis: Preliminary
Results – Jemima Akinsanya, Frances Andrada,
Karan Divyam Kawatra, Jenifer Dwyer, Joan M.
Ohayon, Daniel Reich, Irene CM Cortese, Shila
Azodi
13
Neuromuscular and Clinical
Neurophysiology (EMG)
Neuromuscular Disease: Inherited Muscle
Disorders 5
P17.13-007
Mitochondrial myopathies diagnosed in adulthood:
phenotypic spectrum and long-term outcomes –
Grayson Bernard Beecher, Elie Naddaf
P17.13-008
Adult Onset Multiple Acyl-CoA Dehydrogenase
Deficiency (MADD) Diagnostic Challenge – Jory
Liang, Jennifer A. Roggenbuck, Sarah Heintzman,
Bakri Elsheikh, Adam Quick
P17.13-009
DUX4 siRNA Optimization for the Development
of an Antibody-Oligonucleotide Conjugate (AOC)
for the Treatment of FSHD – Barbora Malecova,
David Sala, Garineh Mary Melikian, Gulin Erdogan,
Rachel Johns, Joanne Young, Erwann Ventre, Sole
Gatto, Matthew Onorato, Adam Pavlicek, Orsolya
Kiraly, Martin Koegler, Arthur A. Levin, Philipp
Hadwiger, William M. Flanagan

12 Neuro-ophthalmology/Neuro- screened for prodromal synucleinopathies – Carly

otology
Neuro-ophthalmology Research: Vision 1
P17.12-001
Deep Learning Can Accurately Distinguish
Between True Papilledema and Optic Disc Drusen
On Ocular Fundus Photographs – Valerie Biousse,
Raymond Najjar, Kanchalika Sathianvichitr, Zhiqun
Tang, Steffen Hamann, Clare Louise Fraser,
J. Alexander Fraser, Mung Yan Lin, Caroline
Vasseneix, Jason Peragallo, Fiona Evann Costello,
Tien Y. Wong, Nancy J. Newman, Dan Milea
Marshall, Isabelle Havis, Vikas Kotagal
P17.13-003
Brain Barriers: Elucidating Complex Language-
Based Barriers to Neurological Care in Limited-
English Proficiency, Refugee, and Immigrant
Populations – Alexandra Miner
P17.13-004
Improving MD-Patient Communication: Patient
satisfaction with communication during neurology
outpatient consultation in Cross-Cultural
Scenarios – Diana Andino, Anam Syed, Fady
Mousa-Ibrahim, Sean D. Ruland

P17.12-002
The Phase III REFLECT Trial: Efficacy and Safety
of Bilateral Gene Therapy for Leber Hereditary
Optic Neuropathy (LHON) – Nancy J. Newman,
Patrick Yu-Wai-Man, Valerio Carelli, Prem S.
Subramanian, Mark L. Moster, An-Guor Wang,
Sean Donahue, Bart Peter Leroy, Valerie Biousse,
Catherine Vignal-Clermont, Alfredo Sadun, Gema
Rebolleda, Elizabeth Fortin, Rudrani Banik, Laure
Blouin, Michel Roux, Magali Taiel, Jose-Alain
Sahel
Information is accurate as of February 8, 2022, and is subject to change.
P17.13-005
Racial Differences In Palliative Care Utilization
And Impact On Inpatient Mortality Length
Stay And Costs Among Patients With Ischemic
Stroke – Mohammad Rauf A. Chaudhry, Kahtan
Fadah, Danish Kherani, Baljinder Singh, Saqib A.
Chaudhry, Mohammad Ghatali, Anantha Ramana
Vellipuram, Paisith Piriyawat, Alberto Maud,
Gustavo J. Rodriguez, Isabel Victoria Narvaez-
Correa
AAN.com/AM 97
 Poster Session 18
1 2
Autoimmune Neurology
Autoimmune Neurology: Clinical
Observations 6
P18.1-001
Paraneoplastic Stiff Person Syndrome:
Persistence of Symptoms is Common Despite
Treatment of Underlying Malignancy – Alexandra
Christina Simpson, Danielle Obando, Alexandra
Balshi, Yujie Wang, Scott Douglas Newsome
P18.1-002
Powassan Encephalitis: A Case Report from Long
Island, New York, USA – Danielle Bazer, Matthew
Orwitz, Nicholas Koroneos, Olga Syritsyna,
Elizbieta Wirkowski
P18.1-003
Combined central and peripheral demyelination
syndrome after COVID-19 vaccination with brisk
response to plasma exchange and steroids –
William Hoffman, Morgan Christina Jordan,
Francis Cloran, John H. Sladky
P18.1-004
Characterization of Neurological Morbidity
Associated with Anti-Thyroid Antibodies:
Hashimoto’s Encephalopathy and Beyond – Mark
Phillips Figgie, Hannah Marie Kelly, Nataliya
Pyatka, Clara Chu, Hesham Ahmed Abboud
1 Neuromuscular and Clinical
Neurophysiology (EMG)
Autonomic Disorders 2
P18.1-005
Autonomic dysfunction following COVID-19
infection: an early experience – Kamal Shouman,
Greg S. Vanichkachorn, William P. Cheshire,
Mariana Suarez, Shahar Shelly, Guillaume
Lamotte, Paola Sandroni, Eduardo E. Benarroch,
Sarah E. Berini, Jeremy K. Cutsforth-Gregory,
Elizabeth A. Coon, Michelle L. Mauermann, Phillip
A. Low, Wolfgang Singer
P18.1-006
Mortality Risk Factors in Patients with Diabetic
Autonomic Neuropathy: Insights from a Structured
Clinical Documentation Toolkit – Alexandru C.
Barboi, Bruce A. Chase, Katerina Markopoulou,
Roberta Frigerio, Sylwia Pocica
P18.1-007
Mycoplasma Pneumoniae Infection Associated
with Autoimmune Small Fiber Neuropathy and
Postural Orthostatic Tachycardia Syndrome (POTS)
– Kamal R. Chemali, Andrew Sandefer
98 2022 AAN Annual Meeting
Thursday, April 7 5:30 p.m.–6:30 p.m.
Global Health
Global Neurology
P18.2-001
Accuracy of Automated Analyzers for the
Estimation of CSF Cell Counts: A Systematic
Review and Meta-Analysis – Greer Waldrop,
Kaitlyn Cocuzzo, Colleen Louise Schneider, Carla
Kim, Teddy G. Goetz, Mashina Chomba, Marie
Smithgall, Kiran Thakur
P18.2-002
Authorship Diversity in Cochrane Systematic
Reviews of Stroke: Inequities in Global
Representation – Vivek Bhat, Ahmad Ozair,
Nishanth R. Subash, Shreyas Bellur, Fawaz Al-
Mufti
P18.2-003
International COVID-19 Vaccine Experience and
Perceptions Survey in Patients with Myasthenia
Gravis: An Interim Analysis – Yingkai Li, Srikanth
Muppidi, Samantha Masterson, Wendi Huff,
Tabitha Karatz, Jeff Guptill
P18.2-004
Quality of Life in Epilepsy patients in India during
Covid-19 pandemic. – Nirmal Surya, Ram Mohan
R. Sankaraneni, Sanjay P. Singh
P18.2-005
Socio-epidemiological Factors associated with
the Incidence of Cerebrospinal Meningitis in
Sub-Saharan Africa – Gabriel D. Pinilla Monsalve,
Natalia Llanos Leyton, Maria Gonzalez-Velez, Jairo
Alonso Quiñones
P18.2-006
WITHDRAWN
3
Aging, Dementia, Cognitive, and
Behavioral Neurology
Aging and Dementia: Clinical Aspects 4
P18.3-001
Learning to PERSEVERE: Feasibility and Efficacy
of Peer Mentor Support and Caregiver Education
in Lewy Body Dementia – Faizan Akram, Serena
Hess, Melissa Levin, Danielle Dodson, Glenn
Thurston Stebbins, Michelle HS Tosin, Bichum
Ouyang, Joshua Chodosh, Jori Fleisher
P18.3-002
Digital Driving Metrics Index Early Mobility
Declines in Patients At Risk for Alzheimer’s
Disease – Jennifer Merickel, Ruiqian Wu, Jun Ha
Chang, Matthew Rizzo, Ying Zhang
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P18.3-003
Huntingtin gene intermediate alleles influence the
progression from Subjective Cognitive Decline to
Mild Cognitive Impairment: a 15-year follow-up
study – Salvatore Mazzeo, Silvia Bagnoli, Sonia
Padiglioni, Filippo Emiliani, Assunta Ingannato,
Giulia Giacomucci, Vittoria Conti, Camilla Ferrari,
Sandro Sorbi, Benedetta Nacmias, Valentina Bessi
P18.3-004
Combination of Antidepressants and
Antipsychotics as Novel Treatment Options for
Psychosis in Alzheimer’s Disease – Peihao Fan,
Lirong Wang, Julia Kofler, Robert A. Sweet
P18.3-005
TRAILBLAZER-ALZ 2: A Phase 3 Study to Assess
Safety and Efficacy of Donanemab in Early
Symptomatic Alzheimer’s Disease – Jennifer
Zimmer, Paul R. Solomon, Cynthia Evans, Ming Lu,
John R. Sims, Dawn A. Brooks, Mark A. Mintun
4 MS and CNS Inflammatory
Disease
MS Digital Tools
P18.4-001
DAMS-Net: A Domain Adaptive Lesion
Segmentation Framework in Patients with
Multiple Sclerosis from Multiple Imaging Centers
– Dongnan Liu, Mariano Cabezas, Geng Zhan,
Dongang Wang, Linda Ly, Kain Kyle, Heidi N.
Beadnall, Helmut Butzkueven, Anneke Van Der
Walt, Melissa Gresle, Katherine Buzzard, Tomas
Kalincik, Jeannette Lechner-Scott, Bruce Taylor,
Robert Hyde, Michael Barnett, Weidong Cai,
Chenyu Wang
P18.4-002
Social Networks in Pediatric-Onset Multiple
Sclerosis are Associated with Less Negative Peer
Pressure – Micky Bacchus, Wendy Sulina Vargas,
Michael Glendinning, Seth Nathatn Levin, Kaho
Onomichi, Philip De Jager, Brenda Banwell
P18.4-003
haMSter: a Smartphone Application for Remote
Patient Monitoring – Patrick Altmann, Markus
Ponleitner, Fritz Leutmezer, Tobias Monschein,
Paulus Stefan Rommer, Thomas Alois Berger,
Gabriel Bsteh
P18.4-004
Digital Performance Measures Show Sensitivity
to Demographic and Disease Characteristics in a
Multiple Sclerosis Cohort Utilizing the MS Care
Connect Mobile App in a Real-world Setting
– Ryan Metzger, Kelly Davis Garrett, Angelene
Christensen, John F. Foley
P18.4-005
User Perspectives on a Digital Therapeutic for
Major Depressive Disorder in Multiple Sclerosis
Patients: A Qualitative Study – Gina Kackloudis,
Eliane Boucher, Eliane Boucher, Acacia C. Parks
 Poster Session 18 Thursday, April 7 5:30 p.m.–6:30 p.m.

P18.4-006
Reliability of Mobile Video Oculography in a
prospective cohort of MS patients – Mikael
Cohen, Solange Hesse, Kevin Polet, Sandrine
Louchart de la Chapelle, Alain Pesce, Christine
Lebrun Frenay
P18.4-007
TELE MS: A Randomized Controlled Trial
Investigating Remote Visits in People with
Multiple Sclerosis – Patrick Altmann, Markus
Ponleitner, Fritz Leutmezer, Paulus Stefan Rommer,
Thomas Alois Berger, Gabriel Bsteh
P18.4-008
Use of MyChart Messages and Telephone Calls in
Patients with Multiple Sclerosis at an Academic
Medical Center – Caralynn Li, Alena Makarova,
Angela Aungst, Derrick Robertson
P18.5-003
Baseline Characteristics and Initial Safety Results
in RESPOND: A Phase 4 Study of Nusinersen in
Children with Spinal Muscular Atrophy (SMA)
Who Received Onasemnogene Abeparvovec
– John Brandsema, Julie Anne Parsons,
Craig McDonald, Richard S. Finkel, Kathryn J.
Swoboda, Ricardo Masson, Yingying Liu, Corinne
Makepeace, Angela Paradis, Zdenek Berger,
Joanne M. Wagner, Kathleen C. Somera-Molina
P18.5-004
A Rare Case of Congenital Myasthenia Syndrome
11 Caused by a Novel Mutation in RAPSN
Diagnosed with Rapid Whole Genome Sequencing
(rWGS). – Graham Kiyoshi Reid, Apostolos
Psychogios, Rachel Supinger, Kallol Kumar Set
7
Practice, Policy, and Ethics
Ethics, Diversity & Research, Oh My... 2
P18.7-001
Patient Satisfaction of Teleneurology during
COVID-19 Pandemic in Detroit – Bowen Song,
Deepti Zutshi, Maryam Jamil Syed, Rohit Ajay
Marawar, Maysaa Merhi Basha, Janaki Patel,
Arshdeep Kaur
P18.7-002
Neurology Resident Burnout and Wellness: A
Quality Assessment Inventory Tool – Daniel
Minsuk Oh, Jennifer S. Hui
P18.7-003
Improving Seizure Management through

P18.4-009
Evaluating Telemedicine Care in Patients
with Neuroimmunological Disorders via a
Questionnaire Based Survey – Huiam Mubarak,
Minhwan Kim, Aimee Borazanci, Tejas Ranade,
Ram Narendra Narayan, Michael Vincent Robers
P18.4-010
Relationship of Superficial White Matter Integrity
and Cognition in Early MS: A Machine Learning
Study – Korhan Buyukturkoglu, Ceren Tozlu,
Christopher Vergara, Valentina Fuentealba, Jacob
Dahan, Amy Kuceyeski, James F. Sumowski, Carlos
Guevara Oliva, Ranganatha Sitaram, Claire Riley,
Pamela Guevara, Victoria Leavitt
6
Interprofessional Collaboration – Michael
Neuro-rehabilitation Miller Chang, Sylvia Bowditch, Caroline Wang,
Kiran M. Kanth, Trishna Kantamneni, Roumelia
Decontreaus, Carissa Reis, Lisa Eller, Daniel
Neuromodulation for Rehabilitation 2
Aquino, Kendra Schomer, Katherine Park
P18.6-001 P18.7-004
Teleintervention for Persisting Symptoms Post- Assessing the DEI needs of an Academic
Acute COVID-19 Illness Using Transcranial Direct Neurology Department – Sonia Kaur Singh, Anjail
Current Stimulation (tDCS) – Tehila Eilam-Stock, Sharrief, Thy Nguyen
Allan George, Matthew Lustberg, Robyn J.
Wolintz, Lauren B. Krupp, Leigh Elkins Charvet
P18.6-002
Visual Field Defect Rehabilitation through
Visual Restoration Therapy – Lakshmanan
Sankaranarayanan, Guhan Ramamurthy, Lakshmi
N. Ranganathan

5 Child Neurology and

Developmental Neurology
Child Neurology: SMA/DMD/Muscle 4
P18.5-001
Pooled Safety Data from the Risdiplam Clinical
Trial Development Program – Basil T. Darras,
Claudia A. Chiriboga, Laurent Servais, Giovanni
Baranello, Enrico Silvio Bertini, John W. Day,
Nicholas Deconinck, Dirk Fischer, Nathalie M.
Goemans, Janbernd Kirschner, Andrea Klein,
Ricardo Masson, Maria Mazurkiewicz Beldzin, Yi
Wang, Silvia Bader-Weder, Ksenija Gorni, Birgit
Jaber, Tammy McIver, Renata Scalco, Eugenio
Mercuri
P18.5-002
Real-world Outcomes of Nusinersen Alone and
Onasemnogene Abeparvovec (OA) Alone or with
Prior Nusinersen in Pediatric Patients with Spinal
Muscular Atrophy (SMA): Interim Analysis of a
US Retrospective Chart Review Study – Omar
Dabbous, Min Yang, Mihaela Georgieva, Walter
Toro Jimenez, Nicole LaMarca, Anish Patel,
Christopher Carley, Sandra P. Reyna
P18.6-003
Treating word finding difficulty in multiple
sclerosis using high-definition transcranial
direct current stimulation targeting the pre-
Supplementary Motor Area – Hsueh-Sheng
Chiang, Julie Fratantoni, Sven Vanneste, Michael
Kraut, John Hart
P18.6-004
Application of Principal Component and
Discriminant Analyses on Hippocampal
Neuromodulation During a Direct Reach Task –
Richard Lee, Roberto Martin Del Campo Vera,
Yelim Lee, Kuang-Hsuan Chen, Rinu Sebastian,
Spencer Kellis, Brian Lee
P18.6-005
Regaining control of movement following a spinal
cord injury using Epidural Electrical Stimulation
coupled with Task Specific Training – Srimathy
Narasimhan, Shankar Balakrishnan
P18.6-006
A Teleintervention Program for Multiple Sclerosis
(MS) Mobility: Exercise with Transcranial Direct
Current Stimulation (tDCS) – Giuseppina Pilloni,
Marilyn Moffat, Lauren B. Krupp, Leigh Elkins
Charvet

Information is accurate as of February 8, 2022, and is subject to change. AAN.com/AM 99

 Poster Session 18
8 9
Epilepsy/Clinical Neurophysiology
(EEG)
Epilepsy/Clinical Neurophysiology (EEG):
Epilepsy Others 2
P18.8-001
Effects of an Evidence-Based Continuous
EEG Triage Protocol on Seizure Detection in
Hospitalized Adults: A Quality Improvement
Analysis – Brent Jacobus
P18.8-002
A Case Report of Second Degree Heart Block and
Sinus Pauses after VNS Placement in Refractory
Epilepsy – Badria Munir, Farman Ali, Eric J.
Seachrist
P18.8-003
Trends in Antiseizure Medication Fills and Cost in
Medicare Beneficiaries with Epilepsy – Samuel
Waller Terman, Chun Chieh Lin, Brian Callaghan,
James F. Burke
P18.8-004
How Long is a Piece of String? A Retrospective
Study of the Correlation Between Length of Stay
in Epilepsy Monitoring Unit and Diagnostic Yield
– Mohammad Hijaz Adenan, Mohamed Khalil,
Kai Sheng Loh, Arif A. Shukralla, Stephen Klaus,
Michael Owen Kinney, Hany El-Naggar, Norman
Delanty
P18.8-005
An Online, Interactive, Self-Paced, Case-Based
Clinical Neurophysiology Curriculum for Neurology
Residents – Valerie Jeanneret Lopez, Spencer
Hutto, Monica B. Dhakar, Denise Fay Chen,
Harshad Ladha, Ruba Al-Ramadhani, Muruvet
Elkay, Rebecca E. Fasano, Panayiotis Mitsias,
Ioannis Karakis
P18.8-006
Petechiae: An Atypical Initial Presentation of
Seizure – Shivanee Sodani, Musab Zorlu, Hasmik
Amirjanyan, Swetha Ade, Ajay M. Tunguturi
P18.8-007
Serving Los Angeles County Patients with
Teleneurology, A Clinical Tool Here to Stay – Bo
Carl Leung, Hasnain Arshad, Shawna W. Benard,
Christianne N. Heck, Laura A. Kalayjian, Jonathan
Kuo, Patricia Lee, George Nune
100 2022 AAN Annual Meeting
Thursday, April 7 5:30 p.m.–6:30 p.m.
Infectious Disease
Infectious Disease: Bacteria, Fungi, and
Parasites on the Mind and Body 3
P18.9-001
Disseminated Cytomegalovirus Infection with
Meningoencephalitis in an Immunosuppressed
Renal Transplant Patient – Jaspreet Johal, Ramiro
Gabriel Castro Apolo, Negar Moheb, Hussam A.
Yacoub
P18.9-002
Nocardia Spinal Abscess in the Immunocompetent
Patient – Jennifer Hannah Newman, Emily
Casaletto, Caio Marconato Matias, Tzu-ying
Chuang, Muhammad Athar
P18.9-003
Central Nervous System Tuberculosis with SARS-
CoV-2 Infection: A Short Case-series from Sri
Lanka – Shanindra Revanka De Alwis, Shiran Ajith
Paranavitane, Senaka Bandusena, Arjuna Hirantha
Fernando
P18.9-004
To Report A Rare Case of Focal Cranial Nerve and
Long Tract Neurologic Deficits associated with
Legionnaire’s disease – Arshdeep Kaur, Shashwat
Pokharel, Sabeena Iqbal Malik
9 Neuro-oncology
Molecular Determinants of Neuro-
oncology 2
P18.9-005
Restoring Levels of a Tumor Suppressor to
Treat Glioblastoma using an RNA Therapeutic
Strategy – Rohan Rao, Donatien Kamdem Toukam,
Debanjan Bhattacharya, Daewoo Han, Jingchu
Huang, Andrew Steckl, Daniel Pomeranz Krummel,
Soma Sengupta
10
Cerebrovascular Disease and
Interventional Neurology
Cerebrovascular Disease: Clinical
Practice 2
P18.10-001
Feeding tube dependence among older stroke
patients with feeding tubes – Corey R. Fehnel,
Yoojin Lee, Tom G. Travison, Sandeep Kumar,
Bridget J. Perry, Julie Lima, Susan Mitchell
P18.10-002
Association Between Mean Platelet Volume And
Severity Of Acute Ischaemic Stroke Assessed
By Modified Rankin Scale – Dinesh Mohan
Chaudhari, Charchit Gupta, Pushpendra Nath
Renjen, Anjali Mishra
Publication Code Key
Publication Code Example: P1.2-003 | P1 = Poster Session Number | 2 = Neighborhood | 003 = Poster Number
P18.10-003
Closing Gaps in Care of Patients with Embolic
Stroke of Unknown Source: A Multi-disciplinary
approach – Lamya Ibrahim, Muhammad Bilal
Tariq, Mohammad Jamil Ahmad, Ijeoma Ekeruo,
Munachi Nkiru Okpala, Nicole Gonzales, Anjail
Sharrief
P18.10-004
Acute Pain: A Consideration in Blood Pressure
Management in Acute Ischemic Stroke in the
Sickle Cell Patient – Joseph Frazee, Jon Alexander
Karel
Cerebrovascular Disease: COVID-19 2
P18.10-005
Pediatric Cerebral Infarction associated with
recent SARS-CoV-2 mild infection treated with
intravenous thrombolysis and endovascular
thrombectomy – Luis Guillermo Manrique, Anusha
Mangalampalli, Deepak N. Reddy
P18.10-006
Neuroimaging in COVID-19 Patients on
Mechanical Ventilation Receiving Sedation:
Insight Beyond Diagnosis – Saman Fatima,
Sudheer Pachipala, Ayush Agarwal, Venugopalan
Y Vishnu, Padma Vasantha Hadakasira
P18.10-007
Cerebrovascular Manifestations of COVID-19 in
Young Adults – Pranusha Pinna, Therese Dunne,
Alejandro Vargas, Laurel Jean Cherian, Gabriela
Trifan, Jose Biller, Ronald Alvarado Dyer, Ivan Da
Silva
P18.10-008
Patterns of Seeking Emergent Stroke Care During
the COVID -19 Pandemic: A Nebraska Stroke
Center Perspective – Mohammad Dibs, Michele
Faulkner, Amna Sohail
P18.10-009
Descriptive Analysis of Acute Ischemic Stroke
in COVID-19 Patients Through The Course of
COVID-19 Pandemic – Jay Liuhong Liu, Keval D.
Shah, Amin Marji, Ayaz M. Khawaja
P18.10-010
Acute stroke patients with low NIHSS did not
delay hospital presentation during COVID – Ali E.
Kaabi, Aaisha Mozumder, Sujani Bandela, Agnelio
Silverio Cardentey, Lee Birnbaum
 Poster Session 18 Thursday, April 7 5:30 p.m.–6:30 p.m.

11
Movement Disorders
Movement Disorders: Ataxia and Tourette
2 Branson
P18.11-001
A systematic review of the spectrum and
prevalence of non-motor symptoms in adults with
progressive cerebellar ataxias – Naveed Malek,
Yaqub Al Sami, Aram Aslanyan, Rajith Nilantha
De Silva
P18.11-002
Tremor in Spinocerebellar Ataxia 12 (SCA12):
Clinical and Electrophysiological Perspective –
Achal K. Srivastava, Manpreet Kaur Kaur Narang,
Roopa Rajan, Mohammed Faruq
P18.11-003
Acute Cerebellar Ataxia after COVID-19 Infection
in a 5-year-old Boy. – Kimberly O’Neill, Aparna
Polavarapu Ramarao
P18.11-004
Unusual Presentation of Self Limiting Neonatal
Seizures Along with Other Neurological
Manifestations in Siblings Diagnosed with
Spinocerebellar Ataxia Type 8 (SCA 8) – Shrikant
Mishra, Shaweta Khosa, Julian Thomas, Gurveer
Singh Khosa, Catherine Yim, Bhavesh Trikamji
P18.11-005
Progressive Ataxia and Palatal Tremor with MRI
Evidence of Hypertrophic Olivary Degeneration –
Jennifer Hislop, Rita Bhatia, Henry Paul Moore
P18.11-006
Cerebellar Fit in an Adult with Chiari II
Malformation – Austin Mefford, Milena Lobaina,
Yi Shen, Laura J. Wu
12 Neuro-ophthalmology/Neuro-
otology
Neuro-ophthalmology Research: Vision 2
P18.12-001
The Impact of a Portable Artificial Vision Device
(OrCam Read) on Vision-Related Quality-of-Life
in Patients with Primary Brain Tumors and Low
Vision – Tanvi Chokshi, Yin Allison Liu
P18.12-002
An Interprofessional Residency Education
and Utilization of the Phone-adapted Panoptic
Ophthalmoscope – Lauryn Currens, Goun Je,
Richard Church, Kate Daniello, Francisco De la
Serna, Jee-young Han, Adalia M. Jun-O’Connell
P18.12-003
A Sneak into the science of the Sneaker colour- Is
it truly related to Cerebral Dominance? – Harini
Pavuluri, Ashalatha Radhakrishnan
P18.12-004
Association Between COVID-19 Vaccination and
Optic Neuritis in Adults: A Vaccine Adverse Event
Reporting System (VAERS) Study – Mustafa
Jaffry, Kranthi Kiran Mandava, Sanjana Rosario,
Kamel Jedidi, Nizar Souayah
P18.12-005
Vision-Specific Quality of Life in Patients with
Post-Acute Sequelae of COVID-19 (PASC) – Peyton
Meyer, Lisena Hasanaj, Peyton Meyer, Steven
Galetta, Sujata P. Thawani, Laura J. Balcer
13 Health Care Disparities
P18.13-005
Can You See Me Now?: Understanding Health
Outcomes in Telehealth Among Seniors – Sherline
Sauveur, Sherline Sauveur, Chantale Octavia
P18.13-006
Pediatric Neurology Patient Disparities in Use of
and Access to Rapid Telehealth Implementation
during the COVID-19 Pandemic – Lindsey Morgan,
Payal B. Patel, Jingyang Chen, John Jay Alexander,
Edward J. Novotny, Mark Wainwright
P18.13-007
Reassessing the Geographical Distribution of
Neurologists in the United States – Kyra Curtis,
Sama Elrahi, Josh Bilello, Prashant Kumar Rai
P18.13-008
Measuring Ambulatory Neurologic Health
Disparities with the Axon Registry – Richard
T. Benson, Sarah M. Benish, Gregory J. Esper,
Brett M. Kissela, Nicole Rosendale, Erika Tatiana
Marulanda-Londono, Omotola A. Hope, Tammy
Thu Ann Pham, Matthew T. Roe, Aracelis Torres,
Amanda Lien, Steven Kaai Kauwe, Aristotle Mante,
Karen Lundgren, Becky Schierman, Lyell K. Jones
P18.13-009
Tightening up Acute Stroke Care in the Stroke
Belt with Telestroke – Theresa Beth Sevilis, Mark
McDonald, Amanda Avila, Gregory Wayne Heath,
Mohammed N. Zaman, Thomas G. Devlin

P18.11-007 Disparities in Neurologic Care and

Social media consumption in adolescents with
tics – Jessica Frey, Tracy Tholanikunnel, Heather
Simpson, Irene Malaty
P18.11-008
Functional Tic Disorders in Children during the
COVID-19 Pandemic – Amy Armstrong-Javors,
Marisela E. Dy-Hollins, Evan Realbuto, Jeremiah
M. Scharf
Education
P18.13-001
Attitudes, Beliefs and Experiences of an Academic
Neurology Department Regarding Systemic
Racism: University of Kentucky Neurology
Residency Study – Thien Nguyen, Khawla M.
Abusamra, Timothy James Ainger, Ima M. Ebong
P18.13-002
Trends in Diversity at a Single US Adult Neurology
Residency Program – Keiko Aun Fukuda, Mathura
Ravishankar, Anne C. Van Cott, Paula R. Clemens,
Sasha Zivkovic, Ajitesh Ojha
P18.13-003
The Diversity of Graduate Medical Education
Leadership in Neurology – Morgan Christina
Jordan, Zahari Tchopev, Jeffrey C. McClean
P18.13-004
Socioeconomic Bias in Ordering Toxicology
Screens in Patients with an Acute Stroke – Fady
Mousa-Ibrahim, Konrad Kubicki, Alexandria
Cummuta, Christopher Richardson, Michael Joel
Schneck, Garry Sigman

Information is accurate as of February 8, 2022, and is subject to change. AAN.com/AM 101

JOIN US
Our hope is to create a tomorrow where neurological
disorders no longer limit human potential—to
help preserve what makes people who they are

gene.com © 2022 Genentech USA, Inc. All rights reserved. M-US-00014873(v1.0)

 VIRTUALVirtual
EXPERIENCE
Experience PostersPOSTERS
There will also be more than 470 abstracts exclusively presented as posters during the 2022 Annual Meeting
Virtual Experience April 24-26. These posters will be available for the duration of the virtual meeting.
Aging and Dementia
P1.001
How did the Early COVID 19 Pandemic Lockdown
Affect Care of Memory Disorder Patients?:
Caregiver views – Krista Schoff, Nakul Katyal, Joel
Isaac Shenker
P1.002
Contribution of Vascular Risk Factors to Dementia
and Dementia Risk Prediction Varies Across
Mid- to Later-Life: The Framingham Heart Study –
Emer McGrath, Alexa Beiser, Adrienne O’Donnell,
Jayandra J. Himali, Matthew Pase, Claudia L.
Satizabal, Sudha Seshadri
P1.003
Person-centered Assessment in Early Alzheimer’s
Disease – Alberto Villarejo Galende, Elena Garcia-
Arcelay, Gerard Pinol-Ripoll, Antonio Del Olmo-
Rodríguez, Felix Vinuela, Merce Boada Rovira,
Emilo Franco Macias, Almudena Ibanez, Mario
Riverol, Albert Puig-Pijoan, Pedro Abizanda, Rafael
Arroyo Gonzalez, Miquel Baquero, Inmaculada
Feria-Vilar, Mircea Balasa, Angel Berbel Garcia,
Eloy Rodriguez-Rodriguez, Vieira Campos Alba,
Guillermo Garcia-Ribas, Silvia Rodrigo-Herrero,
Alberto Lleo, Eduardo Aguera Morales, Carmen
Catalan Flores, Jorge Maurino
P1.004
Prevalence and Cognitive Impact of
Neuropathologies Across the Age Spectrum
– Janice Xing-Yi Li, Hannah Nguyen, Kiana
Scambray, S. Ahmad Sajjadi
P1.005
Gene therapy for DRPLA model mice by AAV-
delivered CRISPR / Cas9. – Shoichiro Ando,
Taisuke Kato, Yuka Koike, Sachiko Hirokawa, Kenta
Kobayashi, Shoji Tsuji, Osamu Onodera
P1.006
Pimavanserin treatment of hallucinations and
delusions in patients with Parkinson’s disease
dementia: post hoc analysis of the HARMONY
trial – Daniel Weintraub, Alberto J. Espay, Vibhash
D. Sharma, Pierre Tariot, Victor Abler, Sanjeev
Pathak, Srdjan Stankovic
P1.007
Infratentorial Pathology in Frontotemporal
Dementia Phenotypes – Mary Clare McKenna,
Siobhan Hutchinson, Peter Bede
Information is accurate as of February 8, 2022, and is subject to change.
Virtual Experience Posters
P1.008
Pallidal Functional Connectivity Changes Are
Associated with Disgust Recognition in Pure
Motor Amyotrophic Lateral Sclerosis – Veronica
Castelnovo, Elisa Canu, Maria Antonietta Magno,
Elena Gatti, Nilo Riva, Barbara Poletti, Vincenzo
Silani, Massimo Filippi, Federica Agosta
P1.009
Cortical Remodeling Across the Lifespan in
Healthy Brain Reveals Structural Network
Vulnerability to Neurodegeneration – Camilla
Cividini, Federica Agosta, Silvia Basaia, Edoardo
G. Spinelli, Veronica Castelnovo, Michela Leocadi,
Davide Calderaro, Maria Antonietta Magno, Elisa
Canu, Massimo Filippi
P1.010
Functional Brain Connectome in Ventral and
Dorsal Variants of Posterior Cortical Atrophy –
Elisa Canu, Federica Agosta, Maria Antonietta
Magno, Silvia Basaia, Camilla Cividini, Francesca
Caso, Giuseppe Magnani, Maxime Montembeault,
Richard Levy, Raffaella Migliaccio, Massimo Filippi
P1.011
Updated US Prevalence Estimates Accounting for
Racial and Ethnic Diversity for Trials and Therapies
Targeting Mild Cognitive Impairment Due to
Alzheimer’s Disease (AD) and Mild AD Dementia
– Cai Gillis, Mattia Gianinazzi, Mina Nejati, Nancy
Maserejian
P1.012
Subgroup Analyses of the Amyloid PET Substudies
From EMERGE and ENGAGE, Phase 3 Clinical
Trials Evaluating Aducanumab in Patients With
Early Alzheimer’s Disease – Raj Rajagovindan,
Tianle Chen, Hao Wu, Ying Tian, Laura Nisenbaum,
Carmen Castrillo-Viguera, Ping He, Samantha Budd
Haeberlein
P1.013
Reductions in Biomarkers of Alzheimer’s Disease
Pathophysiology Following Treatment With
Aducanumab Were Associated With Slowing in
Clinical Decline – Raj Rajagovindan, Tianle Chen,
Laura Nisenbaum, Ying Tian, Bharath Kumar
Kandadi Muralidharan, Gersham Dent, Ping
He, Carmen Castrillo-Viguera, Samantha Budd
Haeberlein
P1.014
Considerations for the Real-World Management
of ARIA From the Aducanumab Phase 3 Studies
EMERGE and ENGAGE – Patrick Burkett, Kimberly
Umans, Carmen Castrillo-Viguera, Derk Purcell,
Jerome Barakos, Sami Fam, Samantha Budd
Haeberlein, Karen Smirnakis
P1.015
Item-Level Analysis of Clinical Measures in
Patients With Early Symptomatic Alzheimer’s
Disease Following Treatment With High-Dose
Aducanumab in the Phase 3 EMERGE Study –
Sharon Cohen, Ping He, Mihaela Levitchi, Ryan
Miller, Fiona Forrestal, Menglan Pang, Carmen
Castrillo-Viguera, Judith Jaeger, Catherine
Mummery, Anton P. Porsteinsson, Jeffrey Lee
Cummings, Ying Tian, Lili Yang, Samantha Budd
Haeberlein
P1.016
ICARE AD-US: Design of a Prospective, Single-
Arm, Multicenter, Noninterventional, Real-World
Study of Aducanumab in the United States –
James E. Galvin, Jeffrey Lee Cummings, Mihaela
Levitchi, Carl DeMoor, Alireza Atri, Verna R. Porter,
Ivana Rubino
P1.017
The Association of Vasomotor Symptoms During
the Menopausal Transition and Cognition in Later
Life – Amalia Peterson, Reena Gottesman, Eliza
Cushman Miller, Sarah Tom
P1.018
Quantitation of Nervous System Proteins NF-L,
t-Tau, p-Tau181, Aß1-42, Aß1-40, GFAP and
Inflammatory Cytokines IL-6, IL-10, TNFa in
Alzheimer’s Disease Plasma. – Ahmed Chenna,
Christos John Petropoulos, John Winslow
P1.019
Masupirdine (SUVN-502), A Serotonin Receptor
Sub-Type 6 Antagonist for the Potential Treatment
of Agitation and Psychosis in Patients with
Dementia of Alzheimer’s Type – Ramakrishna
Nirogi, Rajesh Kumar Badange, Abdul Rasheed
Mohammed, Santosh Kumar Pandey, Vijay Benade,
Ramkumar Subramanian, Pradeep Jayarajan,
Jyothsna Ravula, Satish Jetta, Venkat Jasti
P1.020
Event-related potentials as biomarkers of
cognitive performance in Alzheimer’s disease
patients with cardiovascular risk factors – Anna
Marin, Kylie Schiloski, Ana L. Vives-Rodriguez,
Renée DeCaro, Andrew E. Budson, Katherine Turk
P1.021
Hypertensive Disorders in Pregnancy and Future
Development of Dementia: A Systematic Review
and Meta-analysis – Aaron Ross Switzer, Eric E.
Smith, Aravind Ganesh
AAN.com/AM 103

P1.022
Changes of neuropsychiatric symptoms in
patients with dementia during COVID-19 crisis :
Telephone survey from the Yangcheon Dementia
Reassurance Center – Soo-Hyun Kim, Hyunji Kim,
Seungwon Chung, Hyung Ho Kim, Kee Duk Park,
Geon Ha Kim, Sun Hee Hong, Jee Hyang Jeong,
Geon Ha Kim
P1.023
Investigating the Genetic Characteristics of
Hippocampal Volume and Plasma Aß in a Chinese
Community-Dwelling Population – Xinzhuang
Yang, Mengyao Wan
P1.024
Application of Appropriate Use Criteria for
Cerebrospinal Fluid Testing for Alzheimer Disease
Biomarkers: A Retrospective, Real-World
Assessment in a Dementia Specialty Clinic –
Taylor Krivanek, Seth Gale
P1.025
Duration of Ice Hockey Play and Chronic Traumatic
Encephalopathy Risk – Bobak Abdolmohamadi,
Madeline Uretsky, Evan Nair, Nicole Saltiel,
Raymond Nicks, Daniel Daneshvar, Victor E
Alvarez, Bertrand Huber, Thor D. Stein, Ann C.
McKee, Michael Alosco, Jesse B. Mez
P1.026
Regional White Matter Hyperintensities and
Relation to Cognition in Posterior Cortical Atrophy
and Logopenic Progressive Aphasia – Nha
Trang Thu Pham, Jonathan Graff-Radford, Mary
M. Machulda, Anthony Spychalla, Christopher
Schwarz, Matthew Senjem, Val John Lowe,
Clifford R. Jack, Keith A. Josephs, Jennifer Louise
Whitwell
P1.027
Fatal Familial Insomnia presenting with gait
ataxia, encephalopathy, and cachexia. Updating
the diagnostic paradigm with recommendations
for genetic screening and options for family
counseling – Nara Michaelson
P1.028
One Hundred Centenarians: Brain Pathology and
Relationship to Dementia in The 90+ Study –
Raumin Shawn Neuville, Chuching Ho, S. Ahmad
Sajjadi, Roshni Biswas, Thomas J. Montine, Maria
M. Corrada, Claudia Kawas
P1.029
Retinal optical coherence tomography identifies
early biomarkers for Alzheimer’s and Parkinson’s
disease and cognitive decline – Sarah Shareef,
Sayuri Sekimitsu, Yan Zhao, Tobias Elze, Ayellet
Segre, Janey Wiggs, Nazlee Zebardast
P1.030
White matter hyperintensities in frontotemporal
lobar degeneration – Chloe Anastassiadis, Anna
Vasilevskaya, Foad Taghdiri, Cristina Salvo,
Carmela Tartaglia
104 2022 AAN Annual Meeting
Virtual Experience Posters
Autoimmune Neurology
P1.031
Aflibercept-induced recurrent cranial nerve
neuritis affecting varying cranial nerves – Yifan
Huang, Christian Gericke
P1.032
Giant Cell Arteritis of the Superior Mesenteric
Artery Presenting with Wernicke Encephalopathy
from Thiamine Deficiency – Sarah Shapiro,
Ludovica Farese, David Roman Renner
P1.033
The Diagnostic Utility of Cerebral Angiography
for Primary Central Nervous System Vasculitis:
Analysis of Patients from a Tertiary Centre –
Abhishek Gupta, Saiju Jacob
P1.034
Atypical presentation of rare entity autoimmune
autonomic ganglionopathy: Another potential
cause of hypertensive crisis. – Baljinder Singh,
Jananisree Ravichandran, Isabel Victoria
Narvaez- Correa, Mohammad Rauf A. Chaudhry,
Mohammad Ghatali, Paisith Piriyawat, Isabel
Victoria Narvaez- Correa
P1.035
Incidence of Skin Changes in Patients with
Myasthenia Gravis Prescribed Mycophenolate
mofetil or Azathioprine – Callee Brooks, Erin R.
Dark, Stephanie Hwang, Stephanie Iyer, Anahit C.
Mehrabyan
P1.036
High-Resolution Manometry is Useful for
Diagnosing Myasthenia Gravis with Mild
Dysphagia – Kenjiro Kunieda, Yuichi Hayashi,
Nobuaki Yoshikura, Akio Kimura, Ichiro Fujishima,
Takayoshi Shimohata
P1.037
Characterization of Neuronal Surface Antigen-
Specific Immunostaining Pattern: Comparison
between In-house and Commercial Brain
Immunohistochemistry – Takahiro Iizuka, Naomi
Nagata, Naomi Kanazawa, Atsuko Yanagida, Hiroki
Suga, Juntaro Kaneko, Eiji Kitamura, Kazutoshi
Nishiyama
P1.038
Autoimmune limbic encephalitis mimicking
progressive supranuclear palsy – Yoya Ono,
Kazuhiro Higashida, Akio Kimura, Takayoshi
Shimohata
P1.039
IgG4-Mediated Chronic Inflammatory
Demyelinating Polyneuropathy: A Severe
Presentation of Contactin-1 Autoimmune
Pathology – Magalie Carey, Katherine Wanda
Zerebiec, Noah A. Kolb, Michael K. Hehir
P1.040
Oligosymptomatic anti-GABA A receptor
encephalitis: a new diagnostic and therapeutic
challenge – Iñigo Oyarzun Irazu, Antonio Cabrera
Muras, Daniel Martínez Cóndor, Clea Gutierrez,
Ivan Caballero, Borja Aguilera, Juan Manuel
Garcia Sanchez, Alejandra Collia Fernandez, Josep
O. Dalmau, Francesc R. Graus, Juan C. Garcia
Monco Carra
P1.041
Takotsubo’s Cardiomyopathy As A Result Of
Guillain-Barre Syndrome: A Case Report And
Review Of The Literature – Arnav Mahajan,
Surasak Komonchan, Vathanyoo Plainetr, Pungjai
Keandoungchun
P1.042
Myelin oligodendrocyte glycoprotein antibody-
associated disease (MOGAD) with Coexistence
of IgG to Glial Fibrillary Acidic Protein and NMDA
Receptor – Nicole Khezri, Ellen Song
P1.043
Mog-Antibody-Associated Disease: an
Argentinian hospital-based study – Analisa
Manin, Sara Palacios, Leandro Miguel Kim,
Victoria Fernandez, Andres M. Villa
P1.044
HLA-DR4-positive Vogt-Koyanagi-Harada (VKH)
Syndrome: Review of pathophysiology and clinical
correlation – Jacob Walter Loeffler, Esther H. Nie,
May Han
P1.045
Cost-Effectiveness of Eculizumab and
Efgartigimod for the Treatment of generalized
Myasthenia Gravis – Pei-Wen Lien, Foluso
Agboola, Mrinmayee Joshi, Dmitriy Nikitin,
Zaid K. Yousif, Shanikumar P. Patel, Vinura
Withanawasam, Saira Jatoi, Eden Abera Gebre,
Jeffrey A. Tice, Jonathan D. Campbell, Daniel
Touchette
P1.046
Safety and Effectiveness of Eculizumab in
Japanese Patients with Aquaporin-4 Antibody-
positive Neuromyelitis Optica Spectrum Disorder:
Interim Analysis of a Post-marketing Surveillance
Study – Ichiro Nakashima, Yo Hoshino, Kazumi
Okamura, Hidekazu Kikui, Kazuo Fujihara
P1.047
Opsoclonus Myoclonus Syndrome in Uterine
Malignancy – Maithreyi Chappidi, Erik Von Burton
P1.048
Mild encephalitis/encephalopathy with reversible
splenial lesion after COVID-19 vaccination
– Hiroya Ohara, Hironori Shimizu, Takehito
Kasamatsu, Akihiro Kajita, Kenji Uno, Kazuma
Sugie, Masako Kinoshita
P1.049
Moderna COVID-19 Vaccine-Induced Immune
Thrombosis of Central Retinal Artery –Report of a
Case – Vai Hong Fong, Yung-Ray Hsu, Sin Yu Chow

P1.050
Guillain-Barre Syndrome Following COVID-19
Vaccination: A Literature Review – Nasrin Jahan,
Maha Hameed, Surya Suresh, Praveen Gowtham
Varma Dasaraju, Harshadayani Jagadish Kumar,
Biki Kumar Sah, Sujan Poudel
P1.051
Dilemma in Differentiating Posterior Reversible
Encephalopathy Syndrome and Lupus Cerebritis in
Systemic Lupus Erythematosus with Multi-Organ
Involvement: A Case Report – Pooja Patnaik,
Alejandra Marcela Marquez, Giovanna Manzano,
Anand Viswanathan
P1.052
Bilateral Facial Weakness as Initial Presentation
of Post COVID-19 Vaccination related Guillain
Barré Syndrome – Khaled Gharaibeh, Taehong
Lim, Ajaz Sheikh
P1.053
Neurologic Immune-related Adverse Events of
Immune Checkpoint Inhibitors – Chen Yan, Merry
Huang, Carol Swetlik, Karlo Toljan, James Bena,
Pauline Funchain, Marisa P. McGinley
P1.054
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
In An Eleven Month Old Child with Atypical
Presentation – Saraswati Nashi, Sumanth S, P.R.
Srijithesh
P1.055
An Atypical Case of anti-GFAP Astrocytopathy
– Maxime Junior Jean, David J Sandness, Ryan
Canissario, Lawrence M. Samkoff
P1.056
An Unusual Case of CLIPPERS – Olivia Kingsford,
Michael Vincent Robers
P1.057
Giant Cell Arteritis and Area Postrema Syndrome:
Where Do We Stand? – Rafael Gemaque Lima
Bentes, William Souza Martins Ferreira, Matheus
Alves Alves Da Silva, Barbara Maini Carvalho,
Christiane Monteiro Siqueira Campos, Hennan
Salzedas Teixeira, Carmen Lancelotti, Alex Baeta
P1.058
Possible association of demyelination
disease with new COVID19 infection – Lama
Alshaikhmubarak, Bader Alonazy
P1.059
Neurological Complications of COVID-19: Guillain-
Barre Syndrome Following Pfizer COVID-19
Vaccine – Sadia Waheed, Angel S. Bayas, Fawzi
Hindi, Zufe Rizvi, Patricio S. Espinosa
Information is accurate as of February 8, 2022, and is subject to change.
Virtual Experience Posters
Autonomic Disorders
P1.060
Characterizing the natural history of progression
in patients with Multiple System Atrophy –
Miguel Angel Perez, Patricio Millar Vernetti, Jose
M. Martinez, Michele Potashman, Irfan Qureshi,
Victoria Wirtz, Gilbert J. L’Italien, Susan Durham,
Judah Michael Ellison, Horacio C. Kaufmann
P1.061
Use of Mayer Wave Activity to Identify Discordant
Cardiovascular Autonomic Function during
the Subacute Period of Spinal Cord Injury as
a Potential Means to Identify Co-Occurring
Traumatic Brain Injury – Michael F. La Fountaine,
Thomas Bryce, Jill M. Wecht
Cognitive and Behavioral Neurology
P1.062
Repetitive Transcranial Magnetic Stimulation
improves neuropsychiatric manifestations in
Adult-onset Leukoencephalopathy with Axonal
Spheroids and Pigmented Glia – Amaar Marefi,
Michaela Barbarosie, Roberta La Piana
P1.063
Neuroanatomical Changes in Self-Reported
Anxiety: A Cluster Analysis – Sanjana Sundara Raj
Sreenath
P1.064
Alzheimer’s Disease Cerebrospinal Fluid
Biomarkers Differentiate Creutzfeldt-Jakob
Disease from its Mimicker Autoimmune
Encephalitis – Bryce Chang, Gregory S. Day,
Jonathan Graff-Radford, Andrew McKeon, Eoin
P. Flanagan, Alicia Algeciras-Schimnich, Ronald
C. Petersen, David T. Jones, Michel Toledano,
Wentao Li
P1.065
Hippocampal Regional Abnormalities Contribute
to Cognition in Multiple Sclerosis – Damiano
Mistri, Laura Cacciaguerra, Elisabetta Pagani,
Paola Valsasina, Alessandro Meani, Federica
Esposito, Massimo Filippi, Maria Assunta Rocca
P1.066
Mapping Topography and Network of Brain Injury
in Patients with Disorders of Consciousness
– Manoj Arachige, Thanh Phan, Udaya K.
Seneviratne
P1.067
Corticobasal Syndrome Associated with a Novel
Lys694del Variant of the TBK1 gene – Kaitlin
Seibert, Heather Smith, Allison Lapins, Peter Pytel,
James A. Mastrianni
P1.068
Seeing Picasso Faces: About a Case of
Prosopometamorphopsia – Claire Emmanuelle
Delpirou Nouh, Venkataditya Dugyala, Ahmad
Al-Awwad
P1.069
Methotrexate-Induced Encephalopathy In
A Patient With Relapsing Polychondritis –
Mohammed Shan Uddin, Ajay Banga, Ariol
Labrada, Roberto E. Sanchez
P1.070
Neurocognitive And Psycho-emotional Disorders
In Patients With Chiari Malformation Type I –
Khristina Derevyanko
P1.071
Mind Over Matter - or is it? Role of Right
Temporoparietal Junction in Functional Neurologic
Disorders – Areeba Siddiqui, Batool Akhlaq
Hussain, Sanaz Attaripour
P1.072
Developing a Preliminary Parkinson’s Disease Risk
Estimator for Decline In Cognition Tool (pPREDICT)
as a Practical and Pragmatic Tool to Estimate Risk
of Cognitive Decline – Tara Carlisle, Kaitlin Olson,
Nichole E. Carlson, Brianne Bettcher, Samantha
K. Holden
Cerebrovascular Disease and
Interventional Neurology
P1.073
Prior Employment Status and Obesity Do Not
Predict Post Stroke Fatigue – Zachary Cooper,
Nadege Gilles, Jessica Rosemarie Sirizzotti,
Steven R. Levine
P1.074
Factors Associated with Anxiety after
Hemorrhagic Stroke – Anlys Olivera, Sarah Ecker,
Aaron S. Lord, Lindsey Gurin, Koto Ishida, Kara R.
Melmed, Jose L. Torres, Barry M. Czeisler, Cen
Zhang, Jennifer A. Frontera, Ariane Lewis
P1.075
AMPA Receptor Modulation Mitigates Post-
Stroke Damage Via Inhibition of Pro-inflammatory
and Apoptotic Biomarkers in Experimental Model
of Stroke – Himanshu Sharma, Reeta KH
P1.076
A Risk Prediction Nomogram for Recurrent Stroke
in Medically Treated Patients with Symptomatic
Intracranial Atherosclerotic Disease – Xuan Tian,
Linfang Lan, Lina Zheng, Hui Fang, Yuming Xu,
Thomas Wai Hong Leung, Xinyi Leng
AAN.com/AM 105

P1.077
Transradial Versus Transfemoral Access for
Woven EndoBridge (WEB) Embolization of
Intracranial Aneurysms: A Propensity-Score
Matched Multicenter Study – Mahmoud Dibas,
Nimer Adeeb, Jose Danilo Bengzon Diestro, Hugo
Cuellar-Saenz, Ahmad Sweid, Sovann Vathana
Lay, Adrien Guenego, Asala Aslan, Leonardo
Renieri, Sri Hari Sundararajan, Guillaume Saliou,
Markus Möhlenbruch, Robert W. Regenhardt,
Justin E. Vranic, Ivan Lylyk, Paul Foreman, Jay
Ashok Vachhani, Vedran Zupancic, Muhammad
Ubaid Hafeez, Caleb Rutledge, Muhammad
Waqas, Vincent Tutino, James D. Rabinov, Yifan
Ren, Clemens M. Schirmer, Mariangela Piano,
Anna Luisa Kühn, Caterina Michelozzi, Stéphanie
Elens, Robert M Starke, Ameer Hassan, Arsalaan
Salehani, Peter Sporns, Jesse Jones, Marios-
Nikos Psychogios, Julian Spears, Boris Lubicz,
Pietro Panni, Ajit Puri, Guglielmo Pero, Christoph
J. Griessenauer, Hamed Asadi, Christopher
Stapleton, Adnan H. Siddiqui, Andrew Ducruet,
Felipe Albuquerque, Peter Tze Man Kan, Vladimir
Kalousek, Pedro Lylyk, Srikanth Boddu, Jared
Knopman, Mohammed Ali Aziz-Sultan, Nicola
Limbucci, Pascal Jabbour, Christophe Cognard,
Aman Patel, Adam A. Dmytriw
P1.078
The Woven EndoBridge (WEB) device for the
treatment of Intracranial Aneurysms: A Decade of
Lessons Learned and Changes in Practice from the
WorldwideWEB Consortium – Mahmoud Dibas,
Nimer Adeeb, Jose Danilo Bengzon Diestro, Hugo
Cuellar-Saenz, Ahmad Sweid, Sovann Vathana
Lay, Adrien Guenego, Asala Aslan, Leonardo
Renieri, Sri Hari Sundararajan, Guillaume Saliou,
Markus Möhlenbruch, Robert W. Regenhardt,
Justin E. Vranic, Ivan Lylyk, Paul Foreman, Jay
Ashok Vachhani, Vedran Zupancic, Muhammad
Ubaid Hafeez, Caleb Rutledge, Muhammad
Waqas, Vincent Tutino, James D. Rabinov, Yifan
Ren, Clemens M. Schirmer, Mariangela Piano,
Anna Luisa Kühn, Stéphanie Elens, Stéphanie
Elens, Robert M Starke, Ameer Hassan, Arsalaan
Salehani, Peter Sporns, Jesse Jones, Marios-
Nikos Psychogios, Julian Spears, Boris Lubicz,
Pietro Panni, Ajit Puri, Guglielmo Pero, Christoph
J. Griessenauer, Hamed Asadi, Christopher
Stapleton, Adnan H. Siddiqui, Andrew Ducruet,
Felipe Albuquerque, Peter Tze Man Kan, Vladimir
Kalousek, Pedro Lylyk, Srikanth Boddu, Jared
Knopman, Mohammed Ali Aziz-Sultan, Nicola
Limbucci, Pascal Jabbour, Christophe Cognard,
Aman Patel, Adam A. Dmytriw
P1.079
Evaluating the Effect of Gender and Diabetes
Mellitus on Stroke Severity – Jessica Rosemarie
Sirizzotti, Zachary Cooper, Bernardus Willems,
Nadege Gilles, Steven R. Levine
106 2022 AAN Annual Meeting
Virtual Experience Posters
P1.080
Hemodynamics Features of Symptomatic
Intracranial Atherosclerotic Disease Associated
with Severity of Ipsilateral Cerebral Small Vessel
Disease – Lina Zheng, Xuan Tian, Jill Abrigo, Xinyi
Leng, Thomas Wai Hong Leung
P1.081
Mobile Stroke Unit Patient Utilization: A Single-
Center Experience – Matthew Orwitz, Jason
Mathew, Danielle Bazer
P1.082
Endovascular Thrombectomy for Treatment of
Acute Ischemic Stroke During Pregnancy and the
Early Postpartum Period – Alis J. Dicpinigaitis,
Chirag Gandhi, Fawaz Al-Mufti
P1.083
Does Perfusion Computed Tomography
Abnormalities in Patients with Transient Ischemic
Attack Predict Subsequent Ischemic Stroke
and Cardiovascular Event? – Aisha Abdulrazaq,
Muhammad Fawad Ishfaq, Adnan I. Qureshi
P1.084
Predicting Stroke Risk in Symptomatic Intracranial
Atherosclerotic Disease: Stroke Mechanisms
as Another Dimension beyond Arterial Luminal
Stenosis – Xinyi Leng, Xueyan Feng, Lina Zheng,
Xuan Tian, Thomas Wai Hong Leung
P1.085
Causal Relationship Between Polycythemia Vera
And Reversible Cerebral Vasoconstriction: A Case
Report – Arnav Mahajan, Surasak Komonchan,
Yodkhwan Wattanasen, Wuttipong Tirakotai
P1.086
Adrenal Abnormalities and Stroke – Hamza
Chaudhry, Tehniyat Baig, Hooman Kamel
P1.087
Early and 30-day Clinical and Neuropsychological
Effects of Iatrogenic Brain Infarcts in the ENACT
Randomized-Controlled Trial – Aravind Ganesh,
Mayank Goyal, Alexis Wilson, Johanna Maria
Ospel, Andrew M. Demchuk, David J. Mikulis,
Julien Poublanc, Timo Krings, Roberta Mary
Anderson, Michael Tymianski, Michael D. Hill
P1.088
Investigating a New Risk Factor of Subarachnoid
Hemorrhage: Opium Use Disorder – Alireza
Zandifar, Zahra Sadat Mortazavi, Luis Octavio
Tierradentro Garcia, Jorge Du Ub Kim, Arastoo
Vossough, Mohammad Saadatnia
P1.089
Risk and Predictors of Relapse after Smoking
Cessation in Patients with Ischemic Stroke and
Transient Ischemic Attack – Neal S. Parikh, Cenai
Zhang, Babak Navi, Hooman Kamel
P1.090
Prescription Smoking-Cessation Medication
Pharmacy Claims After Stroke and Transient
Ischemic Attack – Neal S. Parikh, Yongkang Zhang,
Daniel Restifo, Babak Navi, Hooman Kamel
P1.091
Preadmission Anti-hypertensive Agents May
Affect Cerebral Vasospasm Risk in Aneurysmal
Subarachnoid Hemorrhage – Elijah Malik Persad-
Paisley, Alizeh Shamshad, Saba S. Paracha,
Christoph Stretz, Nicholas S. Potter, Linda C.
Wendell, Bradford B. Thompson, Karen L. Furie,
Jesse Menville, Ali Mahta
P1.092
Thrombolysis for Acute Ischemic Stroke in
Patients with versus without Pre-morbid
Disability: A Meta-analysis – Benjamin Frank
Beland, Fouzi Bala, Mohammed Almekhlafi,
Aravind Ganesh
P1.093
Low Fibrinogen Level as a Predictor of
Hemorrhagic Transformation after Thrombolytic
Therapy for Acute Ischemic Stroke – Alessandro
Iliceto, Roger C. Cheng, Deviyani Mehta, Raymond
Vincent Mirasol, Igor Rybinnik
P1.094
Management of Early Neurologic Deterioration
Due to Stroke Progression or Recurrence –
Joontae Kim, Sura Ryu, Hyunsoo Kim, You-Ri Kang,
Shina Kim
P1.095
Spinal Dural Arteriovenous Fistula: A diagnostic
conundrum for neurologists – Megan Weisenberg,
Meghna Kumar-Pelayo
P1.096
Could The “Modified 8 D’s of Stroke Care”
Improve Sex Disparities in Door-to-Needle Time
in Acute Ischemic Stroke? – Melika Jameie,
Mana Jameie, Ghasem Farahmand, Saba Ilkhani,
Zahra Ranjbar, Hannah Magrouni, Sanaz Heydari,
Mojtaba Shahbazi, Maryam Kaeedi, Rozita Amiri,
Fateme Alizadeh Boroujeni, Mahnaz Varedi,
Bahareh Pourghaz, Mojdeh Ghabaee
P1.097
Effects of Demographics and Socioeconomic
Status on Opioid Use in Patients with
Subarachnoid Hemorrhage – Kareem Joudi,
Linda C. Wendell, Bradford B. Thompson, Jesse
Menville, Karen L. Furie, Ali Mahta
P1.098
Surpass Streamline for the Treatment of
Heterogenous Size Intracranial Aneurysms: A
Multicenter US Real-World Experience – Juan
A. Vivanco-Suarez, Mudassir Farooqui, Milagros
Galecio-Castillo, Cynthia Zevallos, Kimon
Bekelis, Justin Singer, David J Altschul, Johanna
Therese Fifi, Fawaz Al-Mufti, Bradley Gross,
Brian Jankowitz, Peter Tze Man Kan, Margarita
Rabinovich, Sarah Newman, Emanuele Orru, Ajay
Wakhloo, Santiago Ortega Gutierrez
P1.099
Characterizing Post-Operative Stroke in Patient’s
Undergoing Neck Dissection – Derek Woodruff,
Eric Goldstein

P1.100
Effect of Decompression Craniectomy on
Survival and Functional Outcome in Patients with
COVID-19 and Malignant Infarct: A Retrospective
Cohort Study and Review of Literature – Sudheer
Pachipala, Saranya B. Gomathy, Ayush Agarwal,
Venugopalan Y Vishnu, Awadh K. Pandit, Rohit
Bhatia, Padma Vasantha Hadakasira
P1.101
Can Inflammatory Markers Predict TOAST
Subtypes in Young Onset Ischaemic Strokes?
– Tara Hamilton, Shameer Rafee, Christopher
McGuigan
P1.102
Association Between Stroke Severity and Cardiac
Troponins in Acute Stroke – Andrea Kuczynski,
Grace Rzyczniak, Gee Hung Leo Cheong, Petra
Famiyeh, Manav Vyas
P1.103
Team-based Resident Training for Stroke Code
Simulations Decreases Variations in Thrombolytic
Door to Needle Times – Hyeyoung Seol, Peri
Smith, Aidan Azher, Zafer Keser, Aditya Kumar,
Shivika Chandra, Amanda L. Jagolino-Cole, Alicia
Zha
P1.104
Motor Impairment In Intracerebral Hemorrhage
– Mariem Elfekih, Ines Bedoui, Bissene Douma,
Zeineb Brahem, Hajer Derbali, Jamel Zaouali,
Ridha Mrissa
P1.105
A Case of Contrast-Induced Encephalopathy
in The Setting of Acute Stroke Thrombolysis
– Qasem N. Alshaer, Zaid R. Najdawi, Ryan B.
Peterson, Nirav R. Bhatt
P1.106
Endovascular Treatment of Acute Ischemic Stroke
in Patients with versus without Pre-morbid
Disability: A Meta-analysis – Benjamin Frank
Beland, Fouzi Bala, Mohammed Almekhlafi, Eva
Akshitkumar Mistry, Mayank Goyal, Aravind
Ganesh
P1.107
Physician Approaches to Imaging and
Revascularization for Acutely Symptomatic
Carotid Stenosis: Insights from the Hot Carotid
qualitative study – Aravind Ganesh, Benjamin
Frank Beland, Gordon Jewett, David JT Campbell,
Malavika Varma, Ravinder Jeet Singh, Abdulaziz
Sulaiman Al Sultan, John Wong, Bijoy Menon
P1.108
Physician Approaches to Anti-thrombotic
Therapies for Acutely Symptomatic Carotid
Stenosis: Insights from the Hot Carotid Qualitative
Study – Aravind Ganesh, Benjamin Frank Beland,
Gordon Jewett, David JT Campbell, Malavika
Varma, Ravinder Jeet Singh, Abdulaziz Sulaiman
Al Sultan, John Wong, Bijoy Menon
Information is accurate as of February 8, 2022, and is subject to change.
Virtual Experience Posters
P1.109
Direct Oral Anticoagulants and Antiepileptic Drug
Combination on Risk of Ischemic Stroke and Major
Bleeding – a territory-wide review – Bonaventure
Ip, Ho Ko, Hiu Wo Chan, Carly Yeung, Brian Yiu,
Alexander Yuk-Lun Lau, Grace LH Wong, Thomas
Wai Hong Leung
P1.110
A Large Lambl’s Excrescence Causing Embolic
Stroke in a Young Patient: A Case Report and
Review of Literature – Hadi Abou-El-Hassan,
Yusra Azhar, Asad Ikram, Dmitry Belchenko, Tobias
B. Kulik, Michel T. Torbey
P1.111
Hemoglobin Levels And Cerebral Collaterals As
Independent Predictors Of Functional Outcome In
Acute Ischemic Stroke Cases With Large Vessel
Occlusion (LVO) – Sankar Prasad Gorthi, Krithishree
S., Prakashini K
P1.112
Hypertensive Disorders in Pregnancy and Future
Risk of Stroke and Hypertension: A Systematic
Review and Meta-analysis – Aaron Ross Switzer,
Eric E. Smith, Aravind Ganesh
P1.113
Treatment Non-Adherence And Barriers To
Treatment Adherence Among People Diagnosed
With Stroke In A Tertiary Care Hospital Of South
India. – Ashwini Naik, Jyothi Chakrabarty
P1.114
On Evaluating The Potential Of Machine Learning
For Effective Classification Of Ischemic And
Hemorrhagic Stroke In Resource Limited Settings
– Aman Bhardwaj, Yamini Antil, Aanchal Chadha,
Padma Vasantha Hadakasira, Vinny P. Wilson, Amit
Mehndiratta, Venugopalan Y Vishnu, Rahul Garg
P1.115
Presumed Large Vessel Occlusion in Patients
presenting with First-ever Ischemic Stroke at a
Tertiary Teaching Hospital in Tanzania – Sarah
Shali Matuja, Rashid Ali Ahmed, Patricia Munseri,
Khuzeima Shabirhussein Khanbhai, Kezia Kodawa
Tessua, Frederick Richard Lyimo, Gustavo J.
Rodriguez, Alberto Maud, Mohammad Rauf A.
Chaudhry, Mohamed Manji, Faheem Gulamabbas
Sheriff
P1.116
Supranuclear Oculomotor Palsy In Cerebral Venous
Sinus Thrombosis: A Rare Occurrence – Varun
Kumar Singh, Kumar Bismaya, Pratishtha Sengar,
Pratishtha Sengar, Anand Kumar
P1.117
Bow Hunter Syndrome: An intriguing case
of posterior circulation stroke in obstetrics
department – Neenu Alexander, Justin Cornelius
P1.118
The impact of prior multimorbidity on the long-
term risk and costs of institutionalisation after
stroke: a population-based study – Matthew
Downer, Ramon Luengo-Fernandez, Linxin Li, Peter
Rothwell
P1.119
Critical Analysis Of Differentiation Between
Ischemic And Hemorrhagic Stroke In Resource
Limited Settings: A Systematic Review – Aman
Bhardwaj, Padma Vasantha Hadakasira, Vinny P.
Wilson, Amit Mehndiratta, Venugopalan Y Vishnu,
Rahul Garg
P1.120
Re-evaluating Risk Factors, Incidence, and
Outcome of Aneurysmal and Non-aneurysmal
Subarachnoid Hemorrhage – Alireza Zandifar,
Zahra Sadat Mortazavi, Jorge Du Ub Kim, Luis
Octavio Tierradentro Garcia, Seyedeh Zahra Tara,
Arastoo Vossough, Mohammad Saadatnia
P1.121
Contagion Effect of COVID-19 - Cerebral venous
sinus thrombosis – Abhilash Thatikala, Hafsa
Bareen Syeda, Shubham Biyani, Syeda Busmah
Owais, Rucha Bahekar, Sukanthi Kovvuru,
Sanjeeva Reddy Onteddu, Krishna Nalleballe
P1.122
Subtle Neurological Symptoms as Early Signs
of Watershed Infarction in COVID-19 Infection –
Mohammad Amin Najafi, Alireza Zandifar, Mohsen
Kheradmand, Luis Octavio Tierradentro Garcia,
Jorge Du Ub Kim, Fariborz Khorvash, Arastoo
Vossough, Mohammad Saadatnia
P1.123
Factors Associated with Depression after
Hemorrhagic Stroke – Janice Chou, Sarah Ecker,
Anlys Olivera, Aaron S. Lord, Lindsey Gurin, Koto
Ishida, Kara R. Melmed, Jose L. Torres, Barry M.
Czeisler, Cen Zhang, Jennifer A. Frontera, Ariane
Lewis
P1.124
Predictors of Outcome in Patients with
Concurrently-Diagnosed Ischemic and
Hemorrhagic Stroke – Fransisca Indraswari,
Janine Molino, Michael E. Reznik, Abdulrahman
Bukhari, Christopher Leon Guerrero, Shawna M.
Cutting
P1.125
Diagnosis of Stroke and Prognosis of Interventions
Using Imaging and Machine Learning – Kathleen
Miao, Julia Miao
P1.126
Initially Misdiagnosed Bilateral Medial Medullary
Stroke – a Case Report – Isadora Versiani de
Lemos, Priscila Santos Mageste, Matheus Castro,
Alexandra Seide Cardoso, Mariana Soares de
Freitas Tamy, Raimundo Marcial de Brito Neto,
Vanessa Cristina Colares Lessa, Gabriel R. Freitas
AAN.com/AM 107

P1.127
Central vs Local Stroke Adjudication in the IRIS
Trial – Rachel Forman, Catherine Viscoli, Walter
N. Kernan
P1.128
Circulating Inflammatory Biomarkers and Enlarged
Perivascular Spaces: the Framingham Heart Study
– Oluchi Stella Ekenze, Adlin Pinheiro, Serkalem
Demissie, Emelia Benjamin, Ramachandran Vasan,
Charles S. DeCarli, Sudha Seshadri, Jose Rafael
Romero
P1.129
Mysterious case of recurrent cryptogenic strokes
in a young female: A rare case of Parry Romberg
Syndrome – Vijaya Lakshmi Valaparla, Xiangping
Li, Chilvana V. Patel, Arun Singh Chhabra, Hashem
M. Shaltoni, Anand Vilaschandra Patel
P1.130
A comprehensive analysis of stroke risk factors
by HIV serostatus in Uganda: Implications for
stroke prevention in sub-Saharan Africa – Amir
Abdallah Mbonde, Jonathan Chang, Kisekka Abdu
Musubire, Samson Okello, Adrian Kayanja, Acan
Moses, Nkwanga Jacob, Andrew Katende, Felicia
Chow, Deanne Saylor, Cumara Barahona O’Carroll,
Mark Siedner
Child Neurology and Developmental
Neurology
P1.131
Clinical Phenomenology of Functional Tics during
the COVID-19 Pandemic – Jaclyn Martindale,
Gregory Bryan Russell
P1.132
Phenotype of Pathogenic Variant in the Gene
NHLRC1 in Lafora Disease – Apirada Thongsing,
Mohamad Abou Merhi Saifeddine, Daniel Lax
P1.133
Exercise-Induced Rhabdomyolysis: Atypical
Phenotype of a Dystrophinopathy – Anastasia
Railean, Jaclyn Martindale
P1.134
Associations Between Steroid Treatment and
Clinical Outcomes Among Non-ambulatory
Patients with Duchenne Muscular Dystrophy
(DMD) – Craig McDonald, Oscar Mayer, Kan N.
Hor, Jessica Marden, Jonathan Freimark, Henry
Lane, Adina Zeling Zhang, Molly Frean, Claudio
Santos, Richard Allen Able, James Signorovitch
P1.135
Associations Between Deflazacort Versus
Prednisone/Prednisolone and Markers of Disease
Progression in Clinically Important Subgroups of
Patients with Duchenne Muscular Dystrophy –
Craig McDonald, Jessica Marden, Henry Lane,
Adina Zeling Zhang, Ha Nguyen, Claudio Santos,
Richard Allen Able, James Signorovitch
108 2022 AAN Annual Meeting
Virtual Experience Posters
P1.136
Evaluation of 18,911 Individuals with Autism
Reveals that Exome Analysis Provides Higher
Diagnostic Rates and Reduced Time to Diagnosis
than Traditional Testing Strategies – Amanda S.
Lindy, Rebecca Torene, Kyle Retterer, Paul Stephen
Kruszka
P1.137
Efficacy and Safety of Onasemnogene
abeparvovec in Spinal Muscular Atrophy: A
Systematic Review and Meta-Analysis – Aaron
Rodriguez, Fabián Andrés Chávez Ecos, Sandra
Chavez-Malpartida, Giancarlo Alvarado-Gamarra,
Peggy C. Martinez Esteban, Carlos Alva-Diaz
P1.138
Post Covid 19 Immune Mediated Neurological
Manifestations in Children : A single centre study
– Lokesh Saini, Deepthi Krishna, Sarbesh Tiwari,
Daisy Khera, Prawin Kumar, Jagdish Prasad Goyal,
Bharat Choudhary, Kuldeep Singh
P1.139
Patient Factors Predictive of the Use of Genetic
Testing in Infantile Spasms – Kenza El Marzouki,
Senyene Hunter
Epilepsy/Clinical Neurophysiology
(EEG)
P1.140
Brivaracetam use in Hong Kong: a post-marketing
cohort study – Wui Ho, Holy MH Chan, Sze Wai E.
Yeung, Hoi Ki, Hiu Tung Lui, Lok Yiu Chan, Cheuk
Nam Rachel Lo, Yun Hin Ian Leung, William C.Y.
Leung, Chang Shek Kwan
P1.141
Characteristics of Seizure-induced Reversible MRI
Abnormalities in Status Epilepticus – Frederick
P. Mariajoseph, Parveen Sagar, Subramanian
Muthusamy, Shalini Amukotuwa, Udaya K.
Seneviratne
P1.142
Seizure-induced Reversible MRI Abnormalities
in Single Seizures: Current Knowledge and
Future Directions – Frederick P. Mariajoseph,
Subramanian Muthusamy, Shalini Amukotuwa,
Udaya K. Seneviratne
P1.143
Distinguishing Quantitative EEG Correlates
of Psychogenic Non-Epileptic Seizures versus
Epilepsy – Josh Goldenberg, Syphong Dzuy Ha,
Julie Roth, Judy Liu, W. Curt LaFrance, Andrew S.
Blum, Jason B. Richards
P1.144
Focal clonic movements elicited by electrical
cortical stimulation of primary motor cortex –
Neel Fotedar
P1.145
Using Semiology to Classify Epileptic Seizures
versus Psychogenic Non-Epileptic Seizures - A
Meta-Analysis – Subramanian Muthusamy, Udaya
K. Seneviratne, Catherine Tuo-Wei Ding, Thanh
Phan
P1.146
Asystole after VNS battery change: a case report
– Animesh Gupta, LynnMarie Jarratt
P1.147
Effectiveness of epilepsy treatment with Cannabis
Sativa derivatives in children with Dravet
Syndrome – Systematic Review – Layne Nunes
Lins, Hermila Guedes
P1.148
Quality and publication rates of randomized
blinded clinical trial abstracts presented at Annual
Meetings of the American Epilepsy Society 2010-
2019 – Sriram Sunil Kumar, Rohit Das
P1.149
Assessment of COVID-19 Vaccination Status and
Vaccine Tolerance in Patients with Epilepsy in
the State of Kentucky – Rani Priyanka Vasireddy,
Zabeen Kaizar Mahuwala, Meriem K. Bensalem
Owen, Deb Jo McGrath, Beth Stivers
P1.150
Comparison of Levetiracetam vs Carbamazepine
in Epilepsy Patients: A Systematic Review –
Jeremiah Wijaya, Fellisa Meliani, Rivaldo Steven
Heriyanto, Rivaldo Steven Heriyanto, Gilbert
Sterling Octavius
P1.151
ELEVATE Study 410: Phase IV Study of Perampanel
as Monotherapy or First Adjunctive Therapy in
Patients Aged =4 Years with Focal-Onset Seizures
(FOS) or Generalized Tonic-Clonic Seizures (GTCS)
– Pavel Klein, Omar Samad, Dinesh Kumar, Stella
Leock Ngo, Manoj Malhotra
P1.152
Assessment of Cognition (EpiTrack®) and
Depression (Beck Depression Inventory-II)
Following Perampanel (Monotherapy/First
Adjunctive) in Patients with Epilepsy Enrolled in
The ELEVATE Phase IV Study – Joon Kang, Omar
Samad, Dinesh Kumar, Stella Leock Ngo, Manoj
Malhotra
P1.153
Functional Impairments are Common in Adults
with Epilepsy and Psychogenic Non-epileptic
Seizures – Venkat Prahas Suru, Noah Andrews,
James Bena, Nancy R. Foldvary-Schaefer
P1.154
Perampanel in Elderly Patients: An Overview of
Data from Studies 307, 335, 412, 342, and 506 –
Ilo E. Leppik, Robert T. Wechsler, Dae Won Seo,
Takamichi Yamamoto, Anna Patten, Hugh Jiwoong
Lee, Stella Leock Ngo, Manoj Malhotra

P1.155
Perampanel as Early Add-on Therapy for Epilepsy
Patients with Focal-Onset and Generalized-Onset
Seizures Treated in Clinical Practice – Estevo
Santamarina, Javier Abril, Xiana Rodríguez Osorio,
Takamichi Yamamoto, Rob McMurray, Eugen
Trinka, Wendyl J. D’Souza, Rosaria Renna, Vicente
Villanueva
P1.156
Knowledge and Attitude toward Epilepsy among
the Final and Semi-Final Years Medical Students
at University of Bahri, Sudan – Mohammed Nasir
Mustafa, Lina Gafar Wedaalla, Tibyan Kamal
Ahmed
P1.157
Use of Non-Medical Practices in the Management
of Epilepsy: Experience in a South Eastern
Nigerian Clinic – Chukwuma Emmanuel Nwaze,
Yvonne Emuobome Eghwrudjakpor, Christian
Chidi Nduka, Udomba Ozioma Kosy, Jenny Oriaku
Ojukwu, Nnenna Zinnah Aloziem, Opeyemi
Jeremiah Ajayi, Emmanuel Odion Igue, Jovita Eghe
Egharevba, Stephanie Chiemelie Metu, Samson
Pamilerin Ogunbolu, Ngozi Glory Amadi, Obiamaka
Maria Aghadiuno, Njoku Julie Chidimma,
Adaeze Ruth Avah, Chinomso Daniel Ogumerem,
Jemimah Onua, Ahunna Ugochi Nwogu, Chukwudi
Amarachukwu Nwogu, Chinekwu Anyanwu
P1.158
Patterns of medication use in patients with rare
Mendelian pediatric epilepsies – Ella Nysetvold,
Nivi Ahlawat, Kristina Cotter, Caitlin A. Nichols
P1.159
Prevalence of Depression among Epilepsy patients
in a Tertiary Care Hospital in Sri Lanka – Gimhani
Ratnayake, Athula Dissanayake, Damith Liyanage,
Wasana Senanayake
P1.160
Correlation analysis between multi-dimensional
scale for PDD and ADHD (MSPA) and WAIS-III in
adult epilepsy – Hiromi Kanesaki, Rie S. Tsuburaya,
Kozue Takada, Kazuaki Sato, Hiromitsu Tabata,
Masako Kinoshita
P1.161
Convulsive and Non-convulsive Status Epilepticus:
Prevalence, Related Etiologies, Treatment, and
Outcome. A retrospective Cohort Study in Saudi
Arabia – Abdullah Saleh Alamri, Abdullah kabbani,
Remah Alzayyat, Adel Al Rashidi, Fouad Ahmad
Alsaadi, Shahad Alsheikh, Rawan Salim Alyami,
Sultan Salem Alzahrani, Mohammed Ahmed
Alshammari, Laila Osama Alibrahim
P1.162
Programming of Electronic Medical Record for
ACNS Standardized Critical Care EEG Terminology
– Olga Selioutski, Anne C. Van Cott
P1.163
On Demand EEG Education - a Novel, App-
based Teaching Method Focused on Interictal
Epileptiform Discharge Identification – Jaden
Daniel Barfuss, Fabio Augusto Nascimento E Silva,
Erik P. Duhaime, M. Brandon Westover, Jin Jing
Information is accurate as of February 8, 2022, and is subject to change.
Virtual Experience Posters
P1.164
Meta-analysis of 175 Patients with COVID-19
and Seizures, Status Epilepticus, or Cortical
Myoclonus: An Individual Patient Data Analysis –
Cristina Jageka, Amman Bhasin, Aditi Kappagantu,
Helena Ann Brantz, Rooqash Ali, Brittany M Stopa,
Saef Izzy, Ayaz M. Khawaja
P1.165
Association of clinical variables with cyclic
alternating pattern of encephalopathy (CAPE)
– Rene Andrade-Machado, Jiping Zhou, Deepti
Zutshi
P1.166
Rhythmic Epileptic Discharges in Focal Cortical
Dysplasia : an EEG-pathology Study – Yang Zheng,
Wen-Jie Ming, Lv Jing, Yao Ding, Mei-Ping Ding
General Neurology
P1.167
Diagnostic Approach to Cranial Nerve III Palsy –
Meera Solanki, Kiran Iyer, Alexa Leah Noronha,
Adriana Carola Mendez, Nataliya Ternopolska
P1.168
DTI Abnormalities in Healthy E200K Carriers
May Serve as an Early Biomarker for Genetic
Creuzfeldt-Jakob Disease (gCJD) – Nurit Omer,
Rawan Silbak, Noa Trabulus, Tamara Shiner, Orna
Moore, Mali Gana-Weiss, Orly Goldstein, Tal
Glinka, Avi Orr-Urtreger, Nir Giladi, Amgad Droby,
Noa Bregman
P1.169
Technology as Treatment: Use of Virtual
Complementary and Integrative Therapies by
Patients in Neurology – Mia T. Minen, Neil A.
Busis, Steven Friedman, Maya Catherine Campbell,
Ananya Sahu, Kazi Shafia Maisha, Quazi Ilham
Hossain, Mia Soviero, Deepti Verma, Leslie Yao,
Farng-Yang Foo, Jaydeep M. Bhatt, Laura J. Balcer,
Steven Galetta, Sujata P. Thawani
P1.170
Ischaemic Lumbrosacral Plexopathy following
Infrarenal Aortic Thrombosis – Suzanne Kirstin
Quigley, Emma Troy, Niamh Bermingham, Aisling
Ryan
P1.171
Bilateral facial paralysis as first clinical
manifestation in HIV positive patient – Melissa
Annette Morales Garcia, Jessica Abreu Garcia,
Raymond Manuel Rivera Vergara, Cristina
Alejandra Cruz, Marelisa Albelo Martinez, Jose
Carlos Lopez Puebla, Gishlaine Alfonso, Valerie E.
Wojna
P1.172
A social media survey to understand where
patients with neurologic conditions obtain
information on pregnancy planning, pregnancy,
and breastfeeding – Jenna Alys Brunn, Anita
Valanju Shelgikar, Louise M. O’Brien
P1.173
Demographic Factors and Diagnoses Associated
with Ambulatory Neurology Video Telehealth visit
No-shows – Aashrai Sai Venkat Gudlavalleti, John
Elliott, Rafah Asadi
P1.174
White Matter Involvement in SPG76. A
Retrospective MRI Analysis of 11 Subjects.
– Abdulrahman Alkhalifa, Shihan Chen,
Massimiliano Filosto, Elisa Cali, Henry Houlden,
Wladimir Bocca Pinto, Afagh Alavi, Francesco
Nicita, Stefano Tozza, Sirio Cocozza, Nicola
Carboni, Nazli Basak, Bernard Brais, Guy A.
Rouleau, Roberta La Piana
P1.175
Assessing Patient Demand for Neurologists in
the United States Using Google Trends – Nanda
Krishnan Siva, Haig Pakhchanian, Rahul Raiker,
Phonphanh Dedthanou, Shanawar Ali Waris,
Darshan A. Dave
P1.176
Methylmalonic Acidemia-Uncommonly Missed
Diagnosis in Adults: The Usefulness of MMA
for seizures/weakness/ataxia – Sonia Kalirao,
Brianna Cocuzzo
P1.177
Clinico-Radiological Profile and Treatment
Outcomes in Hypertrophic Pachymeningitis:
A Retrospective Study – Rajesh Kumar Singh,
Manish Salunkhe, Ajay Garg, Ayush Agarwal,
Animesh Das, Divya M. Radhakrishnan, Awadh K.
Pandit, Rohit Bhatia, Padma Vasantha Hadakasira,
Vinay Goel, Rishikesh Kumar, Achal K. Srivastava
P1.178
Wernicke Encephalopathy (WE) In Young Healthy
Teenagers – Irum Hina, Ehtesham Khalid
P1.179
When to resect: Benign yet debilitating
neurological symptoms related to rare cases of
skull-based Epidermoid cysts. – Vanessa Dwairi,
Priya Nidamanuri, Thandar Aung
P1.180
Posterior Reversible Encephalopathy Syndrome
with Spinal Cord Involvement (PRES-SCI) - a
Case Report and Literature Review – Mathura
Ravishankar, Alexandra Urban
P1.181
A Unique Case of Whippets-Induced B12
Deficiency Manifesting as a Subacute Brown-
Sequard Spinal Syndrome – Andrew Shenchi Kao,
Sabeena Iqbal Malik
P1.182
Frequency, Persistence, and Patient-reported
Outcomes of Neurological Symptoms in Mild
COVID-19: Results from the ALBERTA HOPE
COVID-19 Trial – Aravind Ganesh, Ryan Edgar
Rosentreter, Yushi Chen, Rahul Mehta, Graham
Alexander McLeod, Miranda Wan, Jonathan Krett,
Yasamin Mahjoub, Angela Lee, Ilan Schwartz,
Luanne Metz, Eric E. Smith, Michael D. Hill
AAN.com/AM 109

P1.183
Post Lumbar Puncture Spinal Epidural Venous
Engorgement–A Potential Imaging Trap – Khaled
Gharaibeh, Hira Pervez, Ajaz Sheikh
P1.184
A Systematic Review Of Clinical Profile Of
Cerebral Abscess In Post Covid Rhino Orbital
Cerebral Mucormycosis – Amaravathi Markala,
Justin Cornelius, Srujanitha Tadi, Manivannan
Ramraj, Murugan Ponnaiah Kasirajan
P1.185
A Young Man Suffered By Recurrent Headache
and Visual Symptoms – Ning Su, Yan Zhou,
Chenhui Mao, Li-Ying Cui, Yicheng Zhu, Jun Ni
P1.186
Steroid-Responsive Ecchordosis Physaliphora
Diagnosed as CLIPPERS: A Systematic Review
of Literature and Case Report – Thejasvi
Anantasagar Reddy, Carlos Alberto Perez, Anam
Qamar Haque, Rohan S. Samant, Rajesh K. Gupta
P1.187
Managing Rapid Sodium Correction: A Case of
Osmotic Demyelination – Sara Grace Hubacek,
Nelson Parks Douglass, Saurabh G. Shukla
P1.188
Akinetic Mutism Resulting from Cerebral Fat
Embolism from Underlying Hemoglobin SC
Disease Crisis – Elsa Cassandra Rodriguez,
William Remley, Cyra Mae Bunag, Varun Jain,
Bhavana U. Patel
P1.189
A rare case of Foster-Kennedy syndrome
secondary to meningioma causing impaired
venous drainage. – Sahil Naik, Satya Rashmit
Durugu, Shivani Naik
Global Health
P1.190
Socioeconomic Status and Cognitive Function
in Children with HIV: Evidence from the HIV-
Associated Neurocognitive Disorders in Zambia
(HANDZ) Study – Esau G. Mbewe, Pelekelo
Kabundula, Sylvia Mwanza-Kabaghe, Milimo
Mweemba, Alexandra Buda, Heather Adams,
Gretchen L. Birbeck, David Bearden
P1.191
Validation of the NIH Toolbox Cognition Battery in
Children with and without HIV Infection in Zambia
– Pelekelo Kabundula, Esau G. Mbewe, Sylvia
Mwanza-Kabaghe, Milimo Mweemba, Gretchen L.
Birbeck, Heather Adams, David Bearden
110 2022 AAN Annual Meeting
Virtual Experience Posters
Headache
P1.192
Deep phenotyping using cranial autonomic
symptoms in migraine and cluster headache – Jr-
Wei Wu, Chia-Chun Chiang, Shu-Ting Chen
P1.193
Low Levels of Rimegepant in Breast Milk After a
Single 75-mg Dose – Teresa Baker, Robert Croop,
Lisa Kamen, David Stock, Andrea Ivans, Rajinder
K. Bhardwaj, Matt Anderson, Jennifer Madonia,
Joseph Stringfellow, Richard Bertz, Vladimir Coric,
Thomas Wright Hale
P1.194
Acute prolonged motor aura resembling ischemic
stroke after COVID-19 vaccination (CoronaVac):
the first case report – Wanakorn Rattanawong,
Wasan Akaratanawat, Supatporn Tepmongkol,
Aurauma Chutinet, Nijasri Charnnarong
P1.195
Relation of Anxiety and Depression with Personal
Protective Equipment Associated Headache in
Healthcare Workers During COVID-19 Outbreak
– Eva Saragih, Haflin S. Hutagalung, Khairul P.
Surbakti
P1.196
Three-Year Efficacy and Safety of Erenumab in
Participants with Episodic Migraine and 2–4 Prior
Preventive Treatment Failures: Results from the
LIBERTY Study – Uwe Reuter, Peter Goadsby,
Michel D. Ferrari, Gabriel Paiva da Silva Lima,
Subhayan Mondal, Shihua Wen, Tracy E. Stites,
Michal Arkuszewski, Michel Lanteri-Minet, Shaloo
Pandhi
P1.197
Long-term Treatment with Galcanezumab in 29
Patients with Chronic Migraine: Results from the
3-year Continued Access Program of the REGAIN
Study – Amnon Mosek, Lily Li, Hai-An Hsu, Angelo
Camporeale, Gabriel Vainstein
P1.198
Intravenous Ibuprofen for Acute Migraine
Treatment: A Double-Blind Randomized Placebo-
Controlled Pilot Study – John Curran, Hsiangkuo
Yuan, Scott Keith, Mary Hopkins, Stephen D.
Silberstein
P1.199
CGRP as a Marker of Headache Attributed to
COVID-19 Infection – Esra Erdil, Esin Engin, Emine
Nese Tuncer, Tulin Tanridag
P1.200
A Case of ATP1A2 Familial Hemiplegic Migraine
Presenting with Unilateral Encephalopathy and
a Cytotoxic Corpus Callosum Lesion – Emma
Troy, Audrey Reynolds, Brian McNamara, Aine P.
Merwick
P1.201
Prescription Patterns of Triptans in the Treatment
of Migraine – Ariana Barreau, Nicholas Peterman,
Bradley Kaptur, Kristine Carpenter
P1.202
Headache Apps Found in the Commercial
Marketplace: A Systematic Analysis of Features
and Characteristics – Ananya Sahu, Leslie Yao,
Maya Catherine Campbell, Mia Soviero, Quazi
Ilham Hossain, Deepti Verma, Erica Camacho,
John Torous, Mia T. Minen
P1.203
Adherence to the IHS Guidelines for Controlled
Trials of Acute Treatment of Migraine Attacks
with Parenteral NSAIDs – John Waters, John
Curran, Hsiangkuo Yuan
P1.204
Validation of diagnostic criteria for menstrual
migraine – Iris Verhagen, Hermes Spaink, Britt
Willemijn Hele Van Der Arend, Daphne Suzanne
Van Casteren, Antoinentte Maassen Van Den
Brink, G.M. Terwindt
P1.205
Real-world evidence on HRQoL of therapy-
resistant migraine patients undergoing preventive
treatment in an ambulatory care setting – Schirin
Sulaiman, Hannah Maria Haneke, Valerie
Kirchberger, Markus Jahn, Jan-Peter Jansen
P1.206
Recurrent Thunderclap Headaches as a Presenting
Symptom of Coccidioidal Meningitis – Olivia
Kingsford, Madeline Louise Singer, Kerry Louise
Knievel
P1.207
MSQ Utility Mapping of Rimegepant by Change in
Monthly Migraine Days for Preventive Treatment
of Migraine – Karissa Johnston, Gilbert J. L’Italien,
Evan Popoff, Lauren Powell, Fiona O’Sullivan, Linda
Harris, Robert Croop, Vladimir Coric, Richard B.
Lipton
P1.208
Rimegepant Versus Atogepant and Monoclonal
Antibody Treatments for the Prevention of
Migraine: A Systematic Literature Review and
Network Meta-analysis – Evan Popoff, Lauren
Powell, Karissa Johnston, Fiona O’Sullivan, Linda
Harris, Chelsea Leroue, Robert Croop, Vladimir
Coric, James Arthur Moren
P1.209
Assessing Resident Opinions and Implementation
of Quality Care for Headache Patients in
Continuity Clinic – Aakash Bhargava, Ashish
Adlakha, Riya Luhar
P1.210
Presentation of headache and its management in
the Emergency Department amongst a cohort of
diverse reproductive age women – Crystal Jicha,
Jelena M. Pavlovic

Health Care Disparities
P1.211
Impact of COVID-19 on Physical Activity, Diet,
and Stroke Awareness in Homeless Individuals
of Chicago – Joseph Dodson, Antonia Santos,
Annabelle Volgman, Neelum T. Aggarwal
P1.212
Proportion of Life in Canada and Stroke Incidence
and Outcomes in Immigrants – Manav Vyas,
Jiming Fang, Peter Austin, Moira Kapral
P1.213
Race, Ethnic, and Language Differences in
Clinic Follow-up After Stroke Admission – Laura
Okonokhua, Jesus Roberto Varela, Laurel Jean
Cherian, James Conners, Rima Dafer, Nicholas D.
Osteraas, Sarah Song, Alejandro Vargas
P1.214
Autoimmune encephalitis in the Philippines: a
scoping review on the treatment gaps, challenges,
and current state of care – Gerald Tangonan
Pagaling, Christian Wilson Turalde, Roland
Dominic Jamora
P1.215
Influence of Race and Ethnicity on Adherence
to Secondary Stroke Prevention Medications in
an Integrated Managed Care Health System –
William Patrick Neil, Bruce I. Ovbiagele
P1.216
Snowball effect of COVID- 19 : Stroke Care
Underutilization – Abhilash Thatikala, Hafsa
Bareen Syeda, Shubham Biyani, Naren Raj
Arulprakash, Khushboo Verma, Sen Sheng,
Mudassar Kamran, Vishank Arun Shah, Sisira
Yadala, Sanjeeva Reddy Onteddu, Krishna
Nalleballe
P1.217
A Cross-Sectional Analysis of Medical
Crowdfunding Requests for Neurological Patients
and Caregivers in Canada – Erin Balcom, Phillip
Gregoire
History of Neurology
P1.218
The expulsion of Augusta Dejerine-Klumpke from
the Salpêtrière hospital: Pierre Marie’s revenge.
– Leo Coutinho, Matheus Gomes Ferreira, Carlos
Henrique Ferreira Camargo, Olivier Walusinski,
Helio Afonso Ghizoni Teive
Information is accurate as of February 8, 2022, and is subject to change.
Virtual Experience Posters
Infectious Disease
P1.219
Antiviral therapy for Herpes Simplex Virus
encephalitis: Systematic Review and Meta
analysis of RCTs – Sri Harsha Boppana
P1.220
“Long-hauler” impact of COVID-19 on brain
microstructure: a 3-month follow-up study –
Nick Teller, Jordan Chad, Eugenie Roudaia, Ali
Hashemi, Haddas Grosbein, Asaf Gilboa, Maged
Goubran, Ivy Cheng, Sandra E. Black, Rob Fowler,
Chinthaka Heyn, Fuqiang Gao, Mario Masellis,
Jennifer Rabin, Xiang Ji, Aravinthan Jegatheesan,
Benjamin Lam, Allison Sekuler, Bradley MacIntosh,
Simon James Graham, Jean Chen
P1.221
Progressive Multifocal Leukoencephalopathy and
Sphingosine 1-Phosphate Receptor Modulators
Used in Multiple Sclerosis: An Updated Review
of Literature – Durgesh Chaudhary, Samiksha
Srivastava, Katherine Elizabeth Beard, Xue
Bai, Sijin Wen, Syed Hassan Khalid, Shitiz K.
Sriwastava, Robert P. Lisak
P1.222
COVID-19-related acute necrotizing
encephalopathy with extremely high interleukin-6
and RANBP2 mutation in a patient with
recently immunized inactivated virus vaccine
and no pulmonary involvement. – Thanakit
Pongpitakmetha, Pasin Hemachudha, Wanakorn
Rattanawong, Poosanu Thanapornsangsuth,
Thiravat Hemachudha
P1.223
Spectrum of Acute Necrotizing Hemorrhagic
Encephalitis in COVID-19 patients: A case series
and Review – Rohan Sharma, Nidhi Kapoor,
Krishna Nalleballe, Vishank Arun Shah, Shilpa
Haldal, Sanjeeva Reddy Onteddu, Krishna C.
Mylavarapu, Thomas Spradley, Lana Hasan, Murat
Gokden, Manoj Kumar
P1.224
PISA Syndrome in Subacute Sclerosing Pan
Encephalitis: Case Report and Review of
Literature – Amit Shankar Singh, Jeenendra
Prakash Singhvi
P1.225
Subarachnoid Hemorrhage and Cerebral Edema
Caused by Disseminated Coccidiomycosis: A Case
Report – Taylor Stuart Campbell, Trusha Mehta,
Paul H. Janda, Aroucha Vickers, Alan Alexander
Arismendez, Mckenzie Merritt
P1.226
Neurological Spectrum Of Post Covid Rhino
Orbital Cerebral Mucormycosis - An Observational
Study in a Tertiary Care Centre in South India,
Madurai – Justin Cornelius, Manivannan Ramraj,
Murugan Ponnaiah Kasirajan, Amaravathi Markala,
Srujanitha Tadi, Dhileeban Maharajan P, Neenu
Alexander
P1.227
HSV-2 Vasculitis as a Cause of Ischemic Stroke
and Intracerebral Hemorrhage: a Case Report
– Lia Carolina Franco Castro, Shannon Hextrum,
Aimee M. Aysenne
P1.228
Neurognathostomiasis: Varied CNS
Manifestations, A Report of Two Cases – Sridhar
S, Saraswati Nashi, Dipti Baskar
P1.229
Post-acute neurological sequalae of SARS-COV-2
infection – Alanna Mary Rose Balbi, Audrey
Li, Marianna Shnayderman Yugrakh, Marla
Hamberger, Melodie R. Winawer
P1.230
Neuromelioidosis in the guise of a Demyelinating
illness – Gimhani Ratnayake, Athula Dissanayake,
Damith Liyanage, Pratheepa Kuganantharajah
P1.231
Study of patterns of presentation in post
COVID-19 mucormycosis – Shubham Dubey, Ayush
Dubey
P1.232
Herpes Zoster Associated Myelitis: Clinical and
Radiographic Features – James Douglas Triplett,
Michel Toledano, Lyell K. Jones
P1.233
A Case of Cytotoxic Lesion of the Corpus Callosum
Associated with Legionella Pneumonia – Megan
Elizabeth Trenz, Thomas Michael Snyder
Movement Disorders
P1.234
Demographics and Clinical Characteristics of
Autosomal Dominant Spinocerebellar Ataxias in
Canada: A Multi-center Study – Sohaila Abdullah
Alshimemeri, Danah AboAlSamh, Lily Zhou, Sarah
Furtado, Scott W. Kraft, Veronica A. Bruno, Antoine
Duquette, Bernard Brais, Oksana Suchowersky,
Renato Puppi Munhoz, Elizabeth Slow
P1.235
A rapid, ultra-sensitive, RT-QuIC assay, with
novel protocol, for MSA and PD using a single
site skin biopsy and serum neurofilament light
chain. – Diana Angelika Olszewska, Ivan Martinez-
Valbuena, Naomi Visanji, Mario Sousa, Puja
Bhakta, Anna Vasilevskaya, Chloe Anastassiadis,
Carmela Tartaglia, Gabor G. Kovacs, Anthony E.
Lang
P1.236
Mindfulness based program for newly diagnosed
Parkinson’s patients. – Azima Shaji, Nora Ko,
Aaron C. W. Lasker, Alexa Leah Noronha, Yahnily
Ocasio, Parampreet Kaur, Emma Muller, Adriana
Carola Mendez
AAN.com/AM 111

P1.237
Return of individual research reports in an
observational study of Parkinson’s disease:
Participant preferences and influences on future
research participation – Taylor Myers, Ellen
Wagner, Meghan Elizabeth Pawlik, Julia Marie
Soto, Christopher Tarolli, Ruth Schneider, Jamie
Lynn Adams, E. Ray Dorsey, Stella Jensen-Roberts
P1.238
Unraveling the Potential of Specialized Allied
Health Therapy in Parkinson’s Disease – Amir
Hossein Talebi, Jan Ypinga, Marten Munneke,
Bastiaan Roelof Bloem, Sirwan Darweesh
P1.239
Longitudinal follow up of mood symptoms in
cervical dystonia – Fiadhnait O’Keeffe, Andrew
Moriarty, Sean O’Riordan, Michael Hutchinson
P1.240
Treatment of Cervical Dystonia Using Shorter
IncobotulinumtoxinA Injection Intervals Improves
Patient-reported Outcomes in Those With
Inadequate Benefits from Standard Intervals
– Stuart H. Isaacson, David Charles, Cynthia L.
Comella, Daniel D. Truong, Odinachi N. Oguh,
Jennifer S. Hui, Eric Molho, Matthew A. Brodsky,
Erin Furr-Stimming, Georg Comes, Michael Hast,
Robert A. Hauser
P1.241
Injections Of Incobotulinumtoxina at Intervals Less
Than 10 Weeks are Effective and Safe for Cervical
Dystonia Patients with Inadequate Benefit from
Standard Injection Intervals – Cynthia L. Comella,
Robert A. Hauser, Stuart H. Isaacson, Daniel D.
Truong, Odinachi N. Oguh, Jennifer S. Hui, Eric
Molho, Matthew A. Brodsky, Erin Furr-Stimming,
Georg Comes, Michael Hast, David Charles
P1.242
Association of behavioral activation system with
dopaminergic striatum in Parkinson’s disease
patients – Hidetomo Murakami, Masakazu Ozawa,
Tomotaka Shiraishi, Tadashi Umehara, Shusaku
Omoto, Yasuyuki Iguchi
P1.243
Frontal Low Delta Spectral Power is Lower
in Patients with Parkinson’s Disease than in
Matched Controls – Adeel Ali Memon, Corina
Catiul, Zachary Irwin, Jennifer Pilkington, Allen
Joop, Raima A. Memon, Kimberly Wood, Svjetlana
Miocinovic, Amy W. Amara
P1.244
Effect of LRRK2 and GBA Mutations on
Parkinson’s Disease Clinical Progression in Elderly
Patients – Vincent Chang, Farnaaz Ataullah
Sheikh, Dennis Hasenhuendl, Siyuan Fu, Sagari R.
Bette, Stuart H. Isaacson
P1.245
Functional Movement Disorders in Patients with
Ehlers-Danlos Syndrome – Jason H. Margolesky,
Dyanet Loreta Puentes, Danielle Spengler Shpiner,
Henry Paul Moore, Corneliu C. Luca, Carlos Singer,
Ihtsham Haq
112 2022 AAN Annual Meeting
Virtual Experience Posters
P1.246
Structural and Functional Cerebellar Alterations
in Parkinson’s Disease with Postural Instability
and Gait Disorders – Elisabetta Sarasso, Andrea
Gardoni, Silvia Basaia, M. Antonietta Volonte,
Massimo Filippi, Federica Agosta
P1.247
Motor Cerebro-Cerebellar Networks Breakdown
Among Different Subtypes of Parkinson’s Disease
– Silvia Basaia, Federica Agosta, Alessandro
Francia, Camilla Cividini, Tanya Stojkovic, Iva
Stankovic, Rosa De Micco, Luigi Albano, Elisabetta
Sarasso, Andrea Gardoni, Roberta Balestrino,
Vladana Markovic, Elka Stefanova, Vladimir S.
Kostic, Massimo Filippi
P1.248
Neuroimaging Correlates of Gait Abnormalities
in Progressive Supranuclear Palsy – Irene Sintini,
Kenton Kaufman, Hugo Botha, Stacy Loushin,
Matthew Senjem, Robert I. Reid, Christopher
Schwarz, Clifford R. Jack, Val John Lowe, Keith A.
Josephs, Jennifer Louise Whitwell, Farwa Ali
P1.249
Variation in mortality according to severity and
phenotype in Progressive Supranuclear Palsy –
Duncan Street, Zi Qi Kok, Timothy Rittman, James
Rowe
P1.250
Associations between Baseline Cognitive Function
and Gait Outcomes after Treadmill Training in
Parkinson disease – Raima M. Amin, Raima M.
Amin, Andrew Humbert, Brenna Cholerton, Cyrus
P. Zabetian, Ignacio Mata, Valerie Kelly
P1.251
Long-term Motor and Non-Motor Symptom
Benefits in Patients With Advanced Parkinson’s
Disease Treated With Levodopa-Carbidopa
Intestinal Gel by Baseline Hoehn & Yahr Stage:
Analysis of the DUOGLOBE Study – Francesco
Pontieri, Ray Chaudhuri, Jason Lamar Aldred,
Paul M. Bourgeois, Thomas L. Davis, Esther Cubo
Delgado, Marieta Anca-Herschkovitsch, Robert
Iansek, Mustafa S. Siddiqui, Mihaela A. Simu, Lars
Bergmann, Omar Ladhani, Tianming Gao, David G.
Standaert, Norbert Kovacs
P1.252
Amyloid beta deposition and cognitive decline in
Parkinson’s disease: a study of the PPMI cohort
– Alexander Mihaescu, Mario Masellis, Ariel
Graff-Guerrero, Mikaeel Valli, Carme Uribe, Maria
Diez-Cirarda, Antonio Strafella
P1.253
Success of Home-to-Home Tele-neuropsychology
(TeleNP) in Deep Brain Stimulation (DBS)
Candidacy Assessments of Multicultural PD
Patients: State of Practice for COVID-19 and
Beyond – Marina Sarno, Annelly Buré-Reyes, Scott
Harcourt, Dayana Rodriguez, Wendy Gaztanaga,
Ihtsham Haq, Bonnie E. Levin
P1.254
The real-world use of istradefylline for Parkinson’s
disease: Post-marketing surveillance of safety and
effectiveness in Japan – Makio Takahashi, Satoru
Itou, Shuji Horiguchi, Yukie Tsuji
P1.255
The Hidden Disease Burden and Treatment
Experience of Patients with Essential Tremor:
A Retrospective US Claims Analysis – Drew
Campbell, Kelly E. Lyons, Gabriel M. Belfort
P1.256
PRAX-944-221: A Phase 2 Clinical Trial
Evaluating the Efficacy, Safety, Tolerability, and
Pharmacokinetics of PRAX-944 in Adults with
Essential Tremor – Gabriel M. Belfort, Shane
Raines, Ted Snyder, Bernard M. Ravina
P1.257
PRAX-944-222: A Phase 2 Randomized, Double-
blind, Placebo-controlled Trial of PRAX-944 for
the Treatment of Essential Tremor – Gabriel M.
Belfort, Shane Raines, Ted Snyder, Bernard M.
Ravina
P1.258
Outcome Assessment in Early-Stage Parkinson’s
Disease (PD) Clinical Trials: Are Legacy Patient-
Reported Outcome (PRO) Instruments Fit for
Purpose – Thomas Morel, Sophie Cleanthous,
John Andrejack, Roger Barker, Geraldine Blavat,
Babak Boroojerdi, William H. Brooks, Paul Burns,
Stefan Cano, Casey Gallagher, Lesley Susan
Gosden, Carroll Siu, Ashley R. Slagle, Kate Trenam,
Natasha Ratcliffe, Karlin Schroeder
P1.259
Neurogenetic Traits Outline Vulnerability to
Cortical Disruption in Parkinson’s Disease –
Silvia Basaia, Federica Agosta, Ibai Diez Palacio,
Elisenda Bueicheku, Federico d’Oleire Uquillas,
Manuel Delgado Alvarado, César Caballero-
Gaudes, Maria C. Rodriguez-Oroz, Tanya Stojkovic,
Vladimir S. Kostic, Jorge Sepulcre, Massimo Filippi
P1.260
Real Time Quaking Induced Conversion (RT-QuIC)
for Skin Alpha-Synuclein Seeding Activity in
Parkinson Disease Versus Controls – Steven
Alexander Gunzler, Curtis Tatsuoka, Mohamed
Elkasaby, Alexander Wang, Shu G. Chen, Zerui
Wang, Wenquan Zou
P1.261
An AAV Encoding Human ABCD1 Shows Dose-
Responsive Expression and Function Following
Spinal Cord Delivery in a Rodent Model of
Adrenomyeloneuropathy – Honggeun Park, Tony
Del Rio, Vidyullatha Vasireddy, Tiffany Lutz, Carrie
Ng, Yi Gong, Inge Dijkstra, Stephan Kemp, Casey
Maguire, Sean W. Clark, David William Anderson,
Karen Kozarsky

P1.262
Olfaction and apathy in early Parkinson’s disease
– Alfonso Enrique Martinez Nunez, Katie Latack,
Miguel Situ-Kcomt, Abhimanyu Mahajan
P1.263
Bilateral Alien Limb and the Spectrum of
Creutzfeldt-Jakob Disease Phenomenology: A
Case Series and Review of the Literature. – Dana
Alyse Sugar, Neepa J. Patel
P1.264
Striatal Dopaminergic Deficiency Contributes to
Musculo-skeletal Pain in Parkinson’s Disease –
Katarina Rukavina, Juliet Staunton, Magdalena
Krbot Skoric, Nicola Mulholland, Ben Corcoran,
Alexandra Rizos, K Ray Chaudhuri
P1.265
Olfactory dysfunction is associated with motor
function only in tremor-dominant Parkinson’s
disease – Fardin Nabizadeh, Kasra Pirahesh, Elham
Khalili
P1.266
Comparison Of Electrophysiologic And Ultrasound
Guidance For Onabotulinum Toxin-A Injections In
Focal Upper Extremity Spasticity And Dystonia
– Alexandra Nmashie, Codrin I. Lungu, Mary
Catherine George, Susan Shin, Barbara P. Karp,
Winona Tse, Steven Frucht, Vivian Koo, Katharine
Alter, Elaine Considine, Tianxia Wu, Gina Norato,
Mark Hallett, David M. Simpson
P1.267
Understanding Geo-demographics of Parkinson’s
Disease Among African Americans – Khadar
Haroun, Demetrius S. Geiger, Kevin James Lane,
Chantale Octavia Branson
P1.268
a-synuclein propagation via olfactory pathway
induces olfactory bulb atrophy and widespread
glucose hypometabolism in a non-human primate
model. – Masanori Sawamura, Hirotaka Onoe,
Hideo Tsukada, Norihito Uemura, Kaoru Isa,
Tadashi Isa, Ryosuke Takahashi
P1.269
Enhancing Pandemic-Sensitive Recruitment
Strategies for a Remote, Randomized Placebo-
Controlled Trial for Fracture Prevention in
Patients with Neurodegenerative Parkinsonisms
– Nijee Sharma Luthra, Ethan G. Brown, Samuel
Goldman, Jose-Rafael Pantoja Zuzuarregui, Trisha
F. Hue, Chris Paul Schambach, Ian O. Bledsoe,
Michael Schwarzschild, E. Ray Dorsey, Alberto J.
Espay, Irene Litvan, Nikolaus McFarland, Kyle T.
Mitchell, David G. Standaert, James Beck, Helen
Rowbotham, Cheryl Meng, Jacque Perkins, Primi
Ranola, Raymundo Picos, Dana Robertson Kriesel,
Kenneth Ward Lyles, Steve Cummings, Caroline
M. Tanner
Information is accurate as of February 8, 2022, and is subject to change.
Virtual Experience Posters
P1.270
Estimating the meaningful within-patient change
threshold for the MDS-UPDRS Part III – Stefano
Zanigni, Dylan Trundell, Annabelle Monnet, Nima
Shariati Fokalaei, Emma Moore, Evan Davies,
Nathalie Pross, Gennaro Pagano, Tania Nikolcheva
P1.271
Incidence of Parkinson Disease in North America
– Connie C. Marras, Eric Miklos Roberts, Caroline
M. Tanner, Stephen K. Van Den Eeden, Rodolfo
Savica, Web Ross, Brian Fiske, James Beck,
Allison Wright Willis
P1.272
Long-term Motor and Non-Motor Symptom
Benefits in Patients With Advanced Parkinson’s
Disease Treated With Levodopa-Carbidopa
Intestinal Gel: Final Analysis of the 36-Month
DUOGLOBE Real-world Multinational
Observational Study – Ray Chaudhuri, Norbert
Kovacs, Francesco Pontieri, Jason Lamar Aldred,
Paul M. Bourgeois, Thomas L. Davis, Esther Cubo
Delgado, Marieta Anca-Herschkovitsch, Robert
Iansek, Mustafa S. Siddiqui, Mihaela A. Simu, Lars
Bergmann, Pavnit Kukreja, Omar Ladhani, Jia Jia,
David G. Standaert
P1.273
Differentiating the dopaminergic midbrain
nuclei in early-stage Parkinson’s disease using
quantitative susceptibility mapping and R2*
relaxometry – Erind Alushaj, Nicholas Handfield-
Jones, Alan Kuurstra, Ravi Menon, Adrian Owen,
Ali R. Khan, Penny MacDonald
P1.274
Serum Insulin-like Growth Factor-1 as a biomarker
for Parkinson’s Disease: A systematic review and
meta-analysis. – Mariam Mostafa Alwerdani, Alaa
Salah El-Sayed, Ahmed Hanbal, Esraa G. Sayed,
Mustafa Mohammed Nasser, Mohamed Fahmy
Doheim, Mohamed Mahmoud Salama
P1.275
Soluble urokinase-type plasminogen activator
receptor (SuPAR) in patients with Parkinson’s
disease – Natalie P. Witek, Jessica Joyce, Roshni
A. Patel, Jacob Hawkins, Yuanqing Liu, Bichum
Ouyang, Jeffrey A. Borgia, Jochen Reiser, Deborah
Hall
P1.276
Parkinson’s Disease in patients with Essential
Tremor: a prospective clinical and functional
neuroimaging assessment – Gabriel Sampaio
Froehner, Carlos Henrique Ferreira Camargo,
Giorgio Fabiani, Alex Meira, Rui Kleber Martins-
Filho, Renato Puppi Munhoz, Helio Afonso Ghizoni
Teive
P1.277
Cutaneous Alpha-Synuclein, Dopamine
Transporter Imaging, and Cardiac MIBG Scan
in Multiple System Atrophy – Virgilio Gerald H.
Evidente, Christopher H. Gibbons, Roy L. Freeman,
Danica Luz Evidente, Todd D. Levine
P1.278
Long-term Outcomes for Mood, Anxiety and
Apathy in Dystonia with Bilateral DBS Surgery
– Emma Leone, Varun Jain, Rohini Manoj Kumar,
Nivedita Jha, Lina Ly, Charles Jacobson, Kelly D.
Foote, Michael S. Okun, Aparna Wagle-Shukla
P1.279
New-onset movement disorders after COVID-19
– Emilia M. Gatto, Natalia Gonzalez Rojas, Martin
Cesarini, Javier Ziliani, Jose Etcheverry, Gustavo
Da Prat de Magahlaes
P1.280
Imaging in Late-Onset GM2 Gangliosidosis: A
Systematic Review – Elizabeth Haxton, Neha
Godbole, Olivia Rowe, Florian Eichler, Eva-Maria
Ratai, Christopher D. Stephen
P1.281
Metabolomic markers of the kynurenine and
polyamine pathways are altered in Parkinson’s
disease independent of LRRK2 status – Grace
Crotty, Yuan Ting Chang, Eric A. Macklin, Romeo
Maciuca, Junhua Wang, Manuel Montalban,
Sonnet Davis, Jamal Alkabsh, Rachit Bakshi, Xiqun
Chen, Alberto Ascherio, Giuseppe Astarita, Sarah
Huntwork-Rodriguez, Michael Schwarzschild
MS and CNS Inflammatory Disease
P1.282
Deep Learning Prediction of Response to Disease
Modifying Therapy in Primary Progressive
Multiple Sclerosis – Jean-Pierre René Falet,
Joshua Durso-Finley, Brennan Nichyporuk, Julien
Schroeter, Francesca Bovis, Maria Pia Sormani,
Doina Precup, Tal Arbel, Douglas L. Arnold
P1.283
Analysis and Evaluation of Ponesimod Hepatic
Safety Data – Andrea Vaclavkova, Verena Walter,
Allitia DiBernardo, Maria Ait Tihyaty
P1.284
Determining the Effectiveness of Double Inversion
Recovery (DIR) Brain MRI Sequence in Detecting
Upper Spinal Cord Lesions in Multiple Sclerosis
Patients – Shivam Patel, Jaime Imitola, Leo
Wolansky
P1.285
Acute Disseminated Encephalomyelitis in a Puerto
Rican patient with positive SARS-Cov-2: Casualty
or Causality? – Melissa Annette Morales Garcia,
Johnny A. Sanabria Lopez, Brenda Deliz Roldan
P1.286
Analysis of Post-treatment Relapse Activity
in the Phase 3 OPTIMUM Study of Ponesimod
Compared with Teriflunomide – Ludwig Kappos,
Robert J. Fox, Michel Burcklen, Mark S. Freedman,
Brian Hennessy, Antoine Stos, Philippe Linscheid,
Andrea Vaclavkova, Hilke Kracker, Tatiana
Sidorenko, Carlo Pozzilli
AAN.com/AM 113

P1.287
Impact of the coronavirus SARS COV-2 (COVID19)
pandemic on the quality of life and mood of
patients with multiple sclerosis – Leila Cohen,
Ricardo Alonso, Berenice Silva, Cecilia Pita,
Natalia Ciufia, Orlando Garcea, Barbara Eizaguirre
P1.288
Tracking the immune response to SARS-CoV-2
mRNA vaccines in an open-label multicenter study
in participants with relapsing multiple sclerosis
treated with ofatumumab s.c. (KYRIOS clinical
trial) – Marie Groth, Benjamin Ettle, Tobias Bopp,
Tjalf Ziemssen
P1.289
A multicenter, open label, single-arm, phase
3b study (CONSONANCE) to assess efficacy
of ocrelizumab in patients with primary and
secondary progressive multiple sclerosis: year 1
interim analysis of cognition outcomes – Ralph
H. B. Benedict, Maria Pia Sormani, Marisa P.
McGinley, Douglas L. Arnold, Amit Bar-Or, Robert
A. Bermel, Pavan Bhargava, Declan Chard, Guy
Gherardi, Roland G. Henry, Owain Howell, Beverly
Aagard-Kienitz, Letizia M. Leocani, Catherine
Lubetzki, Agne Kazlauskaite, Thomas Kuenzel,
Xavier Montalban, Finn Sellebjerg, Giancarlo Comi,
Licinio Manuel Craveiro, Helmut Butzkueven
P1.290
A multicentre, open label, single-arm, phase 3b
study (CONSONANCE) to assess the effectiveness
and safety of ocrelizumab in patients with primary
and secondary progressive multiple sclerosis:
year-1 interim analysis – Giancarlo Comi, Robert
A. Bermel, Amit Bar-Or, Marisa P. McGinley,
Douglas L. Arnold, Roland G. Henry, Ralph H. B.
Benedict, Pavan Bhargava, Helmut Butzkueven,
Declan Chard, Guy Gherardi, Owain Howell,
Beverly Aagard-Kienitz, Letizia M. Leocani, Agne
Kazlauskaite, Thomas Kuenzel, Xavier Montalban,
Maria Pia Sormani, Finn Sellebjerg, Licinio Manuel
Craveiro, Catherine Lubetzki
P1.291
Ponesimod Shows Improved Effect on Brain
Volume Compared with Other DMTs, A Model
Based Meta-Analysis – Maria Ait Tihyaty,
Matthew Zierhut, Alexander Keenan, Allitia
DiBernardo
P1.292
Relationships Between Brain Volume and
Disability, Cognition, Motor Function, and MS-
Fatigue in Relapsing Multiple Sclerosis: MS-
Fatigue and Ambulation Move at Their Own Pace
– Frederik Barkhof, Maximilian Schuier, Ibrahim
Turkoz, David J. Williamson, Alexander Keenan,
Maria Ait Tihyaty
114 2022 AAN Annual Meeting
Virtual Experience Posters
P1.293
Signatures of premature immunosenescence
in patients with multiple sclerosis – Melanie
Eschborn, Marc Pawlitzki, Timo Wirth, Christopher
Nelke, Steffen Pfeuffer, Andreas Schulte-
Mecklenbeck, Lisa Lohmann, Leoni Rolfes, Katrin
Pape, Maria Eveslage, Stefan Bittner, Catharina
Groß, Tobias Ruck, Heinz Wiendl, Sven G. Meuth,
Luisa Hildegard Klotz
P1.294
„Back to the roots - from Phenotype to Genotype
in Monozygotic Twins discordant for Multiple
Sclerosis“ – Claudia Janoschka, Marisol Herrera
Rivero, Lisa Ann Gerdes, Kathrin Koch, Heinz
Wiendl, Reinhard Hohlfeld, Monika Stoll, Luisa
Hildegard Klotz
P1.295
Novel EEG Biomarker to Distinguish Anti-NMDAR
Encephalitis from Other Types of Autoimmune
Encephalitis – Tomotaka Mizoguchi, Makoto Hara,
Naotoshi Natori, Satoshi Hirose, Yuki Yokota,
Takayoshi Akimoto, Satoko Ninomiya, Masaki
Ishihara, Katsuhiko Ogawa, Hideto Nakajima
P1.296
Cladribine Tablets in Patients With Relapsing-
Remitting Multiple Sclerosis or Active Secondary
Progressive Multiple Sclerosis After Suboptimal
Response to a Disease-Modifying Therapy (CLICK-
MS and MASTER-2): Interim Baseline and Safety
Review – Augusto A. Miravalle, Joshua D. Katz,
Derrick Robertson, Julie Aldridge, Emily Evans,
Danielle Harlow, Lori Lebson, Jacob Alexander
Sloane, Ann D. Bass, Edward J. Fox
P1.297
MRI Predictors of Upper Cervical Cord Grey
Matter Atrophy in Multiple Sclerosis Patients
– Raffaello Bonacchi, Elisabetta Pagani, Maria
Assunta Rocca, Massimo Filippi
P1.298
Cognitive Reserve Modulates the Impact of
Structural Damage of the Frontal Lobe on
Executive Functioning in Multiple Sclerosis –
Lorenzo Conti, Paolo Preziosa, Elisabetta Pagani,
Massimo Filippi, Maria Assunta Rocca
P1.299
Lesion Location Matters in Multiple Sclerosis:
Clinical and Cognitive Correlates of Juxtacortical
and Subventricular Zone Lesions – Mor Gueye,
Laura Cacciaguerra, Nicolò Tedone, Carmen
Vizzino, Damiano Mistri, Elisabetta Pagani,
Massimo Filippi, Maria Assunta Rocca
P1.300
Resting State Effective Connectivity
Abnormalities of the Papez Circuit Contribute to
Explain Worse Cognitive Performances in Multiple
Sclerosis Patients – Olga Marchesi, Raffaello
Bonacchi, Paola Valsasina, Maria Assunta Rocca,
Massimo Filippi
P1.301
Neurocognitive Impact Of Behçet’s Disease – Ines
Bedoui, Bissene Douma, Mariem Elfekih, Jamel
Zaouali, Ridha Mrissa
P1.302
Investigating the impact of Fingolimod,
Natalizumab and Glatiramer Acetate on Normal
appearing grey matter and Normal appearing
white matter on 3T MRI. – Samiksha Srivastava,
Zena Azo, Vince Marceau, Alek Tasich, Fen Bao,
Carla E. Santiago-Martinez, Jacob Rube, Evanthia
Bernitsas
P1.303
Immunological Subsets characterization in newly
diagnosed RRMS – Emanuele D’Amico, Aurora
Zanghi, Nunziatina Laura Parrinello, Francesco Di
Raimondo, Francesco Patti
P1.304
Sex-Related Differences in Upper Limb Motor
Function in Healthy Subjects and Multiple
Sclerosis Patients: A Multiparamentric MRI Study
– Chiara Maspero, Raffaello Bonacchi, Elisabetta
Pagani, Paola Valsasina, Alessandro Meani, Maria
Assunta Rocca, Massimo Filippi
P1.305
Disability Progression and Improvement Among
Active and Nonactive Secondary Progressive
Multiple Sclerosis Patients in Placebo Arms of
Clinical Trials – Pengcheng Xun, Natalia Sadetsky,
Kiren Kresa-Reahl, Sasha Bogdanovich, Arie
Barlev, Crystal Watson
P1.306
Motor Dysfunction in Relapsing-Remitting
Multiple Sclerosis: Association with Structural
Brain Damage and Cognitive Impairment –
Damiano Mistri, Laura Cacciaguerra, Loredana
Storelli, Alessandro Meani, Claudio Cordani, Maria
Assunta Rocca, Massimo Filippi
P1.307
AMA-VACC: Clinical trial assessing the immune
response to SARS-CoV-2 mRNA vaccines in
siponimod treated patients with secondary
progressive multiple sclerosis – Benedict Rauser,
Tjalf Ziemssen, Marie Groth, Tobias Bopp
P1.308
Treatment Patterns of Active and Nonactive
Secondary Progressive Multiple Sclerosis Patients
in the United States – Dhanalakshmi Thirumalai,
Crystal Watson, Natalia Sadetsky, Arie Barlev,
Eddie Jones, Sasha Bogdanovich
P1.309
Regional Gray Matter Atrophy and White Matter
Microstructural Abnormalities Explain Sex-
Related Differences in Cognitive Performances
in MS – Nicolò Tedone, Paolo Preziosa, Elisabetta
Pagani, Carmen Vizzino, Damiano Mistri, Massimo
Filippi, Maria Assunta Rocca

P1.310
A Deep-Learning Approach to Predicting Disease
Progression in Multiple Sclerosis Using Magnetic
Resonance Imaging – Loredana Storelli, Matteo
Azzimonti, Mor Gueye, Paolo Preziosa, Gioacchino
Tedeschi, Nicola De Stefano, Patrizia Pantano,
Massimo Filippi, Maria Assunta Rocca
P1.311
Advanced Diffusion-Weighted Imaging
Models Better Characterize White Matter
Neurodegeneration and Clinical Outcomes in
Multiple Sclerosis – Loredana Storelli, Elisabetta
Pagani, Alessandro Meani, Paolo Preziosa,
Massimo Filippi, Maria Assunta Rocca
P1.312
Multiple Sclerosis Phenotypes Display Divergent
Dynamic Functional Connectivity Abnormalities
for Thalamic Sub-Regions – Paola Valsasina,
Antonio Carotenuto, Milagros Hidalgo de la Cruz,
Laura Cacciaguerra, Paolo Preziosa, Olga Marchesi,
Maria Assunta Rocca, Massimo Filippi
P1.313
Immune checkpoint inhibitors and multiple
sclerosis – Sarah Conway, Danielle Kei Pua,
Kathryn Holroyd, Kristin Marissa Galetta, Shamik
Bhattacharyya
P1.314
The White Matter Rounds Experience: The
Importance of a Multidisciplinary International
Network to Accelerate the Diagnostic Process
for Adult Patients with Rare White Matter
Disorders – Yutong Huang, Paul Giacomini, Rami
Massie, Sunita Venkateswaran, Roberta La Piana,
Anne-Marie Trudelle, Giulia Fadda, Maryam
Sharifiandorche, Hayet Boudjani, Laurence
Poliquin-Lasnier, Laura Airas, Alexander Saveriano,
Myriam Levesque-Roy, Matthias G. Ziller, Elka
Miller, Claudia Martinez-Rios, Jorge Davila,
Nagwa Wilson, Erin Longbrake, Jack P. Antel,
Bernard Brais, Genevieve Bernard, Carolina A.E.
Rush, Roberta La Piana
P1.315
Longitudinal Extensive Transverse Myelitis: rare
immunotherapy related adverse effect vs COVID-
19-related immunization complication – Aimalohi
Esechie, Xiang Fang, Pankhuri Banerjee, Prashant
Kumar Rai, Neeharika Thottempudi
P1.316
Two Cases of Neurological Complications After
mRNA Vaccination for COVID-19 – Michaela L
Malin, Jerry Lin, Morgan C. Roche, Rose Putnam
Griffin
P1.317
COVID-19 Experiences and Vaccination in People
with Multiple Sclerosis – Jenna Alys Brunn, Galit
Levi Dunietz, Andrew R. Romeo, Tiffany Braley
P1.318
Evaluation of Adult Biotinidase Activity in Patients
with Idiopathic Inflammatory Demyelinating
Diseases – Aysegul Akkan Suzan, Ahmet Kasim
Kilic
Information is accurate as of February 8, 2022, and is subject to change.
Virtual Experience Posters
P1.319
Lowered COVID-19 mRNA vaccine antibody
response in MS patients treated with B -cell
depleting and S1P-receptor-targeting therapies
compared to controls: interim analysis – Sarah
Conway, Maria K. Houtchens, Bonnie Glanz, Taylor
Jane Saraceno, Mariann Polgar-Turcsanyi, Patricia
Gaitan-Walsh, Emily Caroline Casady, Sasha
Winston-Khan, Talia Brianna Feldman, Eunnindy
Dells Sanon, Gauruv Bose, Shrishti Saxena, Aimee
Loven, Choudhury Fabliha Binte Yusuf, Anu Paul,
Rohit Bakshi, Shamik Bhattacharyya, Kristin
Marissa Galetta, Tamara B. Kaplan, Christopher
Severson, Tarun Singhal, Lynn Stazzone, Jonathan
D. Zurawski, Brian Curran Healy, Howard L.
Weiner, Tanuja Chitnis
P1.320
Primary Progressive Multiple Sclerosis:
Retrospective Study of Incidence in Greater
Manchester – Gagana Mallawaarachchi, Jack
Grimshaw, Thomas Jackson, Joyutpal Das, David
Rog
P1.321
Plasma Neurofilament light levels are increased
in people with Radiologically Isolated Syndrome –
Raphael Schneider, Koroboshka Brand-Arzamendi,
Timothy R. Lim, Jeffrey Glaister, Melanie Guenette,
Suradech Suthiphosuwan, Raphael Schneider,
Jiwon Oh
P1.322
The Effect of Demographic Factors on Prescription
of High-Efficacy Disease-Modifying Therapies
in Relapsing Remitting Multiple Sclerosis – Jack
Grimshaw, Gagana Mallawaarachchi, Thomas
Jackson, Joyutpal Das, David Rog
P1.323
Phenotype and recovery from relapses in patients
with Relapsing Remitting Multiple Sclerosis with
their first DMT prescription: an Italian registry
study – Emanuele D’Amico, Aurora Zanghi,
Francesco Patti
P1.324
COVID-19 vaccination uptake in a multi-ethnic
urban sample of MS patients – Vito Pasquale
Arena, Ilya Kister
P1.325
Central Vein Sign and advanced diffusion MRI to
differentiate demyelinating from comorbidities-
related white matter lesions in patients with
multiple sclerosis – Caterina Lapucci, Francesco
Tazza, Silvia Rebella, Luca Roccatagliata, Nicola
Mavilio, Giacomo Boffa, Elvira Sbragia, Nicolo
Bruschi, Elisabetta Mancuso, Maria Cellerino,
Simona Schiavi, Matilde Inglese
P1.326
MRI Outcomes from the Long-term Extension
Study of Tolebrutinib in Patients with Relapsing
Multiple Sclerosis: 18-Month Results – Daniel
Reich, Anthony Traboulsee, Sana Syed, Deborah
Dukovic, Timothy J. Turner, Douglas L. Arnold
P1.327
Evaluating the Effect of BTK Inhibitor Tolebrutinib
in Human Tri-culture – Ross C. Gruber, Anna
Blazier, L Lee, Sean Ryan, Agnes Cheong, Evis
Havari, Timothy J. Turner, Dimitry Ofengeim
P1.328
Humoral and Cellular Responses to SARS-CoV-2
Vaccines in MS Patients on Ocrelizumab and
Other Disease-modifying Therapies: A Prospective
Study From NYU Multiple Sclerosis Care Center
– Ilya Kister, Yury Patskovsky, Ryan Curtin, Iryna
Voloshyna, Katherine Perdomo, Zoe Rimler, Jinglan
Pei, Nicole Ferstler, Velmurugu Yogambigai,
Samantha Tatenda Nyovanie, Mark Joseph
Mulligan, Joseph Jae-Suk Kim, Ethan Tardio,
Tamar Bacon, Lana Zhovtis Ryerson, Marie Ines
Samanovic-Golden, Amber Cornelius, Catarina
Raposo, Jessica Priest, Ryan Christopher Winger,
Michelle Krogsgaard, Gregg Joshua Silverman
P1.329
Preserved T-cell response in B-cell depleted
patients following SARS-CoV-2 vaccination –
Simon Faissner, Neele Heitmann, Ulas Ceylan,
Ricarda Rohling, Marielena Bongert, Ilya
Ayzenberg, Kerstin Hellwig, Stephanie Pfaender,
Ralf Gold
P1.330
Effect of therapeutic plasma exchange in
treatment of severe multiple sclerosis relapse - a
retrospective analysis – Radovan Bunganic, Sarka
Blahutova, Kamila Revendova, Olga Zapletalova,
Pavel Hradilek, Zuzana Cermakova, Radomira
Hrdlickova, Aravind Ganesh, Ondrej Volny
P1.331
Reliability and Acceptance of a Smartphone-
Based Remote Monitoring App (dreaMS) for
People with MS – Results of a Feasibility Study –
Tim Woelfle, Silvan Pless, Andrea Wiencierz, Óscar
Gabriel Reyes Pupo, Ludwig Kappos, Johannes
Lorscheider, Yvonne Naegelin
P1.332
Lymphocyte Depletion and Repopulation Following
Subcutaneous or Intravenous Alemtuzumab in
Patients with Progressive Multiple Sclerosis:
SCALA Study Results – Breogan Rodriguez
Acevedo, Carlos Nos, Darren Phillip Baker, Yanzhen
Wu, Magdalena Chirieac, Chandravathi Vage,
Xavier Montalban
P1.333
Retinal microvascular network alterations in
Tunisian Multiple Sclerosis patients: potential
biomarkers of visual involvement and disease
progression – Mrabet Saloua, Yousra Falfoul,
Amira Souissi, Khaled El Matri, Mrabet Saloua,
Asma Hassairi, Alya Gharbi, Imen Kacem, Leila
ElMatri, Riadh Gouider
AAN.com/AM 115

P1.334
Myelin content monitoring by diffusion biomarkers
in a therapeutic trial with leriglitazone in men
with adrenomyeloneuropathy – Vincent Perlbarg,
Silvia Pascual, Bernardo Blanco, Magali Barbier,
Elise Yazbeck, Dorothee Uriet, Julie Rachline, Uwe
Meya, Marc Martinell, Damien Galanaud, Marc
Engelen, Fanny Mochel
P1.335
Strong T-cell activation in response to SARS-
CoV-2 vaccination in patients with multiple
sclerosis on B-cell depleting therapies – Joyce Lei,
Vanessa Kirschner, Grant Feuer, Michaela L Malin,
Jiayuan Liu, Morgan C. Roche, Jerry Lin, Roberto
Alfonso, Rose Putnam Griffin
P1.336
Neurofilament Serum Levels Do Not Correlate
with Symptom Burden in Stable, Ocrelizumab-
Treated MS Patients Enrolled into SYMptom
Burden on Ocrelizumab, a Longitudinal Study
(SYMBOLS) – Madaline McCluskey, Cheongeun
Oh, Rose-Marie Jungquist, Zoe Rimler, Elizabeth
Douglas, Andrew Joseph Bouley, Ellen S. Lathi,
Joshua D. Katz, Ilya Kister
P1.337
Clinical and radiological spectrum of Anti
Myelin oligodendrocyte glycoprotein antibody
related neurological disorders- An ambispective
observational study – Manish Salunkhe, Pranjal
Gupta, Rohit Bhatia, Rajesh Kumar Singh,
Manjari Tripathi, Padma Vasantha Hadakasira,
Venugopalan Y Vishnu, Awadh K. Pandit, Ayush
Agarwal, Arunmozhimaran Elavarasi, Bhargavi
Ramanujam
P1.338
Patient Practices and Experiences During
COVID-19 Among Individuals Across the United
States Enrolled in MS LifeLines Patient Support
Program – Jacqueline Ann Nicholas, DeMauri
Mackie, Halley Costantino, Lori Lebson, Emily H.
Mulvihill, Amy L. Phillips
P1.339
Single-cell transcriptional profile of brain
macrophages in multiple sclerosis – Takahisa
Mikami, Michael Levy
P1.340
A Cross-Sectional Survey Evaluating Cladribine
Tablets Treatment Patterns Among Patients
with Multiple Sclerosis Across the US Enrolled
in the MS LifeLines Patient Support Program –
Jacqueline Ann Nicholas, DeMauri Mackie, Halley
Costantino, Lori Lebson, Emily H. Mulvihill, Amy L.
Phillips
P1.341
Diagnosis disclosure in multiple sclerosis:
Associations with psychosocial outcomes and
group-based treatment strategies – Anne Kever,
Claire Riley, Victoria Leavitt
116 2022 AAN Annual Meeting
Virtual Experience Posters
P1.342
Challenges in a dynamic world: the importance
of studying cognitive flexibility in Persons with
Multiple Sclerosis – Maria Sol Román, Barbara
Eizaguirre, Pablo Rubio, Ariadna Gatti, Lara
Bardoneschi, Loana De Los Santos, Fernando
Caceres, Sandra Vanotti
P1.343
Serum NfL and GFAP biomarker analysis in early
high versus low efficacy DMT paradigms for MS
– Vanessa Fernanda Moreira Ferreira, Jonathan D.
Zurawski, Brian Curran Healy, Shrishti Saxena, Anu
Paul, Fermisk Saleh, Yanqing Liu, Mariann Polgar-
Turcsanyi, Harald Kropshofer, Howard L. Weiner,
Tanuja Chitnis
P1.344
Exploring the evolution of functional and
structural damage along the visual pathway in
multiple sclerosis related acute optic neuritis. –
Simone Guerrieri, Marco Pisa, Francesca Sangalli,
Vittorio Martinelli, Giancarlo Comi, Letizia Leocani
P1.345
7T MRI leptomeningeal enhancement and brain
atrophy are associated with alterations in the
IL-23 metabolic pathway in patients with multiple
sclerosis – Jonathan D. Zurawski, Renxin Chu,
Youmna Jalkh, Shahamat Tauhid, Tanuja Chitnis,
Howard L. Weiner, Clary B. Clish, Rohit Bakshi,
Chao Wang
P1.346
Impact of Covid-19: Preserving Services for
Patients with Multiple Sclerosis during a Global
Pandemic. – Stephen James Ramsay, Fiona Jane
Magill, Grainne Goldsmith, Fiona Kennedy, Stella
Elaine Hughes, Gavin V. McDonnell
P1.347
IgG4-Related Disease as an Autoimmune
Consequence of Alemtuzumab Therapy for
Management of Multiple Sclerosis – Anna
Tierney, David Nolan, Chris Van Vliet, Wai-Kuen
Leong
P1.348
Migrainous features of multiple sclerosis (MS)
users of MS Care ConnectTM, a self-efficacy
mHealth digital application – Amy L. Dix, John F.
Foley, Katherine Sylvia Geist
P1.349
Implementation of Medication Therapy Disease
Management Pharmacist for Multiple Sclerosis
Patients in a Community Based Neurology Setting
– Muhammad Taimur Ahmad Malik, Melissa
Sartori, Amanda Sharry-Rogers, Allison Cebulko,
Jonathan Brady, Megan E. Esch
P1.350
Cost effectiveness of Ofatumumab in Comparison
with Other Disease Modifying Therapies and Best
Supportive Care for the Treatment of Relapsing-
Remitting Multiple Sclerosis in Canada – Soukaïna
Mouallif, Kim A. Thomas, Nicholas Adlard, Philip
Cooney, Francois Blanchette, Barkha Patel,
Moogeh Baharnoori, Virender Bhan, Fraser M.
Clift, Daniel Grima
Neuro Trauma and Sports Neurology
P1.351
Relationship between Headache Characteristics
and a Remote History of TBI in US Veterans: A 10
Year Retrospective Chart Review – Alec Michael
Giakas, Guoshuai Cai, Alexandra Ross, Xiao M.
Androulakis
P1.352
Autonomic dysfunction after moderate-severe
traumatic brain injury: symptom spectrum and
clinical testing outcomes – Lucia M. Li, Ekawat
Vichayanrat, Helen Lai, Martina Del Giovane,
Valeria Iodice
P1.353
BodyPump Training Associated Vertebral Artery
Dissection - An Unreported Complication – Nurose
Karim, Mark Douglas Johnson
P1.354
Trajectories of Insomnia Following Traumatic
Brain Injury – John Kent Werner, Bryson Hewins,
Andrew Krystal, Jennifer Albrecht, Vincent F.
Capaldi, Pratik Mukherjee, Sonia Jain, Ashlee
McKeon, Michael Timothy Smith, Joseph T.
Giacino, Raquel Gardner, Lindsay Nelson, Scott
Graeme Williams, Jacob Collen, Shelly Sun,
David Schnyer, Amy Markowitz, Geoffrey Manley,
Emerson Wickwire
Neurocritical Care
P1.355
Predictors of Opiate Utilization in the Treatment
of Headache and Impact on 3-month Outcomes
Following Subarachnoid Hemorrhage – Dana
Klavansky, Sheshali Wanchoo, Amanda Lin,
Richard E. Temes, Tania Jean Rebeiz
P1.356
Management and Outcomes of Hospitalized
Patients with Myasthenia Gravis Infected with
COVID-19: A Literature Review – Omar Abbas,
Gustavo A. Patino

P1.357
The Association of Posterior Reversible
Encephalopathy Syndrome with COVID-19: A
Systematic Review – Aqeeb Ur Rehman, Sadaf
Iftikhar, Muhammad Zain Ameer, Ahmad Nawaz,
Muhammad Aemaz Ur Rehman, Hareem Farooq,
Abyaz Asmar, Muhammad Ebaad Ur Rehman
P1.358
Eye opening and blinking in post anoxic coma –
Neel Fotedar, Hemani Ticku
P1.359
The Effect of Dysnatremia in Aneurysmal
Subarachnoid Hemorrhage on Patient Outcomes –
Alexandra Helliwell, Ryan Snow, Christoph Stretz,
Nicholas S. Potter, Linda C. Wendell, Bradford
B. Thompson, Jesse Menville, Karen L. Furie, Ali
Mahta
P1.360
Remote Ischemic Peri-Conditioning and High-dose
Fentanyl as an adjunct to Targeted Temperature
Management in Hypoxic ischemic Brain Injury post
Cardiac Arrest (RESURRECT) – Rajeshwar Kumar,
Mahesh Pundlik Kate, Himani Khatter, Jeyaraj
Durai Pandian
P1.361
Seizure Incidence in Neonates with CHD – Juan
Carlos Duran, Jennifer M. Bain
P1.362
Severe Headache Trajectory Following
Aneurysmal Subarachnoid Hemorrhage: The
Association with Lower Sodium Levels – Robert
Stephen Eisinger, Zachary Sorrentino, Brandon
Lucke-Wold, Sonya Zhou, Brooke Barlow, Brian
Hoh, Carolina B. Maciel, Katharina M. Busl
P1.363
Initiation of EVD Weaning in 5 Simple Steps
– Sachin Ajay Kothari, Mevish S. Siddiq, Scott
Rahimi, Manan Shah, Klepper A. Garcia
P1.364
Delirium and Older Age: Two Independent
Predictors of Worse Outcome in Low-intermediate
Grade Subarachnoid Hemorrhage – Anisha Not
Applicable Baktha, Liqi Shu, Linda C. Wendell,
Bradford B. Thompson, Karen L. Furie, Jesse
Menville, Ali Mahta
P1.365
Association of Hemoglobin Trend and Outcome
in Aneurysmal Subarachnoid Hemorrhage: A
Single Center Cohort Study – Asghar Shah, Ryan
Snow, Christoph Stretz, Nicholas S. Potter, Linda C.
Wendell, Bradford B. Thompson, Jesse Menville,
Karen L. Furie, Ali Mahta
P1.366
A Tiered Compensation Model for Neurocritical
Care Advanced Practice Provider Advancement
through Annual Educational and Procedural
Competencies – Naresh Mullaguri, Anusha
Battineni, Ryan Hakimi
Information is accurate as of February 8, 2022, and is subject to change.
Virtual Experience Posters
P1.367
Splenium Stroke in a Postpartum Female
Following Spinal Anesthesia: A Case Report –
Elisha Danzig, Amandeep Dolla, Lucjan O. Lang
P1.368
Decompressive Craniectomy in Patients with
Severe Cerebral Venous Sinus Thrombosis – Hadi
Abou-El-Hassan, Joshua D. Bernstock, Saef Izzy,
Ayaz M. Khawaja
P1.369
On Consciousness: A Look into Therapeutic
Pathways for Comatose Patients – Rohan
Yarlagadda
P1.370
Stroke as a cause of donor brain death and
prognostic implication in heart transplantation
– Takahisa Mikami, Shinobu Itagaki, Tomohiro
Fujisaki, Toshiki Kuno, David P. Lerner, Joseph D.
Burns, Anelechi Anyanwu
Neuroepidemiology
P1.371
Incidence of Neurodegenerative Diseases in
Elderly Koreans with and without the First
Diagnosed Type 2 Diabetes – Hee-Cheol Kim,
Hojun Lee, Byeong-Churl Jang
P1.372
Estimated Rate of Familial Amyotrophic Lateral
Sclerosis: A Systematic Review and Meta-
Analysis – Julie Barberio, Cathy Lally, Varant
Kupelian, William Dana Flanders
Neuromuscular and Clinical
Neurophysiology (EMG)
P1.373
Accelerated DNA Methylation Age of the TARDBP
3’UTR in the Motor Cortex is Associated with Age
of Sporadic ALS Onset. – Takuma Yamagishi, Yuka
Koike, Akihiro Sugai, Norikazu Hara, Junko Ito, Akio
Yokoseki, Tomohiko Ishihara, Shintaro Tsuboguchi,
Mari Tada, Takeshi Ikeuchi, Akiyoshi Kakita, Osamu
Onodera
P1.374
Neuromuscular Manifestations of COVID-19 –
Billie Hsieh, Ashley Smith, Xiaojing Liu, Kristin
Angelica Brown, Suur Biliciler, Thy Nguyen
P1.375
The prevalence of V122I mutation in African
American individuals with bilateral carpal tunnel
syndrome. A pilot study. – Jeffrey Z. Shije, Maria
Adela B. Bautista, Carmen Smotherman
P1.376
Usefulness of quantitative susceptibility mapping
in ALS – Robin Warner
P1.377
Novel SCN4A sequence variation presenting
as “EMG disease”: A Case Report – Vaishnavi
Sharma, Oscar Soto
P1.378
Prognostic Factors Affecting ALS Progression
through Disease Tollgates – Brian Crum, Fatih
Erenay, Kalyan Pasupathy, Haoran Wu, Osman
Ozaltin, Qu-Ming He
P1.379
Pregnancy course and Musk-positive myasthenia
gravis: a single center case series – Yohei Harada,
Margaret Bettin, Vern C. Juel, Donald B. Sanders,
Lisa Hobson-Webb, Shruti M. Raja, Janice M.
Massey
P1.380
Natural History and Phenotypic Spectrum of
LGMD-D1: Implications for Clinical Trials – Andrew
Ross Findlay, Sarah Elizabeth Robinson, Michelle
Seiffert, Stephanie Poelker, Andrew Ross Findlay
P1.381
Fast Progression in Amyotrophic Lateral Sclerosis:
Pathways and Biomarkers from Multi-Omics
Analysis – Roland G. Huber, Crystal Jing Jing Yeo
P1.382
LGMD D2 TNPO3 related : a wide clinical
spectrum and pathogenetic mechanism – Roberta
Marozzo, Giovanna Cenacchi, Corrado Angelini
P1.383
Effect of 3,4-diaminopyridine phosphate in
symptomatic SOD1-G93A mice – Swathi
Beladakere Ramaswamy, John Stanford, Stanley J.
Iyadurai, Raghav Govindarajan, Richard J. Barohn
P1.384
Novel biomarkers for limb girdle muscular
dystrophy (LGMD) – Diego Lopergolo, Gian
Nicola Gallus, Sara Aguti, Silvia Bianchi, Simona
Salvatore, Anna Rubegni, Gianna Berti, Patrizia
Formichi, Alessandro Malandrini
P1.385
An Exploratory Study of Cognitive Involvement
in Hereditary Transthyretin Amyloidosis – Hacer
Durmus, Arman Cakar, Hasan Demirci, Fatma
Yesim Parman
P1.386
A Case Series Describing Clinical Presentation
and Diagnostic Workup in 3 Patients with Anti-
Neurofascin-155 (NF155) – Melody Badii, Ashley E.
Anderson, Vivek Misra, Sheetal Shroff
P1.387
Nipocalimab’s Selective Targeting of FcRn and
IgG Clearance Preserves Key Immune Functions
– Leona Ling, Steven M. Tyler, Christopher
Beneduce, Julia Brown, Sujatha Kumar, Jay
Duffner, William Avery
AAN.com/AM 117

P1.388
Implications and Predictors of Variability of
Disease Progression in Amyotrophic Lateral
Sclerosis (ALS) – Muzammil Arif Din So Abdul
Jabbar, Yang Guo, Erik P. J. Pioro, Savitha
Ramasamy, Crystal Jing Jing Yeo
P1.389
Predicting Fast Progressors in Amyotrophic Lateral
Sclerosis (ALS): A Machine Learning Approach
– Muzammil Arif Din So Abdul Jabbar, Yang Guo,
Erik P. J. Pioro, Savitha Ramasamy, Crystal Jing
Jing Yeo
P1.390
Multimodal Neuroimaging Reveals Differential
Gray and White Matter Degeneration in Hypo-
and Hypermetabolic Brain Regions of Patients
with ALS-FTD – Erik P. J. Pioro, Venkateswaran
Rajagopalan
P1.391
Spastic Paraparesis in a Patient with Homozygous
SPG7 mutation – Sabrina Bulancea, Adrian
Marchidann, Daphne Robakis, James Christian
Hiana
P1.392
ACE-IIM : Evidence of Autonomic and Cardiac
dysfunction in Idiopathic Inflammatory Myositis
– M M. Samim, Atchayaram Nalini, Sathyaprabha
Talakad, Ashita Barthur, Seena Vengalil, Saraswati
Nashi
P1.393
Single Center Experience of SORD Neuropathy
in Turkey – Arman Cakar, Ayse Candayan, Hacer
Durmus, Esra Battaloglu, Fatma Yesim Parman
P1.394
Clinical Delineation of Myasthenia Gravis in the
Kingdom of Bahrain – Mohamed Falah, Hussein
ALhafnawi, Ahmed Jaradat, Eslam Hamdy Shosha,
Ali Alhilly, Firas Alnidawi, Mariam Mohammed
Alhammadi, Moiz Bakhiet, Fatema Mohamed
Abdulla
P1.395
Incidence of Zoster-Associated Limb Paresis
(ZALP): A Population-Based Analysis from 2008-
2016 – James Douglas Triplett, Michel Toledano,
Lyell K. Jones
P1.396
Use of Repetitive Nerve Stimulation in the
Geisinger Health System Neurophysiology
Laboratory – J. David Avila
P1.397
Patient-reported pain experience during nerve
conduction studies and needle electromyography
– Freddy Paiz, Gil Midroni, Charles Kassardjian
P1.398
Hepatic Steatosis in Patients with Spinal
Muscular Atrophy (SMA) – Crystal Jing Jing Yeo,
Alexis Levine, Basil T. Darras
118 2022 AAN Annual Meeting
Virtual Experience Posters
P1.399
Phenotype Genotype Characterization of FKRP-
related Muscular Dystrophy among Indian Patients
– Gopikrishnan Unnikrishnan, Mainak Bardhan,
Akshata Huddar, Seena Vengalil, Saraswati Nashi,
Hansashree Padmanabha, Atchayaram Nalini
P1.400
CSF biomarkers evaluated by principal component
analysis in a NurOwn Phase 3 clinical trial –
James D. Berry, Merit E. Cudkowicz, Robert H.
Brown, Revital Aricha, Ralph Kern, Anthony J.
Windebank, Nathan P. Staff, Namita Goyal, Robert
G. Miller, Jonathan S. Katz, Matthew Burford,
Yossef Levy, Chaim Lebovits, Yael Gothelf, Bruno
Boulanger, Munish Mehra, Stacy Lindborg
P1.401
Outcomes in POEMS patients: A case series
– Amna Ramzan, Doyle Yuan, Kristin Angelica
Brown, Suur Biliciler, Kazim Ali Sheikh, Thy Nguyen
P1.402
New Patient Access via Telehealth in
Neuromuscular Medicine During COVID-19 –
Shaida Khan, Jaya Raghav Trivedi
P1.403
The Use of Blood Carbonate (HCO3-) and
Base-Excess (SBE) in Predicting Non-Invasive
Ventilation (NIV) Adaptation – Umberto Manera,
Maria Claudia Torrieri, Michela Maria Bellocchia,
Fulvia Ribolla, Antonio Canosa, Rosario Vasta,
Gabriele Mora, Alessio Mattei, Cristina Moglia,
Andrea Calvo, Adriano Chio
P1.404
Rare genetic mutation of TARDBP leading to
intrafamilial clinical phenotype variability; from
pathogenic variant to genetic features modifier –
Imen Kacem, Ikram Sghaier, Nicola Ticozzi, Amira
Nasri, Antonia Ratti, Amina Gargouri, Vincenzo
Silani, Riadh Gouider
P1.405
Is there any role of vitamin D in Cramp-
Fasciculation Syndrome? – Anthony Alexander
Hanna, Lonni Shultz, Anza Memon, Iram Zaman
P1.406
Brain Metabolic Changes in Amyotrophic Lateral
Sclerosis with SOD1 Mutations – Antonio Canosa,
Andrea Calvo, Cristina Moglia, Rosario Vasta,
Francesca Palumbo, Luca Solero, Francesca Di
Pede, Sara Cabras, Vincenzo Arena, Grazia Zocco,
Federico Casale, Maura Brunetti, Luca Sbaiz,
Salvatore Gallone, Maurizio Grassano, Umberto
Manera, Marco Pagani, Adriano Chio
P1.407
Mesial Temporal Enlargement in Adult-Onset
Myotonic Dystrophy Type 1 – Faisal Fecto,
Dana McDonnell, Jacinda B. Sampson, Bryon
Mueller, Kelvin O. Lim, Jeffrey Wozniak, Katharine
Hagerman, John W. Day
P1.408
Bioimpedence analysis, hand grip and
neurophysiology in hereditary transthyretin
amyloidosis with polyneuropathy – Vincenzo Di
Stefano, Ewan Thomas, Valerio Giustino, Andrea
Gagliardo, Antonino Lupica, Salvatore Iacono,
Giuseppe Battaglia, Filippo Brighina
P1.409
Impact of COVID-19 and vaccines in myasthenia
gravis: experience from an Italian cohort –
Antonino Lupica, Vincenzo Di Stefano, Salvatore
Iacono, Pignolo Antonia, Martina Quartana,
Andrea Gagliardo, Brigida Fierro, Filippo Brighina
P1.410
SQSTM1 Gene Mutation Causing Slowly
Progressive Motor Neuron Disease – Blake Kent
Windham, Chandra Sekhar Mannyam, Saurabh G.
Shukla
P1.411
A unique presentation of Cerebrotendinous
Xanthomatosis without tendinous xanthomas. –
Patricia Lee, Said R. Beydoun, Leila Darki
P1.412
Remote Monitoring and Management of
Chemotherapy Induced Peripheral Neuropathy
(REMOTE-CIPN): A Randomized Trial of a Novel
Telemedicine Care Model – Noah A. Kolb, A.
Gordon Smith, Kelsey Barrell, Joan Skelly, Zhi-Jian
Chen, Kathleen Griffith, Joanna Brell, Christina
Echeverria, Kathi Mooney
P1.413
Exploring Protein Changes in Cerebrospinal
Fluid of Spinal Muscular Atrophy Patients Pre-
Nusinersen vs. Post-Nusinersen Treatment using
Bayesian Machine Learning Algorithms – Tahereh
Kamali, Katharine Hagerman, Tina Duong, Dana
McDonnell, Sally Dunaway, Whitney Tang, Jacinda
B. Sampson, John W. Day
P1.414
Hyper nasal speech presenting as Miller Fischer
Syndrome – Gopika Govindan Kutty, Shivani Naik,
Zeng Yu Wang
Neuro-oncology
P1.415
Mycobacterial Meningitis as an Early
Complication of Bacille Calmette-Guerin
Intravesical Chemotherapy in the Setting of
a Systemic Infection. – Madiha Tariq, Nathan
Clarke, Merry Chen
P1.416
Pretreatment Neutrophil-to-Lymphocyte/
Monocyte-to-Lymphocyte Ratio as Prognostic
Biomarkers in Glioma Patients – Sher Ting Ting
Chim, Paul Sanfilippo, Terence John O’Brien, Kate
Drummond, Mastura Monif

P1.417
Stem Cell Factor as a Novel Diagnostic Plasma
Biomarker for Glioblastoma Multiforme Patients
– Amirhosein Kefayat, Parvin Goli, Fatemeh
Ghahremani, Alireza Amouheidari
P1.418
Folic-targeted Gold Nanoclusters as a Novel
Radiosensitizer for Enhancement of The
Radiotherapy Efficacy in Glioblastoma-bearing
Animals – Amirhosein Kefayat, Fatemeh
Ghahremani, Parvin Goli
P1.419
Rapidly Progressive Sensorineural Hearing Loss as
a Presenting Feature of Metastatic Breast Cancer
with Leptomeningeal Carcinomatosis and Positive
Zic4 Antibodies – Aseel Alsalem, Sina Marzoughi,
Tychicus Chen
P1.420
Lest We Forget: Ammonia in Encephalopathic
Cancer Patients – Alexander C. Ou, Ivo W.
Tremont, Sudhakar Tummala
P1.421
Case Report of Selumetinib as a Novel Therapy
in an NF2-Associated Ependymoma – Nigel
Blackwood, Christopher Paul Zetzmann,
Christopher Ray Trevino
P1.422
Primary Central Nervous System T-cell Lymphoma
Mimicking Isolated CNS Angiitis in a Young
Immunocompetent Woman – Badiee Aniss
Moussa, Fatima Mallat, Georgette Dib, Zaher
Chakhachiro, Ahmad Beydoun
P1.423
Neurofibromatosis Type 1 and Metastatic
Testicular Germ Cell Tumor – Sushant Puri, David
Heron, Nikolas Andre Mata-Machado, Mary Lou
Schmidt, Stefania Maraka
P1.424
Awake Craniotomy vs General Anesthesia for
Excision of Brain Tumors: First Case-control Study
from a Low-and-middle-income Country – Jaleed
Ahmed Gilani, Saqib Kamran Bakhshi, Erum Baig,
Altaf Ali Laghari, Daniyal Aziz Khan, Syed Mazin
Junaid, Karim Rizwan Nathani, Faraz Shafiq,
Muhammad Shahzad Shamim, Saad Akhtar Khan,
Syed Ather Enam
P1.425
Is Cancer the Main Cause of Death in Non-
Malignant Meningiomas? – Hazem Maher Gawish,
Khaled Ashraf Mohamed, Khaled Tarek Dardeer,
Ramy Abdelnaby
P1.426
Identification of Challenges Faced by Caregivers
of Patients with Newly Diagnosed Gliomas – Julia
Russell Gomez, Lauryn Hemminger, Sandhya
Seshadri, Jennifer N. Serventi, Nimish A. Mohile,
Benzi Kluger
Information is accurate as of February 8, 2022, and is subject to change.
Virtual Experience Posters
P1.427
Deep learning for prediction of IDH mutation
in gliomas- a meta-analysis of evaluation of
diagnostic test performance with a Bayesian
approach – Mert Karabacak, Burak Berksu Ozkara,
Seren Mordag, Sotirios Bisdas
P1.428
Natural history study of cutaneous neurofibromas
in people with NF1: Research in Progress – Carlos
Guillermo Romo, Joshua Roberts, Bronwyn
Slobogean, Shannon Langmead, Xiobu Ye, Sewon
Kang, Verena Staedtke, Jaishri Blakeley
P1.429
Multi-parametric Biomarker Development to
Predict Malignant Conversion in Patients with
Neurofibromatosis type 1: Research in Progress
– Carlos Guillermo Romo, Jaishri Blakeley, Joshua
Roberts, Shannon Langmead, Laura Fayad, Shivani
Ahlawat
P1.430
Baseline cognition in patients with benign and
low grade brain tumors prior to RT – Sara Hardy,
Michael T. Milano, Nimish A. Mohile, Alan
Finkelstein, Michelle Janelsins
P1.431
Lambert-Eaton Myasthenic Syndrome and
Paraneoplastic Cerebellar Degeneration as
Harbingers of Merkel Cell Carcinoma with
Unknown Primary: A Rare Case Presentation. –
Chindo Bala Mallum, Ahmer Asif, Oleksandra Los,
Evgeny Sidorov
P1.432
Depression & Neurotoxicity in a Population of
Brain Tumor Patients Treated with a Short Course
of Prophylactic Levetiracetam – Matthew Jordan
Goldman, Kaitlyn Melnick, Marcia Hodik, Yu Wang,
Maryam Rahman, Jean E. Cibula
P1.433
Alpelisib induced diabetes ketoacidosis and
resultant status epilepticus – Sangeetha
Poongunam Isaac, Eileen Montalvan, Mohammed
Afraz Pasha, Udit Yadav
Neuro-ophthalmology/Neuro-otology
P1.434
Cassava Flour and Isolated Mydriasis – Ammar
Abdulraheem Ah Jumah, Rami Al-Hader, Hassan
Osama Mostafa Aboul Nour, Dace Zvirbulis
P1.435
Neurosyphilis Presenting as Mimicker of Giant
Cell Arteritis with Bilateral Papilledema – Yensea
Mayra Costas Encarnacion, Janice Leon
P1.436
Resident Simulation (SIM) Education for Neuro-
Ophthalmology Examination Skills To assess
resident baseline and post-simulation (SIM)
learning sessions for neuro-ophthalmologic
examination skills. – George Park, Scott Grossman,
Lisena Hasanaj, Janet C. Rucker, Steven Galetta,
Laura J. Balcer
P1.437
Breastfeeding Nystagmus Secondary to Tullio’s
Phenomenon – Caroline Menton, Brooke
Hartenstein, Adam Shipley, Isabella Canut, Hannah
M. Rosenblum, Charles Maitland
P1.438
Real-World Cost and Utilization Analysis of
Botulinum Toxin Agents in Blepharospasm: A
National Retrospective Cohort Study – Rashid
Kazerooni, Daniel Rootman, Robert Goldberg, Liza
M. Cohen
P1.439
All-Trans Retinoic Acid-Induced Pseudotumor
Cerebri in Patients with Acute Promyelocytic
Leukemia: A Review – Sahar Noorani, Alden P.
Gregston, Melanie Truong-Le
Neuro-rehabilitation
P1.440
Physiotherapy with Dual-Tasks Improves Cognition
and Resting-State Functional Connectivity in
Parkinson’s Disease with Postural Instability and
Gait Disorders – Michela Leocadi, Elisa Canu,
Elisabetta Sarasso, Andrea Gardoni, Silvia Basaia,
Veronica Castelnovo, M. Antonietta Volonte,
Massimo Filippi, Federica Agosta
P1.441
Fragmentation of pre-hospital acute spinal cord
injury care – Shawna Huckell, Clayton Peterson, H
Francis Farhadi, Jan M. Schwab
AAN.com/AM 119

Technological Advances and Other
Factors that Impact Care in Pain and
Palliative Medicine
P1.442
Cognitive Decline Overtime in Patients with
Chronic Pain and Headache: a Systematic Review
– Karen Dos Santos Ferreira, Ana Velly
P1.443
Medical Aid in Dying: Perspective from a Tertiary
Care Movement Center – Lisa Damron, Robert
Hess, Kevin M. McGehrin, Jane Mello Reynolds,
Ece Bayram, David Gerhard Coughlin, Irene Litvan
P1.444
Features, Functionalities, and the Future of
Commercial Pain Applications – Maya Catherine
Campbell, Mia Soviero, Deepti Verma, Quazi Ilham
Hossain, Leslie Yao, Ananya Sahu, Erica Camacho,
John Torous, Mia T. Minen
P1.445
Durability of 10-kHz Spinal Cord Stimulation
for Painful Diabetic Neuropathy: 18-Month
Multicenter Randomized Controlled Trial Results –
Erika Petersen, Thomas Stauss, James Scowcroft,
Lisa Brooks, Judith White, Shawn Sills, Kasra
Amirdelfan, Maged Guirguis, Jijun Xu, Cong Yu,
Ali Nairizi, Denis Patterson, Vincent Galan, Richard
Bundschu, Neel Mehta, Dawood Sayed, Shivanand
Pramod Lad, David DiBenedetto, Khalid Sethi, Paul
Wu, Charles E. Argoff, Christian Nasr, Rod Taylor,
David Caraway, Nagy Mekhail
P1.446
Acupuncture-induced Changes in Nociception,
Measured by Pain-related Evoked Potentials: A
Pilot Mechanistic Study – Alexandra Dimitrova,
Alisha Harrington, Tab Memmott, Jonathan Sisley,
Barry S. Oken
P1.447
Virtual Neuropalliative Care Curriculum Improves
Residents’ Confidence and Knowledge – Tarini
Goyal, Laura Elizabeth Donovan, Alexander Frolov
A Pandemic & Its Promise of Progress
P1.448
Lessons Learned From the COVID-19 Pandemic
and Recommendations for Reducing Non-
Compliance in Clinical Research – Matthew
Gooden, Gina Norato, Sandra Martin, Avindra
Nath, Lauren N. Reoma
P1.449
Brace Yourself: The Emotional Burden of
Diagnosing a Chronic Neurological Illness on
Neurologists and Patients – Anna Gershteyn,
Julia Russell Gomez, Christopher Mooney, Margie
Hodges Shaw, Benzi Kluger
120 2022 AAN Annual Meeting
Virtual Experience Posters
P1.450
Strategies for Behavioral Research in Neurology:
Lessons Learned During the COVID-19 Pandemic
and Applications for the Future – Kazi Shafia
Maisha, Mia T. Minen, Ami Zarrillo Cuneo
P1.451
The practice of teleneurology in the Philippines
during the COVID-19 pandemic – Gerald Tangonan
Pagaling, Adrian Isidoro Espiritu, Marie Antoinette
Dellosa, Carl Froilan Leochico, Paul Matthew
Dimagniva Pasco
P1.452
Optimizing the “Stroke Alert” Activation Protocol
for Hospitalized Patients – Lisa Surowiec, Tyler
Kendrick Simons, Oriana Tascione, Leticia Tornes,
Erika Tatiana Marulanda-Londono, Neeta Garg
P1.453
Time Spent in the Electronic Health Record by
Neurologists: Analyzing daily use inside and
outside the clinic using EPIC Signal data – Oliver
Nguyen, Kea Turner, Nate Apathy, Lisa J. Merlo,
Tanja Magoc, Sue Feldman, Adolfo Ramirez
Zamora, Irene Malaty
P1.454
Patient Satisfaction and Access Metrics during
Pre and Post COVID-19 Pandemic in a Rural
Neurology Setting – Muhammad Taimur Ahmad
Malik, Edward Stefanowicz
Research Methodology and Education
P1.455
#NeuroTwitterNetwork #HowToNeuroTwitter
Guide 2020-2021: Increasing Access to Resources
For #FutureNeurologists – Aaron Simon Zelikovich,
Eric Christopher Lawson, Giana Dawod, Dylan
Franco Del Papa, Mikel Shea Ehntholt, Evan
Kolesnick, Jaclyn Martindale, Oluwasinmisola
Opeyemi, Alexandria Pecoraro, Stephanie Linet
Reyes, Andrew Yoo, Aaron L. Berkowitz, Matthew
S. Robbins
P1.456
Social media and social networks in neurology and
neuroscience education: current applications and
potential implementation – Stefano Sandrone
P1.457
Development and Implementation of a
Comprehensive Suite of Neurology Electives for
Medical Students – Alina Masters-Israilov, Harini
Sarva, Joseph E. Safdieh
P1.458
Predictors of Narrative Evaluation Quality of
Undergraduate Medical Students – Robert Ian
Thompson-Stone, Jennifer Pascoe, Christopher
Mooney, Valerie Lang, Jaclyn Burch, Melanie
Braun, Michael Kelly, Christopher Mooney
P1.459
Developing a NeuroTwitter Onboarding Curriculum
for Neurologists, Trainees and Students: A
Prospective Study – Aaron Simon Zelikovich,
Joseph E. Safdieh, Matthew S. Robbins
P1.460
Prediction of Stroke in Dizziness and Vision
Change During Emergency Triage – Carla Nicole
Wood, Abhinav Katti, Alan H. Yee, Don Noel
P1.461
Towards the improvement of neurology clerks’
narrative evaluations: a multi-pronged faculty
development initiative – Robert Ian Thompson-
Stone, Stephen Joseph Powell, Spencer Dahl,
Carly Eiduson, Benjamin Reinhardt, Christopher
Mooney
P1.462
Neurology Research Day Presentations by
Residents: From Abstract to Publication –
Chandrasekhar Sundarrajan, Shruti Veera
Raghavan, Shilpa Chitnis, Marisara Dieppa, Steven
Vernino, Lauren Phillips, Rohit Das
P1.463
Development of an intensive preparedness
initiative to better equip students participating
in the MGH Youth Neurology Education and
Research Program – Sarah Micucci, Madison
Elizabeth Ellin, Nicte I. Mejia
P1.464
@NMatch2022: The Expansion of a Student-
Led Social Media-Based Initiative that supports
Neurology and Child Neurology Residency
Applicants – Gabriela Figueiredo Pucci, Tara
Samiee, Natalie Sholl, Shreya Louis, Adnan
Husein, Theandra Chioma Madu, Carolina Isabel
Rodriguez Rivera, Jenny Rotblat
P1.465
A Novel Interdisciplinary Education Tool on
Neuromuscular Respiratory Failure – Rebecca
DiBiase, Lauren Koffman
Sleep
P1.466
Analyzing the Current State of Sleep Apps in the
App Marketplace and in Literature: A Systematic
Review. – Quazi Ilham Hossain, Deepti Verma,
Leslie Yao, Ananya Sahu, Mia Soviero, Maya
Catherine Campbell, Erica Camacho, John Torous,
Mia T. Minen
P1.467
REM Sleep Distribution and Timing in
Hypersomnia – Margaret Blattner, Robert J.
Thomas
 Virtual Experience Posters

P1.468
Sleep-Wake Intracerebral Fluid Tracking (SWIFT)
using Continuous Wave Functional Near- Infrared
Spectroscopy (CW fNIRS): A Novel Approach to
Visualizing TBI-Associated Neurodegeneration
– Sean Young, John Kent Werner, Matthew C.
Miller, Sara Lippa, Clara Scholl, William Coon,
Monique Beaudoin, Joseph Angelo, Franck G.
Amyot, Kimbra L. Kenney, John Kent Werner
P1.469
Samelisant (SUVN-G3031), a Histamine-3(H3)
Receptor Inverse Agonist in Animal Models
of Sleep Disorders – Ramakrishna Nirogi, Anil
Shinde, Abdul Rasheed Mohammed, Vinod Goyal,
Santosh Kumar Pandey, Veera Raghava Chowda
Palacharla, Ramkumar Subramanian, Renny
Abraham, Jyothsna Ravula, Satish Jetta, Venkat
Jasti
P1.470
Patient Preference and Nocturnal Experience
With Sodium Oxybate Treatment for Narcolepsy:
Interim Data From RESTORE – Asim Roy, John
Harsh, Akinyemi Ajayi, Thomas Patrick Stern, David
J. Seiden, Jordan Scott Dubow
P1.471
Allergic Contact Dermatitis to Silicone causing
PAP Intolerance – Subhendu Rath, Neeraj Kaplish
P1.472
Atypical Sleep-related Rhythmic Movement
Disorder – Subhendu Rath, Qurratul Shamim-
Uzzaman

Information is accurate as of February 8, 2022, and is subject to change. AAN.com/AM 121